<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006712" GROUP_ID="FERTILREG" ID="939206033110365197" MERGED_FROM="" MODIFIED="2009-02-18 11:15:59 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Exported from Review Manager 4.2.10&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.2.9&lt;br&gt;Exported from Review Manager 4.2.8&lt;/p&gt;" NOTES_MODIFIED="2009-02-18 11:15:59 +0100" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="0049" REVMAN_SUB_VERSION="5.0.18" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.3">
<COVER_SHEET MODIFIED="2009-02-18 11:15:59 +0100" MODIFIED_BY="[Empty name]">
<TITLE>Pain control in first trimester surgical abortion</TITLE>
<CONTACT>
<PERSON ID="736E924C82E26AA2008F53C8381FA3B3" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Regina-Maria</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Renner</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>rennerr@ohsu.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dept. of Obstetrics and Gynaecology</DEPARTMENT>
<ORGANISATION>Oregon Health and Science University</ORGANISATION>
<ADDRESS_1>3181 SW Sam Jackson Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Portland</CITY>
<ZIP>OR 97239</ZIP>
<REGION>Oregon</REGION>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2009-02-18 11:15:25 +0100" MODIFIED_BY="Anja Helmerhorst">
<PERSON ID="736E924C82E26AA2008F53C8381FA3B3" ROLE="AUTHOR">
<PREFIX>Ms</PREFIX>
<FIRST_NAME>Regina-Maria</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Renner</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>rennerr@ohsu.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dept. of Obstetrics and Gynaecology</DEPARTMENT>
<ORGANISATION>Oregon Health and Science University</ORGANISATION>
<ADDRESS_1>3181 SW Sam Jackson Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Portland</CITY>
<ZIP>OR 97239</ZIP>
<REGION>Oregon</REGION>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1/>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="25DF90EE82E26AA201A256C7CD6D5737" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Jeffrey</FIRST_NAME>
<MIDDLE_INITIALS>T.J.</MIDDLE_INITIALS>
<LAST_NAME>Jensen</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>jensenje@ohsu.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dept. of Obstetrics and Gynaecology</DEPARTMENT>
<ORGANISATION>Oregon Health and Science University</ORGANISATION>
<ADDRESS_1>3181 SW Sam Jackson Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Portland</CITY>
<ZIP>OR 97239</ZIP>
<REGION>Oregon</REGION>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1>+1 50 34945113</PHONE_1>
<PHONE_2/>
<FAX_1>+1 50 34945083</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="25E5518782E26AA201A256C79C790E55" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Mark</FIRST_NAME>
<MIDDLE_INITIALS>D.N.</MIDDLE_INITIALS>
<LAST_NAME>Nichols</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>nicholsm@ohsu.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dept. of Obstetrics and Gynaecology</DEPARTMENT>
<ORGANISATION>Oregon Health and Science University</ORGANISATION>
<ADDRESS_1>3181 SW Sam Jackson Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Portland</CITY>
<ZIP>OR 97239</ZIP>
<REGION>Oregon</REGION>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1>+1 50 34943103</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="4D5AB2B282E26AA2007C9B467F7640FA" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Alison</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Edelman</LAST_NAME>
<SUFFIX/>
<POSITION/>
<EMAIL_1>edelmana@ohsu.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Dept. of Obstetrics and Gynaecology</DEPARTMENT>
<ORGANISATION>Oregon Health and Science University</ORGANISATION>
<ADDRESS_1>3181 SW Sam Jackson Street</ADDRESS_1>
<ADDRESS_2/>
<CITY>Portland</CITY>
<ZIP>OR 97239</ZIP>
<REGION>Oregon</REGION>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1>+1 503 4945949</PHONE_1>
<PHONE_2/>
<FAX_1>+1 504 4943111</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2009-02-16 14:16:50 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Minor update: 02/04/07&lt;/p&gt;" NOTES_MODIFIED="2009-02-16 14:16:50 +0100" NOTES_MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="25" MONTH="12" YEAR="2007"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="25" MONTH="12" YEAR="2007"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="10" MONTH="1" YEAR="2011"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="3" YEAR="2007"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2007"/>
</DATES>
<WHATS_NEW MODIFIED="2009-02-18 11:15:59 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;The protocol.&lt;/p&gt;" NOTES_MODIFIED="2009-02-18 11:15:59 +0100" NOTES_MODIFIED_BY="[Empty name]"/>
<HISTORY MODIFIED="2009-02-18 11:15:59 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-02-18 11:15:59 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="1" YEAR="2009"/>
<DESCRIPTION>
<P>Reviewers comments implemeted.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-02-18 11:15:55 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="10" YEAR="2008"/>
<DESCRIPTION>
<P>Implemented the reviewers comments.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-02-11 11:39:54 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="16" MONTH="6" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2009-02-11 11:38:59 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="28" MONTH="1" YEAR="2007"/>
<DESCRIPTION>
<P>Substantive amendment.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2009-02-09 18:49:02 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2009-02-09 18:49:02 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2009-02-09 18:49:02 +0100" MODIFIED_BY="[Empty name]">
<NAME>Dept. of Obstetrics and Gynaecology, Oregon Health and Science University, Portland, USA</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION>
<P>Library services.</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2009-02-16 14:18:16 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2009-02-09 18:19:33 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-08-22 07:26:33 +0200" MODIFIED_BY="[Empty name]">Pain control in first trimester surgical abortion.</TITLE>
<SUMMARY_BODY MODIFIED="2009-02-09 18:19:33 +0100" MODIFIED_BY="[Empty name]">
<P>Multiple methods of pain control in first trimester surgical abortion at less than 14 weeks gestational age using electric or manual suction aspiration are available, and appear both safe and effective. Pain control methods can be divided in local anesthesia, conscious sedation, general anesthesia and non-pharmacological methods. Data to support the benefit of the widely used local aneathetic is inadequate. While general anesthesia achieved complete pain control during the procedure, other forms of anesthesia such as conscious sedation with a paracervical block improved postoperative pain control.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2009-02-10 17:24:53 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2009-02-10 17:23:25 +0100" MODIFIED_BY="[Empty name]">
<P>First trimester abortions especially cervical dilation and suction aspiration are associated with pain, despite various methods of pain control.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2009-02-10 17:23:38 +0100" MODIFIED_BY="[Empty name]">
<P>Compare different methods of pain control during first trimester surgical abortion.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-02-10 17:23:53 +0100" MODIFIED_BY="[Empty name]">
<P>We searched multiple electronic databases with the appropriate key words, as well as reference lists of articles, and contacted professionals to seek other trials.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2009-02-10 17:24:06 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trials comparing methods of pain control in first trimester surgical abortion at less than 14 weeks gestational age using electric or manual suction aspiration. Outcomes included intra- and postoperative pain, side effects, recovery measures and satisfaction.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2009-02-10 17:24:18 +0100" MODIFIED_BY="[Empty name]">
<P>Two reviewers independently extracted data. Meta-analysis results are expressed as weighted mean difference (WMD) or Peto Odds ratio with 95% confidence interval (CI).</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2009-02-10 17:24:42 +0100" MODIFIED_BY="[Empty name]">
<P>We included forty studies with 5131 participants. Due to heterogeneity we divided studies into 7 groups:</P>
<P>
<B>Local anesthesia:</B> Data was insufficient to show a clear benefit of a paracervical block (PCB) compared to no PCB or a PCB with bacteriostatic saline. Pain scores during dilation and aspiration were improved with deep injection (WMD -1.64 95% CI -3.21 to -0.08; WMD 1.00 95% CI 1.09 to 0.91), and with adding a 4% intrauterine lidocaine infusion (WMD -2.0 95% CI -3.29 to -0.71, WMD -2.8 95% CI -3.95 to -1.65 with dilation and aspiration respectively).</P>
<P>
<B>PCB with premedication:</B> Ibuprofen and naproxen resulted in small reduction of intra- and post-operative pain.</P>
<P>
<B>Analgesia:</B> Diclofenac-sodium did not reduce pain.</P>
<P>
<B>Conscious sedation</B>: The addition of conscious intravenous sedation using diazepam and fentanyl to PCB decreased procedural pain.</P>
<P>
<B>General anesthesia (GA):</B> Conscious sedation increased intraoperative but decreased postoperative pain compared to GA (Peto OR 14.77 95% CI 4.91 to 44.38, and Peto OR 7.47 95% CI 2.2 to 25.36 for dilation and aspiration respectively, and WMD 1.00 95% CI 1.77 to 0.23 postoperatively). Inhalation anesthetics are associated with increased blood loss (p&lt;0.001).</P>
<P>
<B>GA with premedication:</B> The COX 2 inhibitor etoricoxib, the non-selective COX inhibitors lornoxicam, diclofenac and ketorolac IM, and the opioid nalbuphine were improved postoperative pain.</P>
<P>
<B>Non-pharmacological intervention</B>: Listening to music decreased procedural pain.</P>
<P>No major complication was observed.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2009-02-10 17:24:53 +0100" MODIFIED_BY="[Empty name]">
<P>Conscious sedation, GA and some non-pharmacological interventions decreased procedural and postoperative pain, while being safe and satisfactory to patients. Data on the widely used PCB is inadequate to support its use, and it needs to be further studied to determine any benefit.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2009-02-16 14:18:16 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2009-01-06 02:50:39 +0100" MODIFIED_BY="[Empty name]">
<P>Elective abortions are among the most common outpatient surgical procedures performed on women with an estimated 46 million performed yearly worldwide (<LINK REF="REF-WHO-2003" TYPE="REFERENCE">WHO 2003</LINK>). Nearly 90% are performed in the first trimester before 13 weeks gestation (<LINK REF="REF-Strauss-2007" TYPE="REFERENCE">Strauss 2007</LINK>). A major complication occurs in less than 1 in 100 women and mortality is around 0.7 in 100,000 (<LINK REF="REF-Hakim_x002d_Elahi-1990" TYPE="REFERENCE">Hakim-Elahi 1990</LINK>; <LINK REF="REF-Bartlett-2004" TYPE="REFERENCE">Bartlett 2004</LINK>; <LINK REF="REF-Koonin-2000" TYPE="REFERENCE">Koonin 2000</LINK>). Although the case-fatality-rate has decreased since the 1970s, anesthesia-related events continue to be the leading cause of morbidity (<LINK REF="REF-Lawson-1994" TYPE="REFERENCE">Lawson 1994</LINK>).</P>
<P>Anesthesia is important for women undergoing an abortion since most will experience pain with the procedure. Key factors that influence the choice of anesthesia or analgesia include effectiveness, safety, side effects, and costs. Other crucial factors include patient preference, practitioner choice or bias, facility resources and medical indications (<LINK REF="REF-Maltzer-1999" TYPE="REFERENCE">Maltzer 1999</LINK>).</P>
<P>Pain perception is a complex phenomenon comprised of both physical and psychosocial elements and their interaction, and varies considerably between women (<LINK REF="REF-Stubblefield-1989" TYPE="REFERENCE">Stubblefield 1989</LINK>). The physical pain women experience with abortion most likely originates from the S2 to S4 parasympathetic fibers (the Frankenhäuser plexus) that innervate the cervix and the lower part of the uterine body (<LINK REF="REF-Scott-1976" TYPE="REFERENCE">Scott 1976</LINK>; <LINK REF="REF-Smith-1991" TYPE="REFERENCE">Smith 1991</LINK>). In addition, the fundus and lower part of uterine body are innervated by sympathetic (<LINK REF="REF-Maltzer-1999" TYPE="REFERENCE">Maltzer 1999</LINK>) fibers from T10 to L1 via the inferior hypogastric nerve, and the ovarian plexus (<LINK REF="REF-Maltzer-1999" TYPE="REFERENCE">Maltzer 1999</LINK>).</P>
<P>Additionally, psychological (affective, motivational, interpretive), and social (context, support) features play into pain perception (<LINK REF="REF-Borgotta-1997" TYPE="REFERENCE">Borgotta 1997</LINK>). Increased pain with abortion has been associated with young age, nulliparity, less education, anxiety, depression, "moral problems" (with the procedure), a retroverted uterus, and dysmenorrhea (<LINK REF="REF-Belanger-1989" TYPE="REFERENCE">Belanger 1989</LINK>, <LINK REF="STD-Glantz-2001" TYPE="STUDY">Glantz 2001</LINK>). A history of prior vaginal delivery correlates well with decreased pain (<LINK REF="REF-Belanger-1989" TYPE="REFERENCE">Belanger 1989</LINK>)). Data on the relationship between pain and gestational age, as well as the amount of cervical dilation performed, has been conflicting (<LINK REF="REF-Belanger-1989" TYPE="REFERENCE">Belanger 1989</LINK>; <LINK REF="REF-Borgotta-1997" TYPE="REFERENCE">Borgotta 1997</LINK>; <LINK REF="REF-Smith-1979" TYPE="REFERENCE">Smith 1979</LINK>).</P>
<P>Due to this complex nature, effective management of abortion-related pain requires a combination of pharmacological and non pharmacological means (<LINK REF="REF-Maltzer-1999" TYPE="REFERENCE">Maltzer 1999</LINK>). Pharmacological methods include local anesthetic, non-steroidal anti-inflammatory medications (NSAID) narcotics, anxiolytics, sedatives, and/or hypnotics. Concerns regarding general anesthesia stem from its association with greater costs and personnel and increased morbidity and mortality based on observational data that includes cases until the mid 1980s (<LINK REF="REF-Maltzer-1999" TYPE="REFERENCE">Maltzer 1999</LINK>; Raeder 1992; <LINK REF="REF-Grimes-1979" TYPE="REFERENCE">Grimes 1979</LINK>; <LINK REF="REF-Lawson-1994" TYPE="REFERENCE">Lawson 1994</LINK>). Therefore, it is less frequently used in the United States (<LINK REF="REF-Lichtenberg-2001" TYPE="REFERENCE">Lichtenberg 2001</LINK>).</P>
<P>Non pharmacological aspects of pain have a considerable impact on pain perception (<LINK REF="REF-Maltzer-1999" TYPE="REFERENCE">Maltzer 1999</LINK>). Active participation in one's own pain management, and control over the life situation have been found to be beneficial (<LINK REF="REF-Belanger-1989" TYPE="REFERENCE">Belanger 1989</LINK>).</P>
<P>Unfortunately, despite these advances, many patients still find surgical abortion extremely uncomfortable; 78-97% report at least moderate procedural pain (<LINK REF="REF-Stubblefield-1989" TYPE="REFERENCE">Stubblefield 1989</LINK>; <LINK REF="REF-Belanger-1989" TYPE="REFERENCE">Belanger 1989</LINK>; <LINK REF="REF-Smith-1979" TYPE="REFERENCE">Smith 1979</LINK>; <LINK REF="REF-Rawling-1998" TYPE="REFERENCE">Rawling 1998</LINK>). Therefore, optimizing pain control should be a goal in every procedure. Opinions may vary how much pain reduction is clinically relevant. Strategies designed to reduce abortion-related pain have great public health importance considering the large numbers of women who undergo first trimester surgical abortions. This review will examine the existing randomized controlled trials to compare the effect of different methods of pain control during first trimester surgical abortion on patient perceived pain, satisfaction, side effects, and safety. The review will investigate preemptive as well as intra operative analgesia, focusing on pharmacological methods administered via mucosal (oral, vaginal, intrauterine, buccal/sublingual), intramuscular, or intravenous routes, but also include non-pharmacological methods.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-08-10 06:14:07 +0200" MODIFIED_BY="[Empty name]">
<P>To compare the effect of different methods of pharmacological and non pharmacological pain control administered prior to or during first trimester surgical abortion (&lt; 14 weeks gestation, electric or manual suction aspiration) on patient perceived pain, satisfaction, side effects, and safety.</P>
</OBJECTIVES>
<METHODS MODIFIED="2009-02-16 14:17:21 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2008-11-12 04:05:30 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES>
<P>All randomized controlled trials, including placebo controlled in any language.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Pregnant women undergoing first trimester surgical abortion at less than 14 weeks gestational age using electric or manual suction aspiration.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-08-10 06:15:10 +0200" MODIFIED_BY="[Empty name]">
<P>Any type of pharmacological pain control administered via mucosal (oral, vaginal, intrauterine, buccal/sublingual), intramuscular, or intravenous routes or non-pharmacological pain control prior to or during a first trimester surgical abortion at less than 14 weeks gestational age using electric or manual suction aspiration.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-11-12 04:05:30 +0100" MODIFIED_BY="[Empty name]">
<P>The main outcome is patient reported effectiveness of pain control on perceived pain during and immediately post abortion using validated scales, e.g. visual analogue, CAT, and Likert scales, categorical or dichotomous assessment (yes versus no).<BR/>Additional outcomes are adverse effects, and side effects (including if the method of pain control causes pain), as well as patient satisfaction.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-08-10 06:16:52 +0200" MODIFIED_BY="[Empty name]">
<P>See: Cochrane Fertility Regulation Group search strategy</P>
<P>Electronic searches<BR/>We searched the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, and POPLINE for articles for trials of pain control in first trimester surgical abortion at less than 14 weeks gestational age using electric or manual suction aspiration. Electronic literature search of 'Cochrane Central Register of Controlled Trials (4th quarter, 2007), MEDLINE (1950 to January 2008), EMBASE (1974 to January 2008), and POPLINE (1927 to December 2007) used the following respective search strategies:</P>
<P>The Cochrane Controlled Trials Register:<BR/>(surgical abortion or abortion or surgical abortion or manual suction aspiration or electric suction aspiration) and (analges* or epidural or lidocaine or fentanyl or NSAID or general anesthesia or narcot* or sedat* or anxiolyt* or pain control or midazolam or diazepam or ibuprofen or NSAID or vicodin or percocet or morphine or propofol or nitrous oxide) and (first trimester)</P>
<P>MEDLINE:<BR/>(analges* OR epidural OR lidocaine OR fentanyl OR NSAID OR general anesthesia OR narcot* OR sedat* OR anxiolyt* OR pain control OR midazolam OR diazepam OR ibuprofen OR NSAID OR vicodin OR percocet OR morphine OR propofol OR nitrous oxide) AND (surgical abortion OR abortion OR surgical abortion OR manual suction aspiration OR electric suction aspiration) AND first trimester AND (randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized controlled trials [mh] OR random allocation [mh] OR double-blind method [mh] OR single-blind method [mh] OR clinical trial [pt] OR clinical trials [mh] OR "clinical trial" [tw] OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR "latin square" [tw] OR placebos [mh] OR placebo* [tw] OR random* [tw] OR research design [mh:noexp] OR comparative study [mh] OR evaluation studies [mh] OR follow-up studies [mh] OR prospective studies [mh] OR cross-over studies [mh] OR control* [tw] OR prospectiv* [tw] OR volunteer* [tw]) NOT (animal [mh] NOT human [mh])</P>
<P>EMBASE:<BR/>((induced abortion! or suction(w)aspiration or surgical(w)abortion) and first(w)trimester) and ((pain(w)control or pain(w)relief) or analgesic agent! or anesthesia! or nonsteroid antiinflammatory agent)</P>
<P>POPLINE:<BR/>(abortion/first trimester termination) &amp; (analges*/anesthes*/(pain &amp; (control/relief)))</P>
<P>There was no language preference in the application of the search.</P>
<P>Other sources:<BR/>We contacted professionals in the field to seek other trials, including unpublished or ongoing trials we might have missed with the electronic search. Reference lists of articles retrieved were also searched.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2009-02-16 14:17:21 +0100" MODIFIED_BY="[Empty name]">
<P>
<U>Selection of studies:</U>
</P>
<P>The primary reviewer evaluated the articles identified from the literature search described above. An additional reviewer evaluated articles in question for inclusion, and in some cases inclusion was based on additional information received from the study's author. Trials under consideration were evaluated for appropriateness for inclusion and methodological quality, including the study design, randomization method, group allocation concealment, and exclusion after randomization without consideration of their results.</P>
<P>A quality score for concealment of allocation has been assigned to each trial using the criteria described in the Cochrane Handbook:</P>
<P>(A) adequate concealment of the allocation</P>
<P>(B) unclear whether adequate concealment of the allocation</P>
<P>(C) inadequate concealment of allocation</P>
<P>(D) allocation concealment not used</P>
<P>Trials scoring A, B, and C were included in this review. The few studies that scored C were included due to their overall importance to the review. </P>
<P>First trimester abortion was defined as an abortion at &lt; 14 weeks gestation. In order for a study to be included, the procedure had to be either electric or manual suction aspiration as opposed to sharp curettage. If the authors did not state the gestational age, but suction aspiration only was performed, we assumed based on common practice that the gestational age was in the first trimester and therefore, included the study. If the authors specified that they performed terminations in the 1st trimester, but did not state that the procedure was performed by suction aspiration versus sharp curettage, and the study was performed in a time period and region where suction aspiration was the predominant procedure method, we assumed that the study used suction aspiration as well, and therefore, included the study. If a sharp curettage check was preformed after suction aspiration, we included the study and noted this step in the individual included study table. If the authors did not state gestational age and did not specify that suction aspiration was performed, or if the procedure was a sharp curettage only, we did not include the study.</P>
<P>Studies were not included if the authors did not measure pain; the primary outcome of this review. Studies were also not included if the only pain-related outcome reported was need for postoperative analgesics, but pain itself was not measured. </P>
<P>
<U>Data extraction and management</U>
</P>
<P>Data extraction was performed independently by two of the reviewers. In case of discrepancies, this was resolved by consensus. Attempts were made to obtain additional information from authors if clarifications were needed. Data was then entered in RevMan 5.</P>
<P>Data in the present review has been based on the analytic method (e.g., intention-to-treat, per-protocol) used in the trial report. The main focus was on procedural-related pain. Given that randomization usually occurred just prior to the procedure and that follow-up was only for the immediate postoperative time period, exclusions after randomization and loss-to-follow-up were not a significant problem. </P>
<P>
<U>Measures of treatment effect</U>
</P>
<P>Data was processed using the RevMan software. Peto odds ratios using a fixed-effects model with 95% confidence interval (CI) were calculated for all dichotomous outcomes. Weighted mean differences (WMD) using a a random-effects model with 95% confidence intervals were used for continuous outcomes. The data from 11-point visual or verbal pain scales was treated as continuous data to allow comparisons to 10 cm scales. </P>
<P>
<U>Data synthesis</U>
</P>
<P>A few studies reported their results as graphs (<LINK REF="STD-Suprapto-1984" TYPE="STUDY">Suprapto 1984</LINK>; <LINK REF="STD-Hall-1997" TYPE="STUDY">Hall 1997</LINK>; <LINK REF="STD-Lindholm-1994" TYPE="STUDY">Lindholm 1994</LINK>; <LINK REF="STD-Marc-2007" TYPE="STUDY">Marc 2007</LINK>) or medians (<LINK REF="STD-Heath-1989" TYPE="STUDY">Heath 1989</LINK>; <LINK REF="STD-Dahl-2000" TYPE="STUDY">Dahl 2000</LINK>; <LINK REF="STD-Kan-2004" TYPE="STUDY">Kan 2004</LINK>; <LINK REF="STD-Kan-2006" TYPE="STUDY">Kan 2006</LINK>; <LINK REF="STD-Wong-2002" TYPE="STUDY">Wong 2002</LINK>) only. Thus, we could not extract data for comparisons, and only descriptions of their results were included. In other studies percentages were reported and we calculated the number of patients based on the total number of participants per group (<LINK REF="STD-Barneschi-1985" TYPE="STUDY">Barneschi 1985</LINK>; <LINK REF="STD-Bonnardot-1987" TYPE="STUDY">Bonnardot 1987</LINK>; <LINK REF="STD-Raeder-1992" TYPE="STUDY">Raeder 1992</LINK>). If the mean and the standard error of the mean (SEM) were reported, we calculated the standard deviation (SD) using the formula standard error (SE) x square root of N (<LINK REF="STD-Bone-1988" TYPE="STUDY">Bone 1988</LINK>; <LINK REF="STD-Collins-1985" TYPE="STUDY">Collins 1985</LINK>; <LINK REF="STD-Hackett-1982" TYPE="STUDY">Hackett 1982</LINK>).  If the mean and the CI were reported we calculated the SD using the formula square root of N x (upper limit - lower limit)/3.92 for 95% CI (<LINK REF="STD-Phair-2002" TYPE="STUDY">Phair 2002</LINK>). Some studies reported categorical outcomes with 3 groups. If deemed appropriate, the result groups were dichotomized for outcomes including pain, side effects or satisfaction to allow for analysis (<LINK REF="STD-Collins-1985" TYPE="STUDY">Collins 1985</LINK>; <LINK REF="STD-Dahl-2000" TYPE="STUDY">Dahl 2000</LINK>; <LINK REF="STD-Phair-2002" TYPE="STUDY">Phair 2002</LINK>; <LINK REF="STD-Suprapto-1984" TYPE="STUDY">Suprapto 1984</LINK>; <LINK REF="STD-Wong-2002" TYPE="STUDY">Wong 2002</LINK>). In case a study compared more than 2 groups, we selected 2 groups at a time for comparison in Revman.</P>
<P>We attempted to contact study authors with missing or unclear data. We found the studies to be included in this review to be extremely heterogeneous and thus, could not perform a single meta-analysis.  However, it was possible to group trials into 7 groups:</P>
<P>Group 1: local anesthesia</P>
<P>Group 2: paracervical block with premedication</P>
<P>Group 3: analgesia per os only</P>
<P>Group 4: conscious sedation</P>
<P>Group 5: general anesthesia</P>
<P>Group 6: general anesthesia with premedication</P>
<P>Group 7: non-pharmacological interventions </P>
<P>For the purpose of this review, conscious sedation was defined as a drug-induced depression of consciousness during which patients responded purposefully to verbal commands (spontaneous respiration with no interventions needed to maintain a patent airway). With deep sedation, the ability to independently maintain ventilation may be impaired and patients may require assisted ventilation. General anesthesia was defined as drug- induced loss of consciousness. Patients are not arousable, not even by painful stimulus. Frequently patients will require assistance in maintaining an open airway, possibly including positive pressure ventilation. Cardiovascular function may be affected (<LINK REF="REF-Steele-2005" TYPE="REFERENCE">Steele 2005</LINK>).</P>
<P>The primary outcome, pain, was assessed at different time points depending on the type of anesthesia used. With local anesthesia, pain was usually assessed during and sometimes after the procedure. In the sedation and general anesthesia groups, pain was assessed postoperatively. Instruments used to assess pain varied; some were dichotomous, others categorical. Some used visual or verbal analogue scales in a continuous way. This further made direct comparison of studies more difficult and increased data heterogeneity. </P>
<P>While many studies used a 11-point VAS (visual/verbal analog scale), some used a 100mm VAS (<LINK REF="STD-Edelman-2004" TYPE="STUDY">Edelman 2004</LINK>; <LINK REF="STD-Edelman-2006" TYPE="STUDY">Edelman 2006</LINK>; <LINK REF="STD-Kan-2004" TYPE="STUDY">Kan 2004</LINK>; <LINK REF="STD-Kan-2006" TYPE="STUDY">Kan 2006</LINK>; <LINK REF="STD-Dahl-2000" TYPE="STUDY">Dahl 2000</LINK>; <LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>; <LINK REF="STD-Liu-2005" TYPE="STUDY">Liu 2005</LINK>; <LINK REF="STD-Suprapto-1984" TYPE="STUDY">Suprapto 1984</LINK>). In order to facilitate comparability, if possible the 100mm VAS was converted to a 11-point VAS by dividing the results by 10 (<LINK REF="STD-Edelman-2004" TYPE="STUDY">Edelman 2004</LINK>; <LINK REF="STD-Edelman-2006" TYPE="STUDY">Edelman 2006</LINK>; <LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>; <LINK REF="STD-Liu-2005" TYPE="STUDY">Liu 2005</LINK>).</P>
<P>Within groups we ordered studies by anesthesia technique, substance and within these subgroups by no intervention/placebo versus intervention. In most instances we chose to create subcategories within an outcome for doses and route of administration rather than different times of outcome assessment. Side effects were listed as subcategories when deemed appropriate for better overview.</P>
<P>Co-interventions were heterogeneous as well, and participants were not randomized to them. They are briefly summarized in the results section and the most important are presented in the Summary of findings table 1; <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>; <LINK REF="SOF-03" TYPE="SOF">Summary of findings table 3</LINK>. An individual and detailed description can be found in the included study tables. They may have affected the results and may have even introduced bias. However, due to their heterogeneity we did not include them in our data analysis<I>
<BR/>
</I>
</P>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2009-02-16 14:17:42 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2009-02-11 11:17:35 +0100" MODIFIED_BY="[Empty name]">
<P>Results of the search</P>
<P>The searches resulted in 49 articles in the Cochrane Central Register of Controlled Trials, 217 in MEDLINE, 92 EMBASE, and 2367 in POPLINE.</P>
<P>
<B>Included studies</B>
</P>
<P>Forty studies met inclusion criteria with a total of 5131 participants. Please see table for details. Based on type of pain control they were divided in the following groups:</P>
<P>Group 1: local anesthetics, local anesthesia technique, premedication and paracervical block (PCB)</P>
<P>Ten studies with 1527 participants investigating local anesthesia met inclusion criteria.</P>
<P>Several studies compared local anesthetics. Kan et al compared PCB with 1% lignocaine with no PCB (<LINK REF="STD-Kan-2004" TYPE="STUDY">Kan 2004</LINK>). Glantz et al compared 14ml of 1% chloroprocaine with bacteriostatic saline (<LINK REF="STD-Glantz-2001" TYPE="STUDY">Glantz 2001</LINK>). Wiebe et al 1992 compared 10ml 2% carbonated lidocaine and 2mg atropine /50ml with 2% plain lidocaine and 2mg atropine/50ml (<LINK REF="STD-Wiebe-1992" TYPE="STUDY">Wiebe 1992</LINK>). In a study in 1995 Wiebe et al added a third arm with 20ml 0.25% bupivacaine, which was compared to 20ml 1% buffered and plain lidocaine (<LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK>). In 1996 she compared 20ml 1% with 0.5% lidocaine (<LINK REF="STD-Wiebe-1996" TYPE="STUDY">Wiebe 1996</LINK>).</P>
<P>Some studies compared different techniques of PCBs, such as deep versus regular injection of 1% lidocaine (3cm versus 1.5cm and a total of 16 versus 10ml) (<LINK REF="STD-Cetin-1997" TYPE="STUDY">Cetin 1997</LINK>) and lidocaine with epinephrine (20ml 1% lidocaine 1-1.5 inch versus 10ml 2% lidocaine 0.5 inch; atropine 2mg/50ml added to lidocaine) (<LINK REF="STD-Wiebe-1992" TYPE="STUDY">Wiebe 1992</LINK>). Others studied injection at different sites of the paracervical area (3, 5, 7 and 9 o'clock versus 4 and 8 o'clock) with 14ml of either 1% chloroprocaine or bacteriostatic (0.9% benzyl alcohol) saline (<LINK REF="STD-Glantz-2001" TYPE="STUDY">Glantz 2001</LINK>), or injection of 10ml 1% lignocaine at the vaginal vault versus the cervix (<LINK REF="STD-Kan-2004" TYPE="STUDY">Kan 2004</LINK>). Of note, even though some paracervical blocks included injecting local anesthesia in the anterior or posterior lip of the cervix, in all other studies the main portion of the local anesthestic was injected at the vaginal vault around the cervix. Phair et al studied the effect of no waiting versus waiting 3-5 minutes between the injection of 12ml 1% buffered lidocaine and dilation (Phair 2002). Wiebe et al had a two step study; the first step was about waiting time, but randomization was not adequate as it was by day of the procedure (<LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK>). The second step of this study investigated the influence of a slow versus fast injection.</P>
<P>Edelman at al studied the effect of intrauterine lidocaine 10ml of 1% and 5ml of 4 % versus placebo given in addition to the PCB with 10ml of 1% lidocaine in 2 different studies (<LINK REF="STD-Edelman-2004" TYPE="STUDY">Edelman 2004</LINK>; <LINK REF="STD-Edelman-2006" TYPE="STUDY">Edelman 2006</LINK>). Li et al compared the topical application to the cervix (directly and via Hegar dilators) of 10ml 2% lignocaine jelly with KY jelly (Li 2006).</P>
<P>Group 2: PCB with premedication</P>
<P>Three studies with 434 participants investigated the effect of premedication, such as ibuprofen 600mg per os (<LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK>), lorazepam 1mg per os (<LINK REF="STD-Wiebe-2003" TYPE="STUDY">Wiebe 2003</LINK>) or naproxen sodium 550mg per os (<LINK REF="STD-Suprapto-1984" TYPE="STUDY">Suprapto 1984</LINK>) followed by a PCB with 1% lidocaine (20ml in <LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK>).</P>
<P>Since patients are awake during the procedure under these different local anesthetic techniques outcomes included pain with dilation, aspiration and post-procedure. Some studies also measured pain with the paracervical/cervical block application (<LINK REF="STD-Glantz-2001" TYPE="STUDY">Glantz 2001</LINK>; <LINK REF="STD-Kan-2004" TYPE="STUDY">Kan 2004</LINK>).</P>
<P>The predominant study instruments used to measure pain were visual and verbal analogue scales; some 11-point, some 100mm. Additional outcomes were anxiety, satisfaction, sedation, side effects, difficulty of the procedure, and varied between the studies.</P>
<P>Group 3: analgesia alone</P>
<P>One study with 100 participants investigated diclofenac sodium 50mg combined with 200mcg misoprostol versus misoprostol alone (<LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>).</P>
<P>Group 4: conscious sedation</P>
<P>Three studies with 274 participants investigated conscious sedation. Kan et al compared entonox (50:50 mixture of nitrous oxide in oxygen) with air after administering 2mg midazolam (another 1mg if sedation inadequate) and 25mcg fentanyl IV. In this study, patients did not receive a PCB (<LINK REF="STD-Kan-2006" TYPE="STUDY">Kan 2006</LINK>). Wong on the other hand compared conscious sedation with midazolam 2mg and fentanyl 25mcg IV with placebo after administering a PCB to all participants (<LINK REF="STD-Wong-2002" TYPE="STUDY">Wong 2002</LINK>). Wells et al compared local cervical block alone with a PCB combined with intravenous sedation with diazepam and fentanyl in 2 of their four arms (<LINK REF="STD-Wells-1992" TYPE="STUDY">Wells 1992</LINK>).</P>
<P>Group 5: general anesthesia (<LINK REF="SOF-02" TYPE="SOF">Summary of results table 2</LINK>)</P>
<P>Fourteen studies with 1812 participants investigated general anesthesia. One of them compared general anesthesia using propofol and alfentanil with conscious sedation using midazolam, alfentanil and PCB with 20ml mepivacaine (<LINK REF="STD-Raeder-1992" TYPE="STUDY">Raeder 1992</LINK>). Hall compared GA using propofol with GA and PCB combined. General anesthesia studies used either fentanyl or alfentanil as opiates for pain control. Four studies investigated inhalational anesthetics, specifically halothane (<LINK REF="STD-Barneschi-1985" TYPE="STUDY">Barneschi 1985</LINK>; <LINK REF="STD-Collins-1985" TYPE="STUDY">Collins 1985</LINK>), enflurane (<LINK REF="STD-Hackett-1982" TYPE="STUDY">Hackett 1982</LINK>) and trichloethylene (<LINK REF="STD-Ogg-1983" TYPE="STUDY">Ogg 1983</LINK>) and compared them to various sedative/hypnotic agents. All studies included at least one sedative/hypnotic agent. Ten studies included propofol (<LINK REF="STD-Bonnardot-1987" TYPE="STUDY">Bonnardot 1987</LINK>; <LINK REF="STD-Boysen-1989" TYPE="STUDY">Boysen 1989</LINK>; <LINK REF="STD-Boysen-1990" TYPE="STUDY">Boysen 1990</LINK>; <LINK REF="STD-Hall-1997" TYPE="STUDY">Hall 1997</LINK>; <LINK REF="STD-Jakobsson-1991" TYPE="STUDY">Jakobsson 1991</LINK>; <LINK REF="STD-Jakobsson-1993" TYPE="STUDY">Jakobsson 1993</LINK>; <LINK REF="STD-Jakobsson-1995" TYPE="STUDY">Jakobsson 1995</LINK>; <LINK REF="STD-Lindholm-1994" TYPE="STUDY">Lindholm 1994</LINK>; <LINK REF="STD-Raeder-1992" TYPE="STUDY">Raeder 1992</LINK>; <LINK REF="STD-Rossi-1995" TYPE="STUDY">Rossi 1995</LINK>), 9 studies included a barbiturate (5 methohexital (<LINK REF="STD-Boysen-1990" TYPE="STUDY">Boysen 1990</LINK>; <LINK REF="STD-Collins-1985" TYPE="STUDY">Collins 1985</LINK>; <LINK REF="STD-Hackett-1982" TYPE="STUDY">Hackett 1982</LINK>; <LINK REF="STD-Jakobsson-1993" TYPE="STUDY">Jakobsson 1993</LINK>; <LINK REF="STD-Ogg-1983" TYPE="STUDY">Ogg 1983</LINK>), 5 thiopental (<LINK REF="STD-Barneschi-1985" TYPE="STUDY">Barneschi 1985</LINK>; <LINK REF="STD-Boysen-1989" TYPE="STUDY">Boysen 1989</LINK>; <LINK REF="STD-Jakobsson-1991" TYPE="STUDY">Jakobsson 1991</LINK>; <LINK REF="STD-Jakobsson-1993" TYPE="STUDY">Jakobsson 1993</LINK>; <LINK REF="STD-Jakobsson-1995" TYPE="STUDY">Jakobsson 1995</LINK>), 4 ketamine (<LINK REF="STD-Barneschi-1985" TYPE="STUDY">Barneschi 1985</LINK>; <LINK REF="STD-Bonnardot-1987" TYPE="STUDY">Bonnardot 1987</LINK>; <LINK REF="STD-Jakobsson-1993" TYPE="STUDY">Jakobsson 1993</LINK>; <LINK REF="STD-Rossi-1995" TYPE="STUDY">Rossi 1995</LINK>), 3 benzodiazepine midazolam (<LINK REF="STD-Bonnardot-1987" TYPE="STUDY">Bonnardot 1987</LINK>; <LINK REF="STD-Raeder-1992" TYPE="STUDY">Raeder 1992</LINK>; <LINK REF="STD-Rossi-1995" TYPE="STUDY">Rossi 1995</LINK>) and 1 etomidate (<LINK REF="STD-Boysen-1989" TYPE="STUDY">Boysen 1989</LINK>).</P>
<P>In studies with general anesthesia, pain was usually assessed postoperatively, either as a dichotomous or categorical variable. Other outcomes included typical side effects such as pain with injection, nausea, vomiting, and apnea, various tests of recovery and time until discharge.</P>
<P>Group 6: general anesthesia with premedication (<LINK REF="SOF-03" TYPE="SOF">Summary of results table 3</LINK>)</P>
<P>Seven studies with 770 participants investigated the influence of premedication with various analgesics on postoperative pain after general anesthesia. Most studies included a cyclooxygenase inhibitor (COX); COX 3 - paracetamol (<LINK REF="STD-Dahl-2000" TYPE="STUDY">Dahl 2000</LINK>; <LINK REF="STD-Hein-1999" TYPE="STUDY">Hein 1999</LINK>; <LINK REF="STD-Hein-2001" TYPE="STUDY">Hein 2001</LINK>), COX 2 etoricoxib (<LINK REF="STD-Liu-2005" TYPE="STUDY">Liu 2005</LINK>), non-selective COX inhibitor ketoroloac (<LINK REF="STD-Jakobsson-1996" TYPE="STUDY">Jakobsson 1996</LINK>), sodium- and potassium-diclofenac (<LINK REF="STD-Jakobsson-1996" TYPE="STUDY">Jakobsson 1996</LINK>) and lornoxicam (<LINK REF="STD-Hein-2001" TYPE="STUDY">Hein 2001</LINK>). Other studies investigated opioids such as nalbuphine (<LINK REF="STD-Bone-1988" TYPE="STUDY">Bone 1988</LINK>), dihydrocodeine (<LINK REF="STD-Heath-1989" TYPE="STUDY">Heath 1989</LINK>), paracetamol with codeine (<LINK REF="STD-Dahl-2000" TYPE="STUDY">Dahl 2000</LINK>). In 5 out of 7 studies, general anesthesia was achieved with propofol (<LINK REF="STD-Dahl-2000" TYPE="STUDY">Dahl 2000</LINK>; <LINK REF="STD-Heath-1989" TYPE="STUDY">Heath 1989</LINK>; <LINK REF="STD-Hein-1999" TYPE="STUDY">Hein 1999</LINK>; <LINK REF="STD-Hein-2001" TYPE="STUDY">Hein 2001</LINK>; <LINK REF="STD-Liu-2005" TYPE="STUDY">Liu 2005</LINK>), in one of them enflurane (<LINK REF="STD-Bone-1988" TYPE="STUDY">Bone 1988</LINK>) and in another desflurane (<LINK REF="STD-Liu-2005" TYPE="STUDY">Liu 2005</LINK>) was added. Thiopental was used in the 2 other studies (<LINK REF="STD-Bone-1988" TYPE="STUDY">Bone 1988</LINK>; <LINK REF="STD-Jakobsson-1996" TYPE="STUDY">Jakobsson 1996</LINK>). All but one (<LINK REF="STD-Liu-2005" TYPE="STUDY">Liu 2005</LINK>) included either fentanyl (<LINK REF="STD-Bone-1988" TYPE="STUDY">Bone 1988</LINK>; <LINK REF="STD-Hein-1999" TYPE="STUDY">Hein 1999</LINK>; <LINK REF="STD-Hein-2001" TYPE="STUDY">Hein 2001</LINK>) or alfentanil (<LINK REF="STD-Dahl-2000" TYPE="STUDY">Dahl 2000</LINK>; <LINK REF="STD-Heath-1989" TYPE="STUDY">Heath 1989</LINK>; <LINK REF="STD-Jakobsson-1996" TYPE="STUDY">Jakobsson 1996</LINK>) for anesthesia.</P>
<P>Group 7: non-pharmacological intervention</P>
<P>Four very different studies with 214 participants investigated non-pharmacological interventions. In a recent study, the effect of hypnosis was investigated compared to standard care in patients who all received a PCB (<LINK REF="STD-Marc-2007" TYPE="STUDY">Marc 2007</LINK>). Shapiro et al compared 3 groups; one control and two treatment arms with self-administered methoxyflurane (0.5 volume % with 5l oxygen per minute) and stereophonic headphones with music chosen by patient (<LINK REF="STD-Shapiro-1975" TYPE="STUDY">Shapiro 1975</LINK>). A further study compared provision of sensory information (3 minute audio taped message containing orienting information as well as nine sensations related to abortion, and identified by over 50% of women in a previous pilot study) with provision of general information. They also compared PCB versus PCB plus intravenous sedation with diazepam and fentanyl (<LINK REF="STD-Wells-1992" TYPE="STUDY">Wells 1992</LINK>). Wells et al 1989 compared 4 groups: Relaxation exercise for 10 minutes prior to the procedure versus pleasant imagery (beach or mountain), 7 minute practice session prior to the procedure versus analgesic imagery, 8 minute practice session prior to the procedure versus attention control no instruction in a technique but advise to use coping strategy that worked in a previous painful experience and 10-15 minutes prior to the procedure (<LINK REF="STD-Wells-1989" TYPE="STUDY">Wells 1989</LINK>). All participants received a PCB.</P>
<P>Within the different anesthetic groups medications, doses, technique and route of administration and timing varied, as did at what time and with which study instrument pain was assessed. This minimized the option for meta-analysis.</P>
<P>Co-interventions were either given to all participants, i.e. if a certain preoperative anxiety score was measured or were optional per patient request. They included cervical ripening with laminaria or misoprostol (not optional), premedication/anesthesia induction with either an anxiolytic, benzodiazepine or opiate. The most important ones are included in summary of findings table 1 to 3. They were too heterogeneous to be listed in a meaningful way here in the text, but they are described in detail in the included study tables.</P>
<P>Studies were conducted in Europe as well as in North America. Many were hospital based; others were conducted in freestanding abortion clinics, especially in North America. In several studies a sharp curettage check was performed after suction evacuation (<LINK REF="STD-Jakobsson-1991" TYPE="STUDY">Jakobsson 1991</LINK>; <LINK REF="STD-Jakobsson-1995" TYPE="STUDY">Jakobsson 1995</LINK>; <LINK REF="STD-Cetin-1997" TYPE="STUDY">Cetin 1997</LINK>; <LINK REF="STD-Glantz-2001" TYPE="STUDY">Glantz 2001</LINK>; Miller 1996a; <LINK REF="STD-Marc-2007" TYPE="STUDY">Marc 2007</LINK>; <LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK>). Included studies had been published in English, French and Italian.</P>
<P>
<B>Excluded studies</B>
</P>
<P>Twenty-nine studies were excluded. Please see tables for details.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2009-01-07 04:53:50 +0100" MODIFIED_BY="[Empty name]">
<P>Information regarding randomization and allocation concealment obtained from the publications and written correspondence with the authors proved these two areas to be adequate in most of the included studies.</P>
<P>Allocation concealment was adequate in 23 included studies and unclear in 14 studies. Three studies had inadequate allocation concealment. They had a research assistant draw up the syringes, or used an envelope but did not designate it as opaque.</P>
<P>Randomization was described in 25 of the studies; most often computer randomization. In 16 studies, the authors stated that they did randomize, but not how this was performed. The lack of information on randomization and allocation concealment likely derives from the fact that many of these publications were from the 1970s, 1980s and early 1990s.</P>
<P>Blinding: Patients were blinded in many studies. The surgeons and anesthesiologists could not always be blinded due to the individual study designs,. which may have introduced bias. However, assessors of postoperative outcomes were usually, blinded.</P>
<P>Follow-up and exclusions: Due to the short follow-up period until discharge after surgery, loss to follow-up did not occur. In several studies patients were excluded after inappropriate inclusion; more often data collection was incomplete. This made true intention to treat analysis more difficult.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2009-02-16 14:17:42 +0100" MODIFIED_BY="[Empty name]">
<P>Forty trials with a total of 5131 participants were included in this review. Due to the variety of interventions, trials were grouped as listed below. Secondary to heterogeneity, most of them could not be combined for meta-analysis. In studies involving general anesthesia, pain could only be assessed postoperatively. Data on side effects were combined for some comparisons. Major complications with any of the methods were rarely mentioned and if so, they were included in the table of included studies. Data on additional outcomes such as time until discharge or satisfaction was reported, if measured. Due to study heterogeneity, we decided not to report individual results on the multitude of tests used to assess for recovery. Some data regarding general anesthetics was only of historical interest, and therefore not all results were reported. This includes various tests of recovery and some of the side effects.</P>
<P>
<LINK REF="STD-Wiebe-1992" TYPE="STUDY">Wiebe 1992</LINK> and <LINK REF="STD-Wells-1992" TYPE="STUDY">Wells 1992</LINK> had 2 study steps each and <LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK> had 4 study steps/phases. Some of these belonged to different anesthesia groupings, thus the sum of all studies listed below exceeds 41 included trials.</P>
<P>Group 1: local anesthesia technique, local anesthetics, premedication and PCB</P>
<P>We included 12 studies with 1961 participants investigating local anesthesia with or without premedication.</P>
<P>
<B>Local anesthetics (Comparison 1)</B>
</P>
<P>Bacteriostatic saline PCB was compared with local anesthetics in one study (<LINK REF="STD-Glantz-2001" TYPE="STUDY">Glantz 2001</LINK>;<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>, <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>, <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). Glantz et al found better pain control during injection of the paracervical block (WMD -0.90 95% CI -1.78 to -0.02), during aspiration (WMD -1.50 95% CI -2.45 to -0.55) and postoperative (WMD -1.5 95% CI -2.54 to -0.46, N = 79) pain control with 1% chloroprocaine injected at 2 or 4 sites compared to bacteriostati saline. In the subanalysis for each site PCB and aspiration were only less painful with a 4 site injection while postoperative pain was only less after a 2 site injection. Pain with dilation was not studied. Kan et al did not observe a difference in pain with either dilation, aspiration or postoperatively when comparing PCB using lignocaine with no injection in patients with conscious sedation (<LINK REF="STD-Kan-2004" TYPE="STUDY">Kan 2004</LINK>) (only medians reported, N = 135).</P>
<P>A PCB with buffered 2% lidocaine was more effective at controlling pain with cervical dilation and at the end of the procedure than plain 2% lidocaine (WMD -0.80 95% CI -0.89 to -0.71, WMD -0.40 95% CI -0.49 to -0.31, N = 167) (<LINK REF="STD-Wiebe-1992" TYPE="STUDY">Wiebe 1992</LINK>, <LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK>, <LINK REF="FIG-06" TYPE="FIGURE">Figure 6</LINK>). Buffered 1% lidocaine improved pain with aspiration compared to plain 1% lidocaine (WMD -0.96 95% CI -1.67 to -0.25, N = 124), but not postoperative pain (<LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK>, <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>). Pain control with aspiration did not differ when comparing lidocaine 0.5% with 1%, or 1% lidocaine with 0.25% bupivacaine (<LINK REF="STD-Wiebe-1996" TYPE="STUDY">Wiebe 1996</LINK>; <LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK>, <LINK REF="FIG-07" TYPE="FIGURE">Figure 7</LINK>, <LINK REF="FIG-08" TYPE="FIGURE">Figure 8</LINK>).</P>
<P>
<B>Local anesthesia technique (Comparison 2)</B>
</P>
<P>Deep injection achieved better pain control than regular injection for cervical dilation and aspiration when combining the results of 2 studies with a total of 113 patients (WMD -1.64 95% CI -3.21 to -0.08 and WMD 1.00 95% CI 1.09 to 0.91) (<LINK REF="STD-Cetin-1997" TYPE="STUDY">Cetin 1997</LINK>; <LINK REF="STD-Wiebe-1992" TYPE="STUDY">Wiebe 1992</LINK>, <LINK REF="FIG-09" TYPE="FIGURE">Figure 9</LINK>; <LINK REF="FIG-10" TYPE="FIGURE">Figure 10</LINK>).</P>
<P>Pain with PCB injection, aspiration and postoperatively did not differ when comparing a 4 site (3-5-7-9 o&#8217;clock) with a 2 site (4-8 o&#8217;clock) injection (<LINK REF="STD-Glantz-2001" TYPE="STUDY">Glantz 2001</LINK>, <LINK REF="FIG-11" TYPE="FIGURE">Figure 11</LINK>; <LINK REF="FIG-12" TYPE="FIGURE">Figure 12</LINK>; <LINK REF="FIG-13" TYPE="FIGURE">Figure 13</LINK>). Similarly it did not differ when comparing a cervical block with lignocaine injected at 4 and 8 o&#8217;clock into the cervix versus the vaginal vault in patients with conscious sedation (<LINK REF="STD-Kan-2004" TYPE="STUDY">Kan 2004</LINK>). Kan et al only reported medians and thus the actual data could not be abstracted.</P>
<P>Waiting 3 minutes between PCB and dilation improved pain with cervical dilation (WMD -0.7 95% CI -1.37 to -0.03, N = 194), but not with aspiration or postoperative pain (<LINK REF="STD-Phair-2002" TYPE="STUDY">Phair 2002</LINK>, <LINK REF="FIG-14" TYPE="FIGURE">Figure 14</LINK>, <LINK REF="FIG-15" TYPE="FIGURE">Figure 15</LINK>; <LINK REF="FIG-16" TYPE="FIGURE">Figure 16</LINK>). Of note in the original article no significant results were described. Since only confidence intervals were reported, we calculated standard deviation as described in the data synthesis section, and obtained these results.</P>
<P>Slow versus fast injection did not alter the pain experience with PCB injection (<LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK>; <LINK REF="FIG-17" TYPE="FIGURE">Figure 17</LINK>).</P>
<P>A 1 % intrauterine lidocaine infusion plus PCB was not more effective in controlling pain with cervical dilation or aspiration as compared to PCB with intrauterine placebo, but a 4% intrauterine lidocaine infusion plus PCB was (WMD -2.0 95% CI -3.29 to -0.71, WMD -2.8 95% CI -3.95 to -1.65, N = 80 each study). In addition, postoperative pain (30 minutes) was less after a 4% intrauterine lidocaine infusion, but results were not statistically significant (<LINK REF="STD-Edelman-2004" TYPE="STUDY">Edelman 2004</LINK>; <LINK REF="STD-Edelman-2006" TYPE="STUDY">Edelman 2006</LINK>, <LINK REF="FIG-18" TYPE="FIGURE">Figure 18</LINK>; <LINK REF="FIG-19" TYPE="FIGURE">Figure 19</LINK>; <LINK REF="FIG-20" TYPE="FIGURE">Figure 20</LINK>).</P>
<P>Topical lignocaine gel compared to KY jelly did not alter pain with cervical dilation or postoperative pain, but alleviated pain with aspiration (WMD -0.87 95% CI -1.60 to -0.14, N = 131) (<LINK REF="STD-Li-2006" TYPE="STUDY">Li 2006</LINK>, <LINK REF="FIG-21" TYPE="FIGURE">Figure 21</LINK>; <LINK REF="FIG-22" TYPE="FIGURE">Figure 22</LINK>; <LINK REF="FIG-23" TYPE="FIGURE">Figure 23</LINK>; <LINK REF="FIG-24" TYPE="FIGURE">Figure 24</LINK>).</P>
<P>
<B>PCB with premedication (Comparison 3)</B>
</P>
<P>Ibuprofen, given 30 minutes preoperatively, improved pain control with aspiration and postoperatively compared to placebo (WMD -0.78 95% CI -1.52 to -0.04, WMD -0.93 95% CI -1.62 to -0.24, N 193) (<LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK>, <LINK REF="FIG-27" TYPE="FIGURE">Figure 27</LINK>; <LINK REF="FIG-28" TYPE="FIGURE">Figure 28</LINK>), while lorazepam, given 1 hour preoperatively, did not make a difference (<LINK REF="STD-Wiebe-2003" TYPE="STUDY">Wiebe 2003</LINK>, <LINK REF="FIG-29" TYPE="FIGURE">Figure 29</LINK>). Naproxen, given 1-2 hours preoperatively, decreased pain compared to placebo (max pain during procedure p&lt;=0.001, 15 minutes postoperatively p&lt;=0.0001, 30 minutes postoperatively p&lt;=0.002) (<LINK REF="STD-Suprapto-1984" TYPE="STUDY">Suprapto 1984</LINK>). Respective values for naproxen versus no drug were p&lt;=0.001 with abortion and p=0.059 30 minutes postoperatively. No significant difference was found difference between placebo and no-drug group. Only the graphs with mean pain scores were presented in the article (<LINK REF="STD-Suprapto-1984" TYPE="STUDY">Suprapto 1984</LINK>).</P>
<P>
<U>Additional outcomes and sub-analysis results reported in studies for comparisons 1, 2 and 3:</U>
</P>
<P>Lorazepam received per patient request did not affect pain in patients undergoing the procedure with a PCB (<LINK REF="STD-Wiebe-1992" TYPE="STUDY">Wiebe 1992</LINK>; <LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK>). It also did not significantly impact anxiety in a RCT Wiebe 2003.</P>
<P>Subanalysis for nulliparity versus multiparity was performed, and showed significantly lower pain scores with multiparity on arrival in the OR, with cervical manipulation/dilation and overall intraoperatively. Multiparous women were significantly more satisfied; type of anesthesia did not alter satisfaction (<LINK REF="STD-Li-2006" TYPE="STUDY">Li 2006</LINK>).</P>
<P>Many studies did not study patient satisfaction but in those that did satisfaction was high in both study arms (<LINK REF="STD-Edelman-2004" TYPE="STUDY">Edelman 2004</LINK>; <LINK REF="STD-Edelman-2006" TYPE="STUDY">Edelman 2006</LINK>; <LINK REF="STD-Phair-2002" TYPE="STUDY">Phair 2002</LINK>; <LINK REF="STD-Kan-2004" TYPE="STUDY">Kan 2004</LINK>; <LINK REF="FIG-25" TYPE="FIGURE">Figure 25</LINK>; <LINK REF="FIG-26" TYPE="FIGURE">Figure 26</LINK>).</P>
<P>
<B>Group 2: analgesia alone (Comparison 4)</B>
</P>
<P>One study investigated diclofenac sodium 50mg, given 4 hours preoperatively, combined with 200mcg misoprostol compared to misoprostol alone and did not find differences in pain control with aspiration or postoperatively, or with acceptability of pain control (<LINK REF="STD-Li-2003" TYPE="STUDY">Li 2003</LINK>, <LINK REF="FIG-30" TYPE="FIGURE">Figure 30</LINK>, <LINK REF="FIG-31" TYPE="FIGURE">Figure 31</LINK>, <LINK REF="FIG-32" TYPE="FIGURE">Figure 32</LINK>). If broken down in nulliparous and multiparous, there was significant less pain with diclofenac sodium in multiparous women during the procedure (mean 58 (SD 27) versus 63(27)).</P>
<P>
<B>Group 3: conscious sedation (Comparison 5)</B>
</P>
<P>Three studies investigated conscious sedation. Pain with aspiration and 1 hour postoperatively did not differ when comparing entonox (50:50 mixture of nitrous oxide in oxygen) with air when added to conscious sedation with midazolam and fentanyl (<LINK REF="STD-Kan-2006" TYPE="STUDY">Kan 2006</LINK>). Only median and 95% CI were reported. Anxiety, satisfaction level as well as side effects (nausea, dizziness, dry mouth and drowsiness) did not significantly vary between groups (<LINK REF="STD-Kan-2006" TYPE="STUDY">Kan 2006</LINK>).</P>
<P>While pain with aspiration and postoperatively did not differ comparing conscious sedation using midazolam 2mg and fentanyl 25mcg IV with placebo after administering a PCB to all participants (only medians were reported), satisfaction was higher with conscious sedation (Peto OR 3.69 95% CI 1.63 to 8.36, N = 100) (<LINK REF="STD-Wong-2002" TYPE="STUDY">Wong 2002</LINK>, <LINK REF="FIG-33" TYPE="FIGURE">Figure 33</LINK>). No difference was observed in sedation. Postoperative more dizziness (p=0.015) and drowsiness (p&lt;0.001) was noted in the conscious sedation group. Multiple regression showed that sedation (decreased, p=0.008) and gestational age (increased, p=0.024) affected pain (<LINK REF="STD-Wong-2002" TYPE="STUDY">Wong 2002</LINK>). A second study compared PCB and conscious IV sedation using diazepam and fentanyl with PCB alone (<LINK REF="STD-Wells-1992" TYPE="STUDY">Wells 1992</LINK>). In this study, which does not report SDs, women with IV sedation reported less pain (Mean 4.54 versus 6.30, p=0.003 (F (1.8)=9.40) N = 84). Pain intensity further correlated with subjective distress (r=0.74, p&gt;0.001) and behavioral distress (r=0.54, p&lt;0.001) (<LINK REF="STD-Wells-1992" TYPE="STUDY">Wells 1992</LINK>, <LINK REF="FIG-34" TYPE="FIGURE">Figure 34</LINK>).</P>
<P>
<B>Group 4: general anesthesia (Comparison 6)</B>
</P>
<P>14 studies investigated general anesthesia.</P>
<P>
<U>Inhalation anesthetics:</U>
</P>
<P>Four studies included inhalation anesthetics (<LINK REF="STD-Barneschi-1985" TYPE="STUDY">Barneschi 1985</LINK>; <LINK REF="STD-Collins-1985" TYPE="STUDY">Collins 1985</LINK>; <LINK REF="STD-Hackett-1982" TYPE="STUDY">Hackett 1982</LINK>; <LINK REF="STD-Ogg-1983" TYPE="STUDY">Ogg 1983</LINK>). Halothane did not change postoperative reported pain compared to alfentanil when added to methohexitone (<LINK REF="STD-Collins-1985" TYPE="STUDY">Collins 1985</LINK>). For the forest plots we dichotomized the 3 groups by combining nil and slight pain versus moderate/severe pain (<LINK REF="STD-Collins-1985" TYPE="STUDY">Collins 1985</LINK>, <LINK REF="FIG-35" TYPE="FIGURE">Figure 35</LINK>). Adding halothane, enflurane or fentanyl to thiopental did not affect postoperative pain (<LINK REF="STD-Barneschi-1985" TYPE="STUDY">Barneschi 1985</LINK>, <LINK REF="FIG-36" TYPE="FIGURE">Figure 36</LINK>, <LINK REF="FIG-37" TYPE="FIGURE">Figure 37</LINK>). Trichlorethylene did not change pain control compared to methohexital (<LINK REF="STD-Ogg-1983" TYPE="STUDY">Ogg 1983</LINK>, <LINK REF="FIG-38" TYPE="FIGURE">Figure 38</LINK>). Enflurane compared to fentanyl did not affect pain when added to methohexitone (<LINK REF="STD-Hackett-1982" TYPE="STUDY">Hackett 1982</LINK>). The data cannot be shown in graph due to inaccurate numbers in the publication that could not be successfully verified with the author (<LINK REF="STD-Hackett-1982" TYPE="STUDY">Hackett 1982</LINK>).</P>
<P>
<U>Side effects of inhalation anesthetics:</U> Higher blood loss was noted with inhalation anesthetics, such as enflurane (<LINK REF="STD-Hackett-1982" TYPE="STUDY">Hackett 1982</LINK>) and halothane (<LINK REF="STD-Collins-1985" TYPE="STUDY">Collins 1985</LINK>) per reported study results. Since no CI was given we could not recalculate this (<LINK REF="FIG-39" TYPE="FIGURE">Figure 39</LINK>).</P>
<P>Data on nausea and vomiting was controversial; less with halothane compared to fentanyl (<LINK REF="STD-Collins-1985" TYPE="STUDY">Collins 1985</LINK>), more with enflurane compared to fentanyl (<LINK REF="STD-Hackett-1982" TYPE="STUDY">Hackett 1982</LINK>), no difference with trichlorethylene (<LINK REF="STD-Ogg-1983" TYPE="STUDY">Ogg 1983</LINK>,<LINK REF="FIG-42" TYPE="FIGURE">Figure 42</LINK> ). Halothane anesthesia was associated with more cough compared to alfentanil given for maintenance after methohexitone induction. However it was associated with less limb movement. Since only ranges were given, we could not recalculate the statistics (<LINK REF="STD-Collins-1985" TYPE="STUDY">Collins 1985</LINK>).</P>
<P>Laryngospasm, pain on induction, and intraoperative muscle movement did not differ between trichloethylene and total IV anesthesia (<LINK REF="STD-Ogg-1983" TYPE="STUDY">Ogg 1983</LINK>,<LINK REF="FIG-42" TYPE="FIGURE">Figure 42</LINK> ). Severe anesthesia complications, as well as apnea (<LINK REF="STD-Collins-1985" TYPE="STUDY">Collins 1985</LINK>) did not differ (<LINK REF="STD-Collins-1985" TYPE="STUDY">Collins 1985</LINK>; <LINK REF="STD-Hackett-1982" TYPE="STUDY">Hackett 1982</LINK>, <LINK REF="FIG-40" TYPE="FIGURE">Figure 40</LINK>, <LINK REF="FIG-41" TYPE="FIGURE">Figure 41</LINK>). Anesthesia with volatile agents was considered safe and reliable (<LINK REF="STD-Barneschi-1985" TYPE="STUDY">Barneschi 1985</LINK>).</P>
<P>Recovery time after halothane was longer compared to alfentanil (WMD 7.6 95% CI 5.71 to 9.49, N 66) (<LINK REF="STD-Collins-1985" TYPE="STUDY">Collins 1985</LINK>), while enflurane and fentanyl did not differ (<LINK REF="STD-Hackett-1982" TYPE="STUDY">Hackett 1982</LINK>, <LINK REF="FIG-43" TYPE="FIGURE">Figure 43</LINK> ). Memory function as part of the recovery testing did not differ between groups (<LINK REF="STD-Ogg-1983" TYPE="STUDY">Ogg 1983</LINK>). Anesthesia with volatile agents was considered safe and reliable (<LINK REF="STD-Barneschi-1985" TYPE="STUDY">Barneschi 1985</LINK>).</P>
<P>
<U>Sedatives, hypnotics and opiates</U>
</P>
<P>Ten studies included propofol. Postoperative pain did not differ comparing propofol with etomidate (<LINK REF="STD-Boysen-1989" TYPE="STUDY">Boysen 1989</LINK>, <LINK REF="FIG-44" TYPE="FIGURE">Figure 44</LINK>). In a meta-analysis of 3 studies with 350 patients comparing propofol and thiopental, no differences in postoperative pain were measured regardless of adding fentanyl or alfentanil (<LINK REF="STD-Jakobsson-1993" TYPE="STUDY">Jakobsson 1993</LINK>; <LINK REF="STD-Jakobsson-1995" TYPE="STUDY">Jakobsson 1995</LINK>; <LINK REF="STD-Boysen-1989" TYPE="STUDY">Boysen 1989</LINK>, <LINK REF="FIG-45" TYPE="FIGURE">Figure 45</LINK>).</P>
<P>Propofol was associated with decreased postoperative pain compared to methohexital (Peto OR 0.28 95% CI 0.10 to 0.80, N 100) (<LINK REF="STD-Jakobsson-1993" TYPE="STUDY">Jakobsson 1993</LINK>, <LINK REF="FIG-46" TYPE="FIGURE">Figure 46</LINK>). However, Boysen et al 1990 showed a trend towards the reverse, and when combining both studies there was no significant difference in postoperative pain (<LINK REF="STD-Boysen-1990" TYPE="STUDY">Boysen 1990</LINK>; <LINK REF="STD-Jakobsson-1993" TYPE="STUDY">Jakobsson 1993</LINK>).</P>
<P>Midazolam and propofol when added to fentanyl did not differ in reported postoperative pain (<LINK REF="STD-Rossi-1995" TYPE="STUDY">Rossi 1995</LINK>, <LINK REF="FIG-47" TYPE="FIGURE">Figure 47</LINK>).</P>
<P>Combination of propofol and alfentanil achieved better postoperative pain control compared to 0.5mg/kg ketamine and 0.25mg/kg midazolam (Peto OR 0.18 95% CI 0.07 to 0.47, N 100); the trend when using 1mg/kg ketamine and 0.1mg/kg midazolam was not significant (<LINK REF="STD-Bonnardot-1987" TYPE="STUDY">Bonnardot 1987</LINK>, <LINK REF="FIG-48" TYPE="FIGURE">Figure 48</LINK>). Ketamine was associated with more postoperative pain than fentanyl when added to propofol (Peto OR 7.13 95% CI 2.99-17.0, N 100) (<LINK REF="STD-Jakobsson-1993" TYPE="STUDY">Jakobsson 1993</LINK>, <LINK REF="FIG-49" TYPE="FIGURE">Figure 49</LINK>). Even though Rossi et al (<LINK REF="STD-Rossi-1995" TYPE="STUDY">Rossi 1995</LINK>) did not confirm this, the association remained significant in the meta-analysis (Peto OR 4.66 95% CI 2.16 to 10.06, N 180) (<LINK REF="FIG-49" TYPE="FIGURE">Figure 49</LINK>). The combination of ketamine and diazepam compared to thiopental and fentanyl did not change pain (<LINK REF="STD-Barneschi-1985" TYPE="STUDY">Barneschi 1985</LINK>, <LINK REF="FIG-50" TYPE="FIGURE">Figure 50</LINK>).</P>
<P>Adding alfentanil to propofol reduced postoperative pain (Peto OR 0.16 95% CI 0.06 to 0.40, N 100) (<LINK REF="STD-Bonnardot-1987" TYPE="STUDY">Bonnardot 1987</LINK>, <LINK REF="FIG-51" TYPE="FIGURE">Figure 51</LINK>). In Jakobsson et al 1991 adding alfentanil compared to placebo did not change pain, but fentanyl did (Peto OR 0.23 95% CI 0.11 to 0.51, N 208) (<LINK REF="STD-Jakobsson-1991" TYPE="STUDY">Jakobsson 1991</LINK>, <LINK REF="FIG-52" TYPE="FIGURE">Figure 52</LINK>). However, by the time of discharge the pain was the same. Adding alfentanil to propofol postoperative pain was higher compared to fentanyl (Peto OR 1.96 95% CI 1.07 to 3.6, N 210) (<LINK REF="STD-Jakobsson-1991" TYPE="STUDY">Jakobsson 1991</LINK>; <LINK REF="STD-Jakobsson-1995" TYPE="STUDY">Jakobsson 1995</LINK>, combined in a meta-analysis, <LINK REF="FIG-53" TYPE="FIGURE">Figure 53</LINK>). In the arm with thiopental, pain did not differ (<LINK REF="STD-Jakobsson-1995" TYPE="STUDY">Jakobsson 1995</LINK>, <LINK REF="FIG-54" TYPE="FIGURE">Figure 54</LINK>). At 30 minutes postoperatively pain was less in the fentanyl (p&lt;0.05) and alfentanil (p&lt;0.01) group compared to placebo (<LINK REF="STD-Lindholm-1994" TYPE="STUDY">Lindholm 1994</LINK>). Pain intensity was equal among the groups at 120 and 180 minutes. Only a graph but no raw data was available (<LINK REF="STD-Lindholm-1994" TYPE="STUDY">Lindholm 1994</LINK>).</P>
<P>One study investigated if a PCB added to GA altered postoperative pain control (<LINK REF="STD-Hall-1997" TYPE="STUDY">Hall 1997</LINK>). Pain and postoperative pain medication consumption did not change. Only a graph but no raw data was available. It further did not alter nausea, or time until discharge (no absolute numbers or only medians given in article).</P>
<P>
<U>Side effects of Sedatives, hypnotics and opiates (</U>
<LINK REF="FIG-55" TYPE="FIGURE">Figure 55</LINK>
<U>):</U> Various side effects comparing propofol with other sedative hypnotic agents and inhalation anesthetics were measured. Please see figures for complete list of Peto ORs and CIs.</P>
<P>Increased pain on injection was associated with propofol and etomidate compared to thiopental (<LINK REF="STD-Boysen-1989" TYPE="STUDY">Boysen 1989</LINK>) and ketamine (<LINK REF="STD-Bonnardot-1987" TYPE="STUDY">Bonnardot 1987</LINK>), as well as with fentanyl versus ketamine added to propofol (<LINK REF="STD-Rossi-1995" TYPE="STUDY">Rossi 1995</LINK>). Propofol alone caused more pain with injection compared to alfentanil and propofol (<LINK REF="STD-Bonnardot-1987" TYPE="STUDY">Bonnardot 1987</LINK>).</P>
<P>Propofol was associated with increased apnea compared to etomidate but not thiopental or methohexital (<LINK REF="STD-Boysen-1989" TYPE="STUDY">Boysen 1989</LINK>; <LINK REF="STD-Boysen-1990" TYPE="STUDY">Boysen 1990</LINK>).</P>
<P>Muscle movement was increased with etomidate compared to propofol and thiopental and methohexital compared to propofol (<LINK REF="STD-Boysen-1989" TYPE="STUDY">Boysen 1989</LINK>; <LINK REF="STD-Boysen-1990" TYPE="STUDY">Boysen 1990</LINK>). Intraoperative movement was further increased with thiopental and fentanyl compared to ketamine and diazepam as well as thiopental and halothane (<LINK REF="STD-Barneschi-1985" TYPE="STUDY">Barneschi 1985</LINK>).</P>
<P>Nausea was decreased with propofol compared to methohexital in one study (<LINK REF="STD-Jakobsson-1993" TYPE="STUDY">Jakobsson 1993</LINK>), but not another (<LINK REF="STD-Boysen-1990" TYPE="STUDY">Boysen 1990</LINK>). It was also decreased with thiopental and fentanyl compared to ketamine and diazepam (<LINK REF="STD-Barneschi-1985" TYPE="STUDY">Barneschi 1985</LINK>). Vomiting was decreased with propofol and alfentanil compared to ketamine and midazolam (<LINK REF="STD-Bonnardot-1987" TYPE="STUDY">Bonnardot 1987</LINK>).</P>
<P>Dreams were increased with ketamine compared to other sedative hypnotics (<LINK REF="STD-Jakobsson-1993" TYPE="STUDY">Jakobsson 1993</LINK>).</P>
<P>Nausea, vomiting, laryngospasm and overall complications did not differ when comparing alfentanil or fentanyl with each other or placebo (<LINK REF="STD-Jakobsson-1991" TYPE="STUDY">Jakobsson 1991</LINK>; <LINK REF="STD-Lindholm-1994" TYPE="STUDY">Lindholm 1994</LINK>; <LINK REF="FIG-56" TYPE="FIGURE">Figure 56</LINK>). Propofol induction dose was significantly lower in the alfentanil group compared to fentanyl (p&lt;0.05; only medians given). The total propofol dose required, and the number of people moving to surgical stimulus was significantly lower in both the fentanyl and alfentanil group compared to the normal saline control group (p&lt;0.01), while recovery measures were improved in the alfentanil group compared to the NS control group (<LINK REF="STD-Lindholm-1994" TYPE="STUDY">Lindholm 1994</LINK>).</P>
<P>Time to discharge was shorter after propofol compared to thiopental in the meta-analysis of 2 studies (WMD 14.69 95% CI 24.95 to 4.43, N 200) (<LINK REF="STD-Jakobsson-1993" TYPE="STUDY">Jakobsson 1993</LINK>; <LINK REF="STD-Jakobsson-1995" TYPE="STUDY">Jakobsson 1995</LINK>; <LINK REF="FIG-57" TYPE="FIGURE">Figure 57</LINK>). Adding an opioid compared to placebo did not alter the time (<LINK REF="STD-Jakobsson-1991" TYPE="STUDY">Jakobsson 1991</LINK>). Per study reports: Overall propofol was associated with a better recovery compared to etomidate and thiopental (<LINK REF="STD-Boysen-1989" TYPE="STUDY">Boysen 1989</LINK>), and a similar recovery compared to methohexital (<LINK REF="STD-Boysen-1990" TYPE="STUDY">Boysen 1990</LINK>). Pain significantly correlated to prolonged time until hospital discharge (<LINK REF="STD-Jakobsson-1991" TYPE="STUDY">Jakobsson 1991</LINK>).</P>
<P>Recovery was faster in propofol/fentanyl group compared to ketamine/fentanyl and fentanyl/midazolam as assessed per Steward score (only medians reported) (<LINK REF="STD-Rossi-1995" TYPE="STUDY">Rossi 1995</LINK>). Speed and quality of psychomotor and sensory tests was significantly better in the propofol groups compared to the ketamine groups (<LINK REF="STD-Bonnardot-1987" TYPE="STUDY">Bonnardot 1987</LINK>), as it was in the thiopentane group compared to ketamine (<LINK REF="STD-Barneschi-1985" TYPE="STUDY">Barneschi 1985</LINK>).</P>
<P>
<U>Conscious sedation versus general anesthesia</U>
</P>
<P>Only one study with 59 patients directly compared conscious sedation with general anesthesia (<LINK REF="STD-Raeder-1992" TYPE="STUDY">Raeder 1992</LINK>). With conscious sedation pain with dilation and aspiration was higher as assessed by the anesthesiologist (Peto OR 14.77 95% CI 4.91 to 44.38, and Peto OR 7.47 95% CI 2.2 to 25.36, <LINK REF="FIG-58" TYPE="FIGURE">Figure 58</LINK>; <LINK REF="FIG-59" TYPE="FIGURE">Figure 59</LINK>). However, postoperative patient reported pain was decreased (WMD 1.00 95% CI 1.77 to 0.23, <LINK REF="FIG-60" TYPE="FIGURE">Figure 60</LINK>). Risk for apnea was reduced with conscious sedation (Peto OR 0.10 95% CI 0.02 to 0.46, <LINK REF="FIG-61" TYPE="FIGURE">Figure 61</LINK>), and duration of sleep shorter (WMD 9.5 95% CI 11.5 to 7.5, <LINK REF="FIG-62" TYPE="FIGURE">Figure 62</LINK>). Except for better p-deletion score (a test in which patients are shown a sheet of randomly written letters, and are instructed to delete with a pen all p&#8217;s as fast and accurately as possible during a 3 minute period) 30 min after the procedure in the general anesthesia group, there was no difference in the recovery functions between the groups, as per reported results (<LINK REF="STD-Raeder-1992" TYPE="STUDY">Raeder 1992</LINK>).</P>
<P>
<B>Group 5: general anesthesia with premedication (Comparison 7)</B>
</P>
<P>Seven studies investigated the influence of premedication with various analgesics (selective or non-selective COX inhibitor or opioids) on postoperative pain after general anesthesia (mostly propofol and fentanyl or alfentanil).</P>
<P>The selective COX 3 inhibitor paracetamol given as a suppository at the end of the procedure did not improve pain control compared to placebo (<LINK REF="STD-Hein-1999" TYPE="STUDY">Hein 1999</LINK>; <LINK REF="FIG-63" TYPE="FIGURE">Figure 63</LINK>). Even when adding codeine to the paracetamol suppository and giving it 1 hour preoperatively, pain did not improve compared to placebo (<LINK REF="STD-Dahl-2000" TYPE="STUDY">Dahl 2000</LINK>; <LINK REF="FIG-64" TYPE="FIGURE">Figure 64</LINK>). The non-selective COX inhibitor lornoxicam significantly decreased postoperative pain compared to paracetamol dosed orally (Peto OR 0.36 95% CI 0.17 to 0.78, N 140), which in turn did not change pain compared to placebo. All test drugs were given 1 hour before anesthesia (<LINK REF="STD-Hein-2001" TYPE="STUDY">Hein 2001</LINK>; <LINK REF="FIG-65" TYPE="FIGURE">Figure 65</LINK>; <LINK REF="FIG-66" TYPE="FIGURE">Figure 66</LINK>). Diclofenac IM and ketorolac IM both decreased postoperative pain compared to NaCl when given 10-20 minutes before the anesthesia (Peto OR 0.37 95% CI 0.14 to 0.92, and Peto OR 0.32 95% CI 0.12 to 0.81, N 100) (<LINK REF="STD-Jakobsson-1996" TYPE="STUDY">Jakobsson 1996</LINK>; <LINK REF="FIG-67" TYPE="FIGURE">Figure 67</LINK>), and did not differ when compared to each other. Diclofenac orally was associated with more postoperative pain compared to ketorolac IM (Peto OR 3.17 95% CI 1.24 to 8.13, N 100), and did not improve pain control compared to NaCl (<LINK REF="STD-Jakobsson-1996" TYPE="STUDY">Jakobsson 1996</LINK>). The COX 2 inhibitor etoricoxib, given 30-60 minutes preoperatively did not improve pain control immediately postoperative, but by the time of discharge (WMD 0.7 95% CI -1.2 to -0.2, N 40) (<LINK REF="STD-Liu-2005" TYPE="STUDY">Liu 2005</LINK>; <LINK REF="FIG-68" TYPE="FIGURE">Figure 68</LINK>).</P>
<P>
<U>Side effects</U> (<LINK REF="FIG-69" TYPE="FIGURE">Figure 69</LINK>) comparing COX inhibitors with placebo did not show any difference regarding antiemetic requirements, nausea, vomiting, anxiety or satisfaction except for diclofenac IM decreasing nausea and anxiety compared to NaCl (Peto OR 0.13 95% CI 0.02 to 0.93 and Peto OR 0.29 95% CI 0.09 to 0.94, N 100) (<LINK REF="STD-Jakobsson-1996" TYPE="STUDY">Jakobsson 1996</LINK>). Ketorolac decreased anxiety compared to Nacl (OR 0.29 95% CI 0.09 to 0.94, N 100) (<LINK REF="STD-Jakobsson-1996" TYPE="STUDY">Jakobsson 1996</LINK>). Time to discharge was the same in all groups (<LINK REF="STD-Hein-1999" TYPE="STUDY">Hein 1999</LINK>; <LINK REF="STD-Hein-2001" TYPE="STUDY">Hein 2001</LINK>; <LINK REF="STD-Jakobsson-1996" TYPE="STUDY">Jakobsson 1996</LINK>; <LINK REF="STD-Liu-2005" TYPE="STUDY">Liu 2005</LINK>; <LINK REF="FIG-70" TYPE="FIGURE">Figure 70</LINK>).</P>
<P>Nalbuphine achieved better 1 hour postoperative pain control than fentanyl (Peto OR 0.21 95% CI 0.05 to 0.86, N 40); after 2 hours the difference was not significant anymore (<LINK REF="STD-Bone-1988" TYPE="STUDY">Bone 1988</LINK>; <LINK REF="FIG-71" TYPE="FIGURE">Figure 71</LINK>). The incidence of postoperative pain and nausea was the same when comparing dihydrocodeine po with placebo (<LINK REF="STD-Heath-1989" TYPE="STUDY">Heath 1989</LINK>). Only medians were reported in that study.</P>
<P>
<U>Side effects:</U> Nausea and recovery (reaction time) did not differ between nalbuphine and fentanyl (<LINK REF="STD-Bone-1988" TYPE="STUDY">Bone 1988</LINK>; <LINK REF="FIG-72" TYPE="FIGURE">Figure 72</LINK>). Of note, nausea was reported as a mean despite the fact that it was a categorical measurement with a score between 1-3. Paracetamol with codeine suppository compared to placebo did not change nausea or awakeness/sleepiness at most time points measured, except for more women being sleepy at 30 minutes postoperatively after paracetamol with codeine (Peto OR 3.17 95% CI 1.39 to 7.23) and less fully awake (Peto OR 0.35 95% CI 0.15 to 0.79, N 90) (<LINK REF="STD-Dahl-2000" TYPE="STUDY">Dahl 2000</LINK>; <LINK REF="FIG-73" TYPE="FIGURE">Figure 73</LINK>). Time to discharge was not affected (<LINK REF="STD-Dahl-2000" TYPE="STUDY">Dahl 2000</LINK>; <LINK REF="FIG-74" TYPE="FIGURE">Figure 74</LINK>).</P>
<P>
<B>Group 6: Non-pharmacological intervention (Comparison 9)</B>
</P>
<P>Four very different studies investigated non-pharmacological interventions. In patients with a PCB, hypnosis did not did not change the level of comfort during the procedure compared to standard care; however, it decreased the requests for nitrous oxide  (Peto OR 0.12 95% CI 0.03 to 0.54) (<LINK REF="STD-Marc-2007" TYPE="STUDY">Marc 2007</LINK>; <LINK REF="FIG-75" TYPE="FIGURE">Figure 75</LINK>; <LINK REF="FIG-76" TYPE="FIGURE">Figure 76</LINK>). Listening to stereo music compared to self-administration of methoxyflurane decreased pain with aspiration (Peto OR 0.17 95% CI 0.04-0.63, N 98). No statistics were reported in the study and thus results were dichotomized to enter them into Revman (<LINK REF="STD-Shapiro-1975" TYPE="STUDY">Shapiro 1975</LINK>; <LINK REF="FIG-77" TYPE="FIGURE">Figure 77</LINK>). Providing sensory (3 minute audio taped message containing orienting information as well as nine sensations related to abortion and identified by over 50% of women in a previous pilot study) compared to general information did not affect procedural pain or distress (<LINK REF="STD-Wiebe-1992" TYPE="STUDY">Wiebe 1992</LINK>). Relaxation did not change procedural or postoperative pain in patients with local anesthesia compared to pleasant or analgesic imagery, or a control group (<LINK REF="STD-Wells-1989" TYPE="STUDY">Wells 1989</LINK>)</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2009-02-16 14:18:16 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Summary of main results</B>
</P>
<P>Various methods of pain control for first trimester surgical abortion have been studied. Local anesthesia, IV sedation, general anesthesia and some forms of non-pharmacological pain control have been found to effectively decrease pain during and after the procedure while being safe and satisfactory to patients. Data on the effect of a PCB is heterogeneous and very limited. While one small study showed a pain reduction with injection and aspiration when using 1% chloroprocaine compared to normal saline for a 4 point PCB (<LINK REF="STD-Glantz-2001" TYPE="STUDY">Glantz 2001</LINK>), another study did not show a benefit of a PCB compared to no PCB (<LINK REF="STD-Kan-2004" TYPE="STUDY">Kan 2004</LINK>). Data on buffered lidocaine compared to non-buffered lidocaine in the PCB was conflicting (<LINK REF="STD-Wiebe-1992" TYPE="STUDY">Wiebe 1992</LINK>; <LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK>). Pain with cervical dilation was improved with deep injection of the paracervical block (<LINK REF="STD-Cetin-1997" TYPE="STUDY">Cetin 1997</LINK>; <LINK REF="STD-Wiebe-1992" TYPE="STUDY">Wiebe 1992</LINK>), waiting 3 minutes between PCB and dilation (<LINK REF="STD-Phair-2002" TYPE="STUDY">Phair 2002</LINK>), and with adding a 4% intrauterine lidocaine infusion to PCB (<LINK REF="STD-Edelman-2006" TYPE="STUDY">Edelman 2006</LINK>). All but waiting 3 minutes also decreased pain with aspiration. Premedication with ibuprofen and naproxen (p&lt;0.001) improved intra- and post-operative pain (<LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK>; <LINK REF="STD-Suprapto-1984" TYPE="STUDY">Suprapto 1984</LINK>). The addition of conscious IV sedation using diazepam and fentanyl to PCB decreased pain with the procedure (<LINK REF="STD-Wells-1992" TYPE="STUDY">Wells 1992</LINK>). Adding a PCB to general anesthesia has not been shown to reduce postoperative pain (<LINK REF="STD-Hall-1997" TYPE="STUDY">Hall 1997</LINK>).</P>
<P>In regard to general anesthesia, a shift from inhalational anesthetics to sedatives and hypnotics has decreased procedure related blood loss. Propofol has been shown to be superior to ketamine in multiple studies, and shortened time until discharge compared to some other hypnotics. Adding opioids to general anesthesia has been found to be beneficial for postoperative pain. No major complications were observed in any study.</P>
<P>
<B>Overall completeness evidence</B>
</P>
<P>Various countries, decades of years, settings in which the procedure was provided and pain management options have been represented by the included studies. Methods of pain control varied widely and were often combined regimens. In order to synthesize the data, we grouped the included trials as mentioned previously. Trials were too heterogeneous regarding combination of medications, doses, and routes of administration, to be combined in a large meta-analysis. Therefore, we focused on the primary outcome of pain and were unable to draw firm conclusion on side effects or complications. In addition, the nature of general anesthesia, which achieves complete pain control during the surgery, challenges the ability to compare it to any other form of anesthesia. Pain during deep conscious sedation and general anesthesia can only be assessed by an observer and cannot be patient reported which decreases comparability to other forms of anesthesia.</P>
<P>
<B>Quality of evidence (</B>
<LINK REF="SOF-04" TYPE="SOF">Summary of results table 4</LINK>
<B>)</B>
</P>
<P>Randomization and allocation concealment were not specified in one third and one half of the studies respectively. This likely derives from the fact that many publications were from the 1970s to early 1990s. Three studies (<LINK REF="STD-Hein-1999" TYPE="STUDY">Hein 1999</LINK>; <LINK REF="STD-Wiebe-1992" TYPE="STUDY">Wiebe 1992</LINK>; <LINK REF="STD-Wiebe-1996" TYPE="STUDY">Wiebe 1996</LINK>) had inadequate allocation concealment, but were included due to their overall importance to the review. Only Wiebe 1992 had significant results of decreased pain with a deep PCB, which should be treated with skepticism.</P>
<P>Several studies reported incomplete data, and some of the general anesthesia literature did not contain detailed gynecologic information (e.g. type of procedure sharp curettage versus suction). Not all authors could be successfully contacted to obtain missing information.</P>
<P>Some studies had statistically significant results, however, they only detected a small change in pain (WMD &lt;1) (<LINK REF="STD-Cetin-1997" TYPE="STUDY">Cetin 1997</LINK>, <LINK REF="STD-Li-2006" TYPE="STUDY">Li 2006</LINK>, <LINK REF="STD-Liu-2005" TYPE="STUDY">Liu 2005</LINK>, <LINK REF="STD-Phair-2002" TYPE="STUDY">Phair 2002</LINK>, <LINK REF="STD-Wiebe-1992" TYPE="STUDY">Wiebe 1992</LINK>, <LINK REF="STD-Wiebe-1995" TYPE="STUDY">Wiebe 1995</LINK>), or did not measure the amount in pain reduction they had determined in their power calculations (i.e. <LINK REF="STD-Phair-2002" TYPE="STUDY">Phair 2002</LINK>). Of note Phair et al did not originally report any statistical signficant results, but in our reanalysis, pain with dilation was reduced. This raises the questions of quality of evidence, and points out that clinical significant pain reduction is hard to determine.</P>
<P>
<B>Applicability of evidence</B>
</P>
<P>Severe complications are rare; therefore, none of the included studies were powered to detect these. Due to short follow up, delayed side effects may have been missed. However, most of the medications studied do not have a long half life. </P>
<P>Recommendations by the WHO on safe abortion (<LINK REF="REF-WHO-2003" TYPE="REFERENCE">WHO 2003</LINK>) as well as by the Royal College of Obstetricians and Gynaecologists (<LINK REF="REF-RCOG-2004" TYPE="REFERENCE">RCOG 2004</LINK>) favor local/IV sedation, over general anesthesia. These recommendations are based on data from the 1970-1980s. Overall the case-fatality-rate from general anesthesia has decreased since the 1970s to 0.7 from 4.1 in 100,000 in 1972, but anesthesia-related events continued to be the leading cause of morbidity between 1977 and 1987 (<LINK REF="REF-Lawson-1994" TYPE="REFERENCE">Lawson 1994</LINK>). However, one large abortion-related study did not show a significant difference in complications between local and general anesthesia (<LINK REF="REF-Hakim_x002d_Elahi-1990" TYPE="REFERENCE">Hakim-Elahi 1990</LINK>). Data from the closed claims project of the American society of anesthesiologists has shown a decrease in the percentage of death and brain damage claims related to respiratory events between the period 1970-1979 and the period 1990-1994 from 56% to 39% (<LINK REF="REF-Cheney-1999" TYPE="REFERENCE">Cheney 1999</LINK>). This is thought to be due to improved monitoring including pulse oximetry and capnography (<LINK REF="REF-Cheney-1999" TYPE="REFERENCE">Cheney 1999</LINK>). There is a paucity of an up-to date observational data summary on risks of general anesthesia in first trimester surgical abortions.</P>
<P>In any case, in order to prevent complications, the provider must have a profound respect for the continuum from anxiolysis to unconsciousness. It is imperative that patients be monitored appropriately by qualified personnel who are knowledgeable about pharmacokinetics and pharmacodynamics and who are experienced in airway management resuscitation (<LINK REF="REF-Steele-2005" TYPE="REFERENCE">Steele 2005</LINK>). Therefore, the setting in which abortions take place strongly affects available resources and risks from anesthesia.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2009-01-12 15:20:08 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2009-01-12 15:20:08 +0100" MODIFIED_BY="[Empty name]">
<P>Methods of pain control including local anesthesia, IV sedation, general anesthesia and non-pharmacological methods for first trimester surgical abortion have been studied. Many have been found to effectively decrease pain during and after the procedure while being safe and satisfactory to patients. No major complications were observed in any study. Many patients still find the procedure extremely uncomfortable due to pain with cervical dilation and aspiration, unless given general anesthesia. Given how widely used the PCB is, the paucity of data supporting the benefit of a PCB as shown in this review is surprising and concerning.</P>
<P>Given these findings, factors such as women&#8217;s preference, medical risk factors for anesthesia complications, setting and resources availability should be considered when choosing a method of pain control. Trials were too heterogeneous to be combined in a large meta-analysis.</P>
<P>Considering the small WMD of some significant results, as well as the quality of evidence the strongest evidence supports:</P>
<P>1) Data on the effect of a PCB and buffered lidocaine are conflicting. PCB with local anesthetic such chloroprocaine reduced pain with PCB injection, cervical dilation and aspiration in only one small study, and only when injected at 4 sites, but not when injected at only 2 sites. Another study did not show any benefit of a PCB over no PCB. A deep injection technique seems to reduce pain with cervical dilation and aspiration. Strong evidence supports adding intrauterine 4% lidocaine, but one must be prepared for patients reporting lidocaine exposure sumptoms (i.e. ear ringing).</P>
<P>2) Conscious sedation combined with PCB do not achieve the same pain control as general anesthesia during the procedure, but improved postoperative pain control.</P>
<P>3) General anesthesia ideally consists of a combination of propofol (methohexital, etomidate and thiopentane had very similar results, but have fallen out of favour in many places by now for procedural pain control) with an opioid for postoperative pain control.</P>
<P>4) Premedication for general anesthesia: lornoxicam, IM ketorolac or diclofenac.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2009-01-07 04:57:19 +0100" MODIFIED_BY="[Empty name]">
<P>Future studies should aim for using the same outcomes and study instruments to measure pain in order to increase comparability. In order to establish as to whether the PCB is effective of not, a well designed and large study is needed, comparing PCB to a no treatment arm rather than comparing it to placebo, given that the injection of the PCB itself is painful. More studies should try to compare local anesthesia with conscious sedation and general anesthesia regarding pain during and after the procedure as well as regarding side effects, time until discharge, and satisfaction. The nature of general anesthesia, which achieves complete pain control during the surgery, challenges direct comparison to any other form of anesthesia.</P>
<P>Newer observational data on risks of general anesthesia will further help to improve its adequate risk perception. Such data may revise current recommendations.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-08-11 00:29:57 +0200" MODIFIED_BY="[Empty name]">
<P>Dr. P. Thorborg provided clinical expertise in anesthesia related questions</P>
<P>Translators: Jana Jarosch (Russian), Chiara Ghetti (Italian), Annemarie Renner (French)</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2009-02-11 11:20:44 +0100" MODIFIED_BY="[Empty name]">
<P>Dr. Renner has no conflicts of interest<BR/>Dr. Edelman is a consultant for ScheringPharmaceuticals.<BR/>Dr. Jensen has served on the speakers bureau for Wyeth, Ortho-McNeil, Pfizer, and Bayer Healthcare Laboratories. He also is a member of the Wyeth &amp; Berlex Contraceptive Advisory Boards. He has received grant support form Wyeth, Pfizer, Ortho-McNeil, Symbollon, Warner-Chilcott, and Bayer Healthcare laboratories.<BR/>Dr. Nichols has served on the speakers bureau for Organon and Bayer Healthcare. He received research funding from Conceptus (manufacturer of Essure).</P>
<P>Drs. Edelman, Jensen, and Nichols have been involved with several of the studies included in this review. These studies did not receive pharmaceutical funding.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-08-11 00:32:23 +0200" MODIFIED_BY="[Empty name]">
<P>Dr. Renner performed the literature search, data collection and analysis, and drafted the protocol. </P>
<P>Dr. Edelman performed data collection and analysis, edited and advised on the protocol, and provided clinical expertise.</P>
<P>Dr. Jensen and Dr. Nichols edited and advised on the protocol, and provided clinical expertise.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2009-01-07 04:45:38 +0100" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2009-01-07 04:45:38 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2009-01-07 04:45:38 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Barneschi-1985" MODIFIED="2008-08-15 05:15:04 +0200" MODIFIED_BY="[Empty name]" NAME="Barneschi 1985" YEAR="1985">
<REFERENCE MODIFIED="2008-08-15 05:15:04 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barneschi MG, Calamandrei M, Livi P, Marinelli L, Peduto VA.</AU>
<TI>Anesthesia for outpatient termination of pregnancy: a comparison of anesthetictechniques</TI>
<SO>Acta Anaesthesiologica Italiana</SO>
<YR>1985</YR>
<VL>36</VL>
<NO>3</NO>
<PG>411-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bone-1988" MODIFIED="2008-08-15 05:15:33 +0200" MODIFIED_BY="[Empty name]" NAME="Bone 1988" YEAR="1988">
<REFERENCE MODIFIED="2008-08-15 05:15:33 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bone ME, Wilkins CJ, Lew JK</AU>
<TI>A comparison of propofol and methohexitone as anaesthetic agents for electroconvulsive therapy</TI>
<SO>European Journal of Anaesthesiology</SO>
<YR>1988</YR>
<VL>5</VL>
<NO>4</NO>
<PG>279-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bonnardot-1987" MODIFIED="2008-08-10 21:53:05 +0200" MODIFIED_BY="[Empty name]" NAME="Bonnardot 1987" YEAR="1987">
<REFERENCE MODIFIED="2008-08-10 21:53:05 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bonnardot JP, Maillet M, Brulé ML, Deligné P</AU>
<TI>Ambulatory anesthesia and induced abortion. Comparative study of propofol-alfentanyl and ketamine-midazolam combinations</TI>
<TO>Anesthesie ambulatoire et interruption volontaire de grossesse. Etude comparative des associations propofol-alfentanil et ketamine-midazolam</TO>
<SO>Annales francaises d'anesthesie et de reanimation</SO>
<YR>1987</YR>
<VL>6</VL>
<NO>4</NO>
<PG>297-300</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boysen-1989" MODIFIED="2008-08-10 21:50:26 +0200" MODIFIED_BY="[Empty name]" NAME="Boysen 1989" YEAR="1989">
<REFERENCE MODIFIED="2008-08-10 21:50:26 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boysen K, Sanchez R, Krintel JJ, Hansen M, Haar PM, Dyrberg V</AU>
<TI>Induction and recovery characteristics of propofol, thiopental and etomidate</TI>
<SO>Acta anaesthesiologica Scandinavica</SO>
<YR>1989</YR>
<VL>33</VL>
<NO>8</NO>
<PG>689-92</PG>
<IDENTIFIERS MODIFIED="2008-08-10 21:50:22 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="2589002"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Boysen-1990" MODIFIED="2008-08-10 21:54:37 +0200" MODIFIED_BY="[Empty name]" NAME="Boysen 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-08-10 21:54:37 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Boysen K, Sanchez R, Ravn J, Pedersen E, Krintel JJ, Dyrberg V</AU>
<TI>Comparison of induction with and first hour of recovery from brief propofol and methohexital anesthesia</TI>
<SO>Acta anaesthesiologica Scandinavica</SO>
<YR>1990</YR>
<VL>34</VL>
<NO>3</NO>
<PG>212-5</PG>
<IDENTIFIERS MODIFIED="2008-08-10 21:54:35 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="2343720"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cetin-1997" MODIFIED="2008-08-10 22:00:32 +0200" MODIFIED_BY="[Empty name]" NAME="Cetin 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-08-10 22:00:32 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cetin M, Cetin A</AU>
<TI>The role of transvaginal sonography in predicting recurrent preterm labour in patients with intact membranes</TI>
<SO>European journal of obstetrics, gynecology, and reproductive biology</SO>
<YR>1997</YR>
<VL>74</VL>
<NO>1</NO>
<PG>7-11</PG>
<IDENTIFIERS MODIFIED="2008-08-10 22:00:31 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="9243192"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Collins-1985" MODIFIED="2008-08-15 05:19:22 +0200" MODIFIED_BY="[Empty name]" NAME="Collins 1985" YEAR="1985">
<REFERENCE MODIFIED="2008-08-15 05:16:07 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Collins KM, Plantevin OM, Whitburn RH, Doyle JP</AU>
<TI>Outpatient termination of pregnancy: halothane or alfentanil-supplementedanaesthesia.</TI>
<SO>British Journal of Anaesthiology</SO>
<YR>1985</YR>
<VL>57</VL>
<NO>12</NO>
<PG>1226-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dahl-2000" MODIFIED="2008-08-10 22:04:51 +0200" MODIFIED_BY="[Empty name]" NAME="Dahl 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-08-10 22:04:51 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dahl V, Fjellanger F, Raeder JC</AU>
<TI>No effect of preoperative paracetamol and codeine suppositories for pain after termination of pregnancies in general anaesthesia</TI>
<SO>European journal of pain (London, England)</SO>
<YR>2000</YR>
<VL>4</VL>
<NO>2</NO>
<PG>211-5</PG>
<IDENTIFIERS MODIFIED="2008-08-10 22:04:50 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="10957701"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Edelman-2004" MODIFIED="2008-08-10 22:08:59 +0200" MODIFIED_BY="[Empty name]" NAME="Edelman 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-08-10 22:08:59 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edelman A, Nichols MD, Leclair C, Astley S, Shy K, Jensen JT</AU>
<TI>Intrauterine lidocaine infusion for pain management in first-trimester abortions</TI>
<SO>Obstetrics and gynecology</SO>
<YR>2004</YR>
<VL>103</VL>
<NO>6</NO>
<PG>1267-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Edelman-2006" MODIFIED="2008-08-10 22:08:41 +0200" MODIFIED_BY="[Empty name]" NAME="Edelman 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-08-10 22:08:22 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edelman A, Nichols MD, Leclair C, Jensen JT</AU>
<TI>Four percent intrauterine lidocaine infusion for pain management in first-trimester abortions</TI>
<SO>Obstetrics and gynecology</SO>
<YR>2006</YR>
<VL>107</VL>
<NO>2 Pt 1</NO>
<PG>269-75</PG>
<IDENTIFIERS MODIFIED="2008-08-10 22:08:20 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="16449111"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glantz-2001" MODIFIED="2008-08-10 22:11:50 +0200" MODIFIED_BY="[Empty name]" NAME="Glantz 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-08-10 22:11:19 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glantz JC, Shomento S</AU>
<TI>Comparison of paracervical block techniques during first trimester pregnancy termination</TI>
<SO>International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics</SO>
<YR>2001</YR>
<VL>72</VL>
<NO>2</NO>
<PG>171-8</PG>
<IDENTIFIERS MODIFIED="2008-08-10 22:11:17 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="11166751"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hackett-1982" MODIFIED="2008-08-10 22:14:19 +0200" MODIFIED_BY="[Empty name]" NAME="Hackett 1982" YEAR="1982">
<REFERENCE MODIFIED="2008-08-10 22:14:19 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hackett GH, Harris MN, Plantevin OM, Pringle HM, Garrioch DB, Avery AJ</AU>
<TI>Anaesthesia for outpatient termination of pregnancy. A comparison of two anaesthetic techniques</TI>
<SO>British journal of anaesthesia</SO>
<YR>1982</YR>
<VL>54</VL>
<NO>8</NO>
<PG>865-70</PG>
<IDENTIFIERS MODIFIED="2008-08-10 22:14:16 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="7104136"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hall-1997" MODIFIED="2008-08-10 22:16:11 +0200" MODIFIED_BY="[Empty name]" NAME="Hall 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-08-10 22:16:11 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hall G, Ekblom A, Persson E, Irestedt L</AU>
<TI>Effects of prostaglandin treatment and paracervical blockade on postoperativepain in patients undergoing first trimester abortion in general anesthesia.</TI>
<SO>Acta obstetricia et gynecologica Scandinavica</SO>
<YR>1997</YR>
<VL>76</VL>
<NO>9</NO>
<PG>868-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heath-1989" MODIFIED="2008-08-10 22:20:13 +0200" MODIFIED_BY="[Empty name]" NAME="Heath 1989" YEAR="1989">
<REFERENCE MODIFIED="2008-08-10 22:20:13 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heath PJ, Ogg TW</AU>
<TI>Prophylactic analgesia for daycase termination of pregnancy. A double-blind study with controlled release dihydrocodeine</TI>
<SO>Anaesthesia</SO>
<YR>1989</YR>
<VL>44</VL>
<NO>12</NO>
<PG>991-4</PG>
<IDENTIFIERS MODIFIED="2008-08-10 22:20:12 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="2619027"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hein-1999" MODIFIED="2008-08-15 04:54:58 +0200" MODIFIED_BY="[Empty name]" NAME="Hein 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-08-15 04:54:58 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hein A, Jakobsson J, Ryberg G</AU>
<TI>Paracetamol 1 g given rectally at the end of minor gynaecological surgery is not efficacious in reducing postoperative pain</TI>
<SO>Acta anaesthesiologica Scandinavica</SO>
<YR>1999</YR>
<VL>43</VL>
<NO>3</NO>
<PG>248-51</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:54:52 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="10081528"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hein-2001" MODIFIED="2008-08-15 04:54:20 +0200" MODIFIED_BY="[Empty name]" NAME="Hein 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-08-15 04:54:20 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hein A, Norlander C, Blom L, Jakobsson J</AU>
<TI>Is pain prophylaxis in minor gynaecological surgery of clinical value? a double-blind placebo controlled study of paracetamol 1 g versus lornoxicam 8 mg given orally</TI>
<SO>Ambulatory surgery</SO>
<YR>2001</YR>
<VL>9</VL>
<NO>2</NO>
<PG>91-4</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:54:18 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="11454488"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jakobsson-1991" MODIFIED="2008-08-15 04:57:09 +0200" MODIFIED_BY="[Empty name]" NAME="Jakobsson 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-08-15 04:57:09 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jakobsson J, Davidson S, Andreen M, Westgreen M</AU>
<TI>Opioid supplementation to propofol anaesthesia for outpatient abortion: a comparison between alfentanil, fentanyl and placebo</TI>
<SO>Acta anaesthesiologica Scandinavica</SO>
<YR>1991</YR>
<VL>35</VL>
<NO>8</NO>
<PG>767-70</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:57:08 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="1763599"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jakobsson-1993" MODIFIED="2008-08-15 04:57:29 +0200" MODIFIED_BY="[Empty name]" NAME="Jakobsson 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-08-15 04:57:29 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jakobsson J, Oddby E, Rane K</AU>
<TI>Patient evaluation of four different combinations of intravenous anaesthetics for short outpatient procedures</TI>
<SO>Anaesthesia</SO>
<YR>1993</YR>
<VL>48</VL>
<NO>11</NO>
<PG>1005-7</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:57:29 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8285950"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jakobsson-1995" MODIFIED="2008-08-15 05:27:31 +0200" MODIFIED_BY="[Empty name]" NAME="Jakobsson 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-08-15 05:27:31 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jakobsson J, Rane K</AU>
<TI>Anaesthesia for short outpatient procedures. A comparison between thiopentone and propofol in combination with fentanyl or alfentanil</TI>
<SO>Acta anaesthesiologica Scandinavica</SO>
<YR>1995</YR>
<VL>39</VL>
<NO>4</NO>
<PG>503-7</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:58:00 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="7676787"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jakobsson-1996" MODIFIED="2008-08-15 04:58:20 +0200" MODIFIED_BY="[Empty name]" NAME="Jakobsson 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-08-15 04:58:20 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jakobsson J, Rane K, Davidson S</AU>
<TI>Intramuscular NSAIDS reduce post-operative pain after minor outpatient anaesthesia</TI>
<SO>European journal of anaesthesiology</SO>
<YR>1996</YR>
<VL>13</VL>
<NO>1</NO>
<PG>67-71</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:58:20 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8829939"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kan-2004" MODIFIED="2008-08-10 20:39:02 +0200" MODIFIED_BY="[Empty name]" NAME="Kan 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-08-10 20:39:02 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kan AS, Ng EH, Ho PC</AU>
<TI>The role and comparison of two techniques of paracervical block for pain reliefduring suction evacuation for first-trimester pregnancy termination</TI>
<SO>Contraception</SO>
<YR>2004</YR>
<VL>70</VL>
<NO>2</NO>
<PG>159-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kan-2006" MODIFIED="2008-08-10 22:31:31 +0200" MODIFIED_BY="[Empty name]" NAME="Kan 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-08-10 22:31:31 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kan AS, Caves N, Wong SY, Ng EH, Ho PC.</AU>
<TI>A double-blind, randomized controlled trial on the use of a 50:50 mixture ofnitrous oxide/oxygen in pain relief during suction evacuation for the firsttrimester pregnancy termination</TI>
<SO>Human Reproduction</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>10</NO>
<PG>2606-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2003" MODIFIED="2008-08-10 20:40:13 +0200" MODIFIED_BY="[Empty name]" NAME="Li 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-08-10 20:40:13 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li CF, Wong CY, Chan CP, Ho PC</AU>
<TI>A study of co-treatment of nonsteroidal anti-inflammatory drugs (NSAIDs) withmisoprostol for cervical priming before suction termination of first trimesterpregnancy</TI>
<SO>Contraception</SO>
<YR>2003</YR>
<VL>67</VL>
<NO>2</NO>
<PG>101-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li-2006" MODIFIED="2008-08-10 22:31:50 +0200" MODIFIED_BY="[Empty name]" NAME="Li 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-08-10 22:31:50 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li HW, Wong CY, Lo SS, Fan SY</AU>
<TI>Effect of local lignocaine gel application for pain relief during suctiontermination of first-trimester pregnancy: a randomized controlled trial</TI>
<SO>Human Reproduction</SO>
<YR>2006</YR>
<VL>21</VL>
<NO>6</NO>
<PG>1461-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindholm-1994" MODIFIED="2008-08-15 04:59:13 +0200" MODIFIED_BY="[Empty name]" NAME="Lindholm 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-08-15 04:59:13 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindholm P, Helbo-Hansen HS, Jensen B, Bulow K, Nielsen TG</AU>
<TI>Effects of fentanyl or alfentanil as supplement to propofol anaesthesia for termination of pregnancy</TI>
<SO>Acta anaesthesiologica Scandinavica</SO>
<YR>1994</YR>
<VL>38</VL>
<NO>6</NO>
<PG>545-9</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:59:10 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="7976143"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2005" MODIFIED="2008-08-15 05:22:36 +0200" MODIFIED_BY="[Empty name]" NAME="Liu 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-08-15 05:22:30 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu W, Loo CC, Chiu JW, Tan HM, Ren HZ, Lim Y</AU>
<TI>Analgesic efficacy of pre-operative etoricoxib for termination of pregnancy in an ambulatory centre</TI>
<SO>Singapore medical journal</SO>
<YR>2005</YR>
<VL>46</VL>
<NO>8</NO>
<PG>397-400</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:22:29 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="16049609"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marc-2007" MODIFIED="2008-08-10 20:44:03 +0200" MODIFIED_BY="[Empty name]" NAME="Marc 2007" YEAR="2007">
<REFERENCE MODIFIED="2008-08-10 20:44:03 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marc I, Rainville P, Verreault R, Vaillancourt L, Masse B, Dodin S</AU>
<TI>The use of hypnosis to improve pain management during voluntary interruption ofpregnancy: an open randomized preliminary study</TI>
<SO>Contraception</SO>
<YR>2007</YR>
<VL>75</VL>
<NO>1</NO>
<PG>52-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ogg-1983" MODIFIED="2008-08-15 05:01:01 +0200" MODIFIED_BY="[Empty name]" NAME="Ogg 1983" YEAR="1983">
<REFERENCE MODIFIED="2008-08-15 05:01:01 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ogg TW, Jennings RA, Morrison CG</AU>
<TI>Day-case anaesthesia for termination of pregnancy. Evaluation of a total intravenous anaesthetic technique</TI>
<SO>Anaesthesia</SO>
<YR>1983</YR>
<VL>38</VL>
<NO>11</NO>
<PG>1042-6</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:01:01 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="6638451"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Phair-2002" MODIFIED="2008-08-15 05:23:04 +0200" MODIFIED_BY="[Empty name]" NAME="Phair 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-08-15 05:23:04 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Phair N, Jensen JT, Nichols MD</AU>
<TI>Paracervical block and elective abortion: the effect on pain of waiting betweeninjection and procedure</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2002</YR>
<VL>186</VL>
<NO>6</NO>
<PG>1304-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Raeder-1992" MODIFIED="2008-08-15 05:01:36 +0200" MODIFIED_BY="[Empty name]" NAME="Raeder 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-08-15 05:01:36 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Raeder JC</AU>
<TI>Propofol anaesthesia versus paracervical blockade with alfentanil and midazolam sedation for outpatient abortion</TI>
<SO>Acta anaesthesiologica Scandinavica</SO>
<YR>1992</YR>
<VL>36</VL>
<NO>1</NO>
<PG>31-7</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:01:35 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="1539476"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rossi-1995" MODIFIED="2008-08-15 05:23:37 +0200" MODIFIED_BY="[Empty name]" NAME="Rossi 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-08-15 05:23:37 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rossi AE, Lo Sapio D, Oliva O, Vitale O, Ebano A</AU>
<TI>Hospital day-surgery: comparative evaluation of 3 general anesthesia techniques</TI>
<TO>Day hospital chirurgico: valutazione comparative di tre tecniche di anestesia generale</TO>
<SO>Minerva Anestesiologica</SO>
<YR>1995</YR>
<VL>61</VL>
<NO>6</NO>
<PG>265-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shapiro-1975" MODIFIED="2008-08-15 05:01:59 +0200" MODIFIED_BY="[Empty name]" NAME="Shapiro 1975" YEAR="1975">
<REFERENCE MODIFIED="2008-08-15 05:01:59 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shapiro AG, Cohen H</AU>
<TI>Auxiliary pain relief during suction curettage</TI>
<SO>Contraception</SO>
<YR>1975</YR>
<VL>11</VL>
<NO>1</NO>
<PG>25-30</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:01:57 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="1116357"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Suprapto-1984" MODIFIED="2008-08-15 05:24:04 +0200" MODIFIED_BY="[Empty name]" NAME="Suprapto 1984" YEAR="1984">
<REFERENCE MODIFIED="2008-08-15 05:24:04 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Suprapto K, Reed S</AU>
<TI>Naproxen sodium for pain relief in first-trimester abortion</TI>
<SO>American Journal of Obstetics and Gynecology</SO>
<YR>1984</YR>
<VL>150</VL>
<NO>8</NO>
<PG>1000-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wells-1989" MODIFIED="2008-08-15 05:05:52 +0200" MODIFIED_BY="[Empty name]" NAME="Wells 1989" YEAR="1989">
<REFERENCE MODIFIED="2008-08-15 05:05:52 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wells N</AU>
<TI>Management of pain during abortion</TI>
<SO>Journal of advanced nursing</SO>
<YR>1989</YR>
<VL>14</VL>
<NO>1</NO>
<PG>56-62</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:05:49 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="2647807"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wells-1992" MODIFIED="2008-08-10 22:58:05 +0200" MODIFIED_BY="[Empty name]" NAME="Wells 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-08-10 22:58:05 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wells N</AU>
<TI>Reducing distress during abortion: a test of sensory information</TI>
<SO>Journal of Advanced Nursing</SO>
<YR>1992</YR>
<VL>17</VL>
<NO>9</NO>
<PG>1050-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wiebe-1992" MODIFIED="2008-08-15 05:04:27 +0200" MODIFIED_BY="[Empty name]" NAME="Wiebe 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-08-15 05:04:27 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wiebe ER</AU>
<TI>Comparison of the efficacy of different local anesthetics and techniques of local anesthesia in therapeutic abortions</TI>
<SO>American journal of obstetrics and gynecology</SO>
<YR>1992</YR>
<VL>167</VL>
<NO>1</NO>
<PG>131-4</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:04:26 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="1442914"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wiebe-1995" MODIFIED="2008-08-15 05:26:29 +0200" MODIFIED_BY="[Empty name]" NAME="Wiebe 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-08-15 05:26:29 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wiebe ER, Rawling M</AU>
<TI>Pain control in abortion</TI>
<SO>International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics</SO>
<YR>1995</YR>
<VL>50</VL>
<NO>1</NO>
<PG>41-6</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:26:28 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="7556858"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wiebe-1996" MODIFIED="2008-08-15 05:26:50 +0200" MODIFIED_BY="[Empty name]" NAME="Wiebe 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-08-15 05:26:50 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wiebe ER, Rawling M, Janssen P</AU>
<TI>Comparison of 0.5% and 1.0% lidocaine for abortions</TI>
<SO>International Journal of Gynaecology and Obstetrics</SO>
<YR>1996</YR>
<VL>55</VL>
<NO>1</NO>
<PG>71-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wiebe-2003" MODIFIED="2008-08-15 05:07:10 +0200" MODIFIED_BY="[Empty name]" NAME="Wiebe 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-08-15 05:07:10 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wiebe E, Podhradsky L, Dijak V</AU>
<TI>The effect of lorazepam on pain and anxiety in abortion</TI>
<SO>Contraception</SO>
<YR>2003</YR>
<VL>67</VL>
<NO>3</NO>
<PG>219-21</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:07:10 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="12618257"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wong-2002" MODIFIED="2008-08-10 23:00:52 +0200" MODIFIED_BY="[Empty name]" NAME="Wong 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-08-10 23:00:52 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wong CY, Ng EH, Ngai SW, Ho PC</AU>
<TI>A randomized, double blind, placebo-controlled study to investigate the use ofconscious sedation in conjunction with paracervical block for reducing pain intermination of first trimester pregnancy by suction evacuation</TI>
<SO>Human Reproduction</SO>
<YR>2002</YR>
<VL>17</VL>
<NO>5</NO>
<PG>1222-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2009-01-07 04:45:38 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Andolsek-1977" MODIFIED="2008-08-15 04:50:56 +0200" MODIFIED_BY="[Empty name]" NAME="Andolsek 1977" YEAR="1977">
<REFERENCE MODIFIED="2008-08-15 04:50:56 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Andolsek L, Cheng M, Hren M, Ogrinc-Oven M, Ng A, Ratnam S, et al</AU>
<TI>The safety of local anesthesia and outpatient treatment: a controlled study of induced abortion by vacuum aspiration</TI>
<SO>Studies in family planning</SO>
<YR>1977</YR>
<VL>8</VL>
<NO>5</NO>
<PG>118-24</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:50:52 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="867453"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bonazzi-1987" MODIFIED="2008-08-15 05:11:28 +0200" MODIFIED_BY="[Empty name]" NAME="Bonazzi 1987" YEAR="1987">
<REFERENCE MODIFIED="2008-08-15 05:11:28 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bonazzi M, Laveneziana D, Riva A, Vitali C</AU>
<TI>Clotiazepam vs flunitrazepam in premedication in a day hospital regimen</TI>
<TO>Clotiazepam vs flunitrazepam nella premedicazione in regime di day-hospital.</TO>
<SO>Minerva anestesiologica</SO>
<YR>1987</YR>
<VL>53</VL>
<NO>12</NO>
<PG>689-92</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:11:28 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="2901054"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bonazzi-1994" MODIFIED="2008-08-15 04:51:39 +0200" MODIFIED_BY="[Empty name]" NAME="Bonazzi 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-08-15 04:51:39 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bonazzi M, Riva A, Marsicano M, Prampolini F, Speranza R, Andriolli A, et al</AU>
<TI>Trazodone versus flunitrazepam in premedication in day-care surgery</TI>
<TO>Trazodone versus flunitrazepam nella premedicazione in regime di ricovero giornaliero.</TO>
<SO>Minerva anestesiologica</SO>
<YR>1994</YR>
<VL>60</VL>
<NO>3</NO>
<PG>115-21</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:51:37 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8090301"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cade-1993" MODIFIED="2008-08-15 05:09:49 +0200" MODIFIED_BY="[Empty name]" NAME="Cade 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-08-15 05:09:49 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cade L, Ashley J</AU>
<TI>Prophylactic paracetamol for analgesia after vaginal termination of pregnancy</TI>
<SO>Anaesthesia and intensive care</SO>
<YR>1993</YR>
<VL>21</VL>
<NO>1</NO>
<PG>93-6</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:09:48 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8447616"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ciri-1986" MODIFIED="2008-08-15 04:52:45 +0200" MODIFIED_BY="[Empty name]" NAME="Ciri 1986" YEAR="1986">
<REFERENCE MODIFIED="2008-08-15 04:52:45 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ciri F, Berioli M, Bifarini G, Pucci C, Gorietti A, Ballatori E</AU>
<TI>Various pharmacologic combinations in anesthesia for voluntary abortions in day hospitals</TI>
<TO>Associazioni farmacologiche diverse nell'anestesia per l'interruzione volontaria della gravidanza in regime di day-hospital.</TO>
<SO>Minerva anestesiologica</SO>
<YR>1986</YR>
<VL>52</VL>
<NO>1-2</NO>
<PG>15-8</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:52:43 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="3736909"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coad-1986" MODIFIED="2008-08-15 05:28:02 +0200" MODIFIED_BY="[Empty name]" NAME="Coad 1986" YEAR="1986">
<REFERENCE MODIFIED="2008-08-15 05:28:02 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coad NR, Mills PJ, Verma R, Ramasubramanian R</AU>
<TI>Evaluation of blood loss during suction termination of pregnancy: ketaminecompared with methohexitone</TI>
<SO>Acta anaesthesiologica Scandinavica</SO>
<YR>1986</YR>
<VL>30</VL>
<NO>3</NO>
<PG>253-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Corli-1984" MODIFIED="2008-08-15 04:53:06 +0200" MODIFIED_BY="[Empty name]" NAME="Corli 1984" YEAR="1984">
<REFERENCE MODIFIED="2008-08-15 04:53:06 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Corli O, Roma G, Bacchini M, Battagliarin G, Di Piazza D, Brambilla C, et al</AU>
<TI>Double-blind placebo-controlled trial of baclofen, alone and in combination, in patients undergoing voluntary abortion</TI>
<SO>Clinical therapeutics</SO>
<YR>1984</YR>
<VL>6</VL>
<NO>6</NO>
<PG>800-7</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:53:06 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="6391666"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Crawford-1984" MODIFIED="2008-08-15 05:30:15 +0200" MODIFIED_BY="[Empty name]" NAME="Crawford 1984" YEAR="1984">
<REFERENCE MODIFIED="2008-08-15 05:30:09 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Crawford ME, Carl P, Andersen RS, Mikkelsen BO</AU>
<TI>Comparison between midazolam and thiopentone-based balanced anaesthesia for day-case surgery</TI>
<SO>British journal of anaesthesia</SO>
<YR>1984</YR>
<VL>56</VL>
<NO>2</NO>
<PG>165-9</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:30:08 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="6691877"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Edelist-1987" MODIFIED="2008-08-15 05:12:10 +0200" MODIFIED_BY="[Empty name]" NAME="Edelist 1987" YEAR="1987">
<REFERENCE MODIFIED="2008-08-15 05:12:10 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Edelist G</AU>
<TI>A comparison of propofol and thiopentone as induction agents in outpatient surgery</TI>
<SO>Canadian journal of anaesthesia = Journal canadien d'anesthesie</SO>
<YR>1987</YR>
<VL>34</VL>
<NO>2</NO>
<PG>110-6</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:12:09 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="3493852"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Enlund-1996" MODIFIED="2008-08-15 05:07:54 +0200" MODIFIED_BY="[Empty name]" NAME="Enlund 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-08-15 05:07:54 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Enlund M, Kobosko P, Rhodin A</AU>
<TI>A cost-benefit evaluation of using propofol and alfentanil for a short gynecological procedure</TI>
<SO>Acta anaesthesiologica Scandinavica</SO>
<YR>1996</YR>
<VL>40</VL>
<NO>4</NO>
<PG>416-20</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:07:54 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8738684"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eriksson-1995" MODIFIED="2008-08-15 04:53:31 +0200" MODIFIED_BY="[Empty name]" NAME="Eriksson 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-08-15 04:53:31 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eriksson H, Haasio J, Korttila K</AU>
<TI>Comparison of eltanolone and thiopental in anaesthesia for termination of pregnancy</TI>
<SO>Acta anaesthesiologica Scandinavica</SO>
<YR>1995</YR>
<VL>39</VL>
<NO>4</NO>
<PG>479-84</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:53:29 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="7676782"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Erkola-1990" MODIFIED="2008-08-15 05:30:39 +0200" MODIFIED_BY="[Empty name]" NAME="Erkola 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-08-15 05:30:39 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Erkola O</AU>
<TI>Effects of precurarisation on suxamethonium-induced postoperative myalgia during the first trimester of pregnancy</TI>
<SO>Acta Anaesthesiologica Scandinavica</SO>
<YR>1990</YR>
<VL>34</VL>
<NO>1</NO>
<PG>63-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hamar-1989" MODIFIED="2008-08-15 04:53:56 +0200" MODIFIED_BY="[Empty name]" NAME="Hamar 1989" YEAR="1989">
<REFERENCE MODIFIED="2008-08-15 04:53:56 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hamar O, Garamvolgyi G, Kalman A</AU>
<TI>Fentanyl-midazolam-flumazenil anesthesia for induced abortion</TI>
<SO>International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics</SO>
<YR>1989</YR>
<VL>30</VL>
<NO>1</NO>
<PG>69-72</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:53:54 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="2572477"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jakobbson-1990" MODIFIED="2008-08-15 04:55:59 +0200" MODIFIED_BY="[Empty name]" NAME="Jakobbson 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-08-15 04:55:59 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jakobbson J, Andreen M, Westgren M, Thomasson K</AU>
<TI>Discomfort after outpatient abortion using paracervical block: a comparison between two opioids and one non-opioid drug for premedication</TI>
<SO>Gynecologic and obstetric investigation</SO>
<YR>1990</YR>
<VL>30</VL>
<NO>2</NO>
<PG>71-4</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:55:51 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="2245951"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kallela-1994" MODIFIED="2008-08-15 04:58:50 +0200" MODIFIED_BY="[Empty name]" NAME="Kallela 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-08-15 04:58:50 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kallela H, Haasio J, Korttila K</AU>
<TI>Comparison of eltanolone and propofol in anesthesia for termination of pregnancy</TI>
<SO>Anesthesia and analgesia</SO>
<YR>1994</YR>
<VL>79</VL>
<NO>3</NO>
<PG>512-6</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:58:50 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="8067557"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lichtenberg-2003" MODIFIED="2008-08-10 20:59:32 +0200" MODIFIED_BY="[Empty name]" NAME="Lichtenberg 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-08-10 20:59:32 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lichtenberg ES, Hill LJ, Howe M, Heber W, Peipert JF</AU>
<TI>A randomized comparison of propofol and methohexital as general anesthetics for vacuum abortion</TI>
<SO>Contraception</SO>
<YR>2003</YR>
<VL>68</VL>
<NO>3</NO>
<PG>211-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lowenstein-2006" MODIFIED="2008-08-10 21:00:42 +0200" MODIFIED_BY="[Empty name]" NAME="Lowenstein 2006" YEAR="2006">
<REFERENCE MODIFIED="2008-08-10 21:00:42 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lowenstein L, Granot M, Tamir A, Glik A, Deutsch M, Jakobi P, Zimmer EZ</AU>
<TI>Efficacy of suppository analgesia in postabortion pain reduction</TI>
<SO>Contraception</SO>
<YR>2006</YR>
<VL>74</VL>
<NO>4</NO>
<PG>345-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Matambo-1999" MODIFIED="2008-08-15 04:59:33 +0200" MODIFIED_BY="[Empty name]" NAME="Matambo 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-08-15 04:59:33 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Matambo J, Moodley J, Chigumadzi P</AU>
<TI>Analgesia for termination of pregnancy</TI>
<SO>South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde</SO>
<YR>1999</YR>
<VL>89</VL>
<NO>8</NO>
<PG>816</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:59:32 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="10488349"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miller-1996" MODIFIED="2009-01-07 04:45:38 +0100" MODIFIED_BY="[Empty name]" NAME="Miller 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-01-07 04:45:38 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miller L, Jensen MP, Stenchever MA</AU>
<TI>A double-blind randomized comparison of lidocaine and saline for cervical anesthesia</TI>
<SO>Obstetrics and gynecology</SO>
<YR>1996</YR>
<VL>87</VL>
<NO>4</NO>
<PG>600-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="PUBMED" VALUE="8602315"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nielsen-1975" MODIFIED="2008-08-15 04:59:57 +0200" MODIFIED_BY="[Empty name]" NAME="Nielsen 1975" YEAR="1975">
<REFERENCE MODIFIED="2008-08-15 04:59:57 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nielsen JB, Madsen OG, Campbell UD</AU>
<TI>Diazepam as a sedative in induced abortion</TI>
<SO>Acta obstetricia et gynecologica Scandinavica</SO>
<YR>1975</YR>
<VL>54</VL>
<NO>3</NO>
<PG>237-9</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:59:57 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="1099860"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Parkash-1979" MODIFIED="2008-08-15 05:31:32 +0200" MODIFIED_BY="[Empty name]" NAME="Parkash 1979" YEAR="1979">
<REFERENCE MODIFIED="2008-08-15 05:31:32 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Parkash A, Do Rosario YP</AU>
<TI>Effect of anaesthesia on the blood loss in first trimester medical termination ofpregnancies</TI>
<SO>Journal of Obstetics and Gynaecology India</SO>
<YR>1979</YR>
<VL>29</VL>
<NO>6</NO>
<PG>1128-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peters-1978" MODIFIED="2008-08-15 05:08:23 +0200" MODIFIED_BY="[Empty name]" NAME="Peters 1978" YEAR="1978">
<REFERENCE MODIFIED="2008-08-15 05:08:23 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peters FD, Hirsch HA</AU>
<TI>Comparison between intra and para cervical anaesthesia in therapeutic abortion (author's transl)</TI>
<TO>Vergleich von Intra- und Parazervikal-Anasthesie beim Schwangerschaftsabbruch.</TO>
<SO>Geburtshilfe und Frauenheilkunde</SO>
<YR>1978</YR>
<VL>38</VL>
<NO>11</NO>
<PG>946-9</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:08:23 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="710880"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rawling-2001" MODIFIED="2008-08-15 05:32:02 +0200" MODIFIED_BY="[Empty name]" NAME="Rawling 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-08-15 05:32:02 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rawling MJ, Wiebe ER</AU>
<TI>A randomized controlled trial of fentanyl for abortion pain</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2001</YR>
<VL>185</VL>
<NO>1</NO>
<PG>103-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sanders-1984" MODIFIED="2008-08-15 05:34:03 +0200" MODIFIED_BY="[Empty name]" NAME="Sanders 1984" YEAR="1984">
<REFERENCE MODIFIED="2008-08-15 05:34:03 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sanders RS, Sinclair ME, Sear JW</AU>
<TI>Alfentanil in short procedures. A comparison with halothane using etomidate or methohexitone for induction of anaesthesia</TI>
<SO>Anaesthesia</SO>
<YR>1984</YR>
<VL>39</VL>
<NO>12</NO>
<PG>1202-6</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:34:01 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="6440446"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schoeffler-1987" MODIFIED="2008-08-15 05:06:17 +0200" MODIFIED_BY="[Empty name]" NAME="Schoeffler 1987" YEAR="1987">
<REFERENCE MODIFIED="2008-08-15 05:06:17 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schoeffler P, Monteillard C, Ginzac G, Forestier B, Haberer JP</AU>
<TI>The use of isoflurane in brief anesthesia for voluntary interruption of pregnancy</TI>
<TO>Utilisation de l'isoflurane lors d'anesthesies breves pour interruption volontaire de grossesse.</TO>
<SO>Cahiers d'anesthesiologie</SO>
<YR>1987</YR>
<VL>35</VL>
<NO>2</NO>
<PG>83-6</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:06:17 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="3607584"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Verma-1985" MODIFIED="2008-08-15 05:35:34 +0200" MODIFIED_BY="[Empty name]" NAME="Verma 1985" YEAR="1985">
<REFERENCE MODIFIED="2008-08-15 05:35:34 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Verma R, Ramasubramanian R, Sachar RM</AU>
<TI>Anesthesia for termination of pregnancy: midazolam compared with methohexital</TI>
<SO>Anesthesia and analgesia</SO>
<YR>1985</YR>
<VL>64</VL>
<NO>8</NO>
<PG>792-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-West-1985" MODIFIED="2008-08-15 05:10:50 +0200" MODIFIED_BY="[Empty name]" NAME="West 1985" YEAR="1985">
<REFERENCE MODIFIED="2008-08-15 05:10:50 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>West SL, Moore CA, Gillard M, Browne PD</AU>
<TI>Anaesthesia for suction termination of pregnancy</TI>
<SO>Anaesthesia</SO>
<YR>1985</YR>
<VL>40</VL>
<NO>7</NO>
<PG>669-72</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:10:49 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="4025771"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wiebe-2005" MODIFIED="2008-08-15 05:35:51 +0200" MODIFIED_BY="[Empty name]" NAME="Wiebe 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-08-15 05:35:51 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wiebe ER, Trouton KJ, Savoy E</AU>
<TI>Intra-cervical versus i.v. fentanyl for abortion</TI>
<SO>Human Reproduction</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>7</NO>
<PG>2025-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Willdeck_x002d_Lund-1975" MODIFIED="2008-08-15 05:12:30 +0200" MODIFIED_BY="[Empty name]" NAME="Willdeck-Lund 1975" YEAR="1975">
<REFERENCE MODIFIED="2008-08-15 05:12:30 +0200" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Willdeck-Lund G, Zador G</AU>
<TI>Paracervical block with etidocaine for out-patient abortion</TI>
<SO>Acta anaesthesiologica Scandinavica. Supplementum</SO>
<YR>1975</YR>
<VL>60</VL>
<PG>106-9</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:12:29 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="1101603"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-08-22 06:09:29 +0200" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2008-08-22 06:09:29 +0200" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Bartlett-2004" NAME="Bartlett 2004" TYPE="JOURNAL_ARTICLE">
<AU>Bartlett LA, Berg CJ, Shulman HB, Zane SB, Green CA, Whitehead S, Atrash HK</AU>
<TI>Risk factors for legal induced abortion-related mortality in the United States</TI>
<SO>Obstetrics and Gynecolology</SO>
<YR>2004</YR>
<VL>103</VL>
<NO>4</NO>
<PG>729-37</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Belanger-1989" NAME="Belanger 1989" TYPE="JOURNAL_ARTICLE">
<AU>Belanger E, Melzack R, Lauzon P</AU>
<TI>Pain of first-trimester abortion: a study of psychosocial and medical predictors</TI>
<SO>Pain</SO>
<YR>1989</YR>
<VL>36</VL>
<PG>339-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Borgotta-1997" NAME="Borgotta 1997" TYPE="JOURNAL_ARTICLE">
<AU>Borgotta L, Nickinovich D</AU>
<TI>Pain during early abortion</TI>
<SO>The Journal of Reproductive Medicine</SO>
<YR>1997</YR>
<VL>42</VL>
<PG>287-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cheney-1999" MODIFIED="2008-08-15 04:52:22 +0200" MODIFIED_BY="[Empty name]" NAME="Cheney 1999" TYPE="JOURNAL_ARTICLE">
<AU>Cheney FW</AU>
<TI>The American Society of Anesthesiologists Closed Claims Project: what have we learned, how has it affected practice, and how will it affect practice in the future?</TI>
<SO>Anesthesiology</SO>
<YR>1999</YR>
<VL>91</VL>
<NO>2</NO>
<PG>552-6</PG>
<IDENTIFIERS MODIFIED="2008-08-15 04:52:19 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="10443619"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Grimes-1979" NAME="Grimes 1979" TYPE="JOURNAL_ARTICLE">
<AU>Grimes DA, Schulz KF, Cates W, JR, Tyler CW, JR</AU>
<TI>Local versus general anesthesia: which is safer for performing suction curettage abortions?</TI>
<SO>American Journal of Obstetrics and Gynecololgy</SO>
<YR>1979</YR>
<VL>135</VL>
<PG>1030-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hakim_x002d_Elahi-1990" MODIFIED="2008-08-17 18:49:08 +0200" MODIFIED_BY="[Empty name]" NAME="Hakim-Elahi 1990" TYPE="JOURNAL_ARTICLE">
<AU>Hakim-Elahi E, Tovell HM, Burnhill MS</AU>
<TI>Complications of first-trimester abortion: a report of 170,000 cases</TI>
<SO>Obstetrics and gynecology</SO>
<YR>1990</YR>
<VL>76</VL>
<NO>1</NO>
<PG>129-35</PG>
<IDENTIFIERS MODIFIED="2008-08-17 18:49:04 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="2359559"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Koonin-2000" NAME="Koonin 2000" TYPE="OTHER">
<AU>Koonin LM, Strauss LT, Chrisman CE, Parker WY</AU>
<TI>Abortion surveillance--United States, 1997</TI>
<SO>Morbidity &amp; Mortality Weekly Report. CDC Surveillance Summaries</SO>
<YR>2000, Dec 8</YR>
<VL>49</VL>
<NO>11</NO>
<PG>1-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lawson-1994" NAME="Lawson 1994" TYPE="JOURNAL_ARTICLE">
<AU>Lawson HW, Frye A, Atrash HK, Smith JC, Shulman HB, Ramick M</AU>
<TI>Abortion mortality, United States, 1972 through 1987</TI>
<SO>American Journal of Obstetrics and Gynecolology</SO>
<YR>1994</YR>
<VL>171</VL>
<PG>1365-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lichtenberg-2001" MODIFIED="2008-08-17 19:03:15 +0200" MODIFIED_BY="[Empty name]" NAME="Lichtenberg 2001" TYPE="JOURNAL_ARTICLE">
<AU>Lichtenberg ES, Paul M, Jones H</AU>
<TI>First trimester surgical abortion practices: a survey of National Abortion Federation members</TI>
<SO>Contraception</SO>
<YR>2001</YR>
<VL>64</VL>
<NO>6</NO>
<PG>345-52</PG>
<IDENTIFIERS MODIFIED="2008-08-17 19:03:13 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="11834232"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Maltzer-1999" NAME="Maltzer 1999" TYPE="BOOK">
<AU>Maltzer DS, Maltzer MC, Wiebe ER, Halvorson-Boyd G, Boyd C</AU>
<TI>Pain management</TI>
<SO>A clinicinan's guide to medical and surgical abortion</SO>
<YR>1999</YR>
<PG>73-89</PG>
<ED>Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG</ED>
<PB>Philadelphia. PA: Churchill Livingstone</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rawling-1998" NAME="Rawling 1998" TYPE="JOURNAL_ARTICLE">
<AU>Rawling MJ, Wiebe ER</AU>
<TI>Pain control in abortion clinics</TI>
<SO>International Journal of Gynaecology &amp; Obstetrics</SO>
<YR>1998</YR>
<VL>60</VL>
<NO>3</NO>
<PG>293-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RCOG-2004" MODIFIED="2008-08-10 23:43:11 +0200" MODIFIED_BY="[Empty name]" NAME="RCOG 2004" TYPE="OTHER">
<AU>Royal College of Obstetricians and Gynaecologists</AU>
<TI>The Care of Women Requesting Induced Abortion</TI>
<SO>http://www.rcog.org.uk/resources/Public/pdf/induced_abortionfull.pdf</SO>
<YR>2004</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Scott-1976" NAME="Scott 1976" TYPE="JOURNAL_ARTICLE">
<AU>Scott J, Huskisson EC</AU>
<TI>Graphic representation of pain</TI>
<SO>Pain</SO>
<YR>1976</YR>
<VL>2</VL>
<PG>175-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smith-1979" NAME="Smith 1979" TYPE="JOURNAL_ARTICLE">
<AU>Smith GM, Stubblefield PG, Chirchirillo L, McCarthy MJ</AU>
<TI>Pain of first-trimester abortion: its quantification and relations with other variables</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1979</YR>
<VL>133</VL>
<PG>489-98</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smith-1991" NAME="Smith 1991" TYPE="JOURNAL_ARTICLE">
<AU>Smith RP, Heltzel JA</AU>
<TI>Interrelation of analgesia and uterine activity in women with primary dysmenorrhea. A preliminary report</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1991</YR>
<VL>36</VL>
<PG>260-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Steele-2005" NAME="Steele 2005" TYPE="BOOK">
<AU>Steele M, Nielsen KC, Klein SM</AU>
<SO>Ambulatory Anesthesia Perioperative Analgesia</SO>
<YR>2005</YR>
<PB>McGraw-Hill</PB>
<IDENTIFIERS>
<IDENTIFIER TYPE="OTHER" VALUE="ISBN: 0-07-141240-9"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Strauss-2007" MODIFIED="2008-08-15 05:02:49 +0200" MODIFIED_BY="[Empty name]" NAME="Strauss 2007" TYPE="JOURNAL_ARTICLE">
<AU>Strauss LT, Gamble SB, Parker WY, Cook DA, Zane SB, Hamdan S</AU>
<TI>Abortion surveillance--United States, 2004</TI>
<SO>MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries / CDC</SO>
<YR>2007</YR>
<VL>56</VL>
<NO>9</NO>
<PG>1-33</PG>
<IDENTIFIERS MODIFIED="2008-08-15 05:02:47 +0200" MODIFIED_BY="[Empty name]">
<IDENTIFIER TYPE="PUBMED" VALUE="18030283"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Stubblefield-1989" NAME="Stubblefield 1989" TYPE="JOURNAL_ARTICLE">
<AU>Stubblefield PG</AU>
<TI>Control of pain for women undergoing abortion</TI>
<SO>Supplement for International Journal of Gynaecology &amp; Obstetrics</SO>
<YR>1989</YR>
<VL>3</VL>
<PG>131-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2003" MODIFIED="2008-08-10 23:49:08 +0200" MODIFIED_BY="[Empty name]" NAME="WHO 2003" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Safe Abortion:Technical and Policy Guidance for Health Systems</TI>
<SO>http://www.who.int/reproductive-health/publications/safe_abortion/safe_abortion.pdf</SO>
<YR>2003</YR>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2008-08-10 23:45:13 +0200" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2009-01-07 04:45:58 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2009-01-07 04:45:38 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2009-01-06 02:57:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barneschi-1985">
<CHAR_METHODS>
<P>Randomized controlled trial. Hospital in Firenze, Italy.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-07-13 22:28:54 +0200" MODIFIED_BY="[Empty name]">
<P>60 pregnant women. Age: 17-44 years. ASA I or II. Elective pregnancy termination. Gestational age 7-12 weeks.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-01-06 02:57:35 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: fentanyl 1.5mcg/kg IV two minutes prior to induction with thiopentone sodium 5mg/kg IV; maintenance with N2O 60% in O2 via mask and assisted breathing.<BR/>Group 2: ketamine 2mg/kg and diazepam 0.1mg/kg IV; maintenance with N2O 60% in O2 via mask and assisted breathing.<BR/>Group3: thiopentone sodium 5mg/kg IV; maintenance with N2O60% in O2 and enflurane 2.5% after complete cervical dilation via mask and assisted breathing<BR/>Group 4: thiopentone sodium 5mg/kg IV; maintenance with N2O60% in O2 and halotane 2% after complete cervical dilation via mask and assisted breathing<BR/>All participants: premedication with atropine 0.02mg/kg IM 45 minutes prior to the procedure. Vacuum aspiration with or without sharp curettage.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-01-06 02:57:36 +0100" MODIFIED_BY="[Empty name]">
<P>Psychomotor recovery time with Zazzo's test of "deux barrages" and the matrix attentive test. Anesthesia time.<BR/>Intraoperative side-effects: introperative movement.<BR/>Postoperative side-effects: strong abdominal pain, headache, nausea, vomiting, agitation at awakening (all yes/no).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No power analysis done. Randomization method and blinding not further described.<BR/>Per e-mail communication with Dr. Barneschi: Study length 4 months. Randomization with computer tables. Allocation concealment with envelope technique. Blinding of participants and outcome assessor. Vacuum aspiration. No industry sponsorship.<BR/>No major complication reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-07-13 22:31:08 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bone-1988">
<CHAR_METHODS>
<P>Randomized double-blind controlled trial. Leicester Royal Infirmary, Leicester, UK</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-07-13 22:31:08 +0200" MODIFIED_BY="[Empty name]">
<P>40 pregnant women. Age: 16-40 years. ASA I and II. Gestational week up to 12 weeks. Exclusion criteria: history of asthma, drug allergy or sensitivity to opioids.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: nalbuphine 0.25 mg/kg IV.<BR/>Group 2: fentanyl 1.5mcg/kg IV. <BR/>All participants: No premedication.<BR/>One minute after opioid anesthesia was induced in both groups with thiopentone 3-4mg/kg. Maintenance with Bain breathing system with 66% nitrous oxide in oxygen and supplementation with enflurane as needed. Syntocinon 10units IV at onset of cervical dilation. Postoperative analgesia with paracetamol 1g orally 6 hourly.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Postoperative pain reported on a 10cm horizontal linear analog scale at 1, 2 and 4 hours postoperatively.<BR/>Duration of anesthesia, dose of thiopentone, and maximum concentration of enflurane administration. Time until recovery of consciousness (name, date of birth and correct address) and psychomotor function. Patient assessment as asleep, awake, and calm or awake and restless on four different occasions (pre-operatively, 1, 2, and 4 hours postoperatively). Postoperative nausea. Need for postoperative analgesics.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No power calculations. Unclear study length, method of randomization and allocation concealment. Unclear if the procedure was vacuum versus sharp curettage. The author could not be succeessfully contacted to clarify unclear information.<BR/>Outcome assessor in recovery room was blinded. No major complication reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Bonnardot-1987">
<CHAR_METHODS>
<P>Randomized controlled trial. Hospital Tenon, Paris, France. January to October 1986.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>200 pregnant women. ASA I or II.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: propofol 2mg/kg.<BR/>Group 2: ketamine 0.5mg/kg and midazolam 0.25mg/kg.<BR/>Group 3: propofol 2mg/kg and alfentanil 4mcg/kg.<BR/>Group 4: ketamine 1mg/kg and midazolam 0.1mg/kg.<BR/>2 successive series of 2 groups (1 and 2, and 3 and 4):<BR/>All participants premedicated with midazolam 0.25mg/kg orally.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Side effects including postopoperative pain (yes/no) and vomiting (yes/no), pain with injection, visual disturbances and rash were secondary outcomes.<BR/>Primary outcomes: clinical revocery with 4 psychomotor and sensory tests (Newman, Bourdon, Horatz and neursensorial test). Vital signs.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Per e-mail communication with Dr. Maillart, the co-author: randomization with table of numbers, allocation concealment with opaque envelopes, blinding of outcomes assessor, gestational age less than 10 weeks, vacuum evacuation.<BR/>No power calculations. No major complication reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Boysen-1989">
<CHAR_METHODS>
<P>Randomized controlled trial. University of Copenhagen, Denmark.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>60 pregnant women. Age: 18-44 years. Healthy women. Gestational age up to 12 weeks.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: thiopental 4mg/kg<BR/>Group 2: etomidate 0.3mg/kg<BR/>Group 3: propofol 2.5mg/kg<BR/>for induction of anesthesia.<BR/>All participants: No premedication. Alfentanil 15mcg/kg after induction. Additional 1/4 of the induction anesthetic as needed. Oxytocic drugs.<BR/>All under assisted ventilation with 100% oxygen with a face mask.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Postoperative side ffects including pain (yes/no) and vomiting.<BR/>Dosage requirements. Vital signs. Pain on injection of anesthetic. Recovery: Steward score, coin counting test (CCT), continuous auditory reaction time test (CART). Need for postoperative analgesics. Other side effects: apnea, involuntary muscle movements.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No power calculations. Unclear study length, method of randomization and allocation concealment. Unclear if the procedure was vacuum versus sharp curettage. The author could not be succeessfully contacted to clarify unclear information.<BR/>Outcome assessor was blinded. <BR/>Apnea occured in 9, 1 and 3 patients of the propofol, etomidate and thiopental group respectively. There was no significant diffference.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Boysen-1990">
<CHAR_METHODS>
<P>Randomized controlled trial. University of Copenhagen, Denmark.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>40 pregnant women. Age: 22-34 years. Healthy women. Gestational age up to 12 weeks.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: methohexital 2mg/kg IV<BR/>Group 2: propofol 2.5mg/kg IV<BR/>for induction of anesthesia <BR/>All participants: No premedication. All patients received alfentanil 15mcg/kg after induction. Both groups received 25% of induction dose for maintenance as needed. Oxytocic drugs.<BR/>Assisted ventilation with 100% oxygen with a face mask.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Postoperative side ffects including pain (yes/no), nausea, vomiting and headache.<BR/>Dosage requirements, duration of surgery and anesthesia. Vital signs. Intraoperative side effects including pain on injection of anesthetic, apnea, involuntary muscle movements, hiccuping, bronchospasm and coughing. <BR/>Recovery: Coin counting test (CCT), continuous auditory reaction time test (CART).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Unclear study length, method of randomization and allocation concealment. Outcome assessor blinded but not anesthesiologist. Unclear if the procedure was vacuum versus sharp curettage, but assume vacuum given year of publication. Pain was recorded if patient spontaneously complained about it. Patients were not systematically asked about pain. The author could not be succeessfully contacted to clarify unclear information.<BR/>No power calculations. Apnea occured in 10 and 7patients of the methohexital and propofol group respectively. There was no significant diffference.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-01-06 02:57:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cetin-1997">
<CHAR_METHODS>
<P>Randomized controlled trial. Randomization with computerized, random number generation carried out outside the familiy planning unit. Per power analysis 33 patients per group required.<BR/>Cumhuriyet University, School of Medicine, Sivas, Turkey. Study length: May 1996 to November 1996.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>66 pregnant women. Singleton intrauterine pregnancy at 6-11 weeks of gestational age by LMP confirmed bv transvaginal ultrasound.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-01-06 02:57:38 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: deep injection (superficially 1ml, 3ml 3cm deep at 4, 6, 8, and 10 o'clock position; total of 16ml) of PCB<BR/>Group 2: regular injection (1.5cm deep at same 4 positions) of 10ml 1% lidocaine local anesthetic for paracervical block.<BR/>All participants: 5mg oral diazepam 60 minutes prior to procedure if preprocedural anxiety of 6 or more (rated by physician not performing procedure). After 2 minute wait, cervical dilation.<BR/>Vacuum aspiration followed by sharp curette.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-01-06 02:57:39 +0100" MODIFIED_BY="[Empty name]">
<P>Pain associated with dilation and curettage was rated by patient on a verbal analog scale of 0 to 10 (0 = no pain, 10 = severe pain) after the procedure.<BR/>Anxiety score, procedure time, basal cervical dilation and dilation increased obtained. Follow-up visit 4-6weeks after the procedure to assess late complications and to perform a gynecological exam.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-01-06 02:57:40 +0100" MODIFIED_BY="[Empty name]">
<P>Physician not performing procedure rated preprocedural anxiety (scale 1-10). Otherwise blinding is not commented on. Unclear how many got diazepam and in which group they were.<BR/>The author could not be succeessfully contacted to clarify unclear information.<BR/>No adverse effects, no major complications.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Collins-1985">
<CHAR_METHODS>
<P>Randomized controlled trial. St. Thomas Hospital London, UK.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>66 pregnant women. Age: 16-38 years old. ASA 1 or 2. Gestational age &lt;12weeks</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: general anesthesia with 1.5% halothane and 70% nitrous oxide in oxygen for maintenance after methohexitone induction.<BR/>Group 2: general anesthesia with 7mcg/kg alfentanil followed by methohexitone induction and maintenance with alfentanil 0.1-0.2mg increments as needed and 70% nitrous oxyde in oxygen.<BR/>All participants: Oxytocin 5 units IV at onset of cervical dilation.<BR/>Vacuum aspiration.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Postoperative abdominal pain (none, slight or moderate/severe). Need for postoperative analgesia.<BR/>Blood loss as measured by collection of all blood and the aspirate which was then processed and measured in a standardized way as described by Garrioch, Gilbert and Plantevin 1981. Blood volume was determined using the alkaline haematin method of Hallberg and Nielsson (1964).<BR/>Ansethetitc morbidity: duration, hiccup, cough, laryngeal stridor, apnea, limb movement.<BR/>Recovery time, nausea and vomiting.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Randomization and Allocation concelament not described in detail. <BR/>Statistical analysis using the group sequential design, in groups of 20 patients. In case of moderate or sever nausea the anesthetic was considered a "failure" for a particular patient. <BR/>The trial was stopped after 66 patients, since blood loss was significantly higher with halothane use. One patient in the alfentanil and no patient in the halothane group had apnea; defined as no spontaneoeus respirations for more than 30 seconds.<BR/>No power analysis described. Study length, method of randomization and allocation concealment as well as details of blinding are not described. Author could not successfully be contacted regarding missing information.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-10-18 23:28:55 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dahl-2000">
<CHAR_METHODS>
<P>Randomized controlled double-blind trial. Randomization made by pharmacy from a list of random numbers. Per power analysis done to detect reduction in postoperative rescue analgesics from 40 to 20% 46 patients are needed in each group. <BR/>Hospital in Oslo, Norway.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-07-13 22:48:01 +0200" MODIFIED_BY="[Empty name]">
<P>100 pregnant women. ASA I or II. Exclusion criteria: cardiac, pulmonary, or renal disease, extreme obesity, allergy to opioids, or paracetamol.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-18 23:28:55 +0200" MODIFIED_BY="[Empty name]">
<P>Group 1: paracetamol/codeine 800/60mg suppository 1hr prior to surgery.<BR/>Groups 2: placebo suppository, identically looking and at the same time<BR/>All participants: Premedication with midazolam 0.08mg/kg.<BR/>Induction of anestesia for all with propofol 1.5mg/kg and alfentanil 15mcg/kg. Maintenance of anesthesia with 60% nitrous oxide in oxygen and incremental doses of propofol as eeded.<BR/>Vacuum aspiration.<BR/>Rescue analgesic for postoperative pain: ketobemidone 1-2mg IV.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain level measured with visual analog scale (VAS; 0 = no pain, 100 = worst pain ever) and the verbal pain score (VPS; no pain, slight pain, medium pain, strong pain) at 30 and 60 minutes postoperatively as well as before discharge. <BR/>Need for rescue analgesics, occurrence of nausea/vomiting, degree of sedation at 30 and 60 minutes postoperatively as well as before discharge.<BR/>Vital signs, duration of surgery, total amount propofol needed.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Unclear study length, method of allocation concealment. Unclear what the gestational age was, but assume that it was first trimester given that vacuum curettage was used. <BR/>100 patients recruited, but 10 exlcuded due to violation of the protocol (insertion of an IUD, use of NSAIDS). Results are only reported for the remaining 90.<BR/>No major complications reported.<BR/>The author could not be succeessfully contacted to clarify unclear information.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Edelman-2004">
<CHAR_METHODS>
<P>Randomized double-blind placebo-controlled trial. Computer generated block randomization sequence (block size 20), through an inverstigator not involved with recruitement. Study syringes were identically looking and prepared by the study nurse and coordinator who labeled them with consecutive numbers. Subjects were also enrolled with consecutive numbers. The Investigator was blinded. <BR/>Per power analysis 40 women needed per study group.<BR/>Planned Parenthood at Columbia Willamette in Portland, Oregon, USA. Study length: July 2002 to February 2003.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>80 pregnant women. Age: 18 years old or older. Good general health. English speaking. Gestational age: Less than 11 weeks by LMP confirmed by ultrasound. Body weight more than 100lbs (approx 45kg)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: intrauterine infusion of 10ml 1% lidocaine (maximum total lidocaine dose of 200mg).<BR/>Groups 2: intrauterine infusion of 10ml of sterile saline.<BR/>All participants: premedication with 800mg ibuprofen. If requested, 5mg diazepam. Paracervical block with 10ml of 1% lidocaine (1ml 1% nonbuffered lidocaine on the anterior and posterior lip of the cerivx and then 4.5ml of 1% lidocaine at the 4- and 8-o'clock postitions). <BR/>Five experienced surgeons performed all abortions with an electric vacuum pump after dilation of the cervix.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain rated by subjects using a 100mm visual analog scale (VAS; anchors: 0 = none, 100 mm = worst imaginable) at several points in time: 1) before the procedure started (anticipatory pain); 2) following speculum insertion; 3) after intrauterine infusion; 4) following dilation; 5) after suction aspiration; and 6) 30 minutes later in the recovery room. <BR/>Assessment of overall satisfaction level regarding the abortion experience using the VAS, before discharge. Subjects performed all VAS scales concurrently with each step and not from memory.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Serum lidocaine were drawn in a subset (n=10) of subjects to obtain safety data. No patient developed overt symptoms of lidocaine toxycity.<BR/>One protocol violation in lidocaine group with an inadvertant enrollement of a patient who was not premedicated with ibuprofen. Another patient in the lidocaine group received IV narcotics prior to reaspiration. Her 30 minute pain score was conducted after her reaspiraiton. Analysis in accordance with intent to treat.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-07-13 22:36:59 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Edelman-2006">
<CHAR_METHODS>
<P>Randomized double-blind placebo-controlled trial. Computer generated block randomization sequence (block size 20), through an inverstigator not involved with recruitement. Study syringes were identically looking and prepared by the study nurse and coordinator who labeled them with consecutive numbers. Subjects were also enrolled with consecutive numbers. The Investigator was blinded. <BR/>Per power analysis 40 women needed per study group.<BR/>Planned Parenthood at Columbia Willamette in Portland, Oregon, USA. Study length: November 2003 to December 2004.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-07-13 22:36:59 +0200" MODIFIED_BY="[Empty name]">
<P>80 pregnant women. Age: 18 years old or older (mean 26). Good general health. English speaking. Gestational age: Less than 11 weeks by LMP confirmed by ultrasound. Body weight more thn 100lbs (approx 45kg)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: intrauterine infusion of 5ml of 4% lidocaine (maximum total lidocaine dose of 300mg).<BR/>Group 2: intrauterine infusion of 5ml of sterile saline.<BR/>All participants: premedication with 800mg ibuprofen and if requested 5mg diazepam (per recommendation of safety monitoring committee to raise seizure threshold). Paracervical block with 10ml of 1% lidocaine (1ml 1% nonbuffered lidocaine on the anterior and posterior lip of the cerivx and then 4.5ml of 1% lidocaine at the 4- and 8-o'clock postitions). Five experienced surgeons performed all abortions with an electric vacuum pump after dilation of the cervix.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain rated by subjects using a 100mm visual analog scale (VAS; anchors: 0 = none, 100 mm = worst imaginable) at several points in time: 1) before the procedure started (anticipatory pain); 2) following speculum insertion; 3) after intrauterine infusion; 4) following dilation; 5) after suction aspiration; and 6) 30 minutes later in the recovery room. <BR/>Assessment of overall satisfaction level regarding the abortion experience using the VAS, before discharge. Subjects performed all VAS scales concurrently with each step and not from memory.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Serum lidocaine were drawn in a subset (n=8) of subjects to obtain safety data. Interim analysis after 37 subjects studied because of concerns of lidocaine toxicity. Some subjects had lidocaine side effects (including ear ringing, perioral numbness and tingling), but none had overt symptoms of severe toxicity (i.e. seizuers, cardiac arrest or loss of consciousness) or toxic serum range of lidocaine. Safety monitoring committee recommended diazepam for all subsequent subjects to raise seizure threshold.<BR/>3 women withdrew from the trial prior to receiving study medication; 2 were in the lidocaine groups the other in the saline group. One protocol violation in the saline group with the inadvertent enrollment of a subject without premedication with ibuprofen, but diazepam only. Analysis in accordance with intent to treat.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-01-06 02:57:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Glantz-2001">
<CHAR_METHODS>
<P>Randomized controlled trial. Randomization by permuted block technique in sets of four, with blocks randomly ordered by use of a random number table. Ordered opaque sealed envelopes used. Allocation verification done. Double-blind regarding solution injected, but not regarding injection technique. <BR/>Per power analys 18 patients per group required and a total of 72.<BR/>Planned Parenthood of the Rochester Syracuse Region, NY, USA. Study length: October 1997 to January 1999.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>82 pregnant women. Age: 18 years and older. Gestational age: 7-12 weeks by LMP and phyisical exam, with sonogram if needed. Exclusion criteria: significant medical condition increasing risk for complication from procedure in clinic setting</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-01-06 02:57:40 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: paracervical block at 3-5-7-9 o'clock with 5-2-2-5ml of 1% chloroprocaine.<BR/>Group 2: paracervical block at 3-5-7-9 o'clock with 5-2-2-5ml of bacteriostatic (0.9% benzyl alcohol) saline.<BR/>Group 3: paracervical block at 4-8o'clock with 7-7ml of 1% chloroprocaine.<BR/>Group 4: paracervical block at 4-8o'clock with 7-7ml of bacteriostatic (0.9% benzyl alcohol) saline.<BR/>All participants: Laminaria insertion the day prior to the procedure. Iboprofen 600mg po 1hr prior to the procedure. No po or IV sedation.<BR/>Procedure started 3 minutes after paracervical block administration.<BR/>Mechanical vauum aspiration followed by sharp curettage and a final pass with suction.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Patient reported pain on a 10 point box scale (0 = no pain, 10 = worst imaginable pain) with: laminaria insertion, paracervical block administration (measured immediately after administration), aspiration (measured immediately after procedure), recovery room recollection of pain associated with the abortion procedure.<BR/>Dysmenorrhea prior to conception, anxiety regarding the procedure measured on a 10 point box scale and associated with painful laminaria insertion.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Analysis included 79 patients, since 2 changed their mind just after randomization and before receiving the PCB. Another patient turned out to have a gestational age of 15wks after the PCB was administered.<BR/>Dysmenorrhea was also associated with and more painful paracervical block administration and aspiration. No anesthetic complication.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-10-18 23:30:02 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hackett-1982">
<CHAR_METHODS>
<P>Randomized controlled trial at St Thomas' Hospital London, UK. Outcome assessor in recovery room was blinded.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>82 pregnant women. ASA group I or II. Gestational age &lt;12 weeks.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-18 23:30:02 +0200" MODIFIED_BY="[Empty name]">
<P>Group 1 (enflurane): Induction with methohexitone 2mg/kg. Maintenance with 70% nitrous oxide in oxygen and 3% enflurane until cervical dilation completed.<BR/>Group 2 (fentanyl): fentanyl 1.5mcg/kg IV followed by methohexitone 2mg/kg. Maintenance with 70% nitrous oxide in oxygen and incremental doses of methohexitone.<BR/>All participants: Vacuum aspiration (Karmen curettage).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Blood loss, duration of operation, minor complications such as coughing, salivation, hiccup, laryngeal stridor, and limb movements. Recovery observations: Recovery of consciousness assessed by time of first eye opening in response to their name. Nausea, vomiting, abdominal pain (nil, slight, moderate/severe) and need for medication (yes/no) after operation during the first hour and each subsequent hour until discharge.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Unclear study length, method of randomization and allocation concealment. Unclear who was blinded other than the recovery room outcome assessor. Group sequential design to determine trial size. Anestethic agent was considered a failure if moderate to severe nausea occured. The upper boundary was crossed after 74 patients indicating a statistical significnt difference between the anesthesia groups at the 5% level using a one-sided test. <BR/>The author states that the 82 patients were included; 43 in the enflurane and 39 in the fentanyl group. However, patients table 2 with abdominal pain add up to 47 and 110% in the enflurane group. <BR/>Severe complications, defined as delaying the procedure, occured in 4 patients; respiratory depression in one patient in the fentanyl group, prolonged coughing with salivation in one patient in the enflurane group and 2 patients in the fentanyl group.<BR/>The author could not be succeessfully contacted to clarify unclear information.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-01-06 02:57:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hall-1997">
<CHAR_METHODS>
<P>Randomized trial. Outpatient clinic of the Department of Obstetrics and Gynecology at the Karolinska Hospital in Stockholm, Sweden. No power calculation.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>200 pregnant women. Age: older than 18. Outpatient clinic, legal 1st trimester surgical abortion.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-01-06 02:57:41 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: preoperative vaginal prostaglandin (PG) (PGE1, gemeprost 1mg given vaginally 3hrs preoperatively) for cervical softening, surgery in general anesthesia (GA)</P>
<P>Group 2: preoperative PG and surgery in GA and paracervical block (PCB, 10 and 10ml lidocaine 10mg/ml)</P>
<P>Group 3: surgery in GA</P>
<P>Group 4: GA and PCB.</P>
<P>Premedication with morphine 5-10mg IM 60-90 minutes preoperatively. GA with propofol 2mg/kg IV, 60% nitrous oxide in oxygen, breathed spontaneously by mask and isoflurane supplementation as needed.</P>
<P>Dilation of the cervix as needed followed by vacuum suction curettage and 10IU oxytocin IV.</P>
<P>Postoperatively oral medications per patient request: paracetamol 500mg and codeine phosphate 30mg for pain or thiethylperazin 6.5mg for nausea.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain preoperatively, and postoperatively (at 1, 2, 3 and 4 hrs); consumption of analgesics postoperatively; nausea; time interval to discharge home. Study instrument: Visual analog scale (VAS; 10cm from "no pain" to "worst pain ever"; no nausea to extreme nausea) for pain and nausea.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Per e-mail communication with Dr. Persson, the coauthor, the study length was 4 months. Patients were randomized and allocation concealment was with closed envelopes. All investigators were blinded; not the operating gynecologist and not the nurses .<BR/>Women in the two groups receiving PG were significantly younger, of lower gravity and parity than women in the two groups not receiving PG. The discussion does not include this being a possible confounder of the lower pain perception and analgesia need in the latter two groups.<BR/>No major complications reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Heath-1989">
<CHAR_METHODS>
<P>Randomized controlled double-blind trial. Power analysis done to detect 10% reduction in postoperative pain with 80% power. Study underpowered, since 600 patients would have been required per their discussion.<BR/>Hospital in Portsmouth, UK.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>40 pregnant women. Primiparous, gestational age up to 12 weeks. Day-case vaginal termination.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: controlled-released dihydrocodeine 60mg with 20ml of water orally 1hour before surgery.<BR/>Group 2: placebo with 20ml of water orally 1hour before surgery. <BR/>All participants: anesthesia induction with alfentanil 7mcg/kg and propofol 2.5mg/kg. Anesthesia maintenance in all with propofol infusion at 9mcg/kg/hour. Patients breathed 70% nitrous oxide in oxygen via a Bain system. Oxytocin as needed.<BR/>Escape analgesia postoperatively with 1g paracetamol 4 hourly orally per patient request.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain and nausea assessed hourly throughout their admission with a 10cm visual analog scale. A questionnaire after discharge assessed pain and nausea upon arrival at home.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>One anesthesist administered all the anesthetics whilst another performed all the study assessments.<BR/>Unclear study length, method of randomization and allocation concealment. Unclear if the procedure was suction or sharp curettage, but given gestational age and time of publication we assume it was vacuum curettage. Unclear if any loss after randomization. The author could not be succeessfully contacted to clarify unclear information.<BR/>3 patients required atropine to correct bradycardia.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hein-1999">
<CHAR_METHODS>
<P>Randomized controlled double blind trial. Nurse otherwise not involved in study drew the randomized envelope. <BR/>Karolinska Institute at Danderyds Hospital, Denderyd, Sweden.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>140 pregnant women. ASA I-II group. Elective termination of pregnancy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: 1gm paracetamol suppository.<BR/>Group 2: placebo suppository. <BR/>All participants: no premedication. Induction of anesthesia with 0.1mg fentanyl and propofol. Maintenance with nitrous oxide in oxygen 2:1 and additional small doses of propofol as needed. Spontaneous breathing, assisted ventilation as needed. 5 units oxytocin at the end of the procedure.<BR/>All patients: Vacuum aspiration.<BR/>Rescue medication for postoperative pain diclofenac 100mg supp.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Postoperative pain measured with a 10cm visual analog scale (0cm=no pain, 10cm=unbearable pain), measured 30 and 60 minutes postoperatively and at discharge. Analgesic and antiemetic requirements. Time until street fittness.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Per e-mail communication with Dr. Jakobsson: Gestational age 7-12 weeks. Computer-based randomization with envelopes. The study lasted over 2.5 months.<BR/>All procedures were uneventful and no complications were noted. No industry sponsorship.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hein-2001">
<CHAR_METHODS>
<P>Randomized controlled double blind trial. Allocation concealment with envelope technique done by a nurse otherwise not involved in study. Per power analysis 70 needed per group to achieve power of 80%.<BR/>Karolinska Institute at Danderyds Hospital, Denderyd, Sweden.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>210 pregnant women. ASA I-II group. Elective termination of pregnancy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: paracetamol 1gm per os 1 hour preoperatively.<BR/>Group 2: lornoxicam 8mg per os 1 hour preoperatively.<BR/>Group 3: placebo. <BR/>All participants: no other premedication. Induction of anesthesia with 0.1mg fentanyl and 2-2.5mg/kg propofol. Maintenance with nitrous oxide in oxygen 2:1 and additional small doses of propofol (20-30mg) as needed. Spontaneous breathing, assisted ventilation as needed. Some patients received laminaria preoperatively. 5 units oxytocin at the end of the procedure.<BR/>All patients: Vacuum aspiration.<BR/>Rescue medication for postoperative pain diclofenac 100mg supp.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Postoperative pain on 100mm visual analog scale (0=no pain, 100=unbearable pain) measured at 30 and 60 minutes postoperatively and at discharge. Analgesics postoperatively. Antiemetics. Time to discharge</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Unclear method of randomization. For statistics pain was dichotomized. No complications noted. Per e-mail communication gestational age 8-13 weeks, and no industry sponsorship.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Jakobsson-1991">
<CHAR_METHODS>
<P>Randomized controlled trial. Karolinska Institute at Danderyds Hospital, Denderyd, Sweden.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>165 pregnant women. ASA I group. Elective ambulatory termination of pregnancy. Gestational age: 7-12 weeks. Patient age: 17-44.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: alfentanil 0.5mg. <BR/>Group 2: fentanyl 0.1mg.<BR/>Group 3: placebo (saline). <BR/>All participants: anesthesia induced with propofol and thereafter nitrous oxide in oxygen 2:1. Additional boluses of propofol 10-30mg as needed. Paracetamol and diclofenac for postoperative pain on patient request.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Peroperative: Complications during anesthesia, such as laryngospasm. Surgeons opinion about quality of anesthesia. Amount propofol required. <BR/>Postoperative: Complaint of pain to nurse (yes/no). Request for analgesia. Nausea, vomiting. <BR/>Patient self -assessment: qustionnaire just prior to discharge, asking about postoperative pain (slight versus intense) and emesis.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Per e-mail communication with Dr. Jakobsson: Study lasted approximately 3 months. Blinding of patient and outcome assessor. Randomization per computer. Allocation concealment with envelope technique. Gestational age 7-12 weeks. Power analysis done. All underwent vacuum aspiration followed by sharp curettage check.<BR/>One patient in the placebo group was excluded because of pronounced postoperative beeding. Data of 164 patients was analyzed.<BR/>Laryngospasm in 2 patients in the placebo and in one patient in the alfentanil group. Regurgitation requiring intubation in one patient in the placebo group.<BR/>No industry sponsorship.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-01-06 02:57:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jakobsson-1993">
<CHAR_METHODS>
<P>Randomized controlled trial. Karolinska Institute at Danderyds Hospital, Denderyd, Sweden. <BR/>Recovery room outcome assessor was blinded.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-01-06 02:57:41 +0100" MODIFIED_BY="[Empty name]">
<P>200 pregnant women. ASA I group. Termination of pregnancy. Age: 18-45 years.<BR/>Exclusion criteria: weight &lt;45kg and &gt;90kg.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-01-06 02:57:42 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: propofol 20mg IV followed by ketamine 20mg IV just prior to induction of anesthesia.<BR/>Group 2: propofol 20mg and fentanyl 0.1mg IV 3-4 minutes before induction of anesthesia.<BR/>Group 3: thiopentone 50mg and fentanyl 0.1mg IV 3-4 minutes before induction of anesthesia.<BR/>Group 4: methohexitone 20mg and fentanyl 0.1mg IV 3-4 minutes before induction of anesthesia.<BR/>All participants: spontaneous breathing of nitrous oxide in oxygen 1:2; assisted if needed. Maintenance with increments of the respective induction agent as needed.<BR/>Postoperative analgesia with paracetamol or diclofenac and morphine as rescue. Dixyrazine 5mg IV as needed for nausea.<BR/>Vacuum aspiration.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Postoperative pain (yes/no).<BR/>Time to discharge. Awareness with recall, dreams, nausea, vomiting, side effects such as anxiety and psychomimetic effects.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No peroperative complications.<BR/>Per e-mail communication with Dr. Jakobsson: Study lasted approximately a few months. Blinding of patient and outcome assessor. Randomization per computer. Allocation concealment with envelope technique. Gestational age 7-14 weeks. No power analysis done. No industry sponsorship.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-01-06 02:57:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jakobsson-1995">
<CHAR_METHODS>
<P>Randomized controlled trial. Karolinska Institute at Danderyds Hospital, Denderyd, Sweden.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>400 pregnant women. ASA I group. Elective ambulatory termination of pregnancy. Gestational age: 7-13 weeks.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: alfentanil 0.5 mg 1-2 minutes before induction with thiopentone<BR/>Group 2: alfentanil 1.0 mg 1-2 minutes before induction with thiopentone<BR/>Group 3: alfentanil 0.5 mg 1-2 minutes before induction with propofol<BR/>Group 4: alfentanil 1.0 mg 1-2 minutes before induction with propofol<BR/>Group 5: fentanyl 0.05 mg 1-2 minutes before induction with thiopentone<BR/>Group 6: fentanyl 0.1 mg 1-2 minutes before induction with thiopentone<BR/>Group 7: fentanyl 0.05 mg 1-2 minutes before induction with propofol<BR/>Group 8: fentanyl 0.1 mg 1-2 minutes before induction with propofol<BR/>All participants: no premedication. Bolus doses of thiopentone 50mg or propofol 20mg in addition to nitrous oxide in oxygen 2:1 as needed for maintenance. Breathing assisted only if necessary. <BR/>5 IU oxytocin at end of procedure.<BR/>Postoperative analgesia with paracetamol 1 g per rectum and additional central acting analgesics as needed.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-01-06 02:57:42 +0100" MODIFIED_BY="[Empty name]">
<P>Spontanous complaints of pain, emesis, need for analgesics and antiemetics during recovery period. Total dose of induction agent. Time to discharge. Questionnaire prior to discharge asking about memories from the procedure, dreams during anesthesia, grading of postoperative pain (pain versus severe pain), emesis, and anxiety.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Per e-mail communication with Dr. Jakobsson: Study lasted approximately 3-4 months. Blinding of patient and outcome assessor. Randomization per computer. Allocation concealment with envelope technique. Gestational age 7-13 weeks. All underwent vacuum aspiration, followed by sharp curettage check. Power analysis done. <BR/>No major peroperative complications. No industry sponsorship.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-01-06 02:57:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jakobsson-1996">
<CHAR_METHODS>
<P>Randomized controlled double-blind trial. Karolinska Institute at Danderyds Hospital, Denderyd, Sweden.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>200 pregnant women. ASA I group.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-01-06 02:57:43 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: 75mg sodium-diclofenac IM.<BR/>Group 2: 30mg ketorolac IM.<BR/>Group 3: 50mg potassium-diclofenac per os.<BR/>Group 4: 4.2ml NaCl IM<BR/>All groups given 10-20min prior to anesthesia. No other premedication.<BR/>All participants: 0.5mg alfentanil followed by thiopentone and nitrous oxide in oxygen 2:1. Maintenance with 25-50mg thiopentone as needed. Ventilation assisted if necessary. Postoperative pain medication with 1g paracetamol per rectum per patient request. Rescue pain medication with 3-5mg morphine IV.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Postoperative pain (no pain, pain, intense pain). Postoperative emesis. Request for postoperative pain medication and antiemetics. Peri-operative complications. Dreams during anesthesia. Anxiety during recovery.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Per e-mail communication with Dr. Jakobsson: Computer randomization. Sealed envelopes. Elective pregnancy termination. Study length 2-3 months. Gestational age 7-12weeks. No power analysis done. No industry sponsorship. No major complications reported.<BR/>The patients who received oral diclofenac were told that the pill may not contain an active substance. No industry sponsorship.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-01-06 02:57:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kan-2004">
<CHAR_METHODS>
<P>Prospective randomized controlled double-blind trial. Computer generated randomization list. Opaque, sequentially numbered envelopes with allocation information. Per power calculations 40 patients needed in each arm.<BR/>Queen Mary Hospital of University of Hong Kong in Hong Kong, China. Study length: July 2002 to April 2003.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>135 pregnant women. Maternal age &gt;16yrs. Normal general and gynecological examination. Gestational age: equal or less than 12 weeks. Size of the uterus on pelvic examination compatible with estated gestational age. <BR/>Exclusion criteria: allergy or contraindication to lignocaine or prostaglandins. History of severe respiratory, cardiac or liver disease, myasthenia gravis, and psychiatric conditions requiring medication.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-01-06 02:57:43 +0100" MODIFIED_BY="[Empty name]">
<P>Stratification by parity (nulliparous or multiparous). Randomization into 3 groups.<BR/>Group 1: paracervical block (PCB) with 10 mL of 1% lignocaine injected at the 4 and 8 o'clock positions of the vaginal vault 2.5cm beneath the mucosa (5ml each).<BR/>Group 2: Cervical block with 10 mL of 1% lignocaine injected at the 4 and 8 o'clock positions of the cervix 2.5cm beneath the mucosa (5ml each)<BR/>Group 3: no PCB.<BR/>All participants: 400mcg misoprostol vaginally for cervical priming 3-6hrs prior to the procedure. Prophylactic antibiotics. Conscious sedation with 2mg midazolam and 25mcg fentanyl IV 5 minutes prior to cervical dilation. Pethidine IM as needed for additional analgesia.<BR/>Vacuum aspiration (Karmen catheter with an electrical vacuum machine).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain scores measured by 100-point visual analog scale at three points in time: (a) before the operation (following insertion of intravenous catheter), (b) just after the operation to rate pain during PCB, cervical dilation and during suction evacuation (=primary outcome), and (c) 1hr after suction evacuation. <BR/>Secondary outcome measures included: satisfaction levels rated by patient prior to discharge home, sedation level and difficulty of the operation rated by the surgeon, additional analgesia, and adverse effects of PCB. Pain and anxiety were measured with a 100mm linear visual analog scale (VAS: 0 = none, 100 = most severe/painful). Sedation was measured with a sedation scale proposed by Ramsey et al. (1974) (6 very detailed defined levels with increasing sedation from level 1 to 6). Satisfaction levels were excellent, satisfactory, fair and unsatisfactory.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>One patient excluded from study since the uterus was found to be enlarged to 14 weeks of gestation in the operation theater. 134 remaining patients were analyzed. No major complications reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Kan-2006">
<CHAR_METHODS>
<P>Double-blind, randomized controlled trial. Randomization by computer generated randomization list, and allocation by sealed envelope. Per power calculations 40 patients needed in each arm.<BR/>University of Hong Kong, at Queen Mary Hospital, Hong Kong, China. Study length: May 2004 to January 2005.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>90 pregnant women. Inclusion criteria: Maternal age &gt;16yrs, normal general and gyecological examination, gestational age up to 12wks, size of the uterus on pelvic examination compatible with the estimated duration of pregnancy. <BR/>Exclusion criteria: history of severe respiratory or cardiac disease, severe and recurrent liver disease, myasthenia gravis, psychiatric conditions requiring medication or disorders that constitute contraindications to the use of prostaglandins. History of entotox use, uperr respiratory infection, sinus blockage, recent history of middle ear or inner ear surgery or histpry of bone marrow suppression.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: entonox (50:50 mixture of nitrous oxide in oxygen) via face mask and T-piece breathing circuit.<BR/>Group 2: air. <BR/>The the patient was instructed to inhale the study medication. Maintenance by inhalation as needed.<BR/>All participants: 400mcg misoprostol vaginally 3-6hrs prior to procedure. Prophylactic antibiotics. Conscious sedation with 2mg midazolam (another 1mg if sedation inadequate) and 25mcg fentanyl IV. <BR/>Vacuum aspiration.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain scores during venipuncture, insertion of intravenous cannula and during vaginal examination were assessed before the procedure using a 100mm linear VAS (0 = no pain, 100 = worst possible pain). Pain scores during the procedure, and 1 hr after the procedure were assessed 1 hr after the procedure using a VAS. <BR/>Basal anxiety levels assessed using a state anxiety questionnaire and visual analog scale (VAS). Preprocedural anxiety was assessed by a nurse. Sedation measured by doctor using the Ramsay et al (1974) sedation scale. Post-operative side-effects (including nausea, vomiting, dreams, parasthesia, dizziness, dry mouth, memory of operation and euphoria) and satisfaction level assessed 1 hr after the procedure using a questionnaire, as were anxiety and satisfaction level.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No paracervical block given. No major complications reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Li-2003">
<CHAR_METHODS>
<P>Double-blind randomized controlled trial. Computer generated randomization schedule, medication in sealed, numbered opaque envelope and plastic bag. Per power analysis 45 patients needed in each arm.<BR/>University of Hong Kong, at Queen Mary Hospital, Hong Kong, China.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>100 pregnant women; 70 multiparous and 30 nulliparous women. Healthy women, gestational age 7-12wks. Exlusion criteria: significant medical diseases, medical contraindication to the use of NSAIDs or diclofenac sodium, misoprostol or lorazepam.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: arthotec (misoprostol 200mcg and diclofenac sodium 50mg, a non steroidal anti-inflammatory drug=NSAID)<BR/>Group 2: cytotec (misoprostol 200mcg)<BR/>both administered 4hrs prior to procedure. <BR/>All participants: lorazepam 1mg sublingually 30 min prior to procedure, rescue pain medication with pethidine25mg IV. Vacuum aspiration.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain score during procedure was assessed immediately after procedure. Further pain score was assessed 1hr after the procedure. Measurement instrument: visual analogue scale (100mm linear; 0 = no pain, 100 = most severe pain) given by RN blinded to study group assignment. <BR/>Further outcomes measured: Preoperative side effects of medication, cervical priming effect, subject's acceptabiliy of the pain control method (assessed 1 hr after the procedure).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Unclear study length. 70 multiparous women and 30 nulliparous were randomized seperately. Half life of diclofenac sodium is 1-2hrs. No paracervical block. One patient excluded from analysis since the operation was done under general anaesthesia upon her request. No intention to treat analysis, but not possible given that with general anesthesia there is no intraoperative pain measurable. No serious complications observed.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Li-2006">
<CHAR_METHODS>
<P>Prospective double-blind randomized placebo-controlled trial. Computer randomization and allocation with sealed envelopes. Per power analysis for which a decrease of pain level by 0.5 standard deviations chosen as being acceptable 64 patients needed in each arm.<BR/>Family Planning Association of Hong Kong, China. Study length: April to June 2005.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>140 pregnant women. Inclusion criteria: Maternal age: older than 16 years. Gestational age 7-10 weeks at day of procedure. Normal general and gynecological exam. Uterine size corresponding to gestational age or ultrasound dating. Being ethnic Chinese and Cantonese speaking. No history of complicated medical or surgical problems for which operation in community-based day-care setting wa contraindicated.<BR/>Exlusion criteria: Known allergy to lognocaine or prostaglandin or medical contraindication to the use of prostaglandins.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: 2% lignocaine jelly, 3ml applied to cervix, 7ml applied to Hegar dilators and vaginal speculum 1 minute prior to procedure.<BR/>Group 2: KY jelly (placebo) applied in same fashion.<BR/>All subjects: cervical priming with 400micrg misoprostol prior to the procedure (1-2 hours in multiparous, 3-5 hours in nulliparous subjects). Premedication with 5mg diazepam po and 1mg/kg pethidine IM 15-30 minutes prior to the procedure. Rescue pain medicatioin with pethidine repeat dose IM. Suction evacuation with electrical vacuum machine.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain on an 11-point verbal analog scale from 0 to 10 (0 = no pain at all, 10 = intolerable pain) preoperative with pethidine injection, on arrival in the operating room for preoperative pain (i.e. from misoprostol), with cervical manipulation and/or dilation, immdiately after operation for overall intraoperative pain and 1 hour after operation. Before discharge satisfaction toward pain control was assessed (0 = totally unsatisfied to 5 excellent). In addition the surgeon graded the level of patient sedation preoperatively and intraoperatively according to standard scale from 1 to 6, described by Ramsay et al 1974.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Subanalysis for nulliparity versus multiparity was performed. Due to missing part of data 6 patients were excluded in the lignocaine and 3 in the KY jelly group. Results for excluded patients not available. Analysis only includes 64 patients for the lignocaine and 67 patients for the KY Jelly group. No major complications reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Lindholm-1994">
<CHAR_METHODS>
<P>Randomized controlled trial. The study solutions were prepared by the local hospital pharmacy and delivered in blinded identical looking ampoules. Anesthesiologists were blinded as well (pupil size was not assessed intraoperatively). <BR/>Odense University Hospital, Odense, Denmark.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>120 pregnant women. Gestational age &lt;12 weeks. Healthy patients. <BR/>Exclusion criteria: allergy to trial drugs, on medications likely to influence the course of anesthesia, more than 20% overweight.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: normal saline 0.03ml/kg<BR/>Group 2: fentanyl 1.5mcg/kg<BR/>Group 3: alfentanil 15mcg/kg bolus injection.<BR/>All participants: Premedication with lorazepam 2mg orally. <BR/>2 minutes after study medication induction of anesthesia with propofol 2mg/kg IV with lignocaine to lessen pain of injection. Additional increments of propofol 0.5mg/kg IV as needed for induction and maintenance of anesthesia. Alfentanil 100mcg/kg IV as rescue medication if more than four incremental doses of propofol required. Ergometrine 0.5mg IV during operation.<BR/>Postoperative analgesics were paracetamol 1g for moderate pain, pethidine 75mg IM for severe pain.<BR/>Vacuum aspiration.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Postoperative pain intensity assessed with 10cm visual analog scale, anchored with "no pain" at 0 and "worst pain imaginable" at 10cm at 30, 120 and 180 minutes. Need for postoperative analgesics. <BR/>Duration of induction, vital signs, induction dose and total dose of propofol, need for alfentanil, quality of induction movement of patient with surgery stimulus. Recovery: open eyes on command, give birthdate, cooperation score. Complications and side effects during and after the operation.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Unclear randomization. No power analysis mentioned.<BR/>The author could not be succeessfully contacted to clarify unclear information. <BR/>Laryngospasm occured in 1 patient in the fentanyl group. One patient in the control group was difficult to ventilate.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Liu-2005">
<CHAR_METHODS>
<P>Randomized placebo-controlled double-blind trial. Allocation using sealed opaque envelopes. Power calculations done for a power of 0.8 and alpha=0.05 to detect a 20% difference in opioid usage between groups. <BR/>KK Women's and Children's Hospital, Singapore.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>40 pregnant women. ASA I and II, elective first trimester termination of pregnancy in an ambulatory surgical center. <BR/>Exclusion criteria: asthma, gastritis, coagulation disorder, renal impairment, allergy to NSAIDs or COX-2 inhibitors, history of long-tern analgesc use, or use of any agent that may influence the analgesic response.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: etoricoxib 120mg orally with 20ml plain water<BR/>Group 2: placebo <BR/>both 30-60 minutes prior to surgery. <BR/>All participants: general anesthesia with IV propofol 2.0-2.5mg-kg for induction and oxygen nitrous mixture (40:60) and Desfluran (end tidal) 1% at fresh gas flow of 3l/min. Postoperatively per patient request of if verbal analog scale (VAS) for pain &gt;50mm IV fentanyl bolus of 25mcg every 15 minutes until comfortable or VAS&lt;50mm.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Main outcome: post-operative need for fentanyl. Post-operative pain assessed through a blinded observer using a 100mm verbal analogue score (VAS; 0=no pain and 100=the worst imaginable pain). Time points were emergence from general anesthesia, 15 minutes, 30 minutes, and 60 minutes post-operatively and at discharge. <BR/>Further outcomes: side effects (nausea, vomiting gastric pain, heart burn, or dizziness), time to first drink, time to step-down, time between step-down and discharge, and patient satisfaction scores (100-point analogue scale; 0 = very bad experience and 100 = excellent experience) assessed by blinded observer. Via telephone pain sores were assessed at 6 hours and 24 hours post-operatively as well as need for rescue analgesia with acetaminophen 1g every 6 hours.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Unclear study length, and randomization method. Unclear if vacuum or sharp curettage.<BR/>The author could not be succeessfully contacted to clarify unclear information.<BR/>No major complication reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Marc-2007">
<CHAR_METHODS>
<P>Open randomized pilot study. Computer generated list of random numbers in blocks of 6 and 4. Allocation concealment with sealed opaque envelpes. Study period: August to September 2003.<BR/>Family Planning Clinic of the Hospital Saint-Francois d'Assise, University Laval in Quebec City, Canada.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>30 pregnant women. Age 18 yrs or older, Gestational age: between 6 and &lt;14weeks, elective abortion. <BR/>Exclusion criteria: non french speaker, referal from hospital outside of Quebec City, medical condition requiring preplanned IV sedation, daily use of any illegal drug.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: Hypnosis<BR/>Group 2: standard care. <BR/>All participants: paracervical block with total of 12ml 0.5% lidocaine on the cervix at 12 o'clock, and at 4 and 8 o'clock at 1-2cm depth. Vacuum aspiration followed by sharp curettage. Nitrous oxide in oxygen 1: 1 via nose mask per patient request.<BR/>Intracervcal laminaria 4-12 hours prior to surgery for gestational age of 9 weeks or more, stenosis or surgical history of the cervix, age less than 20 zears, gravidity of 5 or more.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Self reported pain and anxiety measured with a 11-point verbal numerical scale (0 = no pain/not unpleasant at all/not anxious, 10 = the most intense pain/unpleasantness/anxious possible) preoperatively, with insertion of the speculum, with maximum dilation, suction and end of curettage as well as in recovery. Use of N2O (dichotomous variable).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>47 patients eligible, 17 refuse to participate, 30 are randomized. One patient in the hypnosis group was excluded after randomization and before hypnotic intervention since IV sedation had been already scheduled. <BR/>Study may be underpowered to detect difference in anxiety and pain. No double-blinding due to hypnosis, may introduce bias. Inability to differentiate between specific and non-specific effect of hypnosis. No major complications reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Ogg-1983">
<CHAR_METHODS>
<P>Randomized controlled trial with additional 2 non-randomized control groups Outcome assessor of side effects was blinded. Addenbrooke's Hospital, Cambridge, UK.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>60 participants. 40 were randomized to the 2 trial arms. Healthy women. Age 16-40. Gestational age &lt;12 weeks. Additional, non-randomized control groups of 10 women each for memory function: 1) Inpatients awaiting minor gynecological surgery who had received no general anesthesia. 2) Ten female nurses</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1 (trichlorethylen): fentanyl 1.5mcg/kg IV followed by methohexitone 1% 1.5mg/kg with 5ml lignocaine. Nitrous oxide 2 5l and oxygen 3l per minute. Trichloethylene 0.5-1%. Spontaneous respiration was maintained via coaxial Bain system. <BR/>Group 2 (total intravenous group, fentanyl): fentanyl 1.5 mcg/kg IV followed by methohexitone 1% 1.5mg/kg with lignocaine 0.1%. Supplements of methohexitone 0.25mg/kg as needed. Spontaneous respiration was maintained Mary Catterral mask.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Drugs administered, duration of anesthesia, immediate recovery time. Side effects during anesthesia and for 2 hours postoperatively including pain on induction and postoperatively (yes/no), as well as hiccoughs, laryngospasm, vomiting, involuntary muscle movements during anesthesia and nausea, vomiting, shivering, dizziness, headache, drowsiness and tearfulness in recovery. Heart rate and mean systolic blood pressure. Memory function.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Unclear study length, method of randomization and allocation concealment. Unclear who was blinded other than assessor of side effects. Unclear if suction curettage or sharp curettage was used for the procedure. Given that at that time suction curettage was predominantly used, we decided to include this study. No power analysis. Small sample size. Pain not measured in detail, only yes versus no, and it is not clear if it was self reported.<BR/>The author could not be succeessfully contacted to clarify unclear information.<BR/>Laryngospasm in one patient in the trichlorethylene group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Phair-2002">
<CHAR_METHODS>
<P>Prospective, randomized, non-blinded (cannot blind waiting versus non waiting) trial. Per power calculations sample size of 196 needed to detect 1cm difference in pain.<BR/>Columbia Willamette Planned Parenthood, Portland, Oregon, USA. Study length: May 2000 to June 2001</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>199 pregnant women. Age 18 yrs or older. Gestational age &lt;11wks. Good general health. English language comprehension. <BR/>Exclusion criteria: major psychiatric symptoms as well as PID, intravenous sedation or misoprostol.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: 3-5 minute wait between injection and dilation of the cervix<BR/>Group 2: no wait. <BR/>All participants: paracervical block (PCB) with total of 12ml 1% buffered lidocaine at 12 (superficially), 4 and 8 o'clock (1-2cm deep). Diazepam 5mg po and /or fentanyl 100mcg IV as additional pain medication per patient request.<BR/>Vacuum aspiration.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Self reported pain and measured with a 10cm visual analog scale with dilation, aspiration and post procedure as well as anticipated pain. Satisfaaction at the end of the procedure (very satisfied, somewhat satisfied, netrual, somewhat dissatisfied, very dissatisfied).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Per e-mail communication: randomization with computer generated random numbers in blocks of 50. Allocation concealment with sequentially numbered opaque envelopes.<BR/>194 women completed the study and were analysed. 2 excluded for administration of extra sedative medications and 2 lost to follow-up. One woman chose to discontinue. No major complications reported. Subanalysis per fentanyl use.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-07-14 00:37:25 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Raeder-1992">
<CHAR_METHODS>
<P>Randomized double-blind (except for intraoperative assessment by anesthesiologist), controlled trial. Hospital in Baerum, Sykehus, Norway</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>59 pregnant women. Inclusion criteria: first trimester abortion, weight 50-80kg, ASA I or II.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-07-14 00:37:25 +0200" MODIFIED_BY="[Empty name]">
<P>Group 1: regional anesthesia (group R). Midazolam 0.1mg/kg IV and alfentanil 0.01mg/kg IV followed by paracervical bock with 20ml mepivicaine 20mg/ml with adrenaline 0.005mg/ml. Patient breathed spontaneous and assisted with oxygen as needed.<BR/>Group 2: general anesthesia (groups G). Alfentanil 0.01mg/kg IV, followed by bolus of propofol 2.0mg/kg. Patients breathed 75% nitrous oxide in oxygen spontaneously by mask and were assisted as needed for dropping oxygen saturation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Anesthesia data: patient discomfort during anesthesia induction, cervical dilation and uterine curettage. Duration of anesthesia, duration of sleep, apnea. Vital signs. Side effects.<BR/>Overall evaluation of the procedure by the anesthesiologist, gynecologist and patient. <BR/>Postoperative function (at 15, 30, 60, 120 and 180 minutes postoperatively): wakefulness, cooperation, postoperative amnesia, drinking, voiding, walking at different time intervals, p-deletion score, Maddox Wing Score.<BR/>Postoperative side effects: Pain, nausea, headache (postoperatively at 0-15, 15-60, 60-120, 120-180 minutes) rated on visual analog scale (0 = no pain to 100 = extreme pain) and blurred vision.<BR/>Postoperative questionnaire (sent 5 days postoperatively): discomfort and side-effects during hospital stay, travel home and at home, wakefulness, everyday function.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-07-13 22:54:44 +0200" MODIFIED_BY="[Empty name]">
<P>Per e-mail communication with the author: Randomization using a table of random numbers generated by computer. Allocation concealment: sealed envelopes. Vacuum aspiration. The investigators of postoperative patient function were blinded.<BR/>No power analysis. 88 consecutive patients were asked to participate, 21 refused, 8 met exclusion criteria. No patient exlcuded after inclusion.<BR/>No signs of mepivicaine toxicity. Apnea, defined as oxygen saturation of less than 85% in more than seconds, in 25% of patients with propofol (none in regional group; statistically significant p&lt;0.0001).<BR/>Patient discomfort with cervical dilation and uterine curettage in the general anesthesia group was likely assessed by the anesthesiologist and not patient reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-01-06 02:57:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rossi-1995">
<CHAR_METHODS>
<P>Randomized controlled trial. Surgical day-case hospital, Napoli, Italy.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>120 pregnant women. ASA I and II. Elective pregnancy termination. Age: 18-40. Gestational age: 6 to 10 weeks. <BR/>Exclusion criteria: allergies to study medications, hypertension, psychiatric problems, drug dependance.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-01-06 02:57:44 +0100" MODIFIED_BY="[Empty name]">
<P>Group 1: fentanyl 0.005mg/kg and midazolam 0.2mg/kg.<BR/>Group 2: fentanyl 0.005mg/kg and propofol 2.5mg/kg.<BR/>Group 3: ketamine 0.5mg/kg and propofol 2.0mg/kg.<BR/>All participants: Premedication with atropin 0.007mg/kg 5 minutes prior to anesthesia induction. Maintenance with 70% nitrous oxide in oxygen after cervical dilation via spontaneous-assisted ventilation. Additional increments of 1/4 dose of anesthetics given as needed.<BR/>Vacuum aspiration (Karman method).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Postoperative pain (yes/no).<BR/>Anesthesia: Quality and rapidity of some neurofunctional aspects of recovery using the Steward Score and the Coin Counting Test respectively.<BR/>Side effects including pain with anesthesia injection, and postoperive rash, halluzinations, tremor, nausea and vomiting, headache, unpleasant dreams.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Unclear study length, method of randomization and allocation concealment. Unclear who was blinded. Unclear if pain was self reported.<BR/>The author could not be succeessfully contacted to clarify unclear information.<BR/>No major complications reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Shapiro-1975">
<CHAR_METHODS>
<P>Randomized controlled trial. University Hospital in Miami, USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>144 pregnant women. Gestational age: 6-12 weeks.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: control<BR/>Group 2: self-administered methoxyflurane (0.5 volume % with 5l oxygen per minute)<BR/>Group 3: stereophonic headphones with music chosen by patient. <BR/>All participants: premedication with Valium 10mg orally 1-2 hours preoperatively. Paracervical block with 20ml of 1% carbocaine. Vacuum aspiration.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain with the procedure scored by patient, physician, nurse and counseler (scoring by staff/patient: 0 = no observalble signs of pain/"absolutely no pain or minimal cramping"; 1+ = some movement or grimace during the procedure/"I had some pain"; 2+ = moderate amount of pain/"It really hurt -- very uncomfortable"; 3+ = severe pain, no relief/"very painful --excruciating"). Amnesia.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Unclear study length, method of randomization and allocation concealment. Not clear which pain assessment shown in results; self reported versus staff assessed.<BR/>The author could not be succeessfully contacted to clarify unclear information.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Suprapto-1984">
<CHAR_METHODS>
<P>Double-blind placebo controlled randomized study. Family planning clinic in Hagerstown, Maryland, USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>137 pregnant women. Age: 16-35years. First trimester elective abortion. General good health.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: single dose naproxen sodium 550mg orally 1-2 hours prior to abortion<BR/>Group 2: placebo<BR/>Group 3: no drug.<BR/>All participants: paracervical block with 1% lidocaine followed by vacuum aspiration.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain during abortion (assessed in recovery room), 15 an 30 minutes postoperatively, assessed with visual analogue scale (0 = no pain to 99 = severe pain). Any adverse effects. Estimated blood loss.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>No major complication observed. Unclear study length, method of randomization and allocation concealment. The author could not be succeessfully contacted to clarify unclear information.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wells-1989">
<CHAR_METHODS>
<P>Randomized controlled trial. Blinding: nurses, counsellors, physicians and technicians were unaware of the interventions that were tested. <BR/>Free standing private reproductive health clinic in the metropolitan area of New England, USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>40 participants. English speaking. Mentally competent. Uncomplicated first trimester abortion. Gestational age 5 - 11 weeks.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: relaxation ecxercise for 10 minutes prior to the procedure<BR/>Group 2: pleasant imagery (beach or mountain) 7 minute practice session prior to the procedure<BR/>Group 3: analgesic imagery 8 minute practice session prior to the procedure<BR/>Group 4: attention control no instruction in a technique but advise to use coping strategy that worked in a previous painful experience; 10-15 minutes prior to the procedure .<BR/>All participants received local anesthesia.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain sensation measured with a 10cm graphic rating scale, distress measured with a 10cm graphic rating scale at worst (assessed at the end or the procedure) as well as in the recovery area. Time participants used the technique during the procedure. Length or procedure, length of time in recovery area, analgesics for the first 24 hours after abortion.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Out of 145 patients 43 agreed to participate. One did not meet inclusions criteria. <BR/>Per e-mail communication with Ms Wells: randomized study, but does not recall method of randomization and allocation concealment. She herself did all the interventions and assessed the outcomes. Study length was 3-4 months in 1985-1986. Study participants underwent vacuum aspiration. Pilot study, undepowered. No industry sponsorship.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wells-1992">
<CHAR_METHODS>
<P>Randomized controlled trial. 2x2 factorial design: first factor type of information provided before the abortion, second factor type of anesthesia.<BR/>Free standing private reproductive health clinic in the metropolitan area of New England, USA.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>84 pregnant women. Inclusion criteria: more than 18 years old, able to read and understand English. <BR/>Age 18 to 44 years. Gestational age: first trimester.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>First factor Group 1: provision of sensory information (3 minute audio taped message containing orienting information as well as nine sensations related to abortion and identified by over 50% of women in a previous pilot study)<BR/>First factor Group 2: provision of general information<BR/>Second factor Group 1: local cervical block<BR/>Second factor Group 2: local cervical block and intravenous sedation with diazepam and fentanyl.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain intensity during abortion measured on a 10 cm VAS with anchors of "no sensation" and "the most intense sensation imaginable".<BR/>Subjective distress measured on a visual analog scale of 10 cm with anchors of "not bad at all " and " most intense bad feeling possible for me". Distress checklist; a 7 item observational checklist tapping four categories of behavior - facial expression, posture, vocalization and verbalization. <BR/>State anxiety measured with the STAI (State - trait anxiety inventory)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>High refusal rate. 94 women agreed to participate (25% acceptance rate), 84 had complete data. Incomplete data: 3 women could not undergo procedure due to gestational age, in 7 cases there was a lack of a blinded observer.<BR/>Per e-mail communication with Ms Wells: study length was between January and March 1988. Study participants underwent vacuum aspiration. Randomization using block randomization, and allocation concealment with envelopes. The research assistent who collected data during the procedure and in the recovery room were blinded. Gestational age was first trimester. Medication dose was not recorded. Per power analysis using a moderate effect size (as defined by Cohen) with a power of .80 and alpha of .05, 42 per group needed.</P>
<P>High refusal rate of 75%.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wiebe-1992">
<CHAR_METHODS>
<P>Randomized double-blind (for phase one), controlled trial. Free-standing urban abortion clinic in British Columbia, Canada.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>249 pregnant women. Mean age 25-28 years depending on group, mean gestational age 8.5-8.7 depending on group. <BR/>Exclusion criteria: unable to understand or unwilling to sign the consent form.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Phase 1 Group 1: 10ml 2% carbonated lidocaine with 2mg atropin/50ml, injected at 3 to 6 sites (12, 3, 6 or 12, 2, 4, 6, 8, 10 o'clock) 1/2 inch deep at the reflection of the vagina off the cervix. <BR/>Phase 1 Group 2: 10ml 2% plain lidocaine with 2mg atropin/50ml, injected at 3 to 6 sites (12, 3, 6 or 12, 2, 4, 6, 8, 10 o'clock) 1/2 inch deep at the reflection of the vagina off the cervix.<BR/>Phase 2 Group 1: 10ml 2% plain lidocaine with 2mg atropin/50ml, injected at 3 to 6 sites (12, 3, 6 or 12, 2, 4, 6, 8, 10 o'clock) 1/2 inch deep at the reflection of the vagina off the cervix.<BR/>Phase 2 Group 2: 20ml 1% plain lidocaine with 1mg atropin/50ml. 1ml injected at 6 sites (12, 2, 4, 6, 8 and 10 o'clock) superficially to blanch the mucous membrane, then 3-4ml injected 1 to 1.5 inches deep at 4 sites (4, 6, 8, and 10 o'clock).<BR/>No delay between injection and procedure.<BR/>All participants: premedication with 1mg lorazepam sublingual 30 minutes prior to procedure per patient request.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Patient reported pain with dilation and procedure measured at end of dilation and at end or procedure. Study instrument: 11 point verbal pain scale (0 = no pain to 10 = worst pain you can imagine). Effect of lorazepam on pain.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Per e-mail communication with Dr. Wiebe: study length was few months at the beginning of 1991. Gestational age at that clinic 6-14 weeks. Study participants underwent vacuum aspiration. Randomization using a table of random numbers generated by computer. Allocation concealment: The nurse drew up the syringes. The nurse was not blinded, but the doctor, couselor and patient were.<BR/>No power analysis. No information on number of people randomized and discontinued availbable. No complication with deep injection.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-07-13 23:02:16 +0200" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wiebe-1995">
<CHAR_METHODS>
<P>Randomized double-blind (blinding of patient, counselor and physician for phase 1 and 2, as well as nurse for phase 1) controlled trial.<BR/>Phase 3: no blinding, randomization by procedure day.<BR/>Phase 4: no blinding.<BR/>Free-standing urban abortion clinic in British Columbia, Canada.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-07-13 23:02:16 +0200" MODIFIED_BY="[Empty name]">
<P>Total of 480 pregnant patients for phase 1, 2 and 4. Phase 3 with 139 pregnant women. First trimester.<BR/>Exclusion criteria: unable to understand or unwilling to sign the consent form. Allergic to lidocaine, bupivacaine or ibuprofen.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Phase 1 Group 1: 600g ibuprofen 30 minutes prior to procedure<BR/>Phase 1 Group 2: placebo 30 minutes prior to procedure<BR/>All participants in phase 1: paracervical block (PCB) with 20ml 1% lidocaine (10ml injected in 4 to 6 sites around the cervix and 5ml each between 3 and 4 o'clock and between 8 and 9 o'clock, about 1 inch deep from the reflection of the vagina into the lower uterine segment, and as decsribed in their included study from 1992). <BR/>Phase 2 Group 1: PCB with 20ml plain 1% lidocaine<BR/>Phase 2 Group 2: PCB with 20ml 1% lidocaine buffered with 2ml 8.4% sodium bicarbonate<BR/>Phase 2 Group 3: PCB wih 20 ml 0.25% bupivacaine<BR/>Phase 3: comparison of waiting time 1, 3, 10 or 20 minutes after administrating PCB with bupivacaine<BR/>Phase 4: fast (30 sec) versus slow (60 sec) injection of buffered lidocaine for PCB on right or left side of cervix (randomized which to speed and side which was first injected). No waiting time. between injection and procedure.<BR/>All participants: premedication with lorazepam 0.5-1mg SL per patient request 30 minutes prior to procedure. Vacuum aspiration followed by sharp curettage.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Phase 1: pain with procedure, measured at end of procedure. Pain 30 minutes after the procedure. <BR/>Phase 2: pain with injection and with procedure.<BR/>Phase 3: pain with procedure. <BR/>Phase 4: pain with injection of each side.<BR/>Pain measured on a verbal 11-point pain scale (0 = no pain to 10 = worst pain you can imagine) in phase 1 to 3, and with a 10cm long visual anlog pain scale in phase 4.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Per power analysis 65 patients per group required to detect mean pain score difference of 1 with a standard deviation of 2 at the 0.05 significance level. Not all groups had that many patients. <BR/>Per e-mail communication with Dr. Wiebe: randomization using tables of computer-generated random numbers, allocation concealment with opaque numbered envelopes.<BR/>Phase 3 was randomized by procedure day, which is not adequate randomization.<BR/>No major complicaions reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wiebe-1996">
<CHAR_METHODS>
<P>Randomized double-blind, controlled trial. Two free-standing urban abortion clinics in British Columbia, Canada.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>209 pregnant women. Maternal age 14 to 42 years. Gestational age 7 to 14 weeks.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: para-cervical block (PCB) with 20 ml1.0% lidocaine<BR/>Group 2: PCB with 20ml 0.5% lidocaine. <BR/>Some patients received preoperative laminaria, lorazepam or ibuprofen.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain with procedure measured with a 11-point verbal pain scale (0 = no pain to 10 = worst pain you can imagine) after the procedure. Anxiety (mild, moderate, severe).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Per e-mail communication with Dr. Wiebe: study length was approximately June to December 1995. Exclusion criteria: inability to understand consent, allergy to lidocaine. Study participants underwent vacuum aspiration. Randomization using a table of random numbers generated by computer. Allocation concealment: The research assistant drew up the syringes. No information on number of people randomized and discontinued availbable. <BR/>No major complications reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wiebe-2003">
<CHAR_METHODS>
<P>Randomized double-blind, placebo-controlled trial. Randomization per computer generated list of random numbers. Allocation with sequentially numbered opaque envelopes. Power analysis done. A difference of 1.5 was chosen to be clinically important. <BR/>Urban free-standing urban abortion clinic in British Columbia, Canada. Study length: July 2000 to November 2001.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>104 pregnant women. Gestational age equal to or less than 14wks. Mean maternal age 25-27.<BR/>Excluded women who were unable to understand or unwilling to sign consent form. Allergy to lorazepam.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: 1mg lorazepam orally<BR/>Group 2: placebo <BR/>both given 1 hour prior to vacuum aspiration. All participants received local anesthesia.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Anxiety and depression prior to counseling and after counseling. Anxiety and pain during procedure assessed after the procedure. All outcomes were assessed with a 11-point verbal scale (0 = no pain/no anxiety to 10 = worst pain you can imagine/most anxious you could be).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Per e-mail communicaion with Dr. Wiebe: Lorazepam was given orally. No participant 14+0 or more wks of gestational age. <BR/>Study also had observational arm with 262 pregnant women, in which patients choosing lorazepam were compared to the group not choosing lorazepam. Mild side effects noted in 3 study subjects.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Wong-2002">
<CHAR_METHODS>
<P>Randomized double-blind, placebo-controlled study. Computer randomization in blocks of 10. Sealed opaque envelope for allocation. Per power analysis 45 participants needed in each arm to detect a difference mean pain score of 1.5 with a power of 80%. <BR/>Queen Mary Hospital in Hong Kong China. Study length: September to December 1999.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>100 pregnant women. Age: &gt;16 years. Gestational age &lt;12 weeks, and uterine size on pelvic exam compatible with estimated gestational age. Normal genereal and gynecological examination. <BR/>Exlusion criteria: severe and recurrent liver disease, myasthenia gravis, psychiatric conditions requiring medication or contraindication to misoprostol.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Group 1: placebo (saline) IV 5 min before cervical dilation<BR/>Group 2: conscious sedation with midazolam 2mg and fentanyl 25mcg IV <BR/>All participants: prophylactic antibiotics. 400mcg misoprostol vaginally 3-6hrs prior to procedure for cervical ripening. Paracervical block with 10ml of 1% lignocaine at 4 and 8 o'clock of the cervix 2 min after study medication. Vacuum aspiration. Rescue pain medication with pethidine 75mg IM.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Pain rated on a 11-point verbal analog scale (0 = no pain to 10 = intolerable pain) during intravenous catheter insertion, suction evacuation (SE), 5 min and 1 hrs after SE. <BR/>Sedation (Ramsay scale). Severity (none, mild, moderate, severe) of post-operative side-effects (nausea, vomiting, dizziness and drowsiness). Satisfaction level (excellent, satisfactory, fair and unsatisfactory) prior to discharge from the hospital (usually 4 hrs after SE).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>3 patients in the conscious sedation group and 1 patient in the placcebo group needed pethidine, and the difference was not statistically significant. All patients completed study and were analysed. No major complications reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2009-01-07 04:45:58 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Andolsek-1977">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain related to the abortion was not reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bonazzi-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Unclear range of gestational age (mean 9.8 with SD of 1.6), unclear if vacuum curettage. The author could not be successsfully contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bonazzi-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Unclear range of gestational age (mean 9.8 with SD of 1.4), unclear if vacuum curettage. The author could not be successsfully contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cade-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomization by hospital medical records number does not qualify as randomization. Unclear if procedure was suction curettage versus sharp D&amp;C</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ciri-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain related to the abortion was not reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Coad-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain is not measured with the procedure, but only as side effect of the anesthesia administration</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Corli-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Amount of pain is measured in a dichotomous fashion only with clamping of the cervix and at what amount of cervical dilation; not with the procedure itself. The range of the gestational age is unclear, however, given that vacuum curettage was performed we assume it was first trimester. The author could not successfully be contacted to clarify questions.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Crawford-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain is not an outcome measured</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Edelist-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain with or after the procedure is not measured, but only pain as side effect of the anesthesia administration (meantioned in the discussion). Unclear if vacuum or sharp curettage. Author could not successfully be contacted to clarify questions.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Enlund-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Outcome of number of days of sick leave depending on anesthetic used leads to follow up of several days, which is beyond the scope of our review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Eriksson-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain with or after the procedure is not measured, but only pain as side effect of the anesthesia administration and postoperative analgesia requirements. Unclear if vacuum or sharp curettage</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-01-06 02:57:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Erkola-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-01-06 02:57:44 +0100" MODIFIED_BY="[Empty name]">
<P>The outcome studied is the treatment of anesthesia side effects. Unclear if the procedure was a dilation and curettage or a vacuum aspiration.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hamar-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain related to the abortion was not reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jakobbson-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomization by date of birth.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kallela-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain related to the abortion was not reported. Only assessed need for postoperative analgesics and pain with injection of anesthetic. Author could not successfully be contacted to clarify questions.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lichtenberg-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain related to the abortion was not reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lowenstein-2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Randomization by day of treatment.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Matambo-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>only letter to editor.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-01-07 04:45:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Miller-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-01-07 04:45:58 +0100" MODIFIED_BY="[Empty name]">
<P>Not adequately allocated</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Nielsen-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not adequately randomized</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Parkash-1979">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Peters-1978">
<CHAR_REASON_FOR_EXCLUSION>
<P>Unclear if randomized. Author could not successfully be contacted.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rawling-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Gestational age up to 14.5 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Sanders-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain related to the abortion was not reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schoeffler-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain related to the abortion was not reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Verma-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain related to the abortion was not reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-West-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Pain related to the abortion was not reported.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wiebe-2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Gestational age up to 16 weeks as per e-mail clarification with the author.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Willdeck_x002d_Lund-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomized. Tried to contact the author, but he passed away.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2009-01-07 04:45:38 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2009-01-07 04:45:38 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Barneschi-1985">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Bone-1988">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Bonnardot-1987">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Boysen-1989">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Boysen-1990">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Cetin-1997">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Collins-1985">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dahl-2000">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Edelman-2004">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Edelman-2006">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Glantz-2001">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Hackett-1982">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Hall-1997">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Heath-1989">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="NO" STUDY_ID="STD-Hein-1999">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Hein-2001">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Jakobsson-1991">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Jakobsson-1993">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Jakobsson-1995">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Jakobsson-1996">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Kan-2004">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Kan-2006">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Li-2003">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Li-2006">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Lindholm-1994">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Liu-2005">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Marc-2007">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ogg-1983">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Phair-2002">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Raeder-1992">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rossi-1995">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shapiro-1975">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Suprapto-1984">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Wells-1989">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Wells-1992">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="NO" STUDY_ID="STD-Wiebe-1992">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Wiebe-1995">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="NO" STUDY_ID="STD-Wiebe-1996">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Wiebe-2003">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Wong-2002">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2009-02-09 20:04:05 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2009-01-07 05:28:25 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-10-20 01:34:35 +0200" MODIFIED_BY="[Empty name]">Local anesthesia</TITLE>
<TABLE COLS="8" ROWS="32">
<TR>
<TD ALIGN="LEFT" COLSPAN="4">
<P>
<B>Local anasthetisia</B>
</P>
</TD>
<TD ALIGN="LEFT" COLSPAN="4">
<P>
<B>WMD</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P> </P>
</TD>
<TD ALIGN="LEFT">
<P>
<B>Treatment</B>
</P>
</TD>
<TD ALIGN="LEFT">
<P>
<B>Control</B>
</P>
</TD>
<TD ALIGN="LEFT">
<P>
<B>Notes, co-treatments</B>
</P>
</TD>
<TD ALIGN="LEFT">
<P>
<B>Dilation</B>
</P>
</TD>
<TD ALIGN="LEFT">
<P>
<B>Aspiration</B>
</P>
</TD>
<TD ALIGN="LEFT">
<P>
<B>Post-op</B>
</P>
</TD>
<TD ALIGN="LEFT">
<P>
<B>Satisfaction</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="8">
<P>
<B>LOCAL ANESTHETICS</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="8">
<P>
<B>Paracervical block (PCB) v placebo/no treatment</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Glantz 2001</P>
</TD>
<TD ALIGN="LEFT">
<P>Chloroprocaine 1%</P>
</TD>
<TD ALIGN="LEFT">
<P>Bacteriostatic saline (0.9% benzyl alcohol)</P>
</TD>
<TD ALIGN="LEFT">
<P>14 ml, 2 sites (4, 8)</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.5 (pain with PCB) ns</P>
</TD>
<TD ALIGN="LEFT">
<P>-1.5 ns</P>
</TD>
<TD ALIGN="LEFT">
<P>-1.9</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Glantz 2001</P>
</TD>
<TD ALIGN="LEFT">
<P>Chloroprocaine 1%</P>
</TD>
<TD ALIGN="LEFT">
<P>Bacteriostatic saline (0.9% benzyl alcohol)</P>
</TD>
<TD ALIGN="LEFT">
<P>14 ml, 4 sites (3, 5, 7, 9),</P>
</TD>
<TD ALIGN="LEFT">
<P>-1.3 (pain with PCB)</P>
</TD>
<TD ALIGN="LEFT">
<P>-1.7</P>
</TD>
<TD ALIGN="LEFT">
<P>-1.3 ns</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Kan 2004</P>
</TD>
<TD ALIGN="LEFT">
<P>Lignocaine 1%</P>
</TD>
<TD ALIGN="LEFT">
<P>No treatment</P>
</TD>
<TD ALIGN="LEFT">
<P>10 ml, 2 sites (4, 8), 2.5 cm deep,</P>
<P>Co-treatment: conscious sedation</P>
<P>Small trial</P>
<P>Also other active arm. Only medians reported.</P>
</TD>
<TD ALIGN="LEFT">
<P>ns</P>
</TD>
<TD ALIGN="LEFT">
<P>ns</P>
</TD>
<TD ALIGN="LEFT">
<P>ns</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="8">
<P>
<B>Various local anesthetics</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Wiebe 1992</P>
</TD>
<TD ALIGN="LEFT">
<P>Carbonated lidocaine 2%</P>
</TD>
<TD ALIGN="LEFT">
<P>Plain lidocaine 2%</P>
</TD>
<TD ALIGN="LEFT">
<P>10 ml, with 2mg atropin/50ml,</P>
<P>No delay, 3 to 6 sites (12, 3, 6 or 12, 2, 4, 6, 8, 10 o'clock)</P>
<P>½ in. deep, no waiting.</P>
<P>All participants: premedication with 1mg lorazepam sublingual 30 minutes prior to procedure per patient request.</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.8</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
<TD ALIGN="LEFT">
<P>-0.4</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Wiebe 1995</P>
</TD>
<TD ALIGN="LEFT">
<P>Carbonated lidocaine 1%</P>
</TD>
<TD ALIGN="LEFT">
<P>Plain lidocaine 1%</P>
</TD>
<TD ALIGN="LEFT">
<P>20ml, (10ml injected in 4 to 6 sites around the cervix and 5ml each between 3 and 4 o'clock and between 8 and 9 o'clock,</P>
<P>1 inch deep, no waiting.</P>
<P>All participants: premedication with lorazepam 0.5-1mg SL per patient request 30 minutes prior to procedure</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
<TD ALIGN="LEFT">
<P>-0.96 ns</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.05 ns</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Wiebe 1996</P>
</TD>
<TD ALIGN="LEFT">
<P>Lidocaine 0.5%</P>
</TD>
<TD ALIGN="LEFT">
<P>Lidocaine 1%</P>
</TD>
<TD ALIGN="LEFT">
<P>20 ml.</P>
<P>Some patients received preoperative laminaria, lorazepam or ibuprofen.</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
<TD ALIGN="LEFT">
<P>0.2 ns</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Wiebe 1995</P>
</TD>
<TD ALIGN="LEFT">
<P>Lidocaine 1%</P>
</TD>
<TD ALIGN="LEFT">
<P>Bupivacaine 0.25%</P>
</TD>
<TD ALIGN="LEFT">
<P>20 ml, as in other groups</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
<TD ALIGN="LEFT">
<P>-0.24 ns</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="8">
<P>
<B>Local anesthesia technique</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="8">
<P>
<B>Depth of paracervical block</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Cetin 1997</P>
</TD>
<TD ALIGN="LEFT">
<P>Deep injection (1ml superficially and 3ml 3cm deep at 4, 6, 8, and 10 o'clock position; total of 16ml)</P>
</TD>
<TD ALIGN="LEFT">
<P>Regular injection (1.5cm deep at same 4 positions)</P>
</TD>
<TD ALIGN="LEFT">
<P>16ml 1% lidocaine.</P>
<P>All participants: 5mg oral diazepam 60 minutes prior to procedure if preprocedural anxiety of 6 or more (rated by physician not performing procedure). After 2 minute wait, cervical dilation.</P>
<P>Vacuum aspiration followed by sharp curette.</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.8</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.9</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Wiebe 1992</P>
</TD>
<TD ALIGN="LEFT">
<P>
<B>Superficially</B> to blanch the mucous membrane: 1ml injected at 6 sites (12, 2, 4, 6, 8 and 10 o'clock).</P>
<P>Then 3-4ml injected 1 to 1.5 inches <B>deep</B> at 4 sites (4, 6, 8, and 10 o'clock). Total of <B>20ml 1% plain</B> lidocaine with 1mg atropin/50ml.</P>
</TD>
<TD ALIGN="LEFT">
<P>½ inch deep at the reflection of the vagina off the cervix.</P>
<P>3 to 6 sites (12, 3, 6 or 12, 2, 4, 6, 8, 10 o'clock). <B>10ml 2% plain</B> lidocaine with 2mg atropin/50ml.</P>
</TD>
<TD ALIGN="LEFT">
<P>No delay</P>
<P>All participants: premedication with 1mg lorazepam sublingual 30 minutes prior to procedure per patient request.</P>
</TD>
<TD ALIGN="LEFT">
<P>-2.4</P>
</TD>
<TD ALIGN="LEFT">
<P>-1.0</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="8">
<P>
<B>Paracervical block 4 sites v 2 sites</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Glantz 2001</P>
</TD>
<TD ALIGN="LEFT">
<P>4 sites bacteriostatic saline (3, 5, 7, 9)</P>
</TD>
<TD ALIGN="LEFT">
<P>2 sites bacteriostatic saline (4, 8)</P>
</TD>
<TD ALIGN="LEFT">
<P>14ml, Also chloroprocaine in 2 groups</P>
</TD>
<TD ALIGN="LEFT">
<P>0.8 (pain with PCB) ns</P>
</TD>
<TD ALIGN="LEFT">
<P>0.1 ns</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.5 ns</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Glantz 2001</P>
</TD>
<TD ALIGN="LEFT">
<P>4 sites 1% chloroprocaine (3, 5, 7, 9)</P>
</TD>
<TD ALIGN="LEFT">
<P>2 sites 1% chloroprocaine (4, 8)</P>
</TD>
<TD ALIGN="LEFT">
<P>14ml, Also saline placebo in 2 groups</P>
</TD>
<TD ALIGN="LEFT">
<P>0 (pain with PCB) ns</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.1 ns</P>
</TD>
<TD ALIGN="LEFT">
<P>0.1 ns</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="8">
<P>
<B>Waiting v no waiting paracervical block</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Phair 2002</P>
</TD>
<TD ALIGN="LEFT">
<P>Waiting 3-5 mins</P>
</TD>
<TD ALIGN="LEFT">
<P>No waiting</P>
</TD>
<TD ALIGN="LEFT">
<P>12ml 1% buffered lidocaine at 12 (superficially, cervix), 4 and 8 o'clock (1-2cm deep, paracervical).</P>
<P>Co-treatment: fentanyl IV and or diazepam per patient request</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.7</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.2 ns</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.1 ns</P>
</TD>
<TD ALIGN="LEFT">
<P>1.58 ns</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="8">
<P>
<B>Slow v fast injection paracervical block</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Wiebe 1995</P>
</TD>
<TD ALIGN="LEFT">
<P>Fast 30 secs</P>
</TD>
<TD ALIGN="LEFT">
<P>Slow 60 secs</P>
</TD>
<TD ALIGN="LEFT">
<P>Lidocaine 1%, 20 ml, no waiting</P>
<P>Factorial design</P>
<P>Outcome: pain with injection</P>
</TD>
<TD ALIGN="LEFT">
<P>0.62 (pain with PCB) ns</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="8">
<P>
<B>Intrauterine infusion </B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Edelman 2004</P>
</TD>
<TD ALIGN="LEFT">
<P>Lidocaine 10ml, 1%</P>
</TD>
<TD ALIGN="LEFT">
<P>Saline placebo 10ml</P>
</TD>
<TD ALIGN="LEFT">
<P>All participants: premedication with 800mg ibuprofen, and if requested, 5mg diazepam. Paracervical block with 10ml of 1% lidocaine (1ml 1% nonbuffered lidocaine on the anterior and posterior lip of the cerivx and then 4.5ml of 1% lidocaine paracervical at the 4- and 8-o'clock postitions).</P>
<P>100mm VAS</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.3 ns</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.4 ns</P>
</TD>
<TD ALIGN="LEFT">
<P>0.7 ns</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.1 ns</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Edelman 2006</P>
</TD>
<TD ALIGN="LEFT">
<P>Lidocaine 5 ml, 4%</P>
</TD>
<TD ALIGN="LEFT">
<P>Saline placebo 5ml</P>
</TD>
<TD ALIGN="LEFT">
<P>Co treatment: ibuprofen 800 mg, cervical lidocaine 1% 10 ml, 4 sites, diazepam mg if requested</P>
<P>100mm VAS</P>
</TD>
<TD ALIGN="LEFT">
<P>-2</P>
</TD>
<TD ALIGN="LEFT">
<P>-2.8</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.5 ns</P>
</TD>
<TD ALIGN="LEFT">
<P>0.5 ns</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="8">
<P>
<B>Topical </B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Li 2006</P>
</TD>
<TD ALIGN="LEFT">
<P>Lignocaine yelly 2%</P>
<P>3 ml ?applied to cervix?, to dilator and speculum</P>
</TD>
<TD ALIGN="LEFT">
<P>Placebo gel</P>
</TD>
<TD ALIGN="LEFT">
<P>Co-treatment: All subjects: cervical priming with 400micrg misoprostol prior to the procedure (1-2 hours in multiparous, 3-5 hours in nulliparous subjects). Premedication with 5mg diazepam po and 1mg/kg pethidine IM 15-30 minutes prior to the procedure. Rescue pain medication with pethidine repeat dose IM.</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.42 ns</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.87</P>
</TD>
<TD ALIGN="LEFT">
<P>-0.51 marginal sig</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="8">
<P>
<B>Cervical block</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Kan 2004</P>
</TD>
<TD ALIGN="LEFT">
<P>Cervical, 2 sites (4, 8), 2.5 cm deep, Lignocaine 1%, 10ml</P>
</TD>
<TD ALIGN="LEFT">
<P>No treatment</P>
</TD>
<TD ALIGN="LEFT">
<P>10ml,</P>
<P>Co-treatment: All patients: 400mcg misoprostol vaginally for cervical priming 3-6hrs prior to the procedure.</P>
<P>Conscious sedation with 2mg midazolam and 25mcg fentanyl IV 5 minutes prior to cervical dilation.</P>
<P>Pethidine IM as needed for additional analgesia.</P>
<P>Small trial</P>
<P>Also other active arm. Only medians reported.</P>
</TD>
<TD ALIGN="LEFT">
<P>ns</P>
</TD>
<TD ALIGN="LEFT">
<P>ns</P>
</TD>
<TD ALIGN="LEFT">
<P>ns</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" COLSPAN="8">
<P>
<B>Cervical v paracervical</B>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT">
<P>Kan 2004</P>
</TD>
<TD ALIGN="LEFT">
<P>Cervical 2.5 cm deep</P>
</TD>
<TD ALIGN="LEFT">
<P>Paracervical, 2.5 cm deep</P>
</TD>
<TD ALIGN="LEFT">
<P>Lidocaine 1%, 10ml , 2 sites (4, 8)</P>
<P>Co-treatment: conscious sedation (details see other arm)</P>
<P>Small trial</P>
<P>Also no treatment arm. Only medians reported.</P>
</TD>
<TD ALIGN="LEFT">
<P>ns</P>
</TD>
<TD ALIGN="LEFT">
<P>ns</P>
</TD>
<TD ALIGN="LEFT">
<P>ns</P>
</TD>
<TD ALIGN="LEFT">
<P> </P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2009-02-09 20:04:05 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2008-10-19 01:15:38 +0200" MODIFIED_BY="[Empty name]">General anesthesia</TITLE>
<TABLE COLS="13" ROWS="15">
<TR>
<TD>
<P>Study</P>
</TD>
<TD>
<P>Fentanyl<SUP>$</SUP>
</P>
</TD>
<TD>
<P>Alfentanil <SUP>$</SUP>
</P>
</TD>
<TD>
<P>Midazolam/diazepam/lorazepam (benzodiazepine)*</P>
</TD>
<TD>
<P>Propofol*</P>
</TD>
<TD>
<P>Ketamine*</P>
</TD>
<TD>
<P>Methohexital (barbiturate)*</P>
</TD>
<TD>
<P>Thiopental (barbiturate)*</P>
</TD>
<TD>
<P>Etomidate<SUP>#</SUP>
</P>
</TD>
<TD>
<P>Halothane <SUP>#</SUP>
</P>
</TD>
<TD>
<P>Enflurane<SUP>#</SUP>
</P>
</TD>
<TD>
<P>Trichlorethylene<SUP>#</SUP>
</P>
</TD>
<TD>
<P>N2O2</P>
</TD>
</TR>
<TR>
<TD>
<P>Barneschi</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
</TR>
<TR>
<TD>
<P>Bonnardot</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Boysen 1989</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Boysen 1990</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Collins</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
</TR>
<TR>
<TD>
<P>Hackett</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
</TR>
<TR>
<TD>
<P>Hall</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
</TR>
<TR>
<TD>
<P>Jakobsson 1991</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>X (vs fent vs placebo)</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
</TR>
<TR>
<TD>
<P>Jakobsson 1993</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Jakobsson 1995</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
</TR>
<TR>
<TD>
<P>Lindholm</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>X vs fent vs NS</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Ogg</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>X</P>
</TD>
<TD>
<P>x</P>
</TD>
</TR>
<TR>
<TD>
<P>Raeder</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
</TR>
<TR>
<TD>
<P>Rossi</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>Opiates<SUP>$</SUP>
<SUP>, </SUP>Sedative hypnotic agents*, Inhalational anesthetic<SUP>#</SUP>
</P>
<P>x= control or intervention, c= co-treatment</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-03" MODIFIED="2009-02-09 20:04:05 +0100" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2008-11-12 05:05:08 +0100" MODIFIED_BY="[Empty name]">General anesthesia with premedication</TITLE>
<TABLE COLS="12" ROWS="8">
<TR>
<TD>
<P>Study</P>
</TD>
<TD>
<P>Fentanyl<SUP>$</SUP>
</P>
</TD>
<TD>
<P>Alfentanil<SUP>$</SUP>
</P>
</TD>
<TD>
<P>Midazolam (benzodiazepine)*</P>
</TD>
<TD>
<P>Propofol*</P>
</TD>
<TD>
<P>Thiopental (barbiturate)*</P>
</TD>
<TD>
<P>Desflurane<SUP>#</SUP>
</P>
</TD>
<TD>
<P>Enflurane#</P>
</TD>
<TD>
<P>N2O2<SUP>#</SUP>
</P>
</TD>
<TD>
<P>Opioid</P>
</TD>
<TD>
<P>Non-selective COX</P>
</TD>
<TD>
<P>Selective  COX</P>
</TD>
</TR>
<TR>
<TD>
<P>Bone</P>
</TD>
<TD>
<P>x</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P>Nalbuphine vs fentanyl</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Dahl</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
<P> </P>
</TD>
<TD>
<P>Paracetamol with codeine</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Paracetamol (COX 3) vs placebo</P>
</TD>
</TR>
<TR>
<TD>
<P>Heath</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P>dihydrocodeine vs placebo</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Hein 1999</P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Paracetamol vs placebo</P>
</TD>
</TR>
<TR>
<TD>
<P>Hein 2001</P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Lornoxicam</P>
</TD>
<TD>
<P>Paracetamol</P>
</TD>
</TR>
<TR>
<TD>
<P>Jakobsson 1996</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Sodium-diclofenac vs ketorolac vs potassium-diclofenac vs NaCl</P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Liu</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>c</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Etoricoxib vs placebo (COX 2)</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>Opiates<SUP>$</SUP>,<SUP> </SUP>Sedative hypnotic agents*, Inhalational anesthetic<SUP>#</SUP>
</P>
<P>x= control or intervention, c= co-treatment</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-04" MODIFIED="2009-02-09 20:04:04 +0100" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2008-10-19 01:26:16 +0200" MODIFIED_BY="[Empty name]">Quality of evidence</TITLE>
<TABLE COLS="7" ROWS="42">
<TR>
<TD>
<P>
<B>Author (year)</B>
</P>
</TD>
<TD>
<P>
<B>Randomization</B>
</P>
</TD>
<TD>
<P>
<B>Randomization unclear</B>
</P>
</TD>
<TD>
<P>
<B>Allocation concealment </B>
</P>
</TD>
<TD>
<P>
<B>Allocation concealment </B>
</P>
<P>
<B>unclear</B>
</P>
</TD>
<TD>
<P>
<B>Allocation concealment </B>
</P>
<P>
<B>Inadequate</B>
</P>
</TD>
<TD>
<P>
<B>Blinding</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>Barneschi</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 envelope</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Participants and outcome assessor= double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Bone</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Bonnardot (1987)</P>
</TD>
<TD>
<P>Table of numbers</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 Opaque envelopes</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Outcome assessor</P>
</TD>
</TR>
<TR>
<TD>
<P>Boysen (1989)</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Boysen (1990)</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Outcome assessor</P>
</TD>
</TR>
<TR>
<TD>
<P>Cetin</P>
</TD>
<TD>
<P>Computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Unclear</P>
</TD>
</TR>
<TR>
<TD>
<P>Collins</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Unclear</P>
</TD>
</TR>
<TR>
<TD>
<P>Dahl</P>
</TD>
<TD>
<P>Random number list</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Edelman 2004</P>
</TD>
<TD>
<P>Computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 identical study syringes</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Edelman 2006</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 identical study syringes</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Glantz</P>
</TD>
<TD>
<P>Permuted block technique</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1opaque sealed envelopes</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Hackett</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Outcome assessor</P>
</TD>
</TR>
<TR>
<TD>
<P>Hall, G</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1 closed envelopes</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Investigators blinded</P>
</TD>
</TR>
<TR>
<TD>
<P>Heath</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Hein 1999</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 nurse drew envelope</P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Hein 2001</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1 envelope</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Jakobsson 1991</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 envelope</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Patient and outcome assessor = double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Jakobsson 1993</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 envelope</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Patient and outcome assessor  = double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Jakobsson 1995</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 envelope</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Patient and outcome assessor  = double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Jakobsson 1996</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 sealed envelope</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Kan 2004</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 opaque envelope</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Kan 2006</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 sealed envelope</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Li 2003</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 sealed envelope</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Li 2006</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 sealed envelope</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Lindholm</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 (identical looking ampoules delivered by pharmacy)</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Anesthesiologist </P>
</TD>
</TR>
<TR>
<TD>
<P>Liu</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>1 sealed opaque envelopes</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Marc</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 sealed opaque envelopes</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
</TR>
<TR>
<TD>
<P>Ogg</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Outcome assessor</P>
</TD>
</TR>
<TR>
<TD>
<P>Phair</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 opaque envelopes</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>NO BLINDING POSSIBLE</P>
</TD>
</TR>
<TR>
<TD>
<P>Raeder</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 sealed envelopes</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Rossi</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Unclear</P>
</TD>
</TR>
<TR>
<TD>
<P>Shapiro</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Unclear</P>
</TD>
</TR>
<TR>
<TD>
<P>Suprapto</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Wells 1989</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>nurses, counselors, physicians and technicians</P>
</TD>
</TR>
<TR>
<TD>
<P>Wells 1992</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 envelopes</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Outcome assessor</P>
</TD>
</TR>
<TR>
<TD>
<P>Wiebe 1992</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 The nurse drew up the syringes</P>
</TD>
<TD>
<P>Some phases double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Wiebe 1995</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 opaque envelopes</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind for some phases</P>
</TD>
</TR>
<TR>
<TD>
<P>Wiebe 1996</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 assistant drew up the syringes</P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Wiebe 2003</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 opaque envelopes</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>Wong 2002</P>
</TD>
<TD>
<P>computer</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>1 opaque envelopes</P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P> </P>
</TD>
<TD>
<P>Double blind</P>
</TD>
</TR>
<TR>
<TD>
<P>
<B>TOTAL</B>
</P>
</TD>
<TD>
<P>
<B>2</B>
<B>4</B>
</P>
</TD>
<TD>
<P>
<B>16</B>
</P>
</TD>
<TD>
<P>
<B>23</B>
</P>
</TD>
<TD>
<P>
<B>14</B>
</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>
<B> </B>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2009-01-07 04:59:36 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2009-01-07 04:59:36 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Local anesthetics</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2009-01-07 04:59:17 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="76" TOTAL_2="82" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with paracervical block or dilation comparing local anesthetics with bacteriostatic normal saline</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Bact NS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours bact NS</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.01.01" MODIFIED="2008-10-19 19:21:07 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>1% chloroprocaine versus bacteriostatic (benzyl alcohol) normal saline 14ml at <I>2 sites</I>- pain with PCB</NAME>
<CONT_DATA CI_END="0.8372356116380966" CI_START="-1.8372356116380975" EFFECT_SIZE="-0.5000000000000004" ESTIMABLE="YES" MEAN_1="3.9" MEAN_2="4.4" MODIFIED="2008-10-19 19:19:33 +0200" MODIFIED_BY="[Empty name]" ORDER="210" SD_1="2.1" SD_2="2.1" SE="0.6822756041366275" STUDY_ID="STD-Glantz-2001" TOTAL_1="18" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.01.02" MODIFIED="2008-10-19 19:21:25 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>1% chloroprocaine versus bacteriostatic (benzyl alcohol) normal saline 14ml at 4<I> sites</I>- pain with PCB</NAME>
<CONT_DATA CI_END="-0.07525586093429237" CI_START="-2.5247441390657084" EFFECT_SIZE="-1.3000000000000003" ESTIMABLE="YES" MEAN_1="3.9" MEAN_2="5.2" MODIFIED="2008-10-19 19:20:08 +0200" MODIFIED_BY="[Empty name]" ORDER="211" SD_1="2.0" SD_2="2.0" SE="0.6248809410409238" STUDY_ID="STD-Glantz-2001" TOTAL_1="20" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.01.03" MODIFIED="2008-10-19 19:21:51 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="41" WEIGHT="0.0" Z="0.0">
<NAME>1% chloroprocaine 14ml versus bacteriostatic (benzyl alcohol) normal saline 14ml <I>all sites combined</I> - pain with PCB</NAME>
<CONT_DATA CI_END="-0.017310611426376354" CI_START="-1.7826893885736235" EFFECT_SIZE="-0.8999999999999999" ESTIMABLE="YES" MEAN_1="3.9" MEAN_2="4.8" ORDER="19" SD_1="2.0" SD_2="2.0" SE="0.45036000433485757" STUDY_ID="STD-Glantz-2001" TOTAL_1="38" TOTAL_2="41" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2009-01-07 04:59:07 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="76" TOTAL_2="82" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing local anesthetics with bacteriostatic normal saline</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Bact NS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours bact NS</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.02.01" MODIFIED="2008-10-19 19:32:55 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>1% chloroprocaine versus bacteriostatic (benzyl alcohol) normal saline 14ml at <I>2 sites</I>- pain with aspiration</NAME>
<CONT_DATA CI_END="0.06210755348550823" CI_START="-3.0621075534855082" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="6.3" MEAN_2="7.8" MODIFIED="2008-10-19 19:32:14 +0200" MODIFIED_BY="[Empty name]" ORDER="213" SD_1="2.5" SD_2="2.4" SE="0.7970082949519548" STUDY_ID="STD-Glantz-2001" TOTAL_1="18" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.02.02" MODIFIED="2008-10-19 19:32:56 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>1% chloroprocaine versus bacteriostatic (benzyl alcohol) normal saline 14ml at 4<I> sites</I>- pain with aspiration</NAME>
<CONT_DATA CI_END="-0.5176611494534897" CI_START="-2.8823388505465104" EFFECT_SIZE="-1.7000000000000002" ESTIMABLE="YES" MEAN_1="6.2" MEAN_2="7.9" MODIFIED="2008-10-19 19:32:44 +0200" MODIFIED_BY="[Empty name]" ORDER="212" SD_1="2.2" SD_2="1.6" SE="0.6032451921936568" STUDY_ID="STD-Glantz-2001" TOTAL_1="20" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.02.03" MODIFIED="2008-10-19 19:32:56 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="41" WEIGHT="0.0" Z="0.0">
<NAME>1% chloroprocaine 14ml versus bacteriostatic (benzyl alcohol) normal saline 14ml <I>all sites combined</I>- pain with aspiration</NAME>
<CONT_DATA CI_END="-0.5462977537192841" CI_START="-2.4537022462807156" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="6.3" MEAN_2="7.8" ORDER="21" SD_1="2.3" SD_2="2.0" SE="0.4865917199516917" STUDY_ID="STD-Glantz-2001" TOTAL_1="38" TOTAL_2="41" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2009-01-07 04:59:36 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="76" TOTAL_2="82" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain postpoperatively comparing local anesthetics with bacteriostatic normal saline</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Bact NS</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours bact NS</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.01" MODIFIED="2008-10-19 19:40:54 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="18" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>1% chloroprocaine 14ml versus bacteriostatic (benzyl alcohol) normal saline 14ml at <I>2 sites</I>- pain postop</NAME>
<CONT_DATA CI_END="-0.3066458486196608" CI_START="-3.49335415138034" EFFECT_SIZE="-1.9000000000000004" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="7.0" MODIFIED="2008-10-19 19:40:54 +0200" MODIFIED_BY="[Empty name]" ORDER="215" SD_1="2.2" SD_2="2.8" SE="0.8129507296810113" STUDY_ID="STD-Glantz-2001" TOTAL_1="18" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.02" MODIFIED="2008-10-19 19:41:23 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="21" WEIGHT="0.0" Z="0.0">
<NAME>1% chloroprocaine 14ml versus bacteriostatic (benzyl alcohol) normal saline 14ml at<I> 4 sites</I>- pain postop</NAME>
<CONT_DATA CI_END="0.06411910968407963" CI_START="-2.664119109684079" EFFECT_SIZE="-1.2999999999999998" ESTIMABLE="YES" MEAN_1="5.2" MEAN_2="6.5" MODIFIED="2008-10-19 19:41:23 +0200" MODIFIED_BY="[Empty name]" ORDER="214" SD_1="2.5" SD_2="1.9" SE="0.6959919266088953" STUDY_ID="STD-Glantz-2001" TOTAL_1="20" TOTAL_2="21" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.03.03" MODIFIED="2008-10-19 19:39:56 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="38" TOTAL_2="41" WEIGHT="0.0" Z="0.0">
<NAME>1% chloroprocaine 14ml versus bacteriostatic (benzyl alcohol) normal saline 14ml <I>all sites combined</I>- pain postop</NAME>
<CONT_DATA CI_END="-0.46344338239631266" CI_START="-2.5365566176036873" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="5.2" MEAN_2="6.7" ORDER="30" SD_1="2.3" SD_2="2.4" SE="0.5288651351657039" STUDY_ID="STD-Glantz-2001" TOTAL_1="38" TOTAL_2="41" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2008-08-27 11:08:24 +0200" MODIFIED_BY="anja helmerhorst" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="86" TOTAL_2="81" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with dilation comparing 2% buffered lidocaine with 2% plain lidocaine</NAME>
<GROUP_LABEL_1>Buffered lidocaine</GROUP_LABEL_1>
<GROUP_LABEL_2>Plain lidocaine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours buffered lidocain</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours plain lidocaine</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.7089592459250733" CI_START="-0.8910407540749263" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="4.4" MEAN_2="5.2" MODIFIED="2008-08-27 11:08:24 +0200" MODIFIED_BY="anja helmerhorst" ORDER="216" SD_1="0.3" SD_2="0.3" SE="0.04645021785759554" STUDY_ID="STD-Wiebe-1992" TOTAL_1="86" TOTAL_2="81" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2008-07-13 20:15:49 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="57" TOTAL_2="67" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing 1% buffered lidocaine with 1% plain lidocaine 20ml each</NAME>
<GROUP_LABEL_1>Buffered lidocaine</GROUP_LABEL_1>
<GROUP_LABEL_2>Plain lidocaine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours buffered lidocain</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours plain lidocaine</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.253807134264068" CI_START="-1.666192865735932" EFFECT_SIZE="-0.96" ESTIMABLE="YES" MEAN_1="2.02" MEAN_2="2.98" ORDER="32" SD_1="1.91" SD_2="2.1" SE="0.3603091032826578" STUDY_ID="STD-Wiebe-1995" TOTAL_1="57" TOTAL_2="67" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2008-07-13 20:15:56 +0200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="143" TOTAL_2="148" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain at end of procedure comparing buffered lidocaine with plain lidocaine</NAME>
<GROUP_LABEL_1>Buffered lidocaine</GROUP_LABEL_1>
<GROUP_LABEL_2>Plain lidocaine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours buffered lidocain</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours plain lidocaine</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.06.01" MODIFIED="2008-07-13 04:41:37 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="86" TOTAL_2="81" WEIGHT="0.0" Z="0.0">
<NAME>2% buffered lidocaine versus 2% lidocaine 10ml each.</NAME>
<CONT_DATA CI_END="-0.30895924592507384" CI_START="-0.49104075407492687" EFFECT_SIZE="-0.40000000000000036" ESTIMABLE="YES" MEAN_1="5.8" MEAN_2="6.2" ORDER="25" SD_1="0.3" SD_2="0.3" SE="0.04645021785759554" STUDY_ID="STD-Wiebe-1992" TOTAL_1="86" TOTAL_2="81" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.06.02" MODIFIED="2008-07-13 04:42:00 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="57" TOTAL_2="67" WEIGHT="0.0" Z="0.0">
<NAME>1% buffered lidocaine versus 1% lidocaine 20ml each.</NAME>
<CONT_DATA CI_END="0.9302180422472399" CI_START="-1.0302180422472396" EFFECT_SIZE="-0.04999999999999982" ESTIMABLE="YES" MEAN_1="5.23" MEAN_2="5.28" ORDER="26" SD_1="2.83" SD_2="2.71" SE="0.5001204358748806" STUDY_ID="STD-Wiebe-1995" TOTAL_1="57" TOTAL_2="67" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2008-07-13 20:16:04 +0200" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="103" TOTAL_2="106" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing 0.5% lidocaine with 1% lidocaine 20ml each</NAME>
<GROUP_LABEL_1>0.5% lidocaine</GROUP_LABEL_1>
<GROUP_LABEL_2>1% lidocaine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours 0.5% lidocaine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours 1% lidocaine</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.8509957381459969" CI_START="-0.45099573814599836" EFFECT_SIZE="0.1999999999999993" ESTIMABLE="YES" MEAN_1="4.6" MEAN_2="4.4" ORDER="23" SD_1="2.3" SD_2="2.5" SE="0.33214678600268627" STUDY_ID="STD-Wiebe-1996" TOTAL_1="103" TOTAL_2="106" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.08" MODIFIED="2008-07-13 20:16:15 +0200" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="67" TOTAL_2="76" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing 1% lidocaine with 0.25% bupivacaine 20ml each</NAME>
<GROUP_LABEL_1>1% lidocaine</GROUP_LABEL_1>
<GROUP_LABEL_2>0.25% bupivacaine</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours 1% lidocaine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours 0.25% bupivacaine</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.4653286694553974" CI_START="-0.9453286694553978" EFFECT_SIZE="-0.2400000000000002" ESTIMABLE="YES" MEAN_1="2.98" MEAN_2="3.22" ORDER="27" SD_1="2.1" SD_2="2.2" SE="0.359868178710905" STUDY_ID="STD-Wiebe-1995" TOTAL_1="67" TOTAL_2="76" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2008-10-20 02:00:15 +0200" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Local anesthesia technique</NAME>
<CONT_OUTCOME CHI2="17.30522795694151" CI_END="-0.07934302799399573" CI_START="-3.2103537408918967" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.6448483844429462" ESTIMABLE="YES" I2="94.22139943785672" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2008-08-27 10:53:24 +0200" MODIFIED_BY="anja helmerhorst" NO="1" P_CHI2="3.1831437603546675E-5" P_Q="1.0" P_Z="0.03946560554302211" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="1.2060339128045598" TOTALS="YES" TOTAL_1="113" TOTAL_2="116" UNITS="" WEIGHT="100.0" Z="2.059298986270951">
<NAME>Pain with dilation comparing a deep paracervical block with a regular injection technique</NAME>
<GROUP_LABEL_1>Deep PCB</GROUP_LABEL_1>
<GROUP_LABEL_2>Regular PCB</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours deep PCB</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours regular PCB</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.05180829107192819" CI_START="-1.5481917089280715" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="3.2" MEAN_2="4.0" ORDER="1" SD_1="1.5" SD_2="1.6" SE="0.38173747825455584" STUDY_ID="STD-Cetin-1997" TOTAL_1="31" TOTAL_2="35" WEIGHT="47.196975972315876"/>
<CONT_DATA CI_END="-2.307888530195449" CI_START="-2.4921114698045517" EFFECT_SIZE="-2.4000000000000004" ESTIMABLE="YES" MEAN_1="2.8" MEAN_2="5.2" MODIFIED="2008-08-27 10:53:24 +0200" MODIFIED_BY="anja helmerhorst" ORDER="2" SD_1="0.3" SD_2="0.3" SE="0.046996511431391025" STUDY_ID="STD-Wiebe-1992" TOTAL_1="82" TOTAL_2="81" WEIGHT="52.80302402768413"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0955472269252906" CI_END="-0.9067553134476207" CI_START="-1.0890240366909096" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.9978896750692652" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2008-08-22 07:33:11 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.7572400453642538" P_Q="1.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="113" TOTAL_2="116" UNITS="" WEIGHT="100.0" Z="21.46092636057513">
<NAME>Pain with aspiration comparing a deep paracervical block with a regular injection technique</NAME>
<GROUP_LABEL_1>Deep PCB</GROUP_LABEL_1>
<GROUP_LABEL_2>Regular PCB</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours deep PCB</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours regular PCB</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.272653483247546" CI_START="-1.5273465167524538" EFFECT_SIZE="-0.8999999999999999" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="3.9" MODIFIED="2008-08-22 07:33:11 +0200" MODIFIED_BY="[Empty name]" ORDER="3" SD_1="1.2" SD_2="1.4" SE="0.3200806350019098" STUDY_ID="STD-Cetin-1997" TOTAL_1="31" TOTAL_2="35" WEIGHT="2.110324930734734"/>
<CONT_DATA CI_END="-0.9078885301954487" CI_START="-1.0921114698045513" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="5.2" MEAN_2="6.2" ORDER="4" SD_1="0.3" SD_2="0.3" SE="0.046996511431391025" STUDY_ID="STD-Wiebe-1992" TOTAL_1="82" TOTAL_2="81" WEIGHT="97.88967506926527"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2008-10-20 01:59:32 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="41" TOTAL_2="38" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with PCB placement comparing 4 site (3-5-7-9 o'clock) with 2 site (4-8 o'clock) PCB</NAME>
<GROUP_LABEL_1>4 site PCB</GROUP_LABEL_1>
<GROUP_LABEL_2>2 site PCB</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.01" MODIFIED="2008-10-19 19:57:58 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Bacteriostatis saline</NAME>
<CONT_DATA CI_END="2.0564824360093663" CI_START="-0.45648243600936644" EFFECT_SIZE="0.7999999999999998" ESTIMABLE="YES" MEAN_1="5.2" MEAN_2="4.4" MODIFIED="2008-10-19 19:57:58 +0200" MODIFIED_BY="[Empty name]" ORDER="216" SD_1="2.0" SD_2="2.1" SE="0.641074247241449" STUDY_ID="STD-Glantz-2001" TOTAL_1="21" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.03.02" MODIFIED="2008-10-19 19:58:26 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="18" WEIGHT="0.0" Z="0.0">
<NAME>1% chloroprocaine</NAME>
<CONT_DATA CI_END="1.307459052975995" CI_START="-1.307459052975995" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.9" MEAN_2="3.9" MODIFIED="2008-10-19 19:58:26 +0200" MODIFIED_BY="[Empty name]" ORDER="218" SD_1="2.0" SD_2="2.1" SE="0.6670832032063166" STUDY_ID="STD-Glantz-2001" TOTAL_1="20" TOTAL_2="18" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2008-10-20 01:59:40 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="41" TOTAL_2="38" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing 4 site (3-5-7-9 o'clock) with 2 site (4-8 o'clock) PCB</NAME>
<GROUP_LABEL_1>4 site injection</GROUP_LABEL_1>
<GROUP_LABEL_2>2 site injection</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours 4% intraut lido</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.04.01" MODIFIED="2008-10-19 20:03:00 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Bacteriostatic Saline</NAME>
<CONT_DATA CI_END="1.35484352142551" CI_START="-1.1548435214255088" EFFECT_SIZE="0.10000000000000053" ESTIMABLE="YES" MEAN_1="7.9" MEAN_2="7.8" MODIFIED="2008-10-19 20:03:00 +0200" MODIFIED_BY="[Empty name]" ORDER="18" SD_1="1.6" SD_2="2.4" SE="0.6402380509660152" STUDY_ID="STD-Glantz-2001" TOTAL_1="21" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.04.02" MODIFIED="2008-10-19 20:01:08 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="18" WEIGHT="0.0" Z="0.0">
<NAME>1% chloroprocaine</NAME>
<CONT_DATA CI_END="1.4044842647580438" CI_START="-1.604484264758043" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="YES" MEAN_1="6.2" MEAN_2="6.3" MODIFIED="2008-10-19 20:01:08 +0200" MODIFIED_BY="[Empty name]" ORDER="219" SD_1="2.2" SD_2="2.5" SE="0.7676081176109476" STUDY_ID="STD-Glantz-2001" TOTAL_1="20" TOTAL_2="18" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2008-10-20 01:59:50 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="41" TOTAL_2="38" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain postoperatively comparing 4 site (3-5-7-9 o'clock) with 2 site (4-8 o'clock) PCB</NAME>
<GROUP_LABEL_1>4 site</GROUP_LABEL_1>
<GROUP_LABEL_2>2 site</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.01" MODIFIED="2008-10-19 20:06:23 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="21" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Bacteriostatic saline</NAME>
<CONT_DATA CI_END="0.9718073656733983" CI_START="-1.9718073656733983" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="7.0" MODIFIED="2008-10-19 20:06:23 +0200" MODIFIED_BY="[Empty name]" ORDER="221" SD_1="1.9" SD_2="2.8" SE="0.7509359239673927" STUDY_ID="STD-Glantz-2001" TOTAL_1="21" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.05.02" MODIFIED="2008-10-19 20:06:42 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="18" WEIGHT="0.0" Z="0.0">
<NAME>1% chloroprocaine</NAME>
<CONT_DATA CI_END="1.5944502251583295" CI_START="-1.3944502251583284" EFFECT_SIZE="0.10000000000000053" ESTIMABLE="YES" MEAN_1="5.2" MEAN_2="5.1" MODIFIED="2008-10-19 20:06:42 +0200" MODIFIED_BY="[Empty name]" ORDER="220" SD_1="2.5" SD_2="2.2" SE="0.7624886155798584" STUDY_ID="STD-Glantz-2001" TOTAL_1="20" TOTAL_2="18" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.06" MODIFIED="2008-10-20 02:00:02 +0200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="101" TOTAL_2="93" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with dilation comparing 3-5 minute wait with no wait after PCB of 12ml 1% buffered lidocaine</NAME>
<GROUP_LABEL_1>Wait 3-5 minutes</GROUP_LABEL_1>
<GROUP_LABEL_2>No wait</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours 3-5 min wait</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no wait</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.027005214175485848" CI_START="-1.3729947858245146" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="4.7" MODIFIED="2008-10-20 01:14:07 +0200" MODIFIED_BY="[Empty name]" ORDER="11" SD_1="2.31" SD_2="2.46" SE="0.34337099616779254" STUDY_ID="STD-Phair-2002" TOTAL_1="101" TOTAL_2="93" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.07" MODIFIED="2008-10-20 02:00:08 +0200" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="101" TOTAL_2="93" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing 3-5 minute wait with no wait after PCB of 12ml 1% buffered lidocaine</NAME>
<GROUP_LABEL_1>3-5 minute wait</GROUP_LABEL_1>
<GROUP_LABEL_2>No wait</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours 3-5 min wait</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no wait</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.43615816936056384" CI_START="-0.8361581693605642" EFFECT_SIZE="-0.20000000000000018" ESTIMABLE="YES" MEAN_1="5.1" MEAN_2="5.3" MODIFIED="2008-10-20 01:16:09 +0200" MODIFIED_BY="[Empty name]" ORDER="12" SD_1="2.31" SD_2="2.21" SE="0.3245764587403128" STUDY_ID="STD-Phair-2002" TOTAL_1="101" TOTAL_2="93" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.08" MODIFIED="2008-10-20 02:00:15 +0200" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="101" TOTAL_2="93" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain postpoperatively comparing 3-5 minute wait with no wait after PCB of 12ml 1% buffered lidocaine</NAME>
<GROUP_LABEL_1>Wait 3-5 minutes</GROUP_LABEL_1>
<GROUP_LABEL_2>No wait</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours 3-5 min wait</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no wait</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.32506317053932204" CI_START="-0.5250631705393223" EFFECT_SIZE="-0.10000000000000009" ESTIMABLE="YES" MEAN_1="1.7" MEAN_2="1.8" MODIFIED="2008-10-20 01:17:12 +0200" MODIFIED_BY="[Empty name]" ORDER="16" SD_1="1.54" SD_2="1.48" SE="0.21687294965222126" STUDY_ID="STD-Phair-2002" TOTAL_1="101" TOTAL_2="93" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.09" MODIFIED="2008-10-19 20:05:16 +0200" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="87" TOTAL_2="87" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with injection comparing fast injection with slow injection of buffered lidocaine</NAME>
<GROUP_LABEL_1>Fast injection</GROUP_LABEL_1>
<GROUP_LABEL_2>Slow injection</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours fast injection</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours slow injection</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.3359799057773551" CI_START="-0.09597990577735493" EFFECT_SIZE="0.6200000000000001" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="1.38" ORDER="13" SD_1="2.97" SD_2="1.67" SE="0.3653025828152523" STUDY_ID="STD-Wiebe-1995" TOTAL_1="87" TOTAL_2="87" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.10" MODIFIED="2008-10-19 20:05:15 +0200" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="75" TOTAL_2="78" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with dilation comparing intrauterine lidocaine with placebo</NAME>
<GROUP_LABEL_1>Iintrauterine lidocaine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intrauterine lido</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.10.01" MODIFIED="2008-10-18 20:19:35 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>1% lidocaine</NAME>
<CONT_DATA CI_END="0.8698479942318627" CI_START="-1.4698479942318632" EFFECT_SIZE="-0.30000000000000027" ESTIMABLE="YES" MEAN_1="3.3" MEAN_2="3.6" MODIFIED="2008-10-18 20:19:35 +0200" MODIFIED_BY="[Empty name]" ORDER="5" SD_1="2.8" SD_2="2.5" SE="0.5968721892134113" STUDY_ID="STD-Edelman-2004" TOTAL_1="40" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.10.02" MODIFIED="2008-10-18 20:19:53 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="35" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>4% lidocaine</NAME>
<CONT_DATA CI_END="-0.7140542161492318" CI_START="-3.285945783850768" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="3.5" MEAN_2="5.5" MODIFIED="2008-10-18 20:19:53 +0200" MODIFIED_BY="[Empty name]" ORDER="6" SD_1="3.0" SD_2="2.6" SE="0.6561068437961842" STUDY_ID="STD-Edelman-2006" TOTAL_1="35" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.11" MODIFIED="2008-10-19 20:05:15 +0200" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="77" TOTAL_2="79" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing intrauterine lidocaine with placebo</NAME>
<GROUP_LABEL_1>Intrauterine lidocaine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intrauterine lido</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.11.01" MODIFIED="2008-10-18 20:48:53 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>1% lidocaine</NAME>
<CONT_DATA CI_END="0.7841167465893544" CI_START="-1.5841167465893533" EFFECT_SIZE="-0.39999999999999947" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="5.1" MODIFIED="2008-10-18 20:48:53 +0200" MODIFIED_BY="[Empty name]" ORDER="7" SD_1="2.8" SD_2="2.6" SE="0.6041522986797286" STUDY_ID="STD-Edelman-2004" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.11.02" MODIFIED="2008-10-18 20:49:02 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>4% lidocaine</NAME>
<CONT_DATA CI_END="-1.6474356075201468" CI_START="-3.952564392479853" EFFECT_SIZE="-2.8" ESTIMABLE="YES" MEAN_1="4.3" MEAN_2="7.1" MODIFIED="2008-10-18 20:49:02 +0200" MODIFIED_BY="[Empty name]" ORDER="8" SD_1="3.0" SD_2="2.0" SE="0.5880538630154094" STUDY_ID="STD-Edelman-2006" TOTAL_1="37" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.12" MODIFIED="2008-10-19 20:05:14 +0200" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="76" TOTAL_2="78" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain 30 min postoperatively comparing intrauterine lidocaine with placebo</NAME>
<GROUP_LABEL_1>Intrauterine lidocaine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intrauterine lido</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.12.01" MODIFIED="2008-10-18 20:55:32 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="39" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>1% lidocaine</NAME>
<CONT_DATA CI_END="1.626229549600057" CI_START="-0.22622954960005748" EFFECT_SIZE="0.6999999999999997" ESTIMABLE="YES" MEAN_1="2.8" MEAN_2="2.1" MODIFIED="2008-10-18 20:55:32 +0200" MODIFIED_BY="[Empty name]" ORDER="9" SD_1="2.1" SD_2="2.1" SE="0.47257478040721035" STUDY_ID="STD-Edelman-2004" TOTAL_1="39" TOTAL_2="40" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.12.02" MODIFIED="2008-10-18 20:55:38 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="37" TOTAL_2="38" WEIGHT="0.0" Z="0.0">
<NAME>4% lidocaine</NAME>
<CONT_DATA CI_END="0.4510906318595306" CI_START="-1.4510906318595307" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.5" MODIFIED="2008-10-18 20:55:38 +0200" MODIFIED_BY="[Empty name]" ORDER="10" SD_1="2.0" SD_2="2.2" SE="0.4852592391297045" STUDY_ID="STD-Edelman-2006" TOTAL_1="37" TOTAL_2="38" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.13" MODIFIED="2008-10-19 20:05:13 +0200" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="64" TOTAL_2="67" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with dilation comparing 2% lignocaine gel 10ml with KY jelly 10ml</NAME>
<GROUP_LABEL_1>Lignocaine gel</GROUP_LABEL_1>
<GROUP_LABEL_2>KY jelly</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lignocaine gel</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours KY jelly</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.3952016572836706" CI_START="-1.2352016572836706" EFFECT_SIZE="-0.41999999999999993" ESTIMABLE="YES" MEAN_1="5.09" MEAN_2="5.51" ORDER="211" SD_1="2.36" SD_2="2.4" SE="0.41592685565340853" STUDY_ID="STD-Li-2006" TOTAL_1="64" TOTAL_2="67" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.14" MODIFIED="2008-10-19 20:05:12 +0200" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="64" TOTAL_2="67" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing 2% lignocaine gel 10ml with KY jelly 10ml</NAME>
<GROUP_LABEL_1>Lignocaine gel</GROUP_LABEL_1>
<GROUP_LABEL_2>KY jelly</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lignocaine gel</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours KY jelly</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.14106285201995783" CI_START="-1.5989371479800423" EFFECT_SIZE="-0.8700000000000001" ESTIMABLE="YES" MEAN_1="6.5" MEAN_2="7.37" ORDER="212" SD_1="2.26" SD_2="1.98" SE="0.37191354215169536" STUDY_ID="STD-Li-2006" TOTAL_1="64" TOTAL_2="67" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.15" MODIFIED="2008-10-19 20:05:11 +0200" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="64" TOTAL_2="67" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain postpoperatively comparing 2% lignocaine gel 10ml with KY jelly 10ml</NAME>
<GROUP_LABEL_1>Lignocaine gel</GROUP_LABEL_1>
<GROUP_LABEL_2>KY jelly</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lignocaine gel</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours KY jelly</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.07580417276624385" CI_START="-1.0958041727662438" EFFECT_SIZE="-0.51" ESTIMABLE="YES" MEAN_1="1.31" MEAN_2="1.82" ORDER="213" SD_1="1.71" SD_2="1.71" SE="0.29888517206795245" STUDY_ID="STD-Li-2006" TOTAL_1="64" TOTAL_2="67" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.16" MODIFIED="2008-10-19 20:05:10 +0200" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="64" TOTAL_2="67" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Satisfaction with pain control comparing lignocaine gel with KY jelly</NAME>
<GROUP_LABEL_1>Lignocaine gel</GROUP_LABEL_1>
<GROUP_LABEL_2>KY jelly</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lignocaine gel</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours KY jelly</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.24447350380023775" CI_START="-0.24447350380023775" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="3.55" MEAN_2="3.55" ORDER="214" SD_1="0.62" SD_2="0.8" SE="0.12473367150040181" STUDY_ID="STD-Li-2006" TOTAL_1="64" TOTAL_2="67" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.17" MODIFIED="2008-10-19 20:05:10 +0200" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="80" TOTAL_2="80" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Satisfaction with the abortion experience comparing intrauterine lidocaine with placebo</NAME>
<GROUP_LABEL_1>Intrauterine lidocaine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours intrauterine lido</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.17.01" MODIFIED="2008-10-18 20:57:17 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>1% intrauterine lidocaine</NAME>
<CONT_DATA CI_END="0.844552174898882" CI_START="-1.0445521748988849" EFFECT_SIZE="-0.10000000000000142" ESTIMABLE="YES" MEAN_1="8.2" MEAN_2="8.3" MODIFIED="2008-10-18 20:57:17 +0200" MODIFIED_BY="[Empty name]" ORDER="14" SD_1="2.3" SD_2="2.0" SE="0.4819232304008596" STUDY_ID="STD-Edelman-2004" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-002.17.02" MODIFIED="2008-10-18 20:57:24 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>4% intrauterine lidocaine</NAME>
<CONT_DATA CI_END="1.4245131624830676" CI_START="-0.4245131624830676" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="8.5" MEAN_2="8.0" MODIFIED="2008-10-18 20:57:24 +0200" MODIFIED_BY="[Empty name]" ORDER="15" SD_1="1.9" SD_2="2.3" SE="0.4716990566028302" STUDY_ID="STD-Edelman-2006" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="88" EVENTS_2="79" I2="0.0" I2_Q="0.0" ID="CMP-002.18" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-10-19 20:05:09 +0200" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="95" TOTAL_2="89" WEIGHT="0.0" Z="0.0">
<NAME>Satisfaction with the abortion experience comparing deep with regular PCB injection technique</NAME>
<GROUP_LABEL_1>Wait 3-5 min</GROUP_LABEL_1>
<GROUP_LABEL_2>No wait</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours 3-5 min wait</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no wait</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.2821841123098965" CI_START="0.5844732050641697" EFFECT_SIZE="1.5820309329455702" ESTIMABLE="YES" EVENTS_1="88" EVENTS_2="79" LOG_CI_END="0.6316653358312121" LOG_CI_START="-0.23323539409925703" LOG_EFFECT_SIZE="0.1992149708659775" ORDER="17" O_E="1.7771739130434838" SE="0.5080469700888192" STUDY_ID="STD-Phair-2002" TOTAL_1="95" TOTAL_2="89" VAR="3.8742912767155264" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2008-07-16 00:35:15 +0200" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Paracervical block with premedication</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2008-07-13 20:16:32 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="96" TOTAL_2="97" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing ibuprofen 600mg po with placebo in addition to PCB</NAME>
<GROUP_LABEL_1>Ibuprofen</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ibuprofen</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.03829143411249325" CI_START="-1.5217085658875056" EFFECT_SIZE="-0.7799999999999994" ESTIMABLE="YES" MEAN_1="5.07" MEAN_2="5.85" ORDER="35" SD_1="2.75" SD_2="2.5" SE="0.37842969143209193" STUDY_ID="STD-Wiebe-1995" TOTAL_1="96" TOTAL_2="97" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2008-07-16 00:35:15 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="96" TOTAL_2="97" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain postpoperatively comparing ibuprofen 600mg po with placebo in addition to PCB</NAME>
<GROUP_LABEL_1>Ibuprofen</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours ibuprofen</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.24010369409952648" CI_START="-1.6198963059004738" EFFECT_SIZE="-0.9300000000000002" ESTIMABLE="YES" MEAN_1="2.81" MEAN_2="3.74" ORDER="37" SD_1="2.42" SD_2="2.47" SE="0.35199437915302917" STUDY_ID="STD-Wiebe-1995" TOTAL_1="96" TOTAL_2="97" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-003.03" MODIFIED="2008-07-16 00:35:15 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="52" TOTAL_2="52" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing 1mg lorazepam po with placebo in addition to PCB</NAME>
<GROUP_LABEL_1>1mg lorazepam po</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lorazepam</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.3406708848638853" CI_START="-0.7406708848638857" EFFECT_SIZE="0.2999999999999998" ESTIMABLE="YES" MEAN_1="5.2" MEAN_2="4.9" ORDER="36" SD_1="2.9" SD_2="2.5" SE="0.5309642896872415" STUDY_ID="STD-Wiebe-2003" TOTAL_1="52" TOTAL_2="52" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2008-10-18 21:07:27 +0200" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Analgesia per os only</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2008-10-18 21:05:46 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="49" TOTAL_2="50" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing diclofenac sodium 50mg/misoprostol 200mcg po with misoprostol 200cmg po</NAME>
<GROUP_LABEL_1>Diclofenac/misoprost</GROUP_LABEL_1>
<GROUP_LABEL_2>Misoprostol</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours diclo/miso</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours miso</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.3648937242133159" CI_START="-1.7648937242133163" EFFECT_SIZE="-0.7000000000000002" ESTIMABLE="YES" MEAN_1="5.7" MEAN_2="6.4" MODIFIED="2008-10-18 21:05:46 +0200" MODIFIED_BY="[Empty name]" ORDER="38" SD_1="2.8" SD_2="2.6" SE="0.543323108288245" STUDY_ID="STD-Li-2003" TOTAL_1="49" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.02" MODIFIED="2008-10-18 21:06:02 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="49" TOTAL_2="50" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain postoperatively comparing diclofenac sodium 50mg/misoprostol 200mcg po with misoprostol 200mcg po</NAME>
<GROUP_LABEL_1>Diclofenac/misoprost</GROUP_LABEL_1>
<GROUP_LABEL_2>Misoprostol</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours diclo/miso</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours miso</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.38935709328325374" CI_START="-1.1893570932832536" EFFECT_SIZE="-0.3999999999999999" ESTIMABLE="YES" MEAN_1="2.2" MEAN_2="2.6" MODIFIED="2008-10-18 21:06:02 +0200" MODIFIED_BY="[Empty name]" ORDER="39" SD_1="2.1" SD_2="1.9" SE="0.40274061131204536" STUDY_ID="STD-Li-2003" TOTAL_1="49" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-004.03" MODIFIED="2008-10-18 21:07:27 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="49" TOTAL_2="50" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Acceptability of pain control comparing diclofenac sodium/misoprostol po with misoprostol po</NAME>
<GROUP_LABEL_1>Diclofenac/miso</GROUP_LABEL_1>
<GROUP_LABEL_2>Miso</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours diclo/miso</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours miso</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.3602458369752326" CI_START="-2.9602458369752322" EFFECT_SIZE="-0.2999999999999998" ESTIMABLE="YES" MEAN_1="3.2" MEAN_2="3.5" MODIFIED="2008-10-18 21:07:27 +0200" MODIFIED_BY="[Empty name]" ORDER="40" SD_1="6.5" SD_2="7.0" SE="1.3572932247525527" STUDY_ID="STD-Li-2003" TOTAL_1="49" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2008-10-18 21:11:04 +0200" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Conscious sedation</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="25" EVENTS_2="10" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 00:49:37 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Satisfaction comparing conscious sedation with placebo</NAME>
<GROUP_LABEL_1>Midazolam &amp; fentanyl</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours midazol/fentanyl</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.357966784810513" CI_START="1.6286864336912619" EFFECT_SIZE="3.6895131271839996" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="10" LOG_CI_END="0.9221006408920563" LOG_CI_START="0.2118374788904999" LOG_EFFECT_SIZE="0.5669690598912781" ORDER="219" O_E="7.5" SE="0.4172120972190692" STUDY_ID="STD-Wong-2002" TOTAL_1="50" TOTAL_2="50" VAR="5.744949494949496" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-005.02" MODIFIED="2008-10-18 21:11:04 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="43" TOTAL_2="41" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing PCB and IV sedation with PCB</NAME>
<GROUP_LABEL_1>PCB and IV sedation</GROUP_LABEL_1>
<GROUP_LABEL_2>PCB</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours PCB/IV sedation</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours PCB</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="4.5" MEAN_2="6.3" MODIFIED="2008-10-18 21:11:04 +0200" MODIFIED_BY="[Empty name]" ORDER="220" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Wells-1992" TOTAL_1="43" TOTAL_2="41" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-006" MODIFIED="2008-10-18 21:31:42 +0200" MODIFIED_BY="[Empty name]" NO="6">
<NAME>General anesthesia</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-006.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-13 20:06:44 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="33" TOTAL_2="33" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing halothane and alfentanil</NAME>
<GROUP_LABEL_1>Halothane</GROUP_LABEL_1>
<GROUP_LABEL_2>Alfentanil</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours halothane</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours alfentanil</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.223902049024055" CI_START="0.5404449314313667" EFFECT_SIZE="1.510889292191064" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="9" LOG_CI_END="0.6257138384884485" LOG_CI_START="-0.26724855183814544" LOG_EFFECT_SIZE="0.1792326433251515" ORDER="43" O_E="1.5" SE="0.5245305283129621" STUDY_ID="STD-Collins-1985" TOTAL_1="33" TOTAL_2="33" VAR="3.634615384615385" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-006.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 00:57:03 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing thiopental and fentanyl with thiopental and halothane</NAME>
<GROUP_LABEL_1>Halothane</GROUP_LABEL_1>
<GROUP_LABEL_2>Fentanyl</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours halothane</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fentanyl</GRAPH_LABEL_2>
<DICH_DATA CI_END="21.36052798587458" CI_START="0.196038155693089" EFFECT_SIZE="2.0463329423584677" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3296119833058593" LOG_CI_START="-0.7076593919382393" LOG_EFFECT_SIZE="0.3109762956838099" ORDER="211" O_E="0.5" SE="1.1967032904743342" STUDY_ID="STD-Barneschi-1985" TOTAL_1="15" TOTAL_2="15" VAR="0.6982758620689655" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-006.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 00:57:06 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="18.644894933307008" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing thiopental and fentanyl with thiopental and enflurane</NAME>
<GROUP_LABEL_1>Enflurane</GROUP_LABEL_1>
<GROUP_LABEL_2>Fentanyl</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enflurane</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fentanyl</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.820467167072353" CI_START="0.0026853936013588454" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8338141226232083" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" ORDER="46" O_E="-0.5" SE="2.0" STUDY_ID="STD-Barneschi-1985" TOTAL_1="15" TOTAL_2="15" VAR="0.25" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-006.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 00:57:08 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing trichlorethylen with total IV (methohexital) anesthesia</NAME>
<GROUP_LABEL_1>Trichlorethylene</GROUP_LABEL_1>
<GROUP_LABEL_2>Total IV</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours trichloethylene</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours total IV</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.5108501351178734" CI_START="0.11772882468889116" EFFECT_SIZE="0.5436905695130004" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.3998207917915063" LOG_CI_START="-0.9291171916110944" LOG_EFFECT_SIZE="-0.2646481999097941" ORDER="65" O_E="-1.0" SE="0.7806247497997998" STUDY_ID="STD-Ogg-1983" TOTAL_1="20" TOTAL_2="20" VAR="1.641025641025641" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.05" MODIFIED="2008-10-18 21:14:37 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="76" TOTAL_2="72" UNITS="ml" WEIGHT="0.0" Z="0.0">
<NAME>Blood loss (ml) comparing inhalational anesthetics with opiates</NAME>
<GROUP_LABEL_1>Inhalation anesth</GROUP_LABEL_1>
<GROUP_LABEL_2>Opiate</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours inhalation anesth</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours opiates</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.05.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="33" WEIGHT="0.0" Z="0.0">
<NAME>comparing halothane with alfentanil</NAME>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="213.0" MEAN_2="89.8" ORDER="66" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Collins-1985" TOTAL_1="33" TOTAL_2="33" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.05.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>comparing enflurane with fentanyl</NAME>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="73.0" MEAN_2="43.9" ORDER="67" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Hackett-1982" TOTAL_1="43" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="18" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-006.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 01:09:11 +0200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="33" TOTAL_2="33" WEIGHT="0.0" Z="0.0">
<NAME>Anesthetic complications comparing halothane and alfentanil</NAME>
<GROUP_LABEL_1>Halothane</GROUP_LABEL_1>
<GROUP_LABEL_2>Alfentanil</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours halothane</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours alfentanil</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.386442663327322" CI_START="0.7870679180614212" EFFECT_SIZE="2.0590036942128713" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="12" LOG_CI_END="0.7313020413036173" LOG_CI_START="-0.1039877896655868" LOG_EFFECT_SIZE="0.3136571258190152" ORDER="44" O_E="3.0" SE="0.49065338146265813" STUDY_ID="STD-Collins-1985" TOTAL_1="33" TOTAL_2="33" VAR="4.153846153846154" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-006.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 01:12:09 +0200" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="86" TOTAL_2="78" WEIGHT="0.0" Z="0.0">
<NAME>Side effects comparing enflurane with fentanyl</NAME>
<GROUP_LABEL_1>Enflurane</GROUP_LABEL_1>
<GROUP_LABEL_2>Fentanyl</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours enflurane</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fentanyl</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-006.07.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>Severe anesthetic complications comparing enflurane with fentanyl</NAME>
<DICH_DATA CI_END="2.3565226900353244" CI_START="0.04318880230467338" EFFECT_SIZE="0.319022558115273" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.37227162576749606" LOG_CI_START="-1.3646288394737707" LOG_EFFECT_SIZE="-0.4961786068531373" ORDER="139" O_E="-1.0975609756097562" SE="1.0202639310786865" STUDY_ID="STD-Hackett-1982" TOTAL_1="43" TOTAL_2="39" VAR="0.9606715579350915" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="10" I2="0.0" ID="CMP-006.07.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>Nausea and vomiting comparing enflurane with fentanyl</NAME>
<DICH_DATA CI_END="0.8165366450579762" CI_START="0.07719828832870601" EFFECT_SIZE="0.2510681806922971" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="-0.08802431994219775" LOG_CI_START="-1.1123923289082909" LOG_EFFECT_SIZE="-0.6002083244252443" ORDER="140" O_E="-3.8170731707317076" SE="0.6017188391701068" STUDY_ID="STD-Hackett-1982" TOTAL_1="43" TOTAL_2="39" VAR="2.761930729063388" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="15" I2="0.0" I2_Q="0.0" ID="CMP-006.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 01:15:45 +0200" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="100" TOTAL_2="100" WEIGHT="0.0" Z="0.0">
<NAME>Side effects comparing trichloethylene with total IV anesthesia</NAME>
<GROUP_LABEL_1>Trichlorethylene</GROUP_LABEL_1>
<GROUP_LABEL_2>IV enesthesia</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours trichlorethylene</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours IV anesth</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="0" I2="0.0" ID="CMP-006.08.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Lanryngospasm comparing trichloethylene with total IV anesthesia</NAME>
<DICH_DATA CI_END="372.3848896839504" CI_START="0.1466175227450357" EFFECT_SIZE="7.38905609893065" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.570992050236215" LOG_CI_START="-0.8338141226232083" LOG_EFFECT_SIZE="0.8685889638065036" ORDER="134" O_E="0.5" SE="2.0" STUDY_ID="STD-Ogg-1983" TOTAL_1="20" TOTAL_2="20" VAR="0.25" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-006.08.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Pain on induction comparing trichloethylene with total IV anesthesia</NAME>
<DICH_DATA CI_END="129.11113502069682" CI_START="0.46981776788555657" EFFECT_SIZE="7.7883698720974" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.1109636990402896" LOG_CI_START="-0.3280705628058871" LOG_EFFECT_SIZE="0.8914465681172012" ORDER="135" O_E="1.0" SE="1.4327007988227578" STUDY_ID="STD-Ogg-1983" TOTAL_1="20" TOTAL_2="20" VAR="0.48717948717948717" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="7" I2="0.0" ID="CMP-006.08.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing trichloethylene with total IV anesthesia</NAME>
<DICH_DATA CI_END="1.452592845489717" CI_START="0.08600497557625264" EFFECT_SIZE="0.35345468195878016" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.16214390078366608" LOG_CI_START="-1.0654764231424299" LOG_EFFECT_SIZE="-0.4516662611793819" ORDER="136" O_E="-2.0" SE="0.7211102550927979" STUDY_ID="STD-Ogg-1983" TOTAL_1="20" TOTAL_2="20" VAR="1.923076923076923" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-006.08.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Vomiting comparing trichloethylene with total IV anesthesia</NAME>
<DICH_DATA CI_END="3.5715497905273104" CI_START="0.1425126812636286" EFFECT_SIZE="0.7134361477487654" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.552856708947621" LOG_CI_START="-0.8461464889342327" LOG_EFFECT_SIZE="-0.14664488999330577" ORDER="137" O_E="-0.5" SE="0.8217814036133182" STUDY_ID="STD-Ogg-1983" TOTAL_1="20" TOTAL_2="20" VAR="1.4807692307692308" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-006.08.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Intraoperative involuntary muscle movement comparing trichloethylene with total IV anesthesia</NAME>
<DICH_DATA CI_END="3.5715497905273104" CI_START="0.1425126812636286" EFFECT_SIZE="0.7134361477487654" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.552856708947621" LOG_CI_START="-0.8461464889342327" LOG_EFFECT_SIZE="-0.14664488999330577" ORDER="138" O_E="-0.5" SE="0.8217814036133182" STUDY_ID="STD-Ogg-1983" TOTAL_1="20" TOTAL_2="20" VAR="1.4807692307692308" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.09" MODIFIED="2008-10-18 21:19:46 +0200" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="76" TOTAL_2="72" UNITS="min" WEIGHT="0.0" Z="0.0">
<NAME>Recovery time (min.) comparing inhalation anesthetics with opiates</NAME>
<GROUP_LABEL_1>Inhalational anesth</GROUP_LABEL_1>
<GROUP_LABEL_2>Opiate</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours inhalation anesth</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours opiate</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.09.01" MODIFIED="2008-10-18 21:19:00 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="33" TOTAL_2="33" WEIGHT="0.0" Z="0.0">
<NAME>Recovery time (min.) comparing halothane and alfentanil</NAME>
<CONT_DATA CI_END="9.488001017913815" CI_START="5.711998982086183" EFFECT_SIZE="7.6" ESTIMABLE="YES" MEAN_1="10.78" MEAN_2="3.18" ORDER="58" SD_1="5.06" SD_2="2.24" SE="0.9632835260270735" STUDY_ID="STD-Collins-1985" TOTAL_1="33" TOTAL_2="33" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-006.09.02" MODIFIED="2008-10-18 21:19:16 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="43" TOTAL_2="39" WEIGHT="0.0" Z="0.0">
<NAME>Recovery time (min.) comparing enflurane with fentanyl</NAME>
<CONT_DATA CI_END="1.8841019690407983" CI_START="-1.484101969040798" EFFECT_SIZE="0.20000000000000018" ESTIMABLE="YES" MEAN_1="7.0" MEAN_2="6.8" ORDER="59" SD_1="3.61" SD_2="4.12" SE="0.859251487437922" STUDY_ID="STD-Hackett-1982" TOTAL_1="43" TOTAL_2="39" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-006.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 01:25:45 +0200" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing propofol with etomidate</NAME>
<GROUP_LABEL_1>Propofol</GROUP_LABEL_1>
<GROUP_LABEL_2>Etomoidate</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours propofol</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours etomidate</GRAPH_LABEL_2>
<DICH_DATA CI_END="8.494096519204948" CI_START="0.39827148025027564" EFFECT_SIZE="1.839281488541781" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.9291171916110944" LOG_CI_START="-0.3998207917915063" LOG_EFFECT_SIZE="0.2646481999097941" ORDER="50" O_E="1.0" SE="0.7806247497997998" STUDY_ID="STD-Boysen-1989" TOTAL_1="20" TOTAL_2="20" VAR="1.641025641025641" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.386426853013288" CI_END="2.0168820962265137" CI_START="0.6080907593690903" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.1074508410996415" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="25" I2="0.0" I2_Q="0.0" ID="CMP-006.11" LOG_CI_END="0.3046805107785203" LOG_CI_START="-0.21603159613593179" LOG_EFFECT_SIZE="0.044324457321294274" METHOD="PETO" MODIFIED="2008-07-16 01:26:37 +0200" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.4961664423892076" P_Q="0.7905803542065245" P_Z="0.7386247189713044" Q="0.07052055952436875" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="170" TOTAL_2="180" WEIGHT="100.0" Z="0.33367513000150784">
<NAME>Postoperative pain comparing propofol with thiopental</NAME>
<GROUP_LABEL_1>Propofol</GROUP_LABEL_1>
<GROUP_LABEL_2>Thiopental</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours propofol</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours thiopental</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.4626050420168069" CI_END="2.752133706861812" CI_START="0.5210692635700397" DF="1.0" EFFECT_SIZE="1.1975192206727905" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" I2="31.628842286699232" ID="CMP-006.11.01" LOG_CI_END="0.4396695293969376" LOG_CI_START="-0.2831045439040846" LOG_EFFECT_SIZE="0.07828249274642643" NO="1" P_CHI2="0.22651639134481327" P_Z="0.6711566796988088" STUDIES="2" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="51.90273216788241" Z="0.42456106844638514">
<NAME>Alfentanil</NAME>
<DICH_DATA CI_END="2.3897879240488145" CI_START="0.1653359100825453" EFFECT_SIZE="0.6285839333986253" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.3783593622443842" LOG_CI_START="-0.781632809725975" LOG_EFFECT_SIZE="-0.20163672374079544" ORDER="51" O_E="-1.0" SE="0.6813851438692469" STUDY_ID="STD-Boysen-1989" TOTAL_1="20" TOTAL_2="20" VAR="2.153846153846154" WEIGHT="20.15047248870729"/>
<DICH_DATA CI_END="5.22353332699263" CI_START="0.6221322259593514" EFFECT_SIZE="1.8027003123355756" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.717964369919935" LOG_CI_START="-0.20611730196253103" LOG_EFFECT_SIZE="0.255923533978702" ORDER="52" O_E="2.0" SE="0.5428101483418094" STUDY_ID="STD-Jakobsson-1995" TOTAL_1="50" TOTAL_2="50" VAR="3.393939393939394" WEIGHT="31.752259679175122"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.8533012514721128" CI_END="2.415967418757407" CI_START="0.428813292276967" DF="1.0" EFFECT_SIZE="1.017840332700198" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="12" I2="0.0" ID="CMP-006.11.02" LOG_CI_END="0.3830910731820072" LOG_CI_START="-0.3677317609247401" LOG_EFFECT_SIZE="0.007679656128633554" NO="2" P_CHI2="0.3556201865073684" P_Z="0.9680179642517657" STUDIES="2" TAU2="0.0" TOTAL_1="100" TOTAL_2="110" WEIGHT="48.097267832117595" Z="0.040094277217024805">
<NAME>Fentanyl</NAME>
<DICH_DATA CI_END="2.3633805437277413" CI_START="0.17550407308818225" EFFECT_SIZE="0.6440364210831414" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.37353365592560206" LOG_CI_START="-0.7557128000004636" LOG_EFFECT_SIZE="-0.19108957203743077" ORDER="53" O_E="-1.0" SE="0.6633249580710799" STUDY_ID="STD-Jakobsson-1993" TOTAL_1="50" TOTAL_2="50" VAR="2.272727272727273" WEIGHT="21.26267389230477"/>
<DICH_DATA CI_END="4.653437336586834" CI_START="0.45981087253775826" EFFECT_SIZE="1.4627717122079487" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.6677738700576684" LOG_CI_START="-0.3374207637598102" LOG_EFFECT_SIZE="0.16517655314892904" ORDER="54" O_E="1.0909090909090908" SE="0.5904563036980729" STUDY_ID="STD-Jakobsson-1995" TOTAL_1="50" TOTAL_2="60" VAR="2.8682993403593904" WEIGHT="26.834593939812823"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.711375722241282" CI_END="1.115993846350119" CI_START="0.15913414019999758" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.42141751412039624" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="13" I2="78.77477707245384" I2_Q="78.77477707245384" ID="CMP-006.12" LOG_CI_END="0.04766179988511276" LOG_CI_START="-0.7982366380159258" LOG_EFFECT_SIZE="-0.3752874190654065" METHOD="PETO" MODIFIED="2008-07-16 22:54:50 +0200" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.02996374695202264" P_Q="0.02996374695202264" P_Z="0.08201765761651342" Q="4.711375722241282" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="70" TOTAL_2="70" WEIGHT="100.0" Z="1.7390972539075409">
<NAME>Postoperative pain comparing propofol with methohexital</NAME>
<GROUP_LABEL_1>Propofol</GROUP_LABEL_1>
<GROUP_LABEL_2>Methohexital</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours propofol</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours methohexital</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="129.11113502069682" CI_START="0.46981776788555657" DF="0.0" EFFECT_SIZE="7.7883698720974" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-006.12.01" LOG_CI_END="2.1109636990402896" LOG_CI_START="-0.3280705628058871" LOG_EFFECT_SIZE="0.8914465681172012" MODIFIED="2008-07-13 20:43:38 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.1519433611234816" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="12.028200086326795" Z="1.432700798822758">
<NAME>Alfentanil</NAME>
<DICH_DATA CI_END="129.11113502069682" CI_START="0.46981776788555657" EFFECT_SIZE="7.7883698720974" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.1109636990402896" LOG_CI_START="-0.3280705628058871" LOG_EFFECT_SIZE="0.8914465681172012" MODIFIED="2008-07-13 20:43:38 +0200" MODIFIED_BY="[Empty name]" ORDER="55" O_E="1.0" SE="1.4327007988227578" STUDY_ID="STD-Boysen-1990" TOTAL_1="20" TOTAL_2="20" VAR="0.48717948717948717" WEIGHT="12.028200086326795"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.7988262632088605" CI_START="0.10013295971813074" DF="0.0" EFFECT_SIZE="0.28282298003464595" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" I2="0.0" ID="CMP-006.12.02" LOG_CI_END="-0.09754766515939119" LOG_CI_START="-0.9994229468201903" LOG_EFFECT_SIZE="-0.5484853059897907" MODIFIED="2008-07-13 20:43:44 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.017128067952117854" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="87.97179991367321" Z="2.38394702160989">
<NAME>Fentanyl</NAME>
<DICH_DATA CI_END="0.7988262632088605" CI_START="0.10013295971813074" EFFECT_SIZE="0.28282298003464595" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.09754766515939119" LOG_CI_START="-0.9994229468201903" LOG_EFFECT_SIZE="-0.5484853059897907" MODIFIED="2008-07-13 20:43:44 +0200" MODIFIED_BY="[Empty name]" ORDER="56" O_E="-4.5" SE="0.5297660048021977" STUDY_ID="STD-Jakobsson-1993" TOTAL_1="50" TOTAL_2="50" VAR="3.5631313131313136" WEIGHT="87.97179991367321"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-006.13" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 22:54:50 +0200" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing propofol and fentanyl with midazolam and fentanyl</NAME>
<GROUP_LABEL_1>Prop and fent</GROUP_LABEL_1>
<GROUP_LABEL_2>Midaz and fent</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours propo and fent</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours midaz and fent</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.212111316150517" CI_START="0.2521194239816883" EFFECT_SIZE="1.5239921911489773" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9643591771968645" LOG_CI_START="-0.5983936937797243" LOG_EFFECT_SIZE="0.1829827417085701" ORDER="57" O_E="0.5" SE="0.9179687721631202" STUDY_ID="STD-Rossi-1995" TOTAL_1="40" TOTAL_2="40" VAR="1.1867088607594938" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-006.14" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 01:38:22 +0200" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="100" TOTAL_2="100" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing propofol and alfentanil with ketamine and midazolam</NAME>
<GROUP_LABEL_1>Propofol/alf</GROUP_LABEL_1>
<GROUP_LABEL_2>Ketamin/midaz</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours propo/alf</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ketamin/midaz</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="17" I2="0.0" ID="CMP-006.14.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Ketamine 0.5mg/kg and midazolam 0.25mg/kg</NAME>
<DICH_DATA CI_END="0.4688697680778812" CI_START="0.06669870304185935" EFFECT_SIZE="0.17684175249734452" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="17" LOG_CI_END="-0.32894776892510913" LOG_CI_START="-1.1758826108696583" LOG_EFFECT_SIZE="-0.7524151898973839" ORDER="48" O_E="-7.0" SE="0.49749371855331" STUDY_ID="STD-Bonnardot-1987" TOTAL_1="50" TOTAL_2="50" VAR="4.040404040404041" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-006.14.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Ketamine 1mg/kg and midazolam 0.1mg/kg</NAME>
<DICH_DATA CI_END="3.4024386662722086" CI_START="0.1599670599622675" EFFECT_SIZE="0.7377520654972807" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5317903051789383" LOG_CI_START="-0.795969437027921" LOG_EFFECT_SIZE="-0.1320895659244913" ORDER="49" O_E="-0.5" SE="0.7799326450890333" STUDY_ID="STD-Bonnardot-1987" TOTAL_1="50" TOTAL_2="50" VAR="1.6439393939393943" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.248703024168039" CI_END="10.058467539525688" CI_START="2.1606649093405466" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="4.6618642037702145" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="7" I2="76.46340555431465" I2_Q="0.0" ID="CMP-006.15" LOG_CI_END="1.002531818709536" LOG_CI_START="0.334587418753443" LOG_EFFECT_SIZE="0.6685596187314894" METHOD="PETO" MODIFIED="2008-07-16 01:46:32 +0200" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.039280476650133345" P_Q="1.0" P_Z="8.72578246267415E-5" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="90" TOTAL_2="90" WEIGHT="100.0" Z="3.923538469123134">
<NAME>Postoperative pain comparing propofol and ketamine with propofol and fentanyl</NAME>
<GROUP_LABEL_1>Propofol ketamine</GROUP_LABEL_1>
<GROUP_LABEL_2>Propofol fentanyl</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours propo and ketam</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours propo and fent</GRAPH_LABEL_2>
<DICH_DATA CI_END="16.995471179487566" CI_START="2.991050074440434" EFFECT_SIZE="7.129818043720087" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="4" LOG_CI_END="1.2303332093906783" LOG_CI_START="0.475823683800668" LOG_EFFECT_SIZE="0.8530784465956731" ORDER="60" O_E="10.0" SE="0.4432026302139591" STUDY_ID="STD-Jakobsson-1993" TOTAL_1="50" TOTAL_2="50" VAR="5.090909090909092" WEIGHT="78.37023914969"/>
<DICH_DATA CI_END="5.2251555768340205" CI_START="0.19138186132362225" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.7180992259131662" LOG_CI_START="-0.7180992259131662" LOG_EFFECT_SIZE="0.0" ORDER="61" O_E="0.0" SE="0.8436300798997816" STUDY_ID="STD-Rossi-1995" TOTAL_1="40" TOTAL_2="40" VAR="1.4050632911392404" WEIGHT="21.629760850310007"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-006.16" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 01:44:41 +0200" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing thiopental and fentanyl with ketamine and diazepam</NAME>
<GROUP_LABEL_1>Thiopental and fent</GROUP_LABEL_1>
<GROUP_LABEL_2>Ketamine and diazepa</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours thiop fent</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours ket diaz</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.909564676063954" CI_START="0.20368404654599842" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.6910429855720925" LOG_CI_START="-0.6910429855720925" LOG_EFFECT_SIZE="0.0" ORDER="68" O_E="0.0" SE="0.8118441408859888" STUDY_ID="STD-Barneschi-1985" TOTAL_1="15" TOTAL_2="15" VAR="1.5172413793103448" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="19" I2="0.0" I2_Q="0.0" ID="CMP-006.17" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 01:48:19 +0200" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing propofol and alfentanil with propofol</NAME>
<GROUP_LABEL_1>Propofol and alfent</GROUP_LABEL_1>
<GROUP_LABEL_2>Propofol</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours propofol and alfe</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours propofol</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.4046966102684675" CI_START="0.061563255425107266" EFFECT_SIZE="0.15784308913485173" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="19" LOG_CI_END="-0.39287043323597226" LOG_CI_START="-1.210678423022188" LOG_EFFECT_SIZE="-0.8017744281290802" ORDER="213" O_E="-8.0" SE="0.48038446141526137" STUDY_ID="STD-Bonnardot-1987" TOTAL_1="50" TOTAL_2="50" VAR="4.333333333333334" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="54" EVENTS_2="60" I2="0.0" I2_Q="0.0" ID="CMP-006.18" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 01:48:19 +0200" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="120" TOTAL_2="88" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing placebo with alfentanil and fentanyl</NAME>
<GROUP_LABEL_1>Opiate</GROUP_LABEL_1>
<GROUP_LABEL_2>Plecebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours opiate</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="35" EVENTS_2="30" I2="0.0" ID="CMP-006.18.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-13 23:26:31 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Alfentanil</NAME>
<DICH_DATA CI_END="1.4674192450561536" CI_START="0.2964642993800024" EFFECT_SIZE="0.6595736641060683" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="30" LOG_CI_END="0.1665542105046567" LOG_CI_START="-0.5280275974625148" LOG_EFFECT_SIZE="-0.18073669347892904" ORDER="211" O_E="-2.5" SE="0.40800079223531716" STUDY_ID="STD-Jakobsson-1991" TOTAL_1="60" TOTAL_2="44" VAR="6.007281553398059" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="19" EVENTS_2="30" I2="0.0" ID="CMP-006.18.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-13 23:26:31 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Fentanyl</NAME>
<DICH_DATA CI_END="0.5087356696736327" CI_START="0.10785597897056289" EFFECT_SIZE="0.23424385518065263" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="30" LOG_CI_END="-0.29350781102337" LOG_CI_START="-0.9671557748827184" LOG_EFFECT_SIZE="-0.6303317929530442" ORDER="212" O_E="-9.26923076923077" SE="0.39570414858218234" STUDY_ID="STD-Jakobsson-1991" TOTAL_1="60" TOTAL_2="44" VAR="6.386439363474465" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.3483307032115568" CI_END="3.6013060931397045" CI_START="1.0705812694339076" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="1.9635403863464516" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="26" I2="0.0" I2_Q="0.0" ID="CMP-006.19" LOG_CI_END="0.5564600358150436" LOG_CI_START="0.029619640828977813" LOG_EFFECT_SIZE="0.2930398383220107" METHOD="PETO" MODIFIED="2008-07-16 01:38:12 +0200" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="0.5550598034399128" P_Q="1.0" P_Z="0.02923172380568973" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="110" TOTAL_2="100" WEIGHT="100.0" Z="2.1803473485049385">
<NAME>Postoperative pain comparing alfentanil with fentanyl when added to propofol</NAME>
<GROUP_LABEL_1>Alfentanil</GROUP_LABEL_1>
<GROUP_LABEL_2>Fentanyl</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours alfentanil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fentanyl</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.72807835197974" CI_START="1.0606617064247619" EFFECT_SIZE="2.2393953766409376" ESTIMABLE="YES" EVENTS_1="35" EVENTS_2="19" LOG_CI_END="0.6746846649016459" LOG_CI_START="0.025576889593987698" LOG_EFFECT_SIZE="0.3501307772478168" ORDER="215" O_E="5.545454545454547" SE="0.381289120351027" STUDY_ID="STD-Jakobsson-1991" TOTAL_1="60" TOTAL_2="50" VAR="6.878459322162408" WEIGHT="65.87558890608545"/>
<DICH_DATA CI_END="4.302947785802721" CI_START="0.539374976949587" EFFECT_SIZE="1.5234508074705333" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" LOG_CI_END="0.6337660761603296" LOG_CI_START="-0.2681092055004693" LOG_EFFECT_SIZE="0.1828284353299302" ORDER="214" O_E="1.5" SE="0.5297660048021977" STUDY_ID="STD-Jakobsson-1995" TOTAL_1="50" TOTAL_2="50" VAR="3.5631313131313136" WEIGHT="34.12441109391455"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-006.20" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 01:38:11 +0200" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing alfentanil with fentanyl when added to thiopental</NAME>
<GROUP_LABEL_1>Alfentanil</GROUP_LABEL_1>
<GROUP_LABEL_2>Fentanyl</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours alfentanil</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fentanyl</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.320873727002171" CI_START="0.30112557182435323" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.5212523622865003" LOG_CI_START="-0.5212523622865004" LOG_EFFECT_SIZE="0.0" ORDER="216" O_E="0.0" SE="0.6123724356957945" STUDY_ID="STD-Jakobsson-1995" TOTAL_1="50" TOTAL_2="50" VAR="2.666666666666667" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="296" EVENTS_2="177" I2="0.0" I2_Q="0.0" ID="CMP-006.21" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 23:37:51 +0200" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="145.34162289384332" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="1300" TOTAL_2="1300" WEIGHT="0.0" Z="0.0">
<NAME>Side effects comparing propofol with other sedative hypnotic agents</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="9" I2="0.0" ID="CMP-006.21.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 23:03:57 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Pain on injection comparing propofol with etomidate</NAME>
<DICH_DATA CI_END="3.421788567711928" CI_START="0.29224482466158835" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="9" LOG_CI_END="0.5342531709815731" LOG_CI_START="-0.5342531709815731" LOG_EFFECT_SIZE="0.0" ORDER="84" O_E="0.0" SE="0.6276459144608478" STUDY_ID="STD-Boysen-1989" TOTAL_1="20" TOTAL_2="20" VAR="2.5384615384615383" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="1" I2="0.0" ID="CMP-006.21.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 23:03:58 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Pain on injection comparing propofol with thiopental</NAME>
<DICH_DATA CI_END="32.89596904592055" CI_START="1.947701328101845" EFFECT_SIZE="8.004468914296353" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="1" LOG_CI_END="1.5171426843218119" LOG_CI_START="0.2895223603957158" LOG_EFFECT_SIZE="0.9033325223587638" ORDER="85" O_E="4.0" SE="0.7211102550927979" STUDY_ID="STD-Boysen-1989" TOTAL_1="20" TOTAL_2="20" VAR="1.923076923076923" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="1" I2="0.0" ID="CMP-006.21.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 23:04:00 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Pain on injection comparing etmoidate with thiopental</NAME>
<DICH_DATA CI_END="32.89596904592055" CI_START="1.947701328101845" EFFECT_SIZE="8.004468914296353" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="1" LOG_CI_END="1.5171426843218119" LOG_CI_START="0.2895223603957158" LOG_EFFECT_SIZE="0.9033325223587638" ORDER="86" O_E="4.0" SE="0.7211102550927979" STUDY_ID="STD-Boysen-1989" TOTAL_1="20" TOTAL_2="20" VAR="1.923076923076923" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="9" I2="0.0" ID="CMP-006.21.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 23:04:02 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Pain on injection comparing propofol with methohexital</NAME>
<DICH_DATA CI_END="2.825019889774617" CI_START="0.23752262727732043" EFFECT_SIZE="0.8191496483121707" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.45102150985066225" LOG_CI_START="-0.6242950115818829" LOG_EFFECT_SIZE="-0.08663675086561036" ORDER="94" O_E="-0.5" SE="0.6316462475921049" STUDY_ID="STD-Boysen-1990" TOTAL_1="20" TOTAL_2="20" VAR="2.5064102564102564" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-006.21.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 23:04:04 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Pain on injection comparing propofol and fentanyl with fentanyl and midazolam</NAME>
<DICH_DATA CI_END="10.646128283362792" CI_START="0.3899359199548579" EFFECT_SIZE="2.03747584676003" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0271916950154807" LOG_CI_START="-0.40900675681085186" LOG_EFFECT_SIZE="0.30909246910231436" ORDER="109" O_E="1.0" SE="0.8436300798997816" STUDY_ID="STD-Rossi-1995" TOTAL_1="40" TOTAL_2="40" VAR="1.4050632911392404" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="0" I2="0.0" ID="CMP-006.21.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 23:04:26 +0200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Pain on injection comparing propofol and fentanyl with propofol and ketamine</NAME>
<DICH_DATA CI_END="58.98130098069227" CI_START="1.0840177481339888" EFFECT_SIZE="7.996047590597685" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="1.7707143477767207" LOG_CI_START="0.03503639276837913" LOG_EFFECT_SIZE="0.9028753702725498" ORDER="108" O_E="2.0" SE="1.019545822516343" STUDY_ID="STD-Rossi-1995" TOTAL_1="40" TOTAL_2="40" VAR="0.9620253164556962" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="2" I2="0.0" ID="CMP-006.21.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 23:04:26 +0200" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Pain with injection comparing propofol and alfentanil with ketamin 1mg/kg and midazolam 0.1mg/kg</NAME>
<DICH_DATA CI_END="13.087518846461412" CI_START="0.8572063576481825" EFFECT_SIZE="3.349433438811276" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.1168573200858138" LOG_CI_START="-0.06691461658344688" LOG_EFFECT_SIZE="0.5249713517511835" ORDER="215" O_E="2.5" SE="0.6953534953651154" STUDY_ID="STD-Bonnardot-1987" TOTAL_1="50" TOTAL_2="50" VAR="2.0681818181818183" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="16" EVENTS_2="2" I2="0.0" ID="CMP-006.21.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:37:34 +0200" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Pain with injection comparing propofol with ketamine 1mg/kg and midazolam 0.1mg/kg</NAME>
<DICH_DATA CI_END="18.051898789179585" CI_START="2.3698974535177264" EFFECT_SIZE="6.540730002961171" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="2" LOG_CI_END="1.2565228899143592" LOG_CI_START="0.37472955430761085" LOG_EFFECT_SIZE="0.8156262221109851" ORDER="214" O_E="7.0" SE="0.5179697702828122" STUDY_ID="STD-Bonnardot-1987" TOTAL_1="50" TOTAL_2="50" VAR="3.7272727272727275" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="16" EVENTS_2="7" I2="0.0" ID="CMP-006.21.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:37:52 +0200" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Pain with injection comparing propofol with propofol and alfentanil</NAME>
<DICH_DATA CI_END="6.910292641839757" CI_START="1.082648520514467" EFFECT_SIZE="2.7352181092208756" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="7" LOG_CI_END="0.8394964395659549" LOG_CI_START="0.034487486748663546" LOG_EFFECT_SIZE="0.43699196315730926" ORDER="216" O_E="4.5" SE="0.47286624374346037" STUDY_ID="STD-Bonnardot-1987" TOTAL_1="50" TOTAL_2="50" VAR="4.472222222222222" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="1" I2="0.0" ID="CMP-006.21.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:37:52 +0200" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Apnea comparing propofol with etomidate</NAME>
<DICH_DATA CI_END="27.084825937417445" CI_START="1.0807440445426761" EFFECT_SIZE="5.41033865200127" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="1" LOG_CI_END="1.4327260489074558" LOG_CI_START="0.03372285102560218" LOG_EFFECT_SIZE="0.733224449966529" ORDER="87" O_E="2.5" SE="0.8217814036133182" STUDY_ID="STD-Boysen-1989" TOTAL_1="20" TOTAL_2="20" VAR="1.4807692307692308" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="3" I2="0.0" ID="CMP-006.21.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:37:51 +0200" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Apnea comparing propofol with thiopental</NAME>
<DICH_DATA CI_END="10.017018422913779" CI_START="0.5342634904256379" EFFECT_SIZE="2.3133800436339538" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="1.0007384725124215" LOG_CI_START="-0.27224450286825724" LOG_EFFECT_SIZE="0.3642469848220822" ORDER="88" O_E="1.5" SE="0.747756501105966" STUDY_ID="STD-Boysen-1989" TOTAL_1="20" TOTAL_2="20" VAR="1.7884615384615383" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="3" I2="0.0" ID="CMP-006.21.12" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:37:51 +0200" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Apnea comparing etomidate with thiopental</NAME>
<DICH_DATA CI_END="2.602992800246887" CI_START="0.044010434443699606" EFFECT_SIZE="0.33846542510674216" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.415472966873211" LOG_CI_START="-1.3564443443302567" LOG_EFFECT_SIZE="-0.4704856887285229" ORDER="89" O_E="-1.0" SE="1.0408329997330665" STUDY_ID="STD-Boysen-1989" TOTAL_1="20" TOTAL_2="20" VAR="0.923076923076923" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="10" I2="0.0" ID="CMP-006.21.13" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:37:50 +0200" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Apnea comparing propofol with methohexital</NAME>
<DICH_DATA CI_END="1.8956057095431345" CI_START="0.15937914279552057" EFFECT_SIZE="0.5496544487814861" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="10" LOG_CI_END="0.2777480081194416" LOG_CI_START="-0.7975685133131036" LOG_EFFECT_SIZE="-0.25991025259683104" ORDER="93" O_E="-1.5" SE="0.6316462475921049" STUDY_ID="STD-Boysen-1990" TOTAL_1="20" TOTAL_2="20" VAR="2.5064102564102564" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="13" I2="0.0" ID="CMP-006.21.14" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:37:50 +0200" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Muscle movements comparing propofol with etomidate</NAME>
<DICH_DATA CI_END="0.5727004217337898" CI_START="0.04815162870371568" EFFECT_SIZE="0.16606160924725147" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.24207249707422046" LOG_CI_START="-1.3173890185067658" LOG_EFFECT_SIZE="-0.7797307577904931" ORDER="90" O_E="-4.5" SE="0.6316462475921049" STUDY_ID="STD-Boysen-1989" TOTAL_1="20" TOTAL_2="20" VAR="2.5064102564102564" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="3" I2="0.0" ID="CMP-006.21.15" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:37:49 +0200" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Muscle movements comparing propofol with thiopental</NAME>
<DICH_DATA CI_END="7.016919414702047" CI_START="0.27999049674521215" EFFECT_SIZE="1.4016671332893371" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.8461464889342327" LOG_CI_START="-0.5528567089476208" LOG_EFFECT_SIZE="0.14664488999330577" ORDER="91" O_E="0.5" SE="0.8217814036133182" STUDY_ID="STD-Boysen-1989" TOTAL_1="20" TOTAL_2="20" VAR="1.4807692307692308" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="13" EVENTS_2="3" I2="0.0" ID="CMP-006.21.16" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:45:30 +0200" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Muscle movements comparing etomidate with thiopental</NAME>
<DICH_DATA CI_END="26.588713610472265" CI_START="2.1858683736605067" EFFECT_SIZE="7.623609917712736" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="3" LOG_CI_END="1.4246973262225855" LOG_CI_START="0.339624006509375" LOG_EFFECT_SIZE="0.8821606663659802" ORDER="92" O_E="5.0" SE="0.6373774391990981" STUDY_ID="STD-Boysen-1989" TOTAL_1="20" TOTAL_2="20" VAR="2.4615384615384617" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="13" I2="0.0" ID="CMP-006.21.17" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:45:31 +0200" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Muscle movements comparing propofol with methohexital</NAME>
<DICH_DATA CI_END="0.4574840882689457" CI_START="0.03760994287463906" EFFECT_SIZE="0.13117145431019428" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="13" LOG_CI_END="-0.339624006509375" LOG_CI_START="-1.4246973262225855" LOG_EFFECT_SIZE="-0.8821606663659802" ORDER="95" O_E="-5.0" SE="0.6373774391990981" STUDY_ID="STD-Boysen-1990" TOTAL_1="20" TOTAL_2="20" VAR="2.4615384615384617" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="2" I2="0.0" ID="CMP-006.21.18" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:45:31 +0200" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Intraoperative movement comparing thiopental and fentanyl with ketamine and diazepam</NAME>
<DICH_DATA CI_END="30.046779517086858" CI_START="1.6199770454834348" EFFECT_SIZE="6.976753765784094" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="2" LOG_CI_END="1.4777979301520636" LOG_CI_START="0.20950886078305841" LOG_EFFECT_SIZE="0.8436533954675609" ORDER="222" O_E="3.5" SE="0.7449992774794993" STUDY_ID="STD-Barneschi-1985" TOTAL_1="15" TOTAL_2="15" VAR="1.8017241379310345" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="9" EVENTS_2="0" I2="0.0" ID="CMP-006.21.19" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:01 +0200" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Intraoperative movement comparing thiopental and fentanyl with thiopental and halothane</NAME>
<DICH_DATA CI_END="73.507827863355" CI_START="3.4089953247765448" EFFECT_SIZE="15.82996656726275" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="0" LOG_CI_END="1.8663335896534714" LOG_CI_START="0.5326264056216337" LOG_EFFECT_SIZE="1.1994799976375528" ORDER="223" O_E="4.5" SE="0.7834262018573375" STUDY_ID="STD-Barneschi-1985" TOTAL_1="15" TOTAL_2="15" VAR="1.6293103448275863" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="0" I2="0.0" ID="CMP-006.21.20" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:15 +0200" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Intraoperative movement comparing ketamine and diazepam with thiopental and halothane</NAME>
<DICH_DATA CI_END="133.25952883863062" CI_START="0.4726304768834543" EFFECT_SIZE="7.936152384138449" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="2.1246982734139985" LOG_CI_START="-0.3254782769576691" LOG_EFFECT_SIZE="0.8996099982281647" ORDER="224" O_E="1.0" SE="1.439245834257849" STUDY_ID="STD-Barneschi-1985" TOTAL_1="15" TOTAL_2="15" VAR="0.48275862068965514" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="5" I2="0.0" ID="CMP-006.21.21" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:15 +0200" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Movement with cervical dilation comparing propofol with ketamin 1mg/kg and midazolam 0.1mg/kg</NAME>
<DICH_DATA CI_END="7.013360078169666" CI_START="0.8353038152047575" EFFECT_SIZE="2.420389727027418" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="5" LOG_CI_END="0.845926136909286" LOG_CI_START="-0.07815553497318006" LOG_EFFECT_SIZE="0.38388530096805296" ORDER="210" O_E="3.0" SE="0.5428101483418094" STUDY_ID="STD-Bonnardot-1987" TOTAL_1="50" TOTAL_2="50" VAR="3.393939393939394" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="5" I2="0.0" ID="CMP-006.21.22" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:15 +0200" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Movement with cervical dilation comparing propofol and alfentanil with ketamin 1mg/kg and midazolam 0.1mg/kg</NAME>
<DICH_DATA CI_END="4.831842761819308" CI_START="0.43813512172643054" EFFECT_SIZE="1.4549914146182013" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.6841127930002199" LOG_CI_START="-0.35839193157278093" LOG_EFFECT_SIZE="0.16286043071371942" ORDER="211" O_E="1.0" SE="0.6123724356957945" STUDY_ID="STD-Bonnardot-1987" TOTAL_1="50" TOTAL_2="50" VAR="2.666666666666667" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="11" EVENTS_2="7" I2="0.0" ID="CMP-006.21.23" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:15 +0200" MODIFIED_BY="[Empty name]" NO="23" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Movement with cervical dilation comparing propofol with propofol and alfentanil</NAME>
<DICH_DATA CI_END="4.719899281424097" CI_START="0.6196399292140877" EFFECT_SIZE="1.7101573192660524" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.6739327312636556" LOG_CI_START="-0.20786060434309278" LOG_EFFECT_SIZE="0.23303606346028138" ORDER="212" O_E="2.0" SE="0.5179697702828122" STUDY_ID="STD-Bonnardot-1987" TOTAL_1="50" TOTAL_2="50" VAR="3.7272727272727275" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-006.21.24" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:15 +0200" MODIFIED_BY="[Empty name]" NO="24" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing propofol and fentanyl with thiopental and fentanyl</NAME>
<DICH_DATA CI_END="2.1500808968548246" CI_START="0.008177884385432009" EFFECT_SIZE="0.13260133104084862" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.3324548005652352" LOG_CI_START="-2.0873590335620484" LOG_EFFECT_SIZE="-0.8774521164984066" ORDER="97" O_E="-1.0" SE="1.4214106244380285" STUDY_ID="STD-Jakobsson-1993" TOTAL_1="50" TOTAL_2="50" VAR="0.494949494949495" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="8" I2="0.0" ID="CMP-006.21.25" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:59:33 +0200" MODIFIED_BY="[Empty name]" NO="25" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing propofol and alfentanil/fentanyl with methohexital and alfentanil/fentanyl</NAME>
<DICH_DATA CI_END="1.6709074173963647" CI_START="0.04126863309261544" EFFECT_SIZE="0.26259486883840705" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.22295238692044358" LOG_CI_START="-1.3843799156674255" LOG_EFFECT_SIZE="-0.580713764373491" ORDER="98" O_E="-1.5" SE="0.9441549509633318" STUDY_ID="STD-Boysen-1990" TOTAL_1="20" TOTAL_2="20" VAR="1.1217948717948718" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.9303939645529434" CI_START="0.017372742304849823" EFFECT_SIZE="0.1271357329320356" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="-0.031333115530096156" LOG_CI_START="-1.7601316223208179" LOG_EFFECT_SIZE="-0.8957323689254568" ORDER="99" O_E="-2.0" SE="1.015504800579495" STUDY_ID="STD-Jakobsson-1993" TOTAL_1="50" TOTAL_2="50" VAR="0.9696969696969697" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="2" I2="0.0" ID="CMP-006.21.26" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:14 +0200" MODIFIED_BY="[Empty name]" NO="26" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing propofol and fentanyl with propofol and ketamine</NAME>
<DICH_DATA CI_END="13.661731830587781" CI_START="0.8676341245034935" EFFECT_SIZE="3.4428744874063506" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="2" LOG_CI_END="1.13550575621186" LOG_CI_START="-0.061663375293021516" LOG_EFFECT_SIZE="0.5369211904594193" ORDER="102" O_E="2.5" SE="0.703223073928743" STUDY_ID="STD-Rossi-1995" TOTAL_1="40" TOTAL_2="40" VAR="2.0221518987341773" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="8" I2="0.0" ID="CMP-006.21.27" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:14 +0200" MODIFIED_BY="[Empty name]" NO="27" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing propofol and fentanyl with midazolam and fentanyl</NAME>
<DICH_DATA CI_END="2.5954407340457912" CI_START="0.27863324220255226" EFFECT_SIZE="0.8503975932890162" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="8" LOG_CI_END="0.41421111637004265" LOG_CI_START="-0.5549670715304811" LOG_EFFECT_SIZE="-0.07037797758021924" ORDER="103" O_E="-0.5" SE="0.569300065082171" STUDY_ID="STD-Rossi-1995" TOTAL_1="40" TOTAL_2="40" VAR="3.085443037974683" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="6" I2="0.0" ID="CMP-006.21.28" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:13 +0200" MODIFIED_BY="[Empty name]" NO="28" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing thiopental and fentanyl with ketamine and diazepam</NAME>
<DICH_DATA CI_END="0.5181216832637977" CI_START="0.015363078029401265" EFFECT_SIZE="0.08921851740926012" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="6" LOG_CI_END="-0.2855682322163215" LOG_CI_START="-1.8135217636493954" LOG_EFFECT_SIZE="-1.0495449979328586" ORDER="217" O_E="-3.0" SE="0.8975274678557507" STUDY_ID="STD-Barneschi-1985" TOTAL_1="15" TOTAL_2="15" VAR="1.2413793103448276" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="3" I2="0.0" ID="CMP-006.21.29" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:10 +0200" MODIFIED_BY="[Empty name]" NO="29" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing thiopental and fentanyl with thiopental and enflurane</NAME>
<DICH_DATA CI_END="1.218166916502836" CI_START="0.011179835807217545" EFFECT_SIZE="0.116700069032911" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.08570680057061957" LOG_CI_START="-1.951564574673479" LOG_EFFECT_SIZE="-0.9329288870514297" ORDER="219" O_E="-1.5" SE="1.1967032904743342" STUDY_ID="STD-Barneschi-1985" TOTAL_1="15" TOTAL_2="15" VAR="0.6982758620689655" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-006.21.30" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:09 +0200" MODIFIED_BY="[Empty name]" NO="30" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing thiopental and fentanyl with thiopental and halothane</NAME>
<DICH_DATA CI_END="2.115817851176342" CI_START="0.007504153802096514" EFFECT_SIZE="0.12600564500231182" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.3254782769576692" LOG_CI_START="-2.1246982734139985" LOG_EFFECT_SIZE="-0.8996099982281647" ORDER="218" O_E="-1.0" SE="1.439245834257849" STUDY_ID="STD-Barneschi-1985" TOTAL_1="15" TOTAL_2="15" VAR="0.48275862068965514" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="2" I2="0.0" ID="CMP-006.21.31" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:09 +0200" MODIFIED_BY="[Empty name]" NO="31" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing ketamine and diazepam with thiopental and halothane</NAME>
<DICH_DATA CI_END="18.34518414016365" CI_START="0.7610901550024373" EFFECT_SIZE="3.7366213403000055" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="2" LOG_CI_END="1.2635220753536518" LOG_CI_START="-0.11856389579053324" LOG_EFFECT_SIZE="0.5724790897815593" ORDER="220" O_E="2.0" SE="0.8118441408859888" STUDY_ID="STD-Barneschi-1985" TOTAL_1="15" TOTAL_2="15" VAR="1.5172413793103448" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="3" I2="0.0" ID="CMP-006.21.32" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:09 +0200" MODIFIED_BY="[Empty name]" NO="32" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="15" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing ketamine and diazepam with thiopental and enflurane</NAME>
<DICH_DATA CI_END="11.659508889953115" CI_START="0.5407207973676967" EFFECT_SIZE="2.5108840960687924" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="1.0666802578951031" LOG_CI_START="-0.2670269261367347" LOG_EFFECT_SIZE="0.3998266658791842" ORDER="221" O_E="1.5" SE="0.7834262018573375" STUDY_ID="STD-Barneschi-1985" TOTAL_1="15" TOTAL_2="15" VAR="1.6293103448275863" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-006.21.33" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:09 +0200" MODIFIED_BY="[Empty name]" NO="33" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Vomiting comparing propofol and fentanyl with propofol and ketamine</NAME>
<DICH_DATA CI_END="20.85819208704145" CI_START="0.3833528599808697" EFFECT_SIZE="2.827728344554633" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3192766626404457" LOG_CI_START="-0.4164012923678958" LOG_EFFECT_SIZE="0.4514376851362749" ORDER="104" O_E="1.0" SE="1.019545822516343" STUDY_ID="STD-Rossi-1995" TOTAL_1="40" TOTAL_2="40" VAR="0.9620253164556962" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-006.21.34" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:09 +0200" MODIFIED_BY="[Empty name]" NO="34" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Vomiting comparing propofol and fentanyl with midazolam and fentanyl</NAME>
<DICH_DATA CI_END="3.4283567622061213" CI_START="0.15716228082553627" EFFECT_SIZE="0.734035672315702" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5350860092241776" LOG_CI_START="-0.8036516770938988" LOG_EFFECT_SIZE="-0.13428283393486062" ORDER="105" O_E="-0.5" SE="0.7863811438016619" STUDY_ID="STD-Rossi-1995" TOTAL_1="40" TOTAL_2="40" VAR="1.6170886075949367" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="9" I2="0.0" ID="CMP-006.21.35" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 23:37:51 +0200" MODIFIED_BY="[Empty name]" NO="35" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Vomiting comparing propofol and alfentanil with ketamine 1mg/kg and midazolam 0.1mg/kg</NAME>
<DICH_DATA CI_END="0.6313423752089259" CI_START="0.046883333560648235" EFFECT_SIZE="0.17204486382305056" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="9" LOG_CI_END="-0.19973506018669027" LOG_CI_START="-1.328981516112756" LOG_EFFECT_SIZE="-0.7643582881497231" ORDER="213" O_E="-4.0" SE="0.6633249580710799" STUDY_ID="STD-Bonnardot-1987" TOTAL_1="50" TOTAL_2="50" VAR="2.272727272727273" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="29" EVENTS_2="11" I2="0.0" ID="CMP-006.21.36" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:08 +0200" MODIFIED_BY="[Empty name]" NO="36" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Dreams comparing propofol and ketamine with propofol and fentanyl</NAME>
<DICH_DATA CI_END="9.787843280936482" CI_START="1.9914417340534045" EFFECT_SIZE="4.414965412778577" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="11" LOG_CI_END="0.9906870069844732" LOG_CI_START="0.2991676042681846" LOG_EFFECT_SIZE="0.6449273056263289" ORDER="96" O_E="9.0" SE="0.406201920231798" STUDY_ID="STD-Jakobsson-1993" TOTAL_1="50" TOTAL_2="50" VAR="6.060606060606061" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="29" EVENTS_2="7" I2="0.0" ID="CMP-006.21.37" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:08 +0200" MODIFIED_BY="[Empty name]" NO="37" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Dreams comparing propofol and ketamine with propofol and thiopental</NAME>
<DICH_DATA CI_END="14.92717149378116" CI_START="2.9389925647716093" EFFECT_SIZE="6.623507079583559" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="7" LOG_CI_END="1.1739775223252311" LOG_CI_START="0.46819848737144" LOG_EFFECT_SIZE="0.8210880048483354" ORDER="100" O_E="11.0" SE="0.414578098794425" STUDY_ID="STD-Jakobsson-1993" TOTAL_1="50" TOTAL_2="50" VAR="5.818181818181818" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="29" EVENTS_2="4" I2="0.0" ID="CMP-006.21.38" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:08 +0200" MODIFIED_BY="[Empty name]" NO="38" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Dreams comparing propofol and ketamine with propofol and methohexital</NAME>
<DICH_DATA CI_END="21.50482164160721" CI_START="4.093231549185672" EFFECT_SIZE="9.382122062893739" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="4" LOG_CI_END="1.33253584491908" LOG_CI_START="0.6120663128566741" LOG_EFFECT_SIZE="0.9723010788878772" ORDER="101" O_E="12.5" SE="0.42320736951515897" STUDY_ID="STD-Jakobsson-1993" TOTAL_1="50" TOTAL_2="50" VAR="5.583333333333334" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-006.21.39" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:08 +0200" MODIFIED_BY="[Empty name]" NO="39" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Hallucinations comparing propofol and fentanyl with propofol and ketamine</NAME>
<DICH_DATA CI_END="2.1465846286540584" CI_START="0.00810592433280145" EFFECT_SIZE="0.13190925886314614" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.33174801512291363" LOG_CI_START="-2.0911974546283956" LOG_EFFECT_SIZE="-0.879724719752741" ORDER="106" O_E="-1.0" SE="1.4232501627054275" STUDY_ID="STD-Rossi-1995" TOTAL_1="40" TOTAL_2="40" VAR="0.49367088607594933" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="2" I2="0.0" ID="CMP-006.21.40" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2008-07-16 16:46:07 +0200" MODIFIED_BY="[Empty name]" NO="40" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Hallucinations comparing fentanyl and midazolam with propofol and ketamine</NAME>
<DICH_DATA CI_END="2.1465846286540584" CI_START="0.00810592433280145" EFFECT_SIZE="0.13190925886314614" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.33174801512291363" LOG_CI_START="-2.0911974546283956" LOG_EFFECT_SIZE="-0.879724719752741" ORDER="107" O_E="-1.0" SE="1.4232501627054275" STUDY_ID="STD-Rossi-1995" TOTAL_1="40" TOTAL_2="40" VAR="0.49367088607594933" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="134" EVENTS_2="126" I2="0.0" I2_Q="0.0" ID="CMP-006.22" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-08-17 22:23:54 +0200" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="840" TOTAL_2="776" WEIGHT="0.0" Z="0.0">
<NAME>Side effects comparing propofol and placebo with propofol and either alfentanil or fentanyl</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="13" EVENTS_2="9" I2="0.0" ID="CMP-006.22.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="100" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing alfentanil with placebo</NAME>
<DICH_DATA CI_END="3.6039337770832454" CI_START="0.22949958210953422" EFFECT_SIZE="0.9094510958765403" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.556776802142886" LOG_CI_START="-0.6392181009227486" LOG_EFFECT_SIZE="-0.041220649389931203" ORDER="116" O_E="-0.1923076923076925" SE="0.7025333263310048" STUDY_ID="STD-Jakobsson-1991" TOTAL_1="60" TOTAL_2="44" VAR="2.0261245475957947" WEIGHT="0.0"/>
<DICH_DATA CI_END="5.6111017472682025" CI_START="0.5292242854296308" EFFECT_SIZE="1.7232328086103073" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="5" LOG_CI_END="0.7490481439264993" LOG_CI_START="-0.2763602348056236" LOG_EFFECT_SIZE="0.23634395456043783" ORDER="117" O_E="1.5" SE="0.6023299575205859" STUDY_ID="STD-Lindholm-1994" TOTAL_1="40" TOTAL_2="40" VAR="2.7563291139240507" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="14" EVENTS_2="9" I2="0.0" ID="CMP-006.22.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="100" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing fentanyl with placebo</NAME>
<DICH_DATA CI_END="3.0486766734918853" CI_START="0.16679825592684847" EFFECT_SIZE="0.7131016421403842" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.48411136783402364" LOG_CI_START="-0.7778084947372832" LOG_EFFECT_SIZE="-0.14684856345162972" ORDER="118" O_E="-0.615384615384615" SE="0.7412579738784493" STUDY_ID="STD-Jakobsson-1991" TOTAL_1="60" TOTAL_2="44" VAR="1.819957488366749" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.862446660589681" CI_START="0.7367171738503064" EFFECT_SIZE="2.2484844472417644" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="5" LOG_CI_END="0.8364789818513584" LOG_CI_START="-0.13269920604916555" LOG_EFFECT_SIZE="0.35188988790109643" ORDER="119" O_E="2.5" SE="0.569300065082171" STUDY_ID="STD-Lindholm-1994" TOTAL_1="40" TOTAL_2="40" VAR="3.085443037974683" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="13" EVENTS_2="14" I2="0.0" ID="CMP-006.22.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="100" TOTAL_2="100" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing alfentanil with fentanyl</NAME>
<DICH_DATA CI_END="4.909381555703235" CI_START="0.32802301632799125" EFFECT_SIZE="1.26901148387506" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6910267866521034" LOG_CI_START="-0.48409568216166504" LOG_EFFECT_SIZE="0.10346555224521915" ORDER="120" O_E="0.5" SE="0.6902727551312428" STUDY_ID="STD-Jakobsson-1991" TOTAL_1="60" TOTAL_2="60" VAR="2.098739495798319" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.137819499551999" CI_START="0.26551216295019897" EFFECT_SIZE="0.7534036629345275" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.32997103405433864" LOG_CI_START="-0.5759155793615565" LOG_EFFECT_SIZE="-0.1229722726536089" ORDER="121" O_E="-1.0" SE="0.5321222809315537" STUDY_ID="STD-Lindholm-1994" TOTAL_1="40" TOTAL_2="40" VAR="3.531645569620253" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="7" I2="0.0" ID="CMP-006.22.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="100" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>Vomiting comparing alfentanil with placebo</NAME>
<DICH_DATA CI_END="1.88426329363668" CI_START="0.033618175055050825" EFFECT_SIZE="0.2516853059979556" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.27514158793888577" LOG_CI_START="-1.473425865704185" LOG_EFFECT_SIZE="-0.5991421388826497" ORDER="122" O_E="-1.3076923076923075" SE="1.0271171778184303" STUDY_ID="STD-Jakobsson-1991" TOTAL_1="60" TOTAL_2="44" VAR="0.9478945251910151" WEIGHT="0.0"/>
<DICH_DATA CI_END="5.081229418625526" CI_START="0.32270052528478566" EFFECT_SIZE="1.2805137260033423" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.7059688038443247" LOG_CI_START="-0.4912003276605569" LOG_EFFECT_SIZE="0.10738423809188385" ORDER="123" O_E="0.5" SE="0.703223073928743" STUDY_ID="STD-Lindholm-1994" TOTAL_1="40" TOTAL_2="40" VAR="2.0221518987341773" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="7" I2="0.0" ID="CMP-006.22.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="100" TOTAL_2="84" WEIGHT="0.0" Z="0.0">
<NAME>Vomiting comparing fentanyl with placebo</NAME>
<DICH_DATA CI_END="5.281293256987347" CI_START="0.2889484844238138" EFFECT_SIZE="1.2353225013753295" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.7227402834429222" LOG_CI_START="-0.5391795791283847" LOG_EFFECT_SIZE="0.09178035215726874" ORDER="124" O_E="0.384615384615385" SE="0.7412579738784493" STUDY_ID="STD-Jakobsson-1991" TOTAL_1="60" TOTAL_2="44" VAR="1.819957488366749" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.5645239354091003" CI_START="0.09393086137828598" EFFECT_SIZE="0.4908033641675744" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.40900675681085186" LOG_CI_START="-1.0271916950154807" LOG_EFFECT_SIZE="-0.3090924691023144" ORDER="125" O_E="-1.0" SE="0.8436300798997816" STUDY_ID="STD-Lindholm-1994" TOTAL_1="40" TOTAL_2="40" VAR="1.4050632911392404" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="1.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="7" I2="0.0" ID="CMP-006.22.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="2" TAU2="0.0" TOTAL_1="100" TOTAL_2="100" WEIGHT="0.0" Z="0.0">
<NAME>Vomiting comparing alfentanil with fentanyl</NAME>
<DICH_DATA CI_END="1.275334908792073" CI_START="0.04846882124577212" EFFECT_SIZE="0.24862417364917694" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="5" LOG_CI_END="0.1056242474686986" LOG_CI_START="-1.3145375421233645" LOG_EFFECT_SIZE="-0.604456647327333" ORDER="126" O_E="-2.0" SE="0.8342100651206134" STUDY_ID="STD-Jakobsson-1991" TOTAL_1="60" TOTAL_2="60" VAR="1.4369747899159664" WEIGHT="0.0"/>
<DICH_DATA CI_END="11.809114811715363" CI_START="0.5413518916116308" EFFECT_SIZE="2.528415836364944" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.07221734496362" LOG_CI_START="-0.26652034135445624" LOG_EFFECT_SIZE="0.402848501804582" ORDER="127" O_E="1.5" SE="0.7863811438016619" STUDY_ID="STD-Lindholm-1994" TOTAL_1="40" TOTAL_2="40" VAR="1.6170886075949367" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="24" EVENTS_2="22" I2="0.0" ID="CMP-006.22.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>No complications comparing alfentanil with placebo</NAME>
<DICH_DATA CI_END="2.9536469444879874" CI_START="0.5071499358869098" EFFECT_SIZE="1.2239043502372438" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="22" LOG_CI_END="0.47035858196298663" LOG_CI_START="-0.2948636250813656" LOG_EFFECT_SIZE="0.0877474784408105" ORDER="128" O_E="1.0" SE="0.449495312328868" STUDY_ID="STD-Lindholm-1994" TOTAL_1="40" TOTAL_2="40" VAR="4.949367088607595" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="26" EVENTS_2="22" I2="0.0" ID="CMP-006.22.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>No complications comparing fentanyl with placebo</NAME>
<DICH_DATA CI_END="3.670935707823912" CI_START="0.6203137229497134" EFFECT_SIZE="1.509016830797222" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="22" LOG_CI_END="0.5647767784070619" LOG_CI_START="-0.20738861100751083" LOG_EFFECT_SIZE="0.17869408369977546" ORDER="129" O_E="2.0" SE="0.45357377202244253" STUDY_ID="STD-Lindholm-1994" TOTAL_1="40" TOTAL_2="40" VAR="4.860759493670886" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="24" EVENTS_2="26" I2="0.0" ID="CMP-006.22.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>No complications comparing alfentanil with fentanyl</NAME>
<DICH_DATA CI_END="1.9915758295583639" CI_START="0.3294734407960124" EFFECT_SIZE="0.810044036562684" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="26" LOG_CI_END="0.29919684688986214" LOG_CI_START="-0.48217958859843224" LOG_EFFECT_SIZE="-0.091491370854285" ORDER="130" O_E="-1.0" SE="0.4589843860815601" STUDY_ID="STD-Lindholm-1994" TOTAL_1="40" TOTAL_2="40" VAR="4.746835443037975" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-006.22.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Laryngospasm or difficulty ventilating comparing alfentanil with placebo</NAME>
<DICH_DATA CI_END="6.820467167072353" CI_START="0.0026853936013588454" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8338141226232083" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" ORDER="131" O_E="-0.5" SE="2.0" STUDY_ID="STD-Lindholm-1994" TOTAL_1="40" TOTAL_2="40" VAR="0.25" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="1" I2="0.0" ID="CMP-006.22.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="11" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Laryngospasm or difficulty ventilating comparing fentanyl with placebo</NAME>
<DICH_DATA CI_END="16.273191489015247" CI_START="0.061450760944773586" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2114727348756547" LOG_CI_START="-1.2114727348756547" LOG_EFFECT_SIZE="0.0" ORDER="132" O_E="0.0" SE="1.4232501627054275" STUDY_ID="STD-Lindholm-1994" TOTAL_1="40" TOTAL_2="40" VAR="0.49367088607594933" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-006.22.12" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="12" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Laryngospasm or difficulty ventilating comparing alfentanil with fentanyl</NAME>
<DICH_DATA CI_END="6.820467167072353" CI_START="0.0026853936013588454" EFFECT_SIZE="0.1353352832366127" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8338141226232083" LOG_CI_START="-2.570992050236215" LOG_EFFECT_SIZE="-0.8685889638065036" ORDER="133" O_E="-0.5" SE="2.0" STUDY_ID="STD-Lindholm-1994" TOTAL_1="40" TOTAL_2="40" VAR="0.25" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="3.1461306820415063" CI_END="-2.2751624031061795" CI_START="-18.35857216992674" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-10.31686728651646" ESTIMABLE="YES" I2="4.644774702959348" I2_Q="17.629352849205862" ID="CMP-006.23" MODIFIED="2008-10-18 21:30:26 +0200" MODIFIED_BY="[Empty name]" NO="23" P_CHI2="0.3696391396633105" P_Q="0.2969996072662212" P_Z="0.01192088112298661" Q="2.4280493952398405" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="3.2872286703660234" TOTALS="SUB" TOTAL_1="220" TOTAL_2="188" UNITS="min." WEIGHT="300.0" Z="2.514477788978083">
<NAME>Time to discharge</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.7180812868016659" CI_END="-4.433586318932434" CI_START="-24.946278681785643" DF="1.0" EFFECT_SIZE="-14.689932500359038" ESTIMABLE="YES" I2="0.0" ID="CMP-006.23.01" MODIFIED="2008-10-18 21:29:43 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.396774027864234" P_Z="0.004997233371904998" STUDIES="2" TAU2="0.0" TOTAL_1="100" TOTAL_2="100" WEIGHT="100.00000000000001" Z="2.807212054539228">
<NAME>Time to discharge (min.) comparing propofol with thiopental</NAME>
<CONT_DATA CI_END="-2.224750116707451" CI_START="-41.775249883292545" EFFECT_SIZE="-22.0" ESTIMABLE="YES" MEAN_1="96.0" MEAN_2="118.0" ORDER="110" SD_1="37.0" SD_2="61.0" SE="10.08959860450355" STUDY_ID="STD-Jakobsson-1993" TOTAL_1="50" TOTAL_2="50" WEIGHT="27.940741449850204"/>
<CONT_DATA CI_END="-0.004123732582019812" CI_START="-23.99587626741798" EFFECT_SIZE="-12.0" ESTIMABLE="YES" MEAN_1="103.0" MEAN_2="115.0" ORDER="111" SD_1="28.0" SD_2="33.0" SE="6.120457499239742" STUDY_ID="STD-Jakobsson-1995" TOTAL_1="50" TOTAL_2="50" WEIGHT="72.0592585501498"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="6.874498374359254" CI_START="-24.874498374359256" DF="0.0" EFFECT_SIZE="-9.0" ESTIMABLE="YES" I2="0.0" ID="CMP-006.23.02" MODIFIED="2008-10-18 21:29:54 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.26648409812941565" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="44" WEIGHT="100.0" Z="1.1111957962307886">
<NAME>Time to discharge (min.) comparing propofol and placebo with propofol and alfentanil</NAME>
<CONT_DATA CI_END="6.874498374359254" CI_START="-24.874498374359256" EFFECT_SIZE="-9.0" ESTIMABLE="YES" MEAN_1="117.0" MEAN_2="126.0" ORDER="112" SD_1="36.0" SD_2="44.0" SE="8.099382692526634" STUDY_ID="STD-Jakobsson-1991" TOTAL_1="60" TOTAL_2="44" WEIGHT="100.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="20.497187145522698" CI_START="-16.497187145522698" DF="0.0" EFFECT_SIZE="2.0" ESTIMABLE="YES" I2="0.0" ID="CMP-006.23.03" MODIFIED="2008-10-18 21:30:02 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.8321692757193015" STUDIES="1" TAU2="0.0" TOTAL_1="60" TOTAL_2="44" WEIGHT="100.0" Z="0.21192021999025615">
<NAME>Time to discharge (min.) comparing propofol and placebo with propofol and fentanyl</NAME>
<CONT_DATA CI_END="20.497187145522698" CI_START="-16.497187145522698" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="128.0" MEAN_2="126.0" ORDER="113" SD_1="52.0" SD_2="44.0" SE="9.437513796899408" STUDY_ID="STD-Jakobsson-1991" TOTAL_1="60" TOTAL_2="44" WEIGHT="100.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="18" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-006.24" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-08-17 22:23:54 +0200" MODIFIED_BY="[Empty name]" NO="24" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="31" TOTAL_2="28" WEIGHT="0.0" Z="0.0">
<NAME>Pain with dilation comparing conscious sedation and PCB with general anesthesia</NAME>
<GROUP_LABEL_1>Consc sed and PCB</GROUP_LABEL_1>
<GROUP_LABEL_2>General anest</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours consc sed and PCB</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Gen anesthesia</GRAPH_LABEL_2>
<DICH_DATA CI_END="44.376323523007" CI_START="4.913715392748324" EFFECT_SIZE="14.766605025143019" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="0" LOG_CI_END="1.647151319080995" LOG_CI_START="0.6914099981069319" LOG_EFFECT_SIZE="1.1692806585939635" ORDER="217" O_E="8.542372881355933" SE="0.561407182936004" STUDY_ID="STD-Raeder-1992" TOTAL_1="31" TOTAL_2="28" VAR="3.1728100327888344" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-006.25" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-08-17 22:23:54 +0200" MODIFIED_BY="[Empty name]" NO="25" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="31" TOTAL_2="28" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing conscious sedation and PCB with general anesthesia</NAME>
<GROUP_LABEL_1>Consc sed and PCB</GROUP_LABEL_1>
<GROUP_LABEL_2>General anesthesia</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours consc sed and PCP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours general anesthes</GRAPH_LABEL_2>
<DICH_DATA CI_END="25.35882208302569" CI_START="2.199832595270722" EFFECT_SIZE="7.468946605506756" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="1" LOG_CI_END="1.404129076704847" LOG_CI_START="0.34238963276929474" LOG_EFFECT_SIZE="0.873259354737071" ORDER="218" O_E="5.169491525423729" SE="0.6236710050627537" STUDY_ID="STD-Raeder-1992" TOTAL_1="31" TOTAL_2="28" VAR="2.5709219506879712" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.26" MODIFIED="2008-08-17 22:23:54 +0200" MODIFIED_BY="[Empty name]" NO="26" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="31" TOTAL_2="28" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing conscious sedation and PCB with general anesthesia</NAME>
<GROUP_LABEL_1>Consc sed and PCB</GROUP_LABEL_1>
<GROUP_LABEL_2>General anesthesia</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours consc sed and PCP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours general anesthes</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.22899255803137142" CI_START="-1.7710074419686286" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="2.4" ORDER="219" SD_1="1.1" SD_2="1.8" SE="0.39337837228144845" STUDY_ID="STD-Raeder-1992" TOTAL_1="31" TOTAL_2="28" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-006.27" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-08-17 22:23:54 +0200" MODIFIED_BY="[Empty name]" NO="27" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="31" TOTAL_2="28" WEIGHT="0.0" Z="0.0">
<NAME>Apnea incidence comparing conscious sedation and PCB with genereal anesthesia</NAME>
<GROUP_LABEL_1>Consc sed with PCB</GROUP_LABEL_1>
<GROUP_LABEL_2>General anesthesia</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours consc sed and PCB</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours general anesthes</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.4567994310561837" CI_START="0.019899939560649067" EFFECT_SIZE="0.09534296549487507" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="7" LOG_CI_END="-0.3402744456757675" LOG_CI_START="-1.701148242611221" LOG_EFFECT_SIZE="-1.020711344143494" ORDER="220" O_E="-3.6779661016949152" SE="0.799384004753824" STUDY_ID="STD-Raeder-1992" TOTAL_1="31" TOTAL_2="28" VAR="1.5649090134622434" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-006.28" MODIFIED="2008-10-18 21:31:42 +0200" MODIFIED_BY="[Empty name]" NO="28" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="31" TOTAL_2="28" UNITS="min." WEIGHT="0.0" Z="0.0">
<NAME>Duration of sleep (min.) comparing conscious sedation and PCB with general anesthesia</NAME>
<GROUP_LABEL_1>Consc sed and PCB</GROUP_LABEL_1>
<GROUP_LABEL_2>General anesthesia</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours consc sed and PCP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours general anesthes</GRAPH_LABEL_2>
<CONT_DATA CI_END="-7.50387985622219" CI_START="-11.49612014377781" EFFECT_SIZE="-9.5" ESTIMABLE="YES" MEAN_1="2.5" MEAN_2="12.0" ORDER="221" SD_1="3.8" SD_2="4.0" SE="1.018447358993814" STUDY_ID="STD-Raeder-1992" TOTAL_1="31" TOTAL_2="28" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-007" MODIFIED="2008-10-18 21:48:33 +0200" MODIFIED_BY="[Empty name]" NO="7">
<NAME>General anesthesia with premedication</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.01" MODIFIED="2008-07-15 23:16:28 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="210" TOTAL_2="210" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing paracetamol supp with placebo</NAME>
<GROUP_LABEL_1>Paracetamol</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours paracetamol supp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.01.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>30 minutes postoperatively</NAME>
<CONT_DATA CI_END="1.297249437415412" CI_START="0.10275056258458837" EFFECT_SIZE="0.7000000000000002" ESTIMABLE="YES" MEAN_1="2.1" MEAN_2="1.4" ORDER="143" SD_1="1.9" SD_2="1.7" SE="0.304724700110022" STUDY_ID="STD-Hein-1999" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.01.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>1 hour postoperatively</NAME>
<CONT_DATA CI_END="0.9528746387391512" CI_START="-0.15287463873915097" EFFECT_SIZE="0.40000000000000013" ESTIMABLE="YES" MEAN_1="1.6" MEAN_2="1.2" ORDER="144" SD_1="1.9" SD_2="1.4" SE="0.28208408067707147" STUDY_ID="STD-Hein-1999" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.01.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>At discharge</NAME>
<CONT_DATA CI_END="0.4989312611754593" CI_START="-0.2989312611754591" EFFECT_SIZE="0.10000000000000009" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="0.7" ORDER="145" SD_1="1.3" SD_2="1.1" SE="0.203540097839643" STUDY_ID="STD-Hein-1999" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="13" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-007.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-17 00:00:59 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="138" TOTAL_2="132" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing paracetamol/codeine supp with placebo</NAME>
<GROUP_LABEL_1>Paracetamol/codeine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours paracet/cod supp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="8" EVENTS_2="7" I2="0.0" ID="CMP-007.02.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>30 minutes postoperatively</NAME>
<DICH_DATA CI_END="3.3479633731208898" CI_START="0.3688795839479481" EFFECT_SIZE="1.1113034401772555" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.5247806981448492" LOG_CI_START="-0.4331153806206056" LOG_EFFECT_SIZE="0.04583265876212179" ORDER="167" O_E="0.33333333333333304" SE="0.5626728983288906" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="3.158551810237203" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-007.02.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>60 minutes postoperatively</NAME>
<DICH_DATA CI_END="3.255640973615971" CI_START="0.15125467759588107" EFFECT_SIZE="0.7017342273483772" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5126365056230012" LOG_CI_START="-0.8202911857818225" LOG_EFFECT_SIZE="-0.1538273400794107" ORDER="168" O_E="-0.577777777777778" SE="0.7829683240296786" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="1.6312165348869467" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-007.02.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>at discharge</NAME>
<DICH_DATA CI_END="1.7635869582907542" CI_START="0.08193494889342612" EFFECT_SIZE="0.3801307765712555" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.24639687856248277" LOG_CI_START="-1.0865308128423408" LOG_EFFECT_SIZE="-0.4200669671399291" ORDER="169" O_E="-1.577777777777778" SE="0.7829683240296786" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="1.6312165348869467" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="23" EVENTS_2="23" I2="0.0" I2_Q="0.0" ID="CMP-007.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-17 00:00:59 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing paracetamol po with placebo</NAME>
<GROUP_LABEL_1>Paracetamol</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours paracetamol po</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.0194347089977787" CI_START="0.4951880818648938" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="23" LOG_CI_END="0.3052298164164485" LOG_CI_START="-0.3052298164164485" LOG_EFFECT_SIZE="0.0" ORDER="161" O_E="0.0" SE="0.3585870101499616" STUDY_ID="STD-Hein-2001" TOTAL_1="70" TOTAL_2="70" VAR="7.776978417266187" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="23" I2="0.0" I2_Q="0.0" ID="CMP-007.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-17 00:00:58 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing paracetamol po with lornoxicam</NAME>
<GROUP_LABEL_1>Lornoxicam</GROUP_LABEL_1>
<GROUP_LABEL_2>Paracetamol</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours lornoxicam</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours paracetamol</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.7821082171010534" CI_START="0.16509239124039315" EFFECT_SIZE="0.35933287599379693" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="23" LOG_CI_END="-0.10673315123910498" LOG_CI_START="-0.7822729419913408" LOG_EFFECT_SIZE="-0.4445030466152229" ORDER="160" O_E="-6.5" SE="0.39681541706375845" STUDY_ID="STD-Hein-2001" TOTAL_1="70" TOTAL_2="70" VAR="6.350719424460432" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="52" EVENTS_2="60" I2="0.0" I2_Q="0.0" ID="CMP-007.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 23:58:50 +0200" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="250" TOTAL_2="250" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing diclofenac with ketorolac and with NaCl</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="16" EVENTS_2="16" I2="0.0" ID="CMP-007.05.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Diclofenac po versus NaCL</NAME>
<DICH_DATA CI_END="2.3073863427966983" CI_START="0.4333907943599669" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="16" LOG_CI_END="0.3631203177534614" LOG_CI_START="-0.3631203177534614" LOG_EFFECT_SIZE="0.0" ORDER="162" O_E="0.0" SE="0.42659734424589074" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="5.494949494949496" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="16" I2="0.0" ID="CMP-007.05.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Diclofenac im versus NaCL</NAME>
<DICH_DATA CI_END="0.9236608013141763" CI_START="0.14471167168019755" EFFECT_SIZE="0.3656015571953233" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="16" LOG_CI_END="-0.03448748674866359" LOG_CI_START="-0.8394964395659549" LOG_EFFECT_SIZE="-0.43699196315730926" ORDER="163" O_E="-4.5" SE="0.47286624374346037" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="4.472222222222222" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="16" I2="0.0" ID="CMP-007.05.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Ketorolac im versus NaCl</NAME>
<DICH_DATA CI_END="0.8087140295631503" CI_START="0.12302319096479768" EFFECT_SIZE="0.31542127463894765" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.09220502268756725" LOG_CI_START="-0.910013012473783" LOG_EFFECT_SIZE="-0.5011090175806752" ORDER="164" O_E="-5.0" SE="0.48038446141526137" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="4.333333333333334" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="16" EVENTS_2="6" I2="0.0" ID="CMP-007.05.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Diclofenac po versus ketorolac im</NAME>
<DICH_DATA CI_END="8.128548708236188" CI_START="1.2365310399526248" EFFECT_SIZE="3.1703631948880653" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="6" LOG_CI_END="0.910013012473783" LOG_CI_START="0.09220502268756725" LOG_EFFECT_SIZE="0.5011090175806752" ORDER="165" O_E="5.0" SE="0.48038446141526137" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="4.333333333333334" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="6" I2="0.0" ID="CMP-007.05.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Diclofenac im versus ketorolac im</NAME>
<DICH_DATA CI_END="3.7992980039992017" CI_START="0.3735573689732954" EFFECT_SIZE="1.1913252143388195" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.579703359471176" LOG_CI_START="-0.4276426920673849" LOG_EFFECT_SIZE="0.07603033370189552" ORDER="166" O_E="0.5" SE="0.591720057117126" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="2.8560606060606064" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.06" MODIFIED="2008-10-18 21:34:50 +0200" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="80" TOTAL_2="80" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing etoricoxib with placebo</NAME>
<GROUP_LABEL_1>Etoricoxib</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours etoricoxib</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.06.01" MODIFIED="2008-10-18 21:33:56 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>15 minutes postoperatively</NAME>
<CONT_DATA CI_END="0.6365325145947853" CI_START="-2.8365325145947855" EFFECT_SIZE="-1.1" ESTIMABLE="YES" MEAN_1="2.6" MEAN_2="3.7" MODIFIED="2008-10-18 21:33:56 +0200" MODIFIED_BY="[Empty name]" ORDER="170" SD_1="2.7" SD_2="2.9" SE="0.8860022573334675" STUDY_ID="STD-Liu-2005" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.06.02" MODIFIED="2008-10-18 21:34:14 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>30 minutes postoperatively</NAME>
<CONT_DATA CI_END="0.9799930417881362" CI_START="-1.5799930417881358" EFFECT_SIZE="-0.2999999999999998" ESTIMABLE="YES" MEAN_1="2.5" MEAN_2="2.8" MODIFIED="2008-10-18 21:34:14 +0200" MODIFIED_BY="[Empty name]" ORDER="172" SD_1="1.8" SD_2="2.3" SE="0.6530696746902278" STUDY_ID="STD-Liu-2005" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.06.03" MODIFIED="2008-10-18 21:34:24 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>60 minutes postoperatively</NAME>
<CONT_DATA CI_END="0.6184924432257591" CI_START="-1.8184924432257592" EFFECT_SIZE="-0.6" ESTIMABLE="YES" MEAN_1="0.9" MEAN_2="1.5" MODIFIED="2008-10-18 21:34:24 +0200" MODIFIED_BY="[Empty name]" ORDER="173" SD_1="1.7" SD_2="2.2" SE="0.6216912416947822" STUDY_ID="STD-Liu-2005" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.06.04" MODIFIED="2008-10-18 21:34:50 +0200" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>at discharge</NAME>
<CONT_DATA CI_END="-0.20030526984455982" CI_START="-1.1996947301554404" EFFECT_SIZE="-0.7000000000000001" ESTIMABLE="YES" MEAN_1="0.1" MEAN_2="0.8" MODIFIED="2008-10-18 21:34:50 +0200" MODIFIED_BY="[Empty name]" ORDER="171" SD_1="0.3" SD_2="1.1" SE="0.25495097567963926" STUDY_ID="STD-Liu-2005" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="66" EVENTS_2="84" I2="0.0" I2_Q="0.0" ID="CMP-007.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 23:58:47 +0200" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="830" TOTAL_2="825" WEIGHT="0.0" Z="0.0">
<NAME>Side effects comparing COX inhibitors with placebo as premedication for general anesthesia</NAME>
<GROUP_LABEL_1>COX inhibitors</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours COX inhibitors</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="1" I2="0.0" ID="CMP-007.07.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Antiemetic requirements comparing paracetamol supp with placebo</NAME>
<DICH_DATA CI_END="20.156405770576413" CI_START="0.383120968485596" EFFECT_SIZE="2.7789101640772573" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.3044130925964346" LOG_CI_START="-0.4166640781177286" LOG_EFFECT_SIZE="0.44387450723935296" ORDER="146" O_E="1.0" SE="1.0109692495468947" STUDY_ID="STD-Hein-1999" TOTAL_1="70" TOTAL_2="70" VAR="0.9784172661870504" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="7" EVENTS_2="4" I2="0.0" ID="CMP-007.07.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Antiemetic requirements comparing paracetamol po with placebo</NAME>
<DICH_DATA CI_END="6.138594548470853" CI_START="0.5277565780756223" EFFECT_SIZE="1.7999121237145572" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.7880689493638711" LOG_CI_START="-0.27756634484334686" LOG_EFFECT_SIZE="0.2552513022602621" ORDER="147" O_E="1.5" SE="0.6259594467970999" STUDY_ID="STD-Hein-2001" TOTAL_1="70" TOTAL_2="70" VAR="2.5521582733812953" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="4" I2="0.0" ID="CMP-007.07.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Antiemetic requirements comparing lornoxicam with placebo</NAME>
<DICH_DATA CI_END="2.5557470953149473" CI_START="0.09813323692289307" EFFECT_SIZE="0.5008030902655629" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4075178758778457" LOG_CI_START="-1.0081838757241344" LOG_EFFECT_SIZE="-0.3003329999231442" ORDER="148" O_E="-1.0" SE="0.8315902167276945" STUDY_ID="STD-Hein-2001" TOTAL_1="70" TOTAL_2="70" VAR="1.446043165467626" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="7" I2="0.0" ID="CMP-007.07.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Antiemetic requirements comparing lornoxicam with paracetamol po</NAME>
<DICH_DATA CI_END="1.1817350189855156" CI_START="0.0800651850334495" EFFECT_SIZE="0.30759686759715593" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="7" LOG_CI_END="0.07252010540002997" LOG_CI_START="-1.0965562883440843" LOG_EFFECT_SIZE="-0.5120180914720271" ORDER="149" O_E="-2.5" SE="0.6867212607067736" STUDY_ID="STD-Hein-2001" TOTAL_1="70" TOTAL_2="70" VAR="2.120503597122302" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="4" I2="0.0" ID="CMP-007.07.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing diclofenac po with NaCl</NAME>
<DICH_DATA CI_END="4.2108391214364795" CI_START="0.237482357117187" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.6243686491602148" LOG_CI_START="-0.6243686491602148" LOG_EFFECT_SIZE="0.0" ORDER="150" O_E="0.0" SE="0.7335144703827386" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="1.8585858585858588" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="4" I2="0.0" ID="CMP-007.07.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing diclofenac im with NaCl</NAME>
<DICH_DATA CI_END="0.9303939645529434" CI_START="0.017372742304849823" EFFECT_SIZE="0.1271357329320356" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="-0.031333115530096156" LOG_CI_START="-1.7601316223208179" LOG_EFFECT_SIZE="-0.8957323689254568" ORDER="151" O_E="-2.0" SE="1.015504800579495" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="0.9696969696969697" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="2" EVENTS_2="4" I2="0.0" ID="CMP-007.07.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Nausea comparing ketorolac im with NaCl</NAME>
<DICH_DATA CI_END="2.560457880066884" CI_START="0.095900755315656" EFFECT_SIZE="0.4955298625232768" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4083176360169345" LOG_CI_START="-1.0181779723066073" LOG_EFFECT_SIZE="-0.30493016814483637" ORDER="152" O_E="-1.0" SE="0.8379305815963922" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="1.4242424242424243" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-007.07.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Vomiting comparing diclofenac po with NaCl</NAME>
<DICH_DATA CI_END="10.42744654834588" CI_START="0.3905551455405617" EFFECT_SIZE="2.0180418489976" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0181779723066073" LOG_CI_START="-0.4083176360169345" LOG_EFFECT_SIZE="0.3049301681448364" ORDER="153" O_E="1.0" SE="0.8379305815963922" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="1.4242424242424243" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-007.07.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Vomiting comparing diclofenac im with NaCl</NAME>
<DICH_DATA CI_END="9.083075818571308" CI_START="0.25341453032979955" EFFECT_SIZE="1.5171629419786155" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9582329393617519" LOG_CI_START="-0.5961684870803041" LOG_EFFECT_SIZE="0.18103222614072387" ORDER="154" O_E="0.5" SE="0.9130630923032185" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="1.1994949494949496" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="2" I2="0.0" ID="CMP-007.07.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Vomiting comparing ketorolac im with NaCl</NAME>
<DICH_DATA CI_END="4.982699036562526" CI_START="0.05146792598685368" EFFECT_SIZE="0.506408121211111" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.6974646558430366" LOG_CI_START="-1.288463332247462" LOG_EFFECT_SIZE="-0.2954993382022126" ORDER="155" O_E="-0.5" SE="1.1665439307064442" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="0.7348484848484849" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="10" I2="0.0" ID="CMP-007.07.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="11" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Anxiety during recovery comparing diclofenac po with NaCl</NAME>
<DICH_DATA CI_END="3.2294294277523234" CI_START="0.4912672448780458" EFFECT_SIZE="1.2595685362456335" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.5091257984092429" LOG_CI_START="-0.30868219137697284" LOG_EFFECT_SIZE="0.10022180351613497" ORDER="156" O_E="1.0" SE="0.48038446141526137" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="4.333333333333334" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="10" I2="0.0" ID="CMP-007.07.12" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="12" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Anxiety during recovery comparing diclofenac im with NaCl</NAME>
<DICH_DATA CI_END="0.9363984579972112" CI_START="0.09206925698165441" EFFECT_SIZE="0.29362137229188573" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="-0.028539310143988278" LOG_CI_START="-1.0358853616825492" LOG_EFFECT_SIZE="-0.5322123359132687" ORDER="157" O_E="-3.5" SE="0.591720057117126" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="2.8560606060606064" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="10" I2="0.0" ID="CMP-007.07.13" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="13" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Anxiety during recovery comparing ketorolac im with NaCl</NAME>
<DICH_DATA CI_END="0.9363984579972112" CI_START="0.09206925698165441" EFFECT_SIZE="0.29362137229188573" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="-0.028539310143988278" LOG_CI_START="-1.0358853616825492" LOG_EFFECT_SIZE="-0.5322123359132687" ORDER="158" O_E="-3.5" SE="0.591720057117126" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" VAR="2.8560606060606064" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="20" EVENTS_2="20" I2="0.0" ID="CMP-007.07.14" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="14" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="100" TOTAL_2="95" WEIGHT="0.0" Z="0.0">
<NAME>Satisfaction with pain management comparing etoricoxib with placebo</NAME>
<DICH_DATA CI_END="1.8764831944871159" CI_START="0.46867093296504125" EFFECT_SIZE="0.9377916236848661" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="20" LOG_CI_END="0.2733446792877671" LOG_CI_START="-0.32913198064735993" LOG_EFFECT_SIZE="-0.02789365067979641" ORDER="159" O_E="-0.5128205128205146" SE="0.3538977723534584" STUDY_ID="STD-Liu-2005" TOTAL_1="100" TOTAL_2="95" VAR="7.984437802042877" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.08" MODIFIED="2008-10-18 21:44:59 +0200" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="550" TOTAL_2="550" UNITS="min." WEIGHT="0.0" Z="0.0">
<NAME>Recovery time (min.) comparing COX inhibitors with placebo as premedication for general anesthesia</NAME>
<GROUP_LABEL_1>COX inhibitors</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours COX inhibitors</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Time to street fittness comparing paracetamol supp with placebo</NAME>
<CONT_DATA CI_END="10.317068657669061" CI_START="-7.317068657669061" EFFECT_SIZE="1.5" ESTIMABLE="YES" MEAN_1="103.6" MEAN_2="102.1" ORDER="177" SD_1="29.4" SD_2="23.5" SE="4.498587079771349" STUDY_ID="STD-Hein-1999" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.02" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Time to discharge comparing paracetamol po with placebo</NAME>
<CONT_DATA CI_END="15.454958199583306" CI_START="-3.454958199583306" EFFECT_SIZE="6.0" ESTIMABLE="YES" MEAN_1="99.0" MEAN_2="93.0" ORDER="178" SD_1="30.0" SD_2="27.0" SE="4.8240469080875" STUDY_ID="STD-Hein-2001" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Time to discharge comparing lornoxicam with placebo</NAME>
<CONT_DATA CI_END="5.871292332233697" CI_START="-9.871292332233697" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="91.0" MEAN_2="93.0" ORDER="179" SD_1="20.0" SD_2="27.0" SE="4.016039271293476" STUDY_ID="STD-Hein-2001" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.04" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0" Z="0.0">
<NAME>Time to discharge comparing lornoxicam with paracetamol po</NAME>
<CONT_DATA CI_END="0.4463825451257666" CI_START="-16.446382545125765" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="91.0" MEAN_2="99.0" ORDER="180" SD_1="20.0" SD_2="30.0" SE="4.3094580368566735" STUDY_ID="STD-Hein-2001" TOTAL_1="70" TOTAL_2="70" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.05" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Time to discharge comparing diclofenac po with NaCl</NAME>
<CONT_DATA CI_END="9.694525169800055" CI_START="-17.694525169800055" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="109.0" MEAN_2="113.0" ORDER="181" SD_1="29.0" SD_2="40.0" SE="6.987131027825369" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.06" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Time to discharge comparing diclofenac im with NaCl</NAME>
<CONT_DATA CI_END="8.929821649064165" CI_START="-16.929821649064166" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="109.0" MEAN_2="113.0" ORDER="182" SD_1="24.0" SD_2="40.0" SE="6.596969000988256" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.07" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Time to discharge comparing ketorolac im with NaCl</NAME>
<CONT_DATA CI_END="7.376664452244153" CI_START="-19.376664452244153" EFFECT_SIZE="-6.0" ESTIMABLE="YES" MEAN_1="107.0" MEAN_2="113.0" ORDER="183" SD_1="27.0" SD_2="40.0" SE="6.8249542123006215" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.08" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Time to discharge comparing diclofenac po with ketorolac im</NAME>
<CONT_DATA CI_END="12.98279595411822" CI_START="-8.98279595411822" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="109.0" MEAN_2="107.0" ORDER="184" SD_1="29.0" SD_2="27.0" SE="5.60357029044876" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.09" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0" Z="0.0">
<NAME>Time to discharge comparing diclofenac im with ketorolac im</NAME>
<CONT_DATA CI_END="12.013095186809956" CI_START="-8.013095186809956" EFFECT_SIZE="2.0" ESTIMABLE="YES" MEAN_1="109.0" MEAN_2="107.0" ORDER="185" SD_1="24.0" SD_2="27.0" SE="5.10881590977792" STUDY_ID="STD-Jakobsson-1996" TOTAL_1="50" TOTAL_2="50" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.08.10" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>Time to discharge comparing etoricoxib with placebo</NAME>
<CONT_DATA CI_END="17.470395137429826" CI_START="-5.470395137429827" EFFECT_SIZE="6.0" ESTIMABLE="YES" MEAN_1="84.0" MEAN_2="78.0" ORDER="186" SD_1="18.0" SD_2="19.0" SE="5.852349955359813" STUDY_ID="STD-Liu-2005" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="22" EVENTS_2="34" I2="0.0" I2_Q="0.0" ID="CMP-007.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-16 23:58:45 +0200" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="40" TOTAL_2="40" WEIGHT="0.0" Z="0.0">
<NAME>Postoperative pain comparing Nalbuphine with fentanyl</NAME>
<GROUP_LABEL_1>Nalbuphine</GROUP_LABEL_1>
<GROUP_LABEL_2>Fentanyl</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours nalbuphine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fentanyl</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="12" EVENTS_2="18" I2="0.0" ID="CMP-007.09.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>1 hour postoperatively</NAME>
<DICH_DATA CI_END="0.8635962944781304" CI_START="0.0511317252077569" EFFECT_SIZE="0.21013607120076472" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="18" LOG_CI_END="-0.06368922980602487" LOG_CI_START="-1.2913095537321209" LOG_EFFECT_SIZE="-0.6774993917690729" ORDER="141" O_E="-3.0" SE="0.7211102550927979" STUDY_ID="STD-Bone-1988" TOTAL_1="20" TOTAL_2="20" VAR="1.923076923076923" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="10" EVENTS_2="16" I2="0.0" ID="CMP-007.09.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>2 hours postoperatively</NAME>
<DICH_DATA CI_END="0.9973867517139616" CI_START="0.07662653114193983" EFFECT_SIZE="0.2764530466295643" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="16" LOG_CI_END="-0.0011364048119949523" LOG_CI_START="-1.1156208343677956" LOG_EFFECT_SIZE="-0.5583786195898953" ORDER="142" O_E="-3.0" SE="0.6546536707079772" STUDY_ID="STD-Bone-1988" TOTAL_1="20" TOTAL_2="20" VAR="2.333333333333333" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-007.10" MODIFIED="2008-10-18 21:48:33 +0200" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="60" TOTAL_2="60" UNITS="msec" WEIGHT="0.0" Z="0.0">
<NAME>Recovery (reaction time (msec.)) comparing nalbuphine with fentanyl</NAME>
<GROUP_LABEL_1>Nalbuphine</GROUP_LABEL_1>
<GROUP_LABEL_2>Fentanyl</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours nalbuphine</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours fentanyl</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.10.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>1 hour postoperatively</NAME>
<CONT_DATA CI_END="50.33776759262564" CI_START="-4.9377675926256615" EFFECT_SIZE="22.69999999999999" ESTIMABLE="YES" MEAN_1="293.0" MEAN_2="270.3" ORDER="174" SD_1="50.98" SD_2="37.12" SE="14.101160945113703" STUDY_ID="STD-Bone-1988" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.10.02" MODIFIED="2008-07-17 00:21:30 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>2 hours postoperatively</NAME>
<CONT_DATA CI_END="37.38519585288465" CI_START="-14.985195852884672" EFFECT_SIZE="11.199999999999989" ESTIMABLE="YES" MEAN_1="265.0" MEAN_2="253.8" MODIFIED="2008-07-17 00:21:30 +0200" MODIFIED_BY="[Empty name]" ORDER="175" SD_1="51.43" SD_2="30.41" SE="13.360039296349393" STUDY_ID="STD-Bone-1988" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-007.10.03" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0" Z="0.0">
<NAME>4 hours postoperatively</NAME>
<CONT_DATA CI_END="28.687187486780093" CI_START="-16.28718748678006" EFFECT_SIZE="6.200000000000017" ESTIMABLE="YES" MEAN_1="248.9" MEAN_2="242.7" ORDER="176" SD_1="44.27" SD_2="25.94" SE="11.473265664142883" STUDY_ID="STD-Bone-1988" TOTAL_1="20" TOTAL_2="20" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="106" EVENTS_2="96" I2="0.0" I2_Q="0.0" ID="CMP-007.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-15 23:18:28 +0200" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="507" TOTAL_2="484" WEIGHT="0.0" Z="0.0">
<NAME>Side effects comparing paracetamol/codeine supp with placebo</NAME>
<GROUP_LABEL_1>Paracetamol/codeine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours paracet/cod supp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="2" I2="0.0" ID="CMP-007.11.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Nausea at 30 minutes postoperatively</NAME>
<DICH_DATA CI_END="11.094705015112048" CI_START="0.5154518092387561" EFFECT_SIZE="2.3913982882426352" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.045115759744038" LOG_CI_START="-0.28781193166078567" LOG_EFFECT_SIZE="0.3786519140416262" ORDER="187" O_E="1.422222222222222" SE="0.7829683240296786" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="1.6312165348869467" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-007.11.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Nausea at 60 minutes postoperatively</NAME>
<DICH_DATA CI_END="10.046611674853942" CI_START="0.3722962128720258" EFFECT_SIZE="1.933989523948877" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.002019616081826" LOG_CI_START="-0.42911138155530315" LOG_EFFECT_SIZE="0.2864541172632614" ORDER="188" O_E="0.9333333333333331" SE="0.8406534322247406" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="1.415031210986267" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="6" EVENTS_2="4" I2="0.0" ID="CMP-007.11.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Nausea at discharge</NAME>
<DICH_DATA CI_END="5.493320997059361" CI_START="0.40170752140951954" EFFECT_SIZE="1.4854993645355714" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7398349773534985" LOG_CI_START="-0.39609003663758446" LOG_EFFECT_SIZE="0.17187247035795697" ORDER="189" O_E="0.8888888888888893" SE="0.6672479761378667" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="2.246081287279789" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="15" EVENTS_2="26" I2="0.0" ID="CMP-007.11.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="4" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Fully awake at 30 minutes postoperatively</NAME>
<DICH_DATA CI_END="0.794055389873184" CI_START="0.15241922652785123" EFFECT_SIZE="0.34789266785136774" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="26" LOG_CI_END="-0.10014920200961255" LOG_CI_START="-0.8169602465903367" LOG_EFFECT_SIZE="-0.45855472429997457" ORDER="190" O_E="-5.955555555555556" SE="0.4210583558586138" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="5.64047163268137" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="29" EVENTS_2="32" I2="0.0" ID="CMP-007.11.05" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="5" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="47" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Fully awake at 60 minutes postoperatively</NAME>
<DICH_DATA CI_END="1.4569724120782022" CI_START="0.2558404052524191" EFFECT_SIZE="0.6105345300207694" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="32" LOG_CI_END="0.16345132843736374" LOG_CI_START="-0.5920308656727702" LOG_EFFECT_SIZE="-0.2142897686177032" ORDER="191" O_E="-2.5054945054945073" SE="0.4437739805174666" STUDY_ID="STD-Dahl-2000" TOTAL_1="47" TOTAL_2="44" VAR="5.077808638248199" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="28" EVENTS_2="14" I2="0.0" ID="CMP-007.11.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="6" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Sleepy at 30 minutes postoperatively</NAME>
<DICH_DATA CI_END="7.228987180949265" CI_START="1.3915921038044754" EFFECT_SIZE="3.171719010176149" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="14" LOG_CI_END="0.8590774546199901" LOG_CI_START="0.14351195580142545" LOG_EFFECT_SIZE="0.5012947052107077" ORDER="192" O_E="6.533333333333335" SE="0.4203267161123703" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="5.660124843945068" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="15" EVENTS_2="8" I2="0.0" ID="CMP-007.11.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="7" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Sleepy at 60 minutes postoperatively</NAME>
<DICH_DATA CI_END="5.431286323462369" CI_START="0.824993385356307" EFFECT_SIZE="2.1167841861731276" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="8" LOG_CI_END="0.7349026982855417" LOG_CI_START="-0.08354953352858645" LOG_EFFECT_SIZE="0.32567658237847763" ORDER="193" O_E="3.2444444444444436" SE="0.48076289237150654" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="4.326514079622694" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="3" I2="0.0" ID="CMP-007.11.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="8" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Asleep but easily arousable at 30 minutes postoperatively</NAME>
<DICH_DATA CI_END="4.955694095382737" CI_START="0.1836426253521016" EFFECT_SIZE="0.9539793887280762" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6951044904426172" LOG_CI_START="-0.7360265071945118" LOG_EFFECT_SIZE="-0.020461008375947307" ORDER="194" O_E="-0.06666666666666687" SE="0.8406534322247406" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="1.415031210986267" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="1" EVENTS_2="4" I2="0.0" ID="CMP-007.11.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="9" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Asleep but easily arousable at 60 minutes postoperatively</NAME>
<DICH_DATA CI_END="1.6333151606354337" CI_START="0.04514334452784205" EFFECT_SIZE="0.27153877995437975" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.2130699932600809" LOG_CI_START="-1.3454062685595614" LOG_EFFECT_SIZE="-0.5661681376497403" ORDER="195" O_E="-1.5555555555555554" SE="0.9154566707747731" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="1.1932306838673878" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="1" I2="0.0" ID="CMP-007.11.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="10" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Heavily asleep at 30 minutes postoperatively</NAME>
<DICH_DATA CI_END="6.523699778553308" CI_START="0.002563579495710508" EFFECT_SIZE="0.12932139416380586" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8144939665439346" LOG_CI_START="-2.591153210693601" LOG_EFFECT_SIZE="-0.8883296220748332" ORDER="196" O_E="-0.5111111111111111" SE="2.0004940101347417" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="0.2498765432098765" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-007.11.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="11" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Heavily asleep at 60 minutes postoperatively</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="197" O_E="0.0" SE="0.0" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="103" EVENTS_2="94" I2="0.0" I2_Q="0.0" ID="CMP-007.12" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-15 23:18:28 +0200" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="138" TOTAL_2="132" WEIGHT="0.0" Z="0.0">
<NAME>Recovery time (discharge ready) comparing paracetamol/codeine supp with placebo</NAME>
<GROUP_LABEL_1>Paracetamol/codeine</GROUP_LABEL_1>
<GROUP_LABEL_2>Placebo</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours parac/cod supp</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours placebo</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="18" EVENTS_2="17" I2="0.0" ID="CMP-007.12.01" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Discharge ready at 30 minutes postoperatively</NAME>
<DICH_DATA CI_END="2.37175718383321" CI_START="0.4393257461850394" EFFECT_SIZE="1.0207712743593702" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="17" LOG_CI_END="0.37507022469254153" LOG_CI_START="-0.3572133446553514" LOG_EFFECT_SIZE="0.008928440018595083" ORDER="198" O_E="0.11111111111111072" SE="0.4301469934970816" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="5.404633097516992" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="41" EVENTS_2="36" I2="0.0" ID="CMP-007.12.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Discharge ready at 60 minutes postoperatively</NAME>
<DICH_DATA CI_END="5.779156275771859" CI_START="0.5576604430929045" EFFECT_SIZE="1.795217772151912" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="36" LOG_CI_END="0.7618644385030198" LOG_CI_START="-0.25363016052144854" LOG_EFFECT_SIZE="0.2541171389907856" ORDER="199" O_E="1.6444444444444457" SE="0.5965065542463087" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="2.810409210708836" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="44" EVENTS_2="41" I2="0.0" ID="CMP-007.12.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="44" WEIGHT="0.0" Z="0.0">
<NAME>Discharge ready at 90 minutes postoperatively</NAME>
<DICH_DATA CI_END="9.581666202270272" CI_START="0.2648285333686524" EFFECT_SIZE="1.5929527951496936" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="41" LOG_CI_END="0.9814410372133004" LOG_CI_START="-0.5770352246063419" LOG_EFFECT_SIZE="0.20220290630347926" ORDER="200" O_E="0.5555555555555571" SE="0.9154566707747731" STUDY_ID="STD-Dahl-2000" TOTAL_1="46" TOTAL_2="44" VAR="1.1932306838673878" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-008" MODIFIED="2008-07-17 00:35:58 +0200" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Non pharmacological interventions</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-008.01" MODIFIED="2008-07-17 00:35:56 +0200" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="NaN" TOTALS="NO" TOTAL_1="14" TOTAL_2="15" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Level of comfort during procedure comparing hypnosis with control group</NAME>
<GROUP_LABEL_1>Hypnosis</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hypnosis</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.7395467935255153" CI_START="-2.339546793525515" EFFECT_SIZE="-0.2999999999999998" ESTIMABLE="YES" MEAN_1="6.3" MEAN_2="6.6" ORDER="209" SD_1="2.6" SD_2="3.0" SE="1.0406042200842465" STUDY_ID="STD-Marc-2007" TOTAL_1="14" TOTAL_2="15" WEIGHT="0.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="5" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-008.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-17 00:35:57 +0200" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="14" TOTAL_2="15" WEIGHT="0.0" Z="0.0">
<NAME>N2O request comparing hypnosis with a control group</NAME>
<GROUP_LABEL_1>Hypnosis</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours hypnosis</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.5408607681515925" CI_START="0.02831025462569096" EFFECT_SIZE="0.12374128681817717" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="13" LOG_CI_END="-0.266914519377317" LOG_CI_START="-1.5480562245227374" LOG_EFFECT_SIZE="-0.9074853719500272" ORDER="210" O_E="-3.6896551724137936" SE="0.7525489793561388" STUDY_ID="STD-Marc-2007" TOTAL_1="14" TOTAL_2="15" VAR="1.765755053507729" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="OR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="3" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-008.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="PETO" MODIFIED="2008-07-17 00:35:58 +0200" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="53" TOTAL_2="45" WEIGHT="0.0" Z="0.0">
<NAME>Pain with aspiration comparing music with methoxyflurane</NAME>
<GROUP_LABEL_1>Music</GROUP_LABEL_1>
<GROUP_LABEL_2>Methoxyflurane</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours music</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours methoxyflurane</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.6297295310006987" CI_START="0.04323284626137343" EFFECT_SIZE="0.165" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="12" LOG_CI_END="-0.20084594009490742" LOG_CI_START="-1.36418617147728" LOG_EFFECT_SIZE="-0.7825160557860937" MODIFIED="2008-07-17 00:34:02 +0200" MODIFIED_BY="[Empty name]" ORDER="213" O_E="0.0" SE="0.683351810541025" STUDY_ID="STD-Shapiro-1975" TOTAL_1="53" TOTAL_2="45" VAR="0.4669696969696969" WEIGHT="0.0"/>
</DICH_OUTCOME>
<OTHER_OUTCOME COLS="4" ID="CMP-008.04" MODIFIED="2008-07-17 00:35:58 +0200" MODIFIED_BY="[Empty name]" NO="4" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Pain (mean) with aspiration comparing ralxation versus pleasant imagery versus analgesic imagery versus contro</NAME>
<TR>
<TH>
<P>relaxation</P>
</TH>
<TH>
<P>pleasant imagery</P>
</TH>
<TH>
<P>analgesic imagery</P>
</TH>
<TH>
<P>control</P>
</TH>
</TR>
<OTHER_DATA ORDER="217" STUDY_ID="STD-Wells-1989">
<TR>
<TD>
<P>6.77</P>
</TD>
<TD>
<P>5.45</P>
</TD>
<TD>
<P>7.36</P>
</TD>
<TD>
<P>5.76</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2008-10-20 02:04:51 +0200" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2008-10-20 02:02:52 +0200" MODIFIED_BY="[Empty name]" NO="1" REF_ID="CMP-001.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Local anesthetics, outcome: 2.1 Pain with paracervical block or dilation comparing local anesthetics with bacteriostatic normal saline.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA6cAAADgCAMAAADId+ALAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2008-10-20 02:02:53 +0200" MODIFIED_BY="[Empty name]" NO="2" REF_ID="CMP-001.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Local anesthetics, outcome: 2.2 Pain with aspiration comparing local anesthetics with bacteriostatic normal saline.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA8UAAADgCAMAAAAdZTRGAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2008-10-20 02:02:55 +0200" MODIFIED_BY="[Empty name]" NO="3" REF_ID="CMP-001.03" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Local anesthetics, outcome: 2.3 Pain postpoperatively comparing local anesthetics with bacteriostatic normal saline.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA5gAAADgCAMAAABRjzm+AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2008-10-20 02:02:55 +0200" MODIFIED_BY="[Empty name]" NO="4" REF_ID="CMP-001.04" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Local anesthetics, outcome: 2.4 Pain with dilation comparing 2% buffered lidocaine with 2% plain lidocaine.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAxsAAABgCAMAAABCDZ9kAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2008-10-20 02:02:50 +0200" MODIFIED_BY="[Empty name]" NO="5" REF_ID="CMP-001.05" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Local anesthetics, outcome: 2.5 Pain with aspiration comparing 1% buffered lidocaine with 1% plain lidocaine 20ml each.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAxsAAABgCAMAAABCDZ9kAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-06" MODIFIED="2008-10-20 02:03:16 +0200" MODIFIED_BY="[Empty name]" NO="6" REF_ID="CMP-001.06" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Local anesthetics, outcome: 2.6 Pain at end of procedure comparing buffered lidocaine with plain lidocaine.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAxsAAACwCAMAAABQM4NLAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-07" MODIFIED="2008-10-20 02:03:33 +0200" MODIFIED_BY="[Empty name]" NO="7" REF_ID="CMP-001.07" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Local anesthetics, outcome: 2.7 Pain with aspiration comparing 0.5% lidocaine with 1% lidocaine 20ml each.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAvMAAABgCAMAAACntg0hAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-08" MODIFIED="2008-10-20 02:03:46 +0200" MODIFIED_BY="[Empty name]" NO="8" REF_ID="CMP-001.08" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Local anesthetics, outcome: 2.8 Pain with aspiration comparing 1% lidocaine with 0.25% bupivacaine 20ml each.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAxsAAABgCAMAAABCDZ9kAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-09" MODIFIED="2008-10-20 02:03:46 +0200" MODIFIED_BY="[Empty name]" NO="9" REF_ID="CMP-002.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.1 Pain with dilation comparing a deep paracervical block with a regular injection technique.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAwAAAACQCAMAAACI0fxiAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-10" MODIFIED="2008-10-20 02:03:44 +0200" MODIFIED_BY="[Empty name]" NO="10" REF_ID="CMP-002.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.2 Pain with aspiration comparing a deep paracervical block with a regular injection technique.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAwAAAACQCAMAAACI0fxiAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAAOtUlEQVR42u1dy67kuA1V36kGEWCAIKsg/8RNkA/NRn+SD8kmGyJJ
J7fKsvV+2fKr6hzMXFfZkkhRJEWpqPYPUgDwufiCCAAYAADAAADg8/C4Jlv8/KMrz18F+HW13/vJ
5Kpx9GAQ1TbG9Py3LCGe+NC8DyNvz/rjqpb5LRvWxeevAjwXNN/7yXRVG0R1oIQWRdLqPrgQ648L
S2lStdmhTKIKpPX6OkB+CxltaBg61tPrHaiWWdLssxZL4CkhnssswvL/TuW9RvafBG7E+sXXAN8i
eIrCXBZR7UeGg5E0dLU+WwI6KwE9saetlLQOJBaKEazfYQbIhCBlH77S9TvTTjBV91UfOf95zCyc
6LUSO86Eb8X65Q2AvUtBc9euATjd/uLEeAeqKyQQzU4FYeV7xGcM3qVZv7wB6IwTGKZ1el7NtmwE
6eNNf16M6HZh5VnVYP0+a4BZcMz2wikHzkOcA3NpwtmLagdrDfbpF/WruWJUYP3yBsBmq+V1NRcV
7QLZJ8xrt9P0a7VlyOj5hm09XWUr1Qa2tEMqwQlnZRF8jsW4+6x9H9Z/3CkZbu/RY61utqEOfNgu
0P7bF9D/z8IPpEMDnwwkwwEwAACAAQAADAAAPgvuLtCSpx0nXGbgp+1v2UGsZ5FHVOMzA0F+Pqc5
6yE1hJ62NHX4fPm1Twftej+i5g8ecD09auKb3d83bMLlQFW6J9dfHlcm8a69y/rQ9MKQakhcazdv
k69LT6eP2jgFpnRI5/egfkHbBEqtdZTPvce43ZHrR6oPvKTE8+K4ODgJ5abq2QR6drPqvdxuJ9c+
1/V6FrnL53RJpqKxcR6sM+maXaQ207PUYnmoOVesLaUuTJXX0c2oCxxPUYecZ7gJ194agM3wuVM5
J81zdmEc5s+7WfVubrdboMkFFLLIa0khUwtTIkXRBzWQGkXP3LXyWKTEc90WTdJBqjy7bbJWnOoC
89GT9I24/vKdXEzUnFfIumGvhg6uOUeae6Q9jcnEkFq150Wlk3maSQ2iVxSGzkYTrszZT6tJClpn
Wps0jQ9Qqhty/RVGpl20+ms0eQwuL5R6qFZWTDVSo+mtTmnUunufweidqfnthVkfnedxA64fqYm6
e90zLlRUqiWLXG/Vx86E9U309OQG53zW1crErPs2QPThB2BuyPVX1jdxfevJqeGfq+KcyrXqETc+
3L4lVvfIY+k57XHN5nTD8qMwr7Efk7H2dzr2ULP7cf3lTz4mZIsz4535SadqmBnL+6bcbG6nQFZ4
lSzygKrKpYjbFnKttJIaRS8hQF+0LVPMfG7Bv6GyqfLLv9zC7s8OqXHceVlwaa7bskG76Oaz6pFr
3yKluNyqxk/v3T24fjSpf18Qh6z6cVKC/u8MnAcAAAA4CX87m4EHZgDgTJytf0iHBj4aMAAABgAA
MAAA+ED4vwOItygRev7nPSen1HSRvVcyEje/cCVl0vNjoTYCueac+tJAT0oScWjM0qRysxF/yw1Z
HjgCMYNCxTamUROFLZBHOND+UERitKXMhZb7O+l/rB5SeJaqKo0Ecs1J8mOhJWrqjlgvI9TBn9ME
RVylOxK1MY0aiYIBhI6OZPYgMo2MLI5CMgKTPf0IJchJ9lmqqpTHmeomKF2sFsVB/c2qdgZ9u6jR
P1zZTE7P39Vfpw/6YgawiGhyE7NfWiIhUsfr/xqN3Vi+UL9NaaWJJg2TIPWSPkn/z3hZxwoDaFEg
aQgIBi4CaO04tgW5TikZwWotpveDzFck0hqNS32shCodl7MD/5/XXQQ3yXkasvlyhMdfPWRtVZcZ
rtajamM0x9ed/lsot/igWPClEnHHRWGl22cAT8lRy5RAF3AoY4nXlwMDKMYNZAMrqvJH/X0SOn3U
roQv38Mo13OUp+GDdhA2uGTpJFAtT1T0702C2aB50lpCLhb732YGIDNfzte0sMxTOmZypcLmvJQn
+DYOTaln7FIsX9ecFsEYlsVfApd25CP+cu1HJSwRe0MQE/nAeYAbo2KTQhsbOACnn93BG2Le2AK2
x1Qj8e/ozhW2g2AANwZteoxQKFwEAwAMAABgAAAAAwCA94ezCBayf+z2gqTSMV9/veT00bvLNqc+
brmewO8XbDw1kC3YSy+9ORMdn1i4o9oxA8r0J3keINnjuAtT0i+WwY9Q1sXEz0U3w+R0ob3SEuKW
6wn8fsHGUwPZ5nrppXcXo+MTlrvyeYDo+EPhPECux3EX5hMxCIHSY/VKihAzUqKcb2kNGO1JnB8x
G4ykzZSqRQZtG9YcQaej2OXnLCREJGYASjva2UspVZ8choZAh43R4EigX/9lm5XTcB4/NgR6pZNQ
q6z81KvhEZBQXT+KumuTZmohdgupHnqVWMZb6HSdB+haQ/U/whogLyiJR3vHUwHUXK4puh/mDdfT
iwQ132g/D9A8Ubq06mcKYABNikGZx62+c8R6YPcW9gyNKbu6aT4P0FyC8iUQ/OQXwWRPxTtuP5Mv
H6SeD1YdaVJKOVj/ZUyPdo9EEP+MmAGcwwGpJPQg9XzwqrWUwN6awN/IWzVXvpdey0O3scp5gKjG
pvMAhOMAPnAe4Ma413mAZDr06ecBkApxaws4tfq7L4KBqwPnAWAAwG3w85JcIQQCPhowAAAGAAAw
AACAAQAADAAAYAAAAAMAABgAAMAAAAAGAAAwAACAAQAADAAAYAAA0IefP2EAwAfjL3++Ejc4EAMc
jP+oixoAv/4uh5TtcWU2N7/v8FTiVVTz8/NSbHr0Xfb0c86WZZ6Z1QfSUxzRc/mw7MwSc6WYbTqq
7lDJFVHe0HifeKZ8PP75+0VDIK2n/11zCMTIzwKT9r9K++NkHiWqHq//9uIwdgi9b2UO6bl8WHbm
T7ql6bi6q//ZIsHQLJ9YqXO0/xt/+HXxEIiNd7cOX6lgcojnidet6bPmK+n/EcPs639Esy6P/ATA
zdRXMHwO/vffay+CJy+hp4nZ8SWe0Jj5qvJ1lH42Tt7bCkJ6nHy8pemNRQZUGbcG+HVtA/DElNPz
yTC4agpX0P/9Q6AKPV13x1kpvp/+f08B99kF4iCe0cz+gPP3kvd6BnArDJeizrskfQVv9Zu6jQHE
oYO+whL3Q9CwSZMu4g5SUOIK4/fz120MIG0R2hqGXbx9+xatWOkr6pFW1+YqswTW9T4ki3iDpIPp
XKvTxfGvSw3EVzrw10aCzpSpzTO9FPFWvO69S2mcPmAR3ELPytU8Tkmx2mypN04RneYoenQG/vTH
K6lHx78O3apG13S5bxgh1RbX+poj9cNdBd/pX4fWwwsCWxcJG/X/FPzjUuk3eD8AcKoR4/0AAAAD
AAAYAADAAAAAi2DgeGx4Yd6dq2IGAD4aj8guhFab2PNdu24d8xZCvxmJ7jiv5zWf/JfZzjfJECm2
MPciKCKvFwZTzhGYl7VHHV6amR+/brivEi9wI/7LeoGrG8BmUPw9Hn+KXs8p5BqfsSLfDp1mqNiC
eSIJ0hEr4j0ila4y3TNmOd0gt1yWm9d/0P9bGsDk56a3p09qvHx8+jWZXeHLAVqX/fwmS/nIJc6K
0fp6TmdGmtoTVW3BuPKwO9ML46letCFwpMCe5E1eNyofVLViANbPCYVuebKE4MHiKWnWKso4aOtH
k3NGdkIhJ8IqtUCZyMza0FKKMnNDhrNlhqGprab+3GkC+KRFcMYApE04rueMmaB43qfEF1o/Qita
WFimolCo2m64zClw85wc5W3mh48Igebloxsdt80/csBkdQkHSJ0txgYD3GANQPUBpw69kHih2BIC
VeY76dbItkrrgplkrd5lBnCdXaDCbqikQ2eyMVB2DpB+V0qS2Uykbr1vq7TOYd/ezdNnVn3kIuZp
/ia7n24+TpGtIm+j3fm27NZH0fB8yZF7LiwXGs4WKkm1s36F8EaOrm9jve3mp4SF4alH9zKN9M8o
Df5lVTdlvR5300z3bFUqhNCWx0cs8ztb6KUkb/sLlyy/h/T0b60stsixe8zSPetOhZBvHKP/R07/
crBlXtv/H++pDtB/6lwDrI+8hkmDjmuB+pt9SyNY641PEIf0b8kNMQAASGnX4bPAIJowAGCLFxeT
nHWXuQoGAAzVqNsHgjgPAIyYPG5L09kGTWbvezlgPUvuMMEs3BB3k+NUNr9fgow1L++/ksIfHC4I
jhoIcvVzQ6fW/A5Aa9V4w+8ANKBnj7ZVxUZVKWXElPLwJbB4N++/msIfZbG6eauT8cACMjENral0
bARFY3qWCoFEZLmISY6T+bbMR06mpyp4Yur6bX0/cR/O7UrWvKhgdjRiUoTmA9lFsOcraTmPIpRw
r76/piiw8E4WuOcH3Iz6bCzkNSReKCa0aUJc0jtgCDCAzmnGT/Ih77BiqxJSyh1Tg4/2YymbDgJF
BsYZgHHF7U5V8nGI1IOUFuWV5LGTZDYeAGw0AKovinMOPcr8p/Z1i5TCf6kwgz2dgVjxEtXii46V
/2rjuPlRb22NuKjTfvRv2yg/BgoVVooePvynV9xzBIVZoUW/of/DoIe3xtr+v9zYi2AP7a+UUr/y
Pc1lUWjy0kDdb85nClJFvUq2YbLbSfLKLw3/YRFvN0kSzWXzN00RCfsR9AqbQS0OledXgc7vsZy/
2DtTOVvclgxfyDfpHw8g6H5jVraOR76N9iPhRCn+QuFDrxB5H8ldDpO7PA7q5JMqyftA4ceiyw8Z
Tl8wX7QFFKzjz9NXe8e8Ud3ccPwt677JpZWg843DV+B67r6B9m1zgUbsYGICyIfty9v0nq9w1RlV
ct6RWNA2ToX8egtBP3xKvpRZN9K+bzIcXaKJt14DFMMVzQktTtbSucB8E0EurbnbaSMbFChGJEUr
SWqxXrtd1EdQ97eRoo1sUKAcC6kgIOGUp+V4EuCUB6++E6yVoHMnmng4PXukaWMGAAoxxxJfm/jD
uWUjEnPTFlFmz0VnYhjOOPBWgvFzW8xto4U2XpAB7BY/3YEUZgDg9jHalgYwAwAfDSyCARgAAMAA
AAAGAAAwAACAAQAADAAAYAAA8L74PxrBBohCkxYhAAAAAElFTkSuQmCC
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-11" MODIFIED="2008-10-20 02:04:03 +0200" MODIFIED_BY="[Empty name]" NO="11" REF_ID="CMP-002.03" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Local anesthesia technique, outcome: 2.3 Pain with PCB placement comparing 4 site (3-5-7-9 o'clock) with 2 site (4-8 o'clock) PCB.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArwAAACwCAMAAADaOU0jAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-12" MODIFIED="2008-10-20 02:04:03 +0200" MODIFIED_BY="[Empty name]" NO="12" REF_ID="CMP-002.04" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.3 Pain with aspiration comparing 4 site (3-5-7-9 o'clock) with 2 site (4-8 o'clock) PCB of 1% chloroprocaine.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtoAAACwCAMAAAAGwDkUAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-13" MODIFIED="2008-10-20 02:04:51 +0200" MODIFIED_BY="[Empty name]" NO="13" REF_ID="CMP-002.05" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 2 Local anesthesia technique, outcome: 2.5 Pain postoperatively comparing 4 site (3-5-7-9 o'clock) with 2 site (4-8 o'clock) PCB.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArgAAACwCAMAAADT0u1ZAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-14" MODIFIED="2008-10-20 02:04:51 +0200" MODIFIED_BY="[Empty name]" NO="14" REF_ID="CMP-002.06" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.4 Pain with dilation comparing 3-5 minute wait with no wait after PCB of 12ml 1% buffered lidocaine.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtEAAABgCAMAAADsHt7MAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-15" MODIFIED="2008-10-20 02:04:50 +0200" MODIFIED_BY="[Empty name]" NO="15" REF_ID="CMP-002.07" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.5 Pain with aspiration comparing 3-5 minute wait with no wait after PCB of 12ml 1% buffered lidocaine.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsoAAABgCAMAAAAzUKTTAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-16" MODIFIED="2008-10-20 02:04:49 +0200" MODIFIED_BY="[Empty name]" NO="16" REF_ID="CMP-002.08" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.6 Pain postpoperatively comparing 3-5 minute wait with no wait after PCB of 12ml 1% buffered lidocaine.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtEAAABgCAMAAADsHt7MAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-17" MODIFIED="2008-10-20 02:04:46 +0200" MODIFIED_BY="[Empty name]" NO="17" REF_ID="CMP-002.09" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.7 Pain with injection comparing fast injection with slow injection of buffered lidocaine.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAu0AAABgCAMAAACe0bx6AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-18" MODIFIED="2008-10-20 02:04:46 +0200" MODIFIED_BY="[Empty name]" NO="18" REF_ID="CMP-002.10" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.8 Pain with dilation comparing intrauterine lidocaine with placebo.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAvwAAACwCAMAAABEg0qDAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-19" MODIFIED="2008-10-20 02:04:46 +0200" MODIFIED_BY="[Empty name]" NO="19" REF_ID="CMP-002.11" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.9 Pain with aspiration comparing intrauterine lidocaine with placebo.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAvkAAACwCAMAAACiqoHHAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-20" MODIFIED="2008-10-20 02:04:46 +0200" MODIFIED_BY="[Empty name]" NO="20" REF_ID="CMP-002.12" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.10 Pain 30 min postoperatively comparing intrauterine lidocaine with placebo.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAvkAAACwCAMAAACiqoHHAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-21" MODIFIED="2008-10-20 02:04:45 +0200" MODIFIED_BY="[Empty name]" NO="21" REF_ID="CMP-002.13" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.11 Pain with dilation comparing 2% lignocaine gel 10ml with KY jelly 10ml.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsoAAABgCAMAAAAzUKTTAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-22" MODIFIED="2008-10-20 02:04:45 +0200" MODIFIED_BY="[Empty name]" NO="22" REF_ID="CMP-002.14" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.12 Pain with aspiration comparing 2% lignocaine gel 10ml with KY jelly 10ml.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtEAAABgCAMAAADsHt7MAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAAHdElEQVR42u1d2bKjOAx1p9Lln9PbfOi86OeoeZkkGG94BWMMnFNd
l4AXyeYgS45I/5ECAG6EF6YAAKMBAIwGgC54j6UOCbYOZZV31Ui0o88HNidsyrZ2++uTl7/RGmIR
+K2XqtvxtlxH7feQzxk3rLXn4SJixWXuOfivWM0OFtfAKGqPyWg1KfqfNpjOYV1sTCjtZaF3T7w+
Pbtd1TGTtmreUDQ5SFWiX31dx/4bmpZDb8lV1B7Wj/4NXixT8zmzD8zzHHnFppm5sH2dVXbHdjf2
9emPzxkKrfr+yGVWPFCUsD4HpqXTbRlc7ZEjQw76Fswz0aKuBze7efPtiSyxG02058LoofCmyZnn
o9O9uIbab3FFaAPu2dTUhWqvMGa4G4ZbwaGItGDKVTg+Shxa7fdFCZ01zEeYAG5ICVGzq8M5JbgX
k8dX+zU0cYNXIw+2vk6ZirusNFmlu+9HdCjrru2qbjN1Rv3M9NhqD8doIlJ7m+T7bewc/J2jeTpV
Myeka7g91aBP1ooGhyLWUmzBrhLutBzsSF9E7T+jZirRtu0xYnHIZuiqz+tsFD8MwzJ662blMVuz
Pn+H+CYPuBajAeBukSEAgNEAGA0AYDQAjIq3G8DPKVGcCvNFoEW+Zg75DNy4eFcLXWApFlaxXuZ+
ge5XbvHciNys86IMOVv3OsWtET2up7Fto7+pUHMGTvl4uVvSV1K8rwWznQpD4whUCWh2wk71BJqU
NWYvk+qAbLbLafwODYB4ydo2ecCk3ucQfvKxk+O9VFWJLFZerJ3NHBl3PgM3OOPzgYgjtoGsZN0G
MvcJTBoxkz7Mq4upr3jIztrmXuZkUI0dP5r8BEo/w8pOeTUtbILMWZa0GC7/EaT8A5nPwPUUznU1
J+smTUuxzFYCVw+Wlz7s5HjT8jLNSpnTlseBNX65xmctkRPJwKsW7B1jBi5WVJeBy6I804WDNStl
7he4mkty0ySCExh7K2ymDx3MlKtp/PKcwTqfpr5F0fNPhXFmjfhMd2UyGwq0e6wLqhWZVMuPrSTu
+hrk4Bq/A2FAfeDQzjUTojIDdye/amVyW0KL5e08rprz86Lx8TV+RX1Eyu+uWC3I4Uf0/Y9SOlBt
rf3bPwUyWwhcom0qeriDCwm5Tg2xG9a35s7FNH65a4Nykaw0Y14tHxxqoRYU50zYmbBWhejMZTJw
Q4sZLc4tx1Y7PSDaLbOBwHAjt3Imx3uOuvy3ekP350DXelyNy3LvqoTGU5SRU+zOUp9GD9P4XcTn
Oqepw69HgNDQeJeNBgAAeCr+OVX6GzYaaI1TOYVsUuBeAKMBMBoAwGjg5vjvv0EUsfejJ+kcZg8/
eDgeRtAUCDWc0gK9dPEkw6W6/PdhWoc3umGNwCkZJvmDMLUnXZCTal2YTJtJPDjef8ci1e8EfScn
dOhAaEuQTJSW6aWLp2hoPtkV11Unr6sygXGRoUFYtWWhVOvCZGkqJwFGr8xR9HZ1e/zjVlWGlJEl
vaXo5VRyxU4bOJJYFHJqBKXmBnAWi1WCxr9uGuNQjM54A50YPXl+xT695uLobV/xzrsgt6q/h9CO
1Ny8y9OYzWIMJpcwegqu9128DkuQjClif8roVa52wRO7rOtStBBY0FnPeb+l17F97W7uchRLLHI5
SjiRY86HfV8C5gIKWRj2roKGcI1QLBEUAtqnGD3y7HgmunwDJbzZIcuHvseNyPQxyQopsm6Iz8Fr
dEJP7Qgtpcwbzy3qjIP8EI/C378j2mh7/3Sa1zXl47mHDndmWhzokEil22/n1dZyh6MqosKCNRoI
TA8xJdU8xasLAPKjx/apNq6e51L81BcT8C34mJQ+tfmj9jqALj7XrmIhHr3uwkYDYDQAIDIEBg0z
b9HQbgkbDcDrAAAwGgDgRwNN/OhHjNLQGPvRD7rZN44M4XUA8KMBAIwGAESGALAHiAwfAvVDCjWB
4rQtrNycQ18rLzwkMPohhNYcqNhQkFsfnY2bFrLFkOBHP8hCH9+mo46x6rDRj8A2a9s507pOnoQf
DdQ/Bl3tdBt5YPQDPGi5qY3s/wC1ABgNh+Mwcp0CRIZAci/hcvLwDctT+LlpP1puY+bm/Wi5f0hg
NHAvwOsAwGgAAKMBAIwGADAa+IC+qKiu/zOVbL2aGvVa/BqZE6rW8At8w3JH8CEN+Ggtfj9r+v1l
0/nXTbf9xCls9L1t9WzcSH3WJ+aKMZBEqoh0W+GcrEt1K5Ewx+VaeL/T6/VLRcsEbPSdCc2GI/Zn
3xaaS6ZIlTonq1LTyu9smxa/D0xsqiT6hY1+nHFWqzZTgBMc9AuCaz07l7jCuajVgpaq4R6DXcBG
P8qPTq7RH4IUe6pUf6FeCwpRmarHDkbf3OtI0r5wQV93xOVRYLEWHLLO9dEhvI57k3q9ilPc+lHc
PlO8MmXNabEWTKkFgoseQNjoG/seZCiiVnfrku912LWd+n6R01YVJVyYKi180ta4RgrIvQNcD6FX
qw39wkYDtQ5Kp1YHEho2GrgZEBkCYDQAgNEAAEYDABgNgNEAAEYDABgNAD3wPww8KXw/nTB3AAAA
AElFTkSuQmCC
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-23" MODIFIED="2008-10-20 02:04:44 +0200" MODIFIED_BY="[Empty name]" NO="23" REF_ID="CMP-002.15" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.13 Pain postpoperatively comparing 2% lignocaine gel 10ml with KY jelly 10ml.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtEAAABgCAMAAADsHt7MAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-24" MODIFIED="2008-10-20 02:04:44 +0200" MODIFIED_BY="[Empty name]" NO="24" REF_ID="CMP-002.16" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.14 Satisfaction with pain control comparing lignocaine gel with KY jelly.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAsoAAABgCAMAAAAzUKTTAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-25" MODIFIED="2008-10-20 02:04:44 +0200" MODIFIED_BY="[Empty name]" NO="25" REF_ID="CMP-002.17" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.15 Satisfaction with the abortion experience comparing intrauterine lidocaine with placebo.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAvkAAACwCAMAAACiqoHHAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-26" MODIFIED="2008-10-20 02:04:43 +0200" MODIFIED_BY="[Empty name]" NO="26" REF_ID="CMP-002.18" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 1 Local anesthesia technique, outcome: 1.16 Satisfaction with the abortion experience comparing deep with regular PCB injection technique.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAApMAAABgCAMAAAB2UQlRAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAAHNklEQVR42u1d25KsKgx1d1nlz+Xt/Oh+yM9RtR9OjzduEYiiDdNr
PUw7LSQBl0nAOPNnGgCgKbwwBQA4CQDgJNAVxkbsoIF/fiw/2X5HvB4O9lt77PVWKeJME+IiWb4t
QSfPaI7sFHorxnFylnsweGz4fuFtGhaW7BPIUkvFheFivUUm7vJIoHZSWdSbH5nT1g1uhZP8HivZ
mZmHSzuDWHKJ76OlLa+Hupt2n9LVLUp6VbJo9RyO2HlYgc+JL6XtbW24PSw1bPCrMc+48oH3oW6x
xOEikRM81lkd9vktjGBvebY9HeotzQeWaM++WOfecT+CBotWtszgYjd9IVNq2OAmY7cwRieq2EPf
hXKxS1borRUFnI/3JfVc9f0U7MzgNtfdiSjMXEP8QUKqTtlp9d9E5febbcx8TuuVoXdg8NjOnfkz
0uXn0ZipTuISOEom2tNYrXjWL7J+1NjlGhE/SckuDO5jf3K9Uec8hpo2MUgEnGXC+kGPUrBLg5vk
pGUeb9uR+8xwhUniWA6LejX28rYHEFrK294BiXpp1RoP9eYJbtbgP6jBABoDni0C4CQAgJMAOAkA
4CQATgLAfXCf42yViX5JTGrzya9lvLJNFdbmeee4tBvJtmiFn5NKLE2OOClucZOtjWMa3MrNbQ+w
xt5fT7a6nKS1PI4UI/UK6q6B0/N51MmdB6okXCH1sBhx08rZGSRbjufOfb6aUTu9vdg6Cpdjr4tj
pyp7fXS/NbH2s/useGu61jmxcwOV1Dja7oPTw6vyO6ZWrqVeeInUXDOvynM4KHKn2CmTtmCu3GG2
bquXT1JYO0hBvcJeK8fs9PACIdlOHFfnldU47r0oUeUXd1gfi2XK+cqFF0pNFyNGikkslqNnnuN3
YevL994kFC4Oq3Wyv/d6ZKtOUq6OiEJNHMxSUYwiqi/8XO3HevGiJ8LSVK4VEI+xs2Fbxzhuq5IU
bY/CfDKqWaHiBFq8ty8LF6Vu0Y8yQ2K/2sZT7S4T5/WlJqHXBu0+bB1jjimZdMsMsqSn8F1CvkG4
LLW0GJHi14q8bPwJdGTrK8gmI2+SWuU7PcjzQHS0wKUCirNgTZVyqBuFRwLFDHY7Q/aI/MSA2A9B
d3CgeVtffs7kVNU5JXR+WsVSD7aOn31r4wbH+aSoJqjyO0z3nHrAOsKzUuVmnG3nzyAHNpE417W8
ZQe2ltVPqhTS4Uv9rZRY379g4DptvtPWsYiRKi7xM2/Pg5K/1VbUmQMA0An++5TiEX4SOMCnqIFa
NaA1gJMAOAkA4CRQD//+PbDGcY7NmtgaL7l1fjNL3it+3AaVGtu4yKh9xOnmChP22TKBZPP+tAKM
qNdMsT4zfN0qdAwXWmY6XH2Zha/ix32U1KjZWxUatF75jHCFCSaYN6ePLyA863b29E1m+GpOOrNj
/cI8O8cXusW7WHOPVL2fzGSKxKbPPjqlpDv1V1saxJU4udykzl1sOosf5flE3ZFNpSZIZ81HXGLi
/TuuRbIrnNzSsCmc4Cl5CW9l7LRcvqmUZnJSXNYtbUKmVUzPtwlHZqfPLtZPZhi+8onGmAgaTWQy
qnzyfRnPXMm1W8aETCvRYx6YLZ2Nmt2dqXeWT9o5KfCILc3bdILxxd1uHqdxFt5f/cT3pYlozVPS
nHPwpmKrosbS2WmahvYpOT7wx8ZHRUQzS2ruZ3jm5g1KVT6pTT6jhLGOVDOJfSYTJJL2C3996c3z
9wH1kw/mxafW/h9zmh+rOsazxYfzioe6/dI1DvDQ6qudDfQe1jgAAE4CANY4v2ShpF4PZdteb3BS
GPwkgNgNAOAkgHwSuC2f/MVjs0TE/mSnF+7XrXEQuwHkkwAATgJY4wBAHWCN093KW3xZwnt1fCqV
kXwP3hSLKdswmI5UhILAyb4o6bxLKn+ff4snes08uxDOijm5YWBkQcgnO2Zn8cU/4QmzdLuu6EgF
/GSnqLIOSITfuusMUdGEfPLrXahIvCuvVtykCLEbvrY1ReDkF7vJRhWBk19MSdOmIuyZd8Y4m5sJ
+5Pzy+HZWGllJLcYzZTn2aQy+0BFeBKcBFoDYjcATgIAOAmAkwBwBXiO0wPmvyHOqvbuf9gOeyb/
OhUF/7RdqztrG+f+OhY42QVYe9ntdWelNL6mu8JQELu78pdEi+Oi9Xj/xX7jX3brkt5N5jZ7B9rd
YCCRxP/tUKh7E0xa+fCTfVLS8X+eL9wjYhwVbRj/aTLsgTMOoXt/lmJrse7lN8GYtHz4yS4d5Eou
JoF67HtIsqGb2fGeHIXQWdoskevoDk7n5cNPdp1PJmMeOysbnokwsCoZpDq6tfLBye5jd5K4rhPj
qtJ1uk9IQOzulpZxPkaRGyKNb/qRtkmk67ovyIef7DGC07Alh1u0dL6y8dOJpEVBNZIuuLxS3cfB
PC3fAeqCgNaA2A2AkwAATgLgJACAkwA4CQDgJABOAgA4CQDgJNAm/geLpiQ//Mtm/AAAAABJRU5E
rkJggg==
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-27" MODIFIED="2008-10-20 02:04:40 +0200" MODIFIED_BY="[Empty name]" NO="27" REF_ID="CMP-003.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 3 Paracervical block with premedication, outcome: 3.1 Pain with aspiration comparing ibuprofen 600mg po with placebo in addition to PCB.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArMAAABgCAMAAAA5DAqBAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-28" MODIFIED="2008-10-20 02:04:39 +0200" MODIFIED_BY="[Empty name]" NO="28" REF_ID="CMP-003.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 3 Paracervical block with premedication, outcome: 3.2 Pain postpoperatively comparing ibuprofen 600mg po with placebo in addition to PCB.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAroAAABgCAMAAADFGSFLAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-29" MODIFIED="2008-10-20 02:04:39 +0200" MODIFIED_BY="[Empty name]" NO="29" REF_ID="CMP-003.03" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 3 Paracervical block with premedication, outcome: 3.3 Pain with aspiration comparing 1mg lorazepam po with placebo in addition to PCB.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAs8AAABgCAMAAADVeW+XAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-30" MODIFIED="2008-10-20 02:04:39 +0200" MODIFIED_BY="[Empty name]" NO="30" REF_ID="CMP-004.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Analgesia per os only, outcome: 4.1 Pain with aspiration comparing diclofenac sodium 50mg/misoprostol 200mcg po with misoprostol 200cmg po.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtMAAABgCAMAAADo6w7xAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-31" MODIFIED="2008-10-20 02:04:39 +0200" MODIFIED_BY="[Empty name]" NO="31" REF_ID="CMP-004.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Analgesia per os only, outcome: 4.2 Pain postoperatively comparing diclofenac sodium 50mg/misoprostol 200mcg po with misoprostol 200mcg po.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtMAAABgCAMAAADo6w7xAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-32" MODIFIED="2008-10-20 02:04:39 +0200" MODIFIED_BY="[Empty name]" NO="32" REF_ID="CMP-004.03" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 4 Analgesia per os only, outcome: 4.3 Acceptability of pain control comparing diclofenac sodium/misoprostol po with misoprostol po.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArAAAABgCAMAAADSO7GCAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-33" MODIFIED="2008-10-20 02:04:38 +0200" MODIFIED_BY="[Empty name]" NO="33" REF_ID="CMP-005.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 5 Conscious sedation, outcome: 5.1 Satisfaction comparing conscious sedation with placebo.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtwAAABgCAMAAAAZ4FV8AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-34" MODIFIED="2008-10-20 02:04:35 +0200" MODIFIED_BY="[Empty name]" NO="34" REF_ID="CMP-005.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 5 Conscious sedation, outcome: 5.2 Pain with aspiration comparing PCB and IV sedation with PCB.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAuMAAABgCAMAAACAGIzJAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-35" MODIFIED="2008-10-20 02:04:35 +0200" MODIFIED_BY="[Empty name]" NO="35" REF_ID="CMP-006.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.1 Postoperative pain comparing halothane and alfentanil.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAosAAABgCAMAAABCKMhNAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-36" MODIFIED="2008-10-20 02:04:35 +0200" MODIFIED_BY="[Empty name]" NO="36" REF_ID="CMP-006.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.2 Postoperative pain comparing thiopental and fentanyl with thiopental and halothane.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAoMAAABgCAMAAABR/4i5AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-37" MODIFIED="2008-10-20 02:04:35 +0200" MODIFIED_BY="[Empty name]" NO="37" REF_ID="CMP-006.03" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.3 Postoperative pain comparing thiopental and fentanyl with thiopental and enflurane.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAoAAAABgCAMAAAC6yDO6AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-38" MODIFIED="2008-10-20 02:04:35 +0200" MODIFIED_BY="[Empty name]" NO="38" REF_ID="CMP-006.04" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.4 Postoperative pain comparing trichlorethylen with total IV (methohexital) anesthesia.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAq8AAABgCAMAAAAEnmvnAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-39" MODIFIED="2008-10-20 02:04:35 +0200" MODIFIED_BY="[Empty name]" NO="39" REF_ID="CMP-006.05" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.5 Blood loss comparing inhalational anesthetics with opiates.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1MAAACwCAMAAADdXsQfAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-40" MODIFIED="2008-10-20 02:04:34 +0200" MODIFIED_BY="[Empty name]" NO="40" REF_ID="CMP-006.06" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.6 Anesthetic complications comparing halothane and alfentanil.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAosAAABgCAMAAABCKMhNAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-41" MODIFIED="2008-10-20 02:04:34 +0200" MODIFIED_BY="[Empty name]" NO="41" REF_ID="CMP-006.07" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.7 Side effects comparing enflurane with fentanyl.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAApQAAACwCAMAAACGsw4HAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-42" MODIFIED="2008-10-20 02:04:29 +0200" MODIFIED_BY="[Empty name]" NO="42" REF_ID="CMP-006.08" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.8 Side effects comparing trichloethylene with total IV anesthesia.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA1gAAAFACAMAAACWWy1FAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAAbiUlEQVR42u1d3crsuHL13tMgck4uBgLDOe9Ud7nPO5znyTMM5KIe
IW8ykAmBgVwENoIPJm1blqr0Z9nt3+612Puz2yVVyZKWqqS2W99MBwDA1viOKgAAEAsAQCwA+FQ8
LlIOGv6yO2d/lfUFnYe1pJCsaI/bMsVmGs3JO3JqsgXI32Um95Lbey/csSqvQix5s7ykutdbpL59
GnhVLvLsPXVEnFfT2yXiJbk/lVb3rMrHtSpwuOuhpmKPQo59/i+5kYvGDK66pwThGjfbjbPFZrSg
U8Wcv6dxpJR3NVBbj7GpvpC71d6bu66bVOXl5lg8Vc54664Kw4Xh0P/hsV6mBH70Evn8p/kGy2RL
zSjBGFXMGxBqMuUZuCwPUYLRAodOxK966lvz6j5VeeHFi4FiLfFW53r7ojgtmysZ4pirgj4G2SLM
UfPLabpAfeE2sfBJEeNVqvJxywqkVhGt00jjJCydgcUCNzzWF0jam1OaDK4azLphVd6TWNwq4nUa
Obi0qqC+9MFLCxGZ7CcO9NFrFjeuyguHglXHrYVqAVWLKlr0smuSjfKL7CXBolsZxlAxy3YHAo/e
pSovSiyOK0ZecOe5uafOx63Vm82WmtGCxjmWUCPMTKfjdFocZIGHqxRWQttv6F391n2q8tt7PISL
kR64Fh7vQSvwCrgWvuG1EQD4qMULAACxAAAAsQAAxAKA20GuCrr1/ehpg9pK9pRjPmUr4pdnlIxX
aKB88dbbWaefCs9GVd/zEg/TD0/jcBe9/PDu3zLcuBYfUVGGRz/a71u96bINuF7LDfnV8xSb21mg
v/gK0WSfZ6uXyKdjyoneHLetxUem2/gXVnh6C8m/ESjfihK37nvblNQ978jq1SWmrvGBraCmEznV
azhNo91cplfstOifS0adqOmuy794Sal7dE8afA7uV4tqjuUe+VDBHUWl829FhRwqiKKQidPXZmjR
OzDqNanSazjVvO5Jl5lMa+w06q+/QpQUIf8ANn36qyM3rMXv2qumtjn/4lI+x+xDyA3jw/P+KbbI
Ud0tDSeI9rSz7kUf186ZpyJTA+5BU1DsPrX4SMPAZV12YY6Fc6zkUWZaM9XMjmAb2snqn3uFKLzR
oJ7MVoWQi0PDqhJ92stZt63FR0qUpd5g57lram8pk6ntPeTVdvL6W18hmoamfETw6Q7qtrX4PZph
JYN4bUVS5CA18FNprY0W8JUzpdr6Uf9D7FRfEBNzBqKpitwZ6TiTWEcKn0W6m9Xidz1VEK+7iHdb
9GyCczk4OGTWZU8TzM+xsuai13BaJj7i3Z2t7czqzyfj2XS6ejkqHWUb4v391u1qse3p9kXmyz/X
h7em9JD5WhrU4pVr8dFEq0WE4E//dUnwCrWI97EAAACAOfzrNYrxgMcC3gvX6NF4bQQAQCwAuCGx
/Dc74jue6TuaC30dmS0KJcJiweOvBZtujSjOSF3mdPpSsrnWSt9R4qHA9yEWcby1R3fJZ2qYy7xq
eHSW1hot/ix89j0ht+XF2sIwVtxvjYduY55teLWTlH/D0+9rJSVc23dKvkUjrCcynXeyQ9ra9BJZ
fXOtFftquWdQpqdsxQ+2i5eDZl/K2nP3LeBOoaAaenUfYb1xFUdbUOrdiaJ9pzi9GO1/lZPJvOJN
MP3ql3uXtLq51rp9tSg8ACMzipeD5l7K0nW27e5bwB2IxenvWnMa4kQ/RODfaco+iEximyufV1zk
QvQjZPlfSZ957Hl2c63V+2qVDGb2aYh/4f2M3beACxArGb/zsgUTEz0Jp4kvKzrMJs8ZVuyWH57m
lwsYiaYXtZPSxAI8W/kWc6w9+rd6rYnK+04dw6vl+2qNb8m1GG/n1Ua7bwE381jJenULebiwXCZX
D5KLjf6E1iyrUdP1dftqdauqJVK+4e5bwLWJFW37lC4Qji9f1Xuc3p3IK2KxCWxWe7L1lBCVN5AN
L97I0LW0udbafbW4S22o17ZmXsriKLLccvct4KLY4ul2in5SMbNzL2+iPBXyiwETvMPb4SKv3Dw2
oJXsnMe+jPWiNeyrBVzZYwEAPNbs4gUAACAWAIBYAABiAQAAYgHAmfg7iAUAm+DrS3z48Tcl099j
2eJPcVgj5PpwMOxCmysL25y+ot/2f0w2lX0eRRZfvUHJKJ1UhLRSk+3wbclV8Kf9++8lYvXNm++3
Vsr14WhereDhisI2p6/pN4WaG2XigxUZtF6nIqRVmoxFh74Kvv3542//nSfW0HJmaDJ16CWZFjxl
sLRL+9LepTRN/tW03JQiplEqzLm1vgnozex03X9IW//59Fniy+lHoTfYcLhUa96sX7U5SVMLP+27
RHsHPRFx6JMXwtbPf/7ld+7qxBoclzzoSMxMHeAmIf7eXbMtZOzMbCirw8modq2R143tML+61hzr
r/9VXryYG1nt0KA+4DfvM5we4Gr7GZPtKqGsyeQoaTpngguU8RfFq4VPt9+yJU90WNnljHXawaKL
43f98Xsc/ul1KpvEgaVP4FU9EGyoMlupXREIAlfBo+KWHvHEyoSQLwlcnFwfrs6rcUlgaWGb0zfo
tyZbZe6DzV/QCp2VgibggqTLRiomCVxM5vo5DWvWJTc7manqD7WWqzJRp6YkTSv+1MoH1hFLhBsm
ehAAuGCEirjwXsTCoHim3zWbaAHOBR7CBQAQCwBALAAAsQAAALEAAMQCABALAAAQCwBALAAAsQAA
ALEAAMQCABALAAAQCwBALAAAsQAAALEAAMQCgHeCejXf7yIfNqP3Z+OvVHNIWvslXy1N0xLPKJhH
Nv/088JBSFPp54rQVJ4+kc4oftCYosoRVTenulQf1DG66P2J1Tcv8dR/orOhk5DvPPUG57n++fov
eXNBb4v9bu0v53OckaoaeaivBl6trEfgFsTKdXcuseLZW8Z/yTU30k4fptGb3f++u/Uc9p+6RI++
TiLJJOgm/ZOJSdrr7TqhXAz7Ujk5ByMVx7ehFJC73oWMnbMoNVaGjKzyuDBpFWwyCgHnzrGI5gdy
YuZpiHU9qW//8YxYjL7Dh6k3+tBm6KO+w+ps7oK6TiKJt82cM+H0coNyl1SVN8riP40i6qSNwCGW
GmXllOpNKk8LE1dBTSVwF2JNTdj353iWEnwYlSMuzn2IUjFXIx4p5iDj2HbNhNLFM/Gk68fLIrCS
waiAQrcXcTyLyt/EJEjuGbgfsZKhW68DkIjtzsEmtisdVYvkJ365gJGIppiPcmUQAixg3H9VsN4d
+PR23sY2t4o4rEE0Gm/nVcfBpVUF4NW7eKwwhBJt0qykl75mIpuCmNYsq1HTdb18To3OrZXE5Rrs
qze/yF4SALckVphZyTkWUdINKTu14FLPYnXoE+amcp0SJ+rYC0omumnBsFAmrTy3IKCzRAq4S234
hbtJY2VCxFFkWShMUgWYY90T327x89/V8ZtenfjBO7wT6BqN+bh/TfJr3/QQviYCPtVjAcDNPBYe
wgUAEAsAQCwAALEAAACxAOBa+AXEAoCN8PXlT3/7dyXR32PZ4n7R4ybvTq4Px2Kx0ZWFbU5f0T9s
am/kmU9ln0eZxRqZvFjl4brLgW9LLoN//PI/JY9ljTG21HuCXB8O5tVSoysL25y+pv95zagzkcqo
LFYnL1V5uB6zEDgdfyif9Yi9knEjoTj0kkwnO6VVze4ZttVvTXrWmDxPHXfdHj+mnYvm2/31yFL9
pMr1b6K5HoXmteGAkfEVB9vEq4kmIpGpE/njWqT5hg998uIrlOuf//j5R3GOJe7DyoMeOIz1Mwdz
amfdK8Oe+u1a9bYDLh0JKl4tewjX2G4M+Kewcfc++27Dru1yIdx8LRYyAteB5tXCp9uvQKM7Oawk
EjRFN+ZHq7wODGBXh+aVWhU0Ngk8bCWMseDVUv2FKutXA01VPbzVNfEoOqZHPLEyIfBI4g8n14eD
ebX0CymXYWlhm9M36A/UU6nch4SY6oJWj8j7PpTLhnrp0pPJXD+jlVcvt5udDFX1h1rLVZmJ/5o0
s0nTfuq64J2JJSIW4w/AJULaBaElcFFiYUw80/OaTbQA5wIP4QIAiAUAIBYAgFgAAIBYAABiAQCI
BQAAiAUAIBYAgFgAAIBYAABiAQCIBQAAiAUAIBYAgFgAAIBYAABiAcA7Qb2a7zeQD/vQ+zPqD7TH
BvNZpdMPBQchiXLESdXFpkL2iXRG8dPE4XSU60qo6+XC/XSMzvapHouYhz7U94LkrJsOm4Oz/bAi
LCRdapRKajIax9QNvFpyk8BneKzgpmSHyvadcVgm19+4iw5ddOGZMKRnkoJu+ByueinxJEwdhlRO
zsFIxZFdrYDc9S5k7JxFqZHyd19UHhcmrYKaSuCt51hE6YhLMhgb3ZoY7J1Hmw4ceTrv8PqeSuE0
pJxGcnLJaeIze6FSkih3SYm1z5FZpNsdPkobgUMsNerbjKK9jPK0MHEV1FQC702sqeFZ0Cl0Bu68
rIv6cAiYKB/9cBisOafFk5crkVRttGfnF6Jobd5BlAxGBRS6vYi7QkXkBck9A59CrGTAz80gVNfl
zvUWomVT9E0m85WOGrGflnBtroCRiEhWREWABYzPnGPND+6ZCfwY1zUvmm27SMatIu9KiBqNt/Mq
ePJ4z7NIAF59tscKA+/zrBa8UDQDozZ/QmuW1ajpul4+p0bn1kriMjHGiuIFAuCDiBVmVrkzMZFx
61wc5PIgdXGmX7FOGXVeDt04LVeXU54LWuNiKwXcpTb8wt2ksTIhimaSpcIkVYA51ifh28E//10d
v+nV76DhHQC6Rhd4XKlO+LVveghfEwGf6rEA4CM8Fh7CBQAQCwBALAAAsQAAALGAq+MXEAsAtufV
b6/l//q69/3r77Fscb/ocZN3J9eHY7HY6LrCDvvRm231hyQhT+fq1WSlJm6AcDrktZfd3vtVXt0e
j5g91hT72STXh4N5tdToysIaf9Ob6Q9J/JkJ5hKp1mjjthjyGgte3YBYY1sPDaoOvcTm+97hMLtn
yPmIjfWbJQa6bAPYa3+x/1vruFTET2vz/7ptL9gmFAytZsPhLA6djAO6bnt4ahKO2Uu3ivmn//2X
/3ttjrX29i7+rKAbIRNP5UL7MDU4YZJlLkaRFfrHm5gLH22dalf2Wj9+/uOzH5ZbtCpo7DhvNmYk
nDkjxjeXnVgsvQnTUtkFFl++1/74GXOsIyYst4vp2nPt5ThM0Y3ZO7TDj88m1vc4/HONZnPBiG0O
VPaclrxDINhwL7bk68wQBr79iP+4efnjiZVbxR1ObTTHcnJ9ODiGWmrUjtP83Qrbrt8lsSZbgSWp
4q01q+sBODMUNPpoYokpiQ9k1sr0Zic7C/SHOsxVYF06fjLxKXCrOZZ7IsCi/a49D3z/gPDNiHWm
R/pImJWeEy10i8ULAABALAAAsQAAxAIAAMQCABALAEAsAABALAAAsQAAxAIAAMQCABALAEAsAABA
LAAAsQAAxAIAAMQCABALAN6KWETkTyhcDH+7cFnmGjasz4mWIJufEmGxIHERmsqTlp26zOlUB5Va
qBdmUaGANyMWMY+dibrpzPeu8fNTkKpwafnF38zO5aeasJB0qVEqqclorNRCW2GY0eU+Aw/dGxra
nVwHYxoPjos8Xhk63XT0OjN5ppRTb83lp1FvN+XrJqXcxcrJ/Rq+VBzZ1QrIXe9CRudpWGqsVEpW
eVyYtApa6xl4w1BQerGkO7lRvu91oeexT06+w/rEuTxjSo7cnc7v9DInhhPlLimx9jkyi/TDw0dp
Q96J0OgLmOEVZ5SnhYmroKYSeFNiTS3ed/94UHW9Q17IDLwcHaPoR+Rhb2gmfxJJ1UZ7zpW0xUGU
DEYFFLq9iNOBp6sIGBOtjyNWMtLvvtkQbREUVTqqFslP/HIBIxFNMR/lyiAEhEDws+ZYxYnEfuza
po9xq8i7EqJG4+28cp/GALcmAK8+1GOple1+PiB6BrczZs6f0JplNWq6rkpa9lkrSVyuhadyykqL
AuATiBVmVlzpB1mZno2zH7Nd4uyczQtyJjjVmyjRynMLAjpLpIBLZZcaKxMijiLLQmGSKsAc6yPw
bYef/yaeDXiq4ob8R0SYwC1x8T2IXwqXXvym5sX8hK+JgLf0WADw8R4LD+ECAIgFACAWAIBYAACA
WAAAYgHAPvj6umrJ9PdYtrhf9Litu5Prw7FYbHR1YRt3sm/X75MMm90bYcI+PwkF/rLJ3LYd8o4q
LLb3vgWx+obMdycr5fpwMK+WGl1dWLu1/pDEEVGYUApsWgKpXqgwFj34BsQaWs4MbagOvSTTgqcM
lmb3DMfoH5li8yJbsRLYa+/lrXYZA35K1f56YqsWQ8HQZDYczuLQyf1gV28wjmH1Ri3xzqW4Ga/2
6UNfqdqLPyvoGjVpW+summlqcMLIZ9b04r1Zcthtm/tx6uPnWLODzhjV+4DfnNHExxg9v+9GJTBi
fga8GbHu2arrOGLblwXNPkWqlwBe69r4Hod/emXKVuafp6xI2YN4ZYzpzI76F5bAnlvr1/ULj8uW
LJ5YmRDymXg918n14eBAcKlRO872dytsu36XpEDEktQFgF56Sq0DL4aCRh9NLDEl8ZFTrHXpzU6W
FugPdZjLJGo4I07yglw3nGONX+5PB+CyayWIC+9FLAyK13HDZkv3DZyyeAEAAIgFACAWAIBYAACA
WAAAYgEAiAUAAIgFACAWAIBYAACAWAAAYgEAiAUAAIgFACAWAIBYAACAWAAAYgHAWxGLiPyJOKPx
JCRbaoRU9mAtn5gy2VeBaIsaom3sUiJ0Z9n7VReb7qNPRKVmokiXb9951VS6HwJ5apC/eUH8rC4e
KnM6e4Jf7mmU05K9tFHP3hIrrHNNDe90vxxnpKpGHtqXZotDS24SyBIr1/9VzT8/DP+eDBzTUmhQ
dtLwyf8VGcZEzsykbsqmJFI6MN7rm/RMCjr9X5RI3ZRIPBVLWk3E8m6FoiR15rbjuxqlrg5EKUP1
SuWTRak4X8dTTfF0Gz6j8zSyAUrDW1F5XJi0CmoqEQpmQ8HSNRqacahM7k/7P30Vj3VM6pNPwF3E
TpahSfgQSZQ9Z2rQmvpYipQHTVKnT6wMqdJTcj8cenAiI3nbcQEnVX4sYC/UFRYrd0mJtc/J1vEo
ok7aCBxiqdEXMMMrzihPC5NWblkloIg11VPfaSYyqLrjKBrQROQ0XCCZlzKhBxclSqPQJFNzYpWm
ns3cZU0Vy8OZ+4sUcFYZ5+rCZy6M6Mwzo32hYuYdRMlg0lhetxcVqrIkYEy0Fq4KhkGJuR6Ac31a
m02wqjWoKebgVHvD9Jy2KCFtERRVDGuR/MQvFzASEeWrMhEQAsGmxYuN+hLPJOBuv247RmWvDvF8
Eq9qOvLOlIc+Tk1LIq288tFAXJWxALxa5LHUevCisZvqAy+HuTqVJC1LY1xwhKNizt1Gt6w8y1aY
ac2yGjVdV7da9lkrSVwmxtjyvEAAlIkVZla5M90iMmz3aYZFJTU/8wlyVrKzgMkqxz2g3pFcDqei
Xn59MU2hr+hpZ7Y+vKBUrKgOEiVaeW5BIClTPDuMbYhq47ka5CiyLBQmX7lAHt82+/nv4waySw2Z
1cK0fVd0l1u9By6+B/GFK+5G353wa9/0EL4mgscCAHis2uIFAAAgFgCAWAAAYgEAAGIBAIgFAFvg
6+uqJdPfY9niftHjtu5Org/HYrHR1YVt3Mm+Xb9PMmx2b4QJ+/wkFPjLJnPbdsg7qrDY3vsWxOob
Mt+drJTrw8G8Wmp0dWHt1vpDEkdEYUIpsGkJpHqhwlj04BsQa2g5M7ShOvSSTAueMlia3TMco39k
is2LbMVKYK+9l7faZQz4KVX764mtWgwFQ5PZcDiLQyf3g129wTiG1Ru1xDuX4ma82qcPfaVqL/6s
oGvUpG2tu2imqcEJI59Z04v3Zslht23ux6mPn2PNDjpjVO8DfnNGEx9j9Py+G5XAiPkZ8GbEumer
ruOIbV8WNPsUqV4CeK1r43sc/umVKVuZf56yImUP4pUxpjM76l9YAnturV/XL1z2tadHPLEyIeQz
8Xquk+vDwYHgUqN2nO3vVth2/S5JgYglqQsAvfSUWgdeDAWNPppYYkriI6dY69KbnSwt0B/qMJdJ
1HBGnOQFuW44xxq/3J8OwGXXShAX3otYGBSv44bNlu4bOGXxAgAAEAsAQCwAALEAAACxAADEAgAQ
CwAAEAsAQCwAALEAAACxAADEAgAQCwAAEAsAQCwAALEAAACxAADEAoC7A5t7Azug7YcTzWla9zEt
U8FjAQBCQQAAsQAAcywA2HCO9aH3Hdj0QCcAdu1hry4ILM1w6uIFQkEAwBwLAEAsAACweAEAewCL
F8AusHKX8rKwcbcvlaGeo2WZYfEeYzWr1uRUgljALrwy8eagWaFt26pcJjPzFFiirhFmxmCiEnMs
YH+KreivK/1RE1+2tFoSwWMB+2LjSfxMFLfTkkHZqsEcC7ifR8t25C22U9/dKkJB4IP9335WQSzg
Tg7rNlZBLOBOvLJ3sYoviIEdp/tDDy59j/W8bhsDraBt9iuoltX7xeFdzWr+eywQCwAQCgIAiAUA
IBYAACAWAIBYwGeAeixIrg7p5ygtpVm3LAu1KaYW4x0eaQK2BB+W6TS18FjAmZ5rHNfJnfsP4cr4
gZyrmC6R1CCSh1Tk3YpPQ+HT2rL0RByuc1l1VBB4LOBoXrHvoep8/OivcJCFy/6zvEDMStylaSI7
S8uSz6RUFwsCjwUc4qpcEPb0AGnv4zhMY3nC9XCOs2p5s7IkKhdkgccC9p9jVQOlPuRaMv+hNgG9
XJanMyIuq15YbhAL2CUUrLKPeDFZ5wS8YVmiTLym3AgFgT24Nc2hUpdCCx1TLJNqqUVFc1nKmpsX
2eGxgB0DQhqX2EQAJS6JkMp35F5cCNGm08RZ6NCsFKg1l6WUSWbLFyQPPN0O3DDSvD5EKGhHRAns
JKxpWfYimB0zPFXaNe+t2ciknbWUux90UPBqT4hQsPaDGVu/yuxec1undVE2eOR3CzTvUczc4oVz
W8PBjs5lGPutP+3CJzf4T1k6G6V2bsP7JpdwvKS1+lOl0WprPVesLGhcIKXE+8agShYFfgvY32NJ
h+DciTVmcA/Gfy78hOkon961FqmVvAuvY08qhVZ9qsTuYHIFNbpAOpMunJZYc9ZPmQDvj++L4yiT
kxp1YqqKzIwlk08oU9iygvwPEZskAQAc7LG8S6l1QmM36qK2vgSSL4vJeBq7wBIWMIATiGXmFzM2
+0XSrKtaWhYf2C1LAN8FHB0K2rnxPFrttmUvYOPLttVp2XJZTNG75ZfTbb4ocFrAcR7LxV1T+OW3
T1HhWEg09PH+GD6V5J1KEmtNDJi4LDayL0sYWfIGk8LJosBpATth8ycvshHbcYtv055MYAxwKv4f
U5XaI/a50sEAAAAASUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-43" MODIFIED="2008-10-20 02:04:29 +0200" MODIFIED_BY="[Empty name]" NO="43" REF_ID="CMP-006.09" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.9 Recovery time comparing inhalation anesthetics with opiates.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA3IAAACwCAMAAAB9wazxAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-44" MODIFIED="2008-10-20 02:04:28 +0200" MODIFIED_BY="[Empty name]" NO="44" REF_ID="CMP-006.10" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.10 Postoperative pain comparing propofol with etomidate.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAooAAABgCAMAAACt6qNzAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-45" MODIFIED="2008-10-20 02:04:28 +0200" MODIFIED_BY="[Empty name]" NO="45" REF_ID="CMP-006.11" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.11 Postoperative pain comparing propofol with thiopental.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArgAAAFwCAMAAABkTfhZAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-46" MODIFIED="2008-10-20 02:04:28 +0200" MODIFIED_BY="[Empty name]" NO="46" REF_ID="CMP-006.12" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.12 Postoperative pain comparing propofol with methohexital.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAs8AAAFQCAMAAAB3dGOOAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-47" MODIFIED="2008-10-20 02:04:28 +0200" MODIFIED_BY="[Empty name]" NO="47" REF_ID="CMP-006.13" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.13 Postoperative pain comparing propofol and fentanyl with midazolam and fentanyl.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtsAAABgCAMAAAD7PE4FAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-48" MODIFIED="2008-10-20 02:04:28 +0200" MODIFIED_BY="[Empty name]" NO="48" REF_ID="CMP-006.14" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.14 Postoperative pain comparing propofol and alfentanil with ketamine and midazolam.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArgAAACwCAMAAADT0u1ZAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAANxklEQVR42u1dS47ENg519zSgKyQ5E3c55wCz4Jkyy8EsAkRAA0mX
rR/1s+RPleV6r4EuW5ZIWn6mKRXL+lATAIyHT3QBAOICAIgLAGV8XccUmv/zShW2Wz8bFOxQqelS
0x8kLlXKVDDlVDercAKRJpqk9ZHYTOs2tad0/uVt/7rSXfRgGHGtd3nDIXmUSpq7yltOgFIbqmeX
tuaXdf71bb8UccPTtv/ZeMzpsbXcyrZXgh0qeNKQt4kMI5zcpnHjsty7GGvW6kXJWTtLYSKOXFZ6
kX1rmvjpBB7F9kvGuDz30HLic28te2zYxs4hELPrHl55DIYyOBBOTpzcsnszjZ2qx//1a5+31h0l
8RFVWBSx5wwXnhIn8XYQ27+mi4PrBxv7Rbpj14yFArkVtGAK2hwQvDEFH8TyCftUno5r+6WI2/9o
IduRLfSmvmZ5VVXeBpFLOw+cROniX9X5g9h+tcFZN5m2iN/iNJvacP+JzJGQa0dLcPjKzh/E9svP
41Lj47/N5667g5xU6r9VEk2zCcGgxnzQq3g6uu1XJS7bbpnvYvadxGF/cQsVpUQzU0A9lnCoilbb
xpqk4V4ex6djSklMYDyXHsPY/nHtJJsL+iPgEsBXvsCQ+EBaIwCPCwAgLgCAuACICwCvR/jNmc18
knPwtJa+susLKSGplFHLTW2obMgW6b16VjJaTV9l+8gXmu9dbV07Y+oPHT4/OKjZIXHJJFVSx0mv
ZdB2gOtdm20h8r8Plt6vp5bRam3g1Q4lcvWYcoeOxphmf2Uuksum5ODnA0FOq0yG4SnIWrVVTbJF
kPkapryu3Am+rZFD9dTObLLuYdK79VSriVzfKfpxRsaThz/yOPfLmMHMFjEuxamtcbKPy7C06WzR
1582edY8f9KcTmpKfBPJuKXc0Ki2TLQ9Tnq3nnpGa2JGPp+K6NkJYqOZ/SkfCalicypZT5m0WM0w
qqUEElGsiaMOa3io03nSW/RUuUH5r/BzPWvyWl5B4THM/krDhL4L2NmiMQpN8pOoLb4v5oMeIn1F
z1pGq08AFIlWwpBwuLv8juj0BNcxzf5KidhJt1MM5JyelvE/nyh9TU9rRqu92fPPsKc72DHN/owi
3MQt1aYziKLaVB6bUtMY3muS1hyTH3eu9KnUlUnHsswPJr9FMg4hls+2k9kxktmfMnALcjGDxEsZ
23GuBfunCUvD0wrlKDSrJsoNzQeca4m2m6V36illtNbqyQ7lyELKdv0Jfncss9uyw7p0E5cavGt2
bUsUQgyzt8e4xeCma8T29HdZgLfvZzbycQEAeA/8fgEbvuBxgW5cgDRIawSGBIgLDAkxqxBMHyRv
QQ0Let42Gwq3s//TVJh2aJm/yCTb1t5hW5yCk/bwXrOA1xGXfOpk8LVZvLXxbbMiMfNQGmwT5u2J
skmB0Ygr3jqdcU+St61vm0354D1kmPG7fFtnXytHIqUjfE+uT/Rce4dt7FJDhRni95kFXCnGDb8W
jeKA+BcAjW+bzad2Gj2uvsi1cgQxUqL35FL0fCi+w9arLhg47TALuBRxHcm4/jim6Bj5VtzyBPdv
Y05Tk/zrqlLhomL8Dtuwcpw4mjUweQh0mAVceVYh/31e+uOH+itjqSSgHH02Da4qIzFKf3iy3qzP
LOBKswq5a0Wr63rUadHrong/b5snFjp0IEa4vMf1LnKOFbnwutSpOc9SVPvZyTbz94gLW/scH20j
O7kfP+wzC3gdcbtSJ/uSUwtbQS2e8gVSOJfCl8w7bCOFZctMsm6XWcCrcYnssCSDt5zSC7Mucr1A
XPsA5moBzAJxL0hcAMTdPTgDgCFnFQAAxAUAEBcAQNyb4BcQFxgQv/5VPPT9feszD3MV9ONf4/SY
VvHW8qkXCctHj8BVheuS9GS1dujUauo1tF1PUEV0z2NDBUdz3RWK1+6oFjp/+evvd71lRZKNEozs
JpbtYWU/HCcO4K1qME0114zM7jS0VU9QRccFKtjJdVcoXnsblRa8nT5A3MRR6OX2Nh++UE3mtp9L
tPFZSq945n1Qbdzuvx90d+t9evbIjo/+yPy7mCbynw0JQTw2ce3N7l2n37J7rppaelNNp/L2qGii
eD/0GLpHzxbeWtYnR//3258ffAsa7iSull2swg8lCisORJvD6nBaNkQKT7lRtus5ul/++O1PhApr
Ma5uvDKPi6NP4JBak/gs575Dz6Z+qTX449f/g7gNfd57VfUoKTzXMLRgRc0T/PddPW7PPK5ed7/6
tGt6SJVnmXKsh1dqi5f/+ro1cXMxbjYSU34qxmzaaqEnMGXHx7gNEk/TvVmP0lFALNr4o1KUGe3q
5wXtIwL5uJeLTfqmxF4B5OO+M3PHiFPGH5wBz5qaUCdNabzv4AwAQFwAAHEBEBcAQFwAAHEBAMQF
QFwAAHEBAMQFQFwAAHEBAMQFQFwAAHEBAMQFABAXAHEB4DUQP90h/9qeaHFRt9yMXMO88Lu5zhUe
qeFtQVReg71HlVg3Z489wIU8LvmVzuVHtAh6yNusUOYSZ44Db+JWeCJYJPImHjdwRukiqIk3m2vT
7HKXhvTYNStNzpvGOU+B057CWm57XifXt/O2eCHOrlDHFFV2H+FTIlSYuY8a7QEuHeOSWzqUa3GA
d13LWr9svNiDw+Qd2mMr9HDsy+0xEneDLxAiRcVQhyk3leeVhwOFBbOSu7HFHuDaxHUk43rUSBEB
yLfivJcO9jnaFtI5I1JUlDomuYKv0Fkwa5M9wFCzCqHD9aRgt3Lz6khIVluLPpsGV5WRWNxm31Me
vnagWYXcxaPS4J3bCNJGHt7P2+aJhQ32AAN4XO8i56hxfuImD+EeZ1qp5u8MF7b2+T/aRtSSSc32
ABci7kxRLl5qebFNZTO6p7K/LcvkePDnC6RILrxlzZT7GJcoUJg1a6M9wOXwwrc1EkduMil4b3uu
iyvcz698zShNyQzxS8fxV7MHxL0ocQEQ98DBGQAMOasAACAuAIC4AADiAiAucG98f1/QqDBXwa0u
3wCdLN+s/Yrqbqn1DoGrCtclmWXatq1z1rEMU7seV8X3hLYFKhQgOi89Ye36VGP5kpS49bV8G65m
vOi6mg5b36hpFVzVXLNgfiNa9fgqrie0lxEI0Ok5hjvaFyisF5UhrrzZH6vN+w9f6G574wIWd1Do
0aPWk1Nt3H4GNuqpLsmnk/PcczIHk/tfscB/P+FqbiGuvdm96/Rbdi9wAapiylPXQdyxFqru8WSb
9JhgIKvHhwRZwbrXzR7c6d+xwCt8c5Zbyzc6fyU6w+zpegR4wnq669Hds5a+PU2P8Q/NJ4xQoSXG
bbrrzfrU+oRrq9Ykql2MeYo/6zoD5bw0aNoY4xYHGr1XdZg+12fb6kdhmwaOIG+Mz74OXHO/+kRm
nTgkUUq1O9Ln6NHbjDvFuV1xwedcjJuNUE0QEGzaaqE3MGXHx7gNEk/TvVmP0rWAODkqCkpHgQXI
x31RbKI2BsJXCBqQj/vOzH1qszcenAEHz5Fsm7XAAxIeFwBxAQDEBQAQFwBxAQDEBQAQFwBxAQDE
BQAQFwBAXADEBQAQFwBAXADEBQAQFwBAXADEBYBhgB9LDgx9whvVjpJ5ht6wEjwugFABAEBcAECM
e9MY9+3O2LMV71W4x3V8k8EZQgUAMS4AgLgAgMEZcF9gcDY0kqXSssfa3qwr6lcbNAykel/mW1GZ
WQMOxB2dt/FSadljbStyhLVU69i+RVgbVF1bIhAx7n0o3M2JbQ61hZDHqSwdgce9Bw4dqujt7+89
XKVCjAuH3HEX7H9j/8kqESoAT3GpR6sEceFwh1QJ4oK3G2YNXq8SX0CMTUkfHRbmcc2K4ZPqkLU2
Cdswt9b7/K+ozM/jgrjAkECoAIC4AADiAgCIC4C4wMVBDxwpL9yg7YqouJMpzFUWZfjK9344cW1z
uW46P8lwhsd9M8/rvOTiGu2OL5kLzLGg2nLM7LGvTFlP2ahoCmok2sg3MUpl+WQtWAqJ4HFvy1v2
DjLcNrTwJX7PFi6bvorbYuIdioJ9jrRNHFkzReXzjq3/+AePe1NXa56vTFNKNq585B7NfIyiQqDB
QoPc4qg+I8a9f4xbHTf98KwjRKVDFFFUe8sI0sY3DOLeOlSospv4EFHNipbHPje2q+n6+UCocGfu
pmEppd6Oqg7WBpwHKErlU9PkReRsESrcPGCg+TEdPq+DouAJ/iiVhUuJrxKK2qFoJrfdn7eYOs9m
+Xj8ITsMIUWTv7saglBBL4gqaHuwJqUvD1gvDX5E6i05yzpSqVc15c4HjB0b0uNmMoT9T/NrXOp7
+YMVue3nHXqSedMVKcXzecWPWYCTPG7oet2HXpzj7Lu025z8nnFetsmko9rG7TnfaiouRVKq2xQS
tdT2A6VDQ2ODhBDn272o0BT43WHxlXdTxh1qpWbXpNx+4e0oy3H7M5Ggtjg++V+SWJGBVLkpDpsP
lTNUSYNkI2mcPKIVHO+9PK6HqpapTKHKN1MrQsuysjV0WUD+JUIqqQDczuM6l1i7yEofRAFdH+Ll
bVG54LVDEwZotySud1qVJ+lRz1nV5N9V0/hQ91WA771fqKDX/FE0G6XLXkzHxbrV6eqyLaronfPT
XTpvCpzunTyueS7bx7N79aR4XPtKM4eUDvdKxydRJZaaKFCxLTrSH1oYaXIKE+NCU+B0h8Xh35xl
n+jPG7xjmvZN8A9MmeqjdJXNdwAAAABJRU5ErkJggg==
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-49" MODIFIED="2008-10-20 02:04:27 +0200" MODIFIED_BY="[Empty name]" NO="49" REF_ID="CMP-006.15" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.15 Postoperative pain comparing propofol and ketamine with propofol and fentanyl.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA0QAAACgCAMAAAAb+lwVAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-50" MODIFIED="2008-10-20 02:04:27 +0200" MODIFIED_BY="[Empty name]" NO="50" REF_ID="CMP-006.16" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.16 Postoperative pain comparing thiopental and fentanyl with ketamine and diazepam.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAuEAAABgCAMAAACE7Vz0AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-51" MODIFIED="2008-10-20 02:04:22 +0200" MODIFIED_BY="[Empty name]" NO="51" REF_ID="CMP-006.17" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.17 Postoperative pain comparing propofol and alfentanil with propofol.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtMAAABgCAMAAADo6w7xAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-52" MODIFIED="2008-10-20 02:04:22 +0200" MODIFIED_BY="[Empty name]" NO="52" REF_ID="CMP-006.18" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.18 Postoperative pain comparing placebo with alfentanil and fentanyl.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAngAAACwCAMAAACrbeP4AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-53" MODIFIED="2008-10-20 02:04:21 +0200" MODIFIED_BY="[Empty name]" NO="53" REF_ID="CMP-006.19" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.19 Postoperative pain comparing alfentanil with fentanyl when added to propofol.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArAAAACgCAMAAADD0682AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-54" MODIFIED="2008-10-20 02:04:21 +0200" MODIFIED_BY="[Empty name]" NO="54" REF_ID="CMP-006.20" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.20 Postoperative pain comparing alfentanil with fentanyl when added to thiopental.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAn4AAABgCAMAAAC0TY+QAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-55" MODIFIED="2008-10-20 02:04:18 +0200" MODIFIED_BY="[Empty name]" NO="55" REF_ID="CMP-006.21" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.21 Side effects comparing propofol with other sedative hypnotic agents.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA5sAAAfgCAMAAAB/H7wzAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-56" MODIFIED="2008-10-20 02:04:18 +0200" MODIFIED_BY="[Empty name]" NO="56" REF_ID="CMP-006.22" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.24 Side effects comparing propofol and placebo with propofol and either alfentanil or fentanyl.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArUAAALwCAMAAAC+632sAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-57" MODIFIED="2008-10-20 02:04:18 +0200" MODIFIED_BY="[Empty name]" NO="57" REF_ID="CMP-006.23" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.23 Time to discharge.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA4YAAAGACAMAAADGa4wLAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-58" MODIFIED="2008-10-20 02:04:18 +0200" MODIFIED_BY="[Empty name]" NO="58" REF_ID="CMP-006.24" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.24 Pain with dilation comparing conscious sedation and PCB with general anesthesia.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAx8AAABgCAMAAABL5j8eAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-59" MODIFIED="2008-10-20 02:04:17 +0200" MODIFIED_BY="[Empty name]" NO="59" REF_ID="CMP-006.25" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.25 Pain with aspiration comparing conscious sedation and PCB with general anesthesia.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA0gAAABgCAMAAAAQLqIvAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAAIcElEQVR42u1dSa7bOBDVNwwQSG96mdypdn3RXtQR+iz9+wYBgQDp
b5kSpyJFyhoo+j0gsUVxeCWxBk7+H2oAAOBV3PAIAACKBABQJADoBfdmmNDXP15TjDPpNH7nuXp7
vZ4BLWcilnMtFQ3pEacImpq8CoXStOaR7v6aexTx1s4D5qmfbwp+VjtXz8lmtmNAaTKFdMV6lglG
pbk1PepWxHs7euR7Dh5TjIGydspPsNYoLMaJ6lcycP9PtGh5kbGzsQQUVpJ1z2Qs7uCYZiZrhOeP
sEJburjBkyKQfkS8Nfd4jcUZH6a5snbKTxh7sXHxQTHalsFo+Mi1hlGL9mNSSFkCLvB7Tj2CjTbi
2Y8gw7MJtp1zF1e/yYvuR8T70Ch4fmLetU0wyVPUTH62pCZljRe59zimRMJFYCktPfnGNm98Epv8
Np/Ctag33YvY9qzdIyYiMYGocBhP5N/KOgQTPvrGj+RGghaJJL7CjfzgeKJLtOYZMZdOh5zpi7oU
8d64WXqERSwkcOl0GK9SX/Eqp0cDy3yjGws9gOtpe20+Bhht61GnIt4a0hjRmrPnGOKEsokzufpk
4Jb0SXlLO5A86Z26sVSdJIMdfZsPalxv3kTEj2b22gnTW1wwa+c+drbFeFpHCqf1MrYww8BZlUq1
KPCKbkwJaQYcUGF/ZWWaV2RHSn/Oa55pie+3MsnQpYgf2LQKAL1PNgAAFAkAoEgAAECRAACKBABQ
JAB4R7g7G6YVDn9pPrcY5q+JbLpsllvxIX6lKiokfDiDhaM6/jJWeMtfL5vzDmyrcZfEjkff0rmK
9Nz1TxUbp6cS+1Dj/CupqYi8jT7tMvAeJ8mElg+DPKvgqbPFt05C19LdhVc+H/LgwZ7uoeCcqbvJ
mZy1/3ld3z/Iw3Mq15kxnheybRXeGZY6m1hd+gwG2WzSrglO2/DZZBccyTrONfUnnTdGmjYqsyeW
LwF7xxKD3VL+aSCOj5rQuv3v3hmh1BmWskqepbm29JEM8kd1Ik7y6SuiRs9SdCrdzfesMT8jsehJ
ohKLG3trbMbXw6KwaQ4e9Oogo+hFnM9A7j8cbuOU3o3ZANqwSnUl3T0O6ypj/+GQMVK0T5heGleW
naE9nIHdspknxP4OaY+VOwE0zhwRN6JIXUt3jxWjehh90EA1bni1Cq/RgCMYlB7VmcyXHCW06oC6
lu4WjJAiC5ybVfQOj7o2hFITXTSsUNTEuVU+6vWfwSB7IsoZW9hTWc7JYSduJPajhza6YYfS3fyw
ncx5eJ5sgm9yg/DVKcHWKbMvX5yhYowktmsI1nZky6VmjHQCgzAbL+bzXwkHdEl8eef5pS6lKzuP
VEWROFXgumc5TzfhvE0eSHfMGCkZs1bNQDT6Q2rQI0h3tkcCAAAALoq/rkP1Do8EtIvr9E4cowAA
KBIAQJEA4Lr4AUUCgGr8+hUk/PzuXbrrSDo9vtMqkaSfBfyPneG1vKa8KanVJkTWM8iIoN1X8WjH
JuivD1tSqsqmmUQ3kx4wv7QFfusfnwlFqupe2r5iFXzsrUduyyu7/9w1XyeynkFOBOXUr4MEt6RU
1XyhpPaUhhJsgY/fP7//l1CkhMXUg+MCtBrfkZbexyGmzrS8vi3l1fMykfUMav2dTVDZqlQ6+3t4
oz32rv4d1vrPl09y9lvcly2mHiMJa8jVuS9EtVKP2ttgBApb7X/jyPFNwjo+otY/f3/75IRHmkx9
9LRd26vkAEe/OGw4dohyen96cFevDCmt8NJjmCI7rVyJjXEENhkj/fHvkBkjzQP5eBAgBTJffWHs
Dnq4UujdSH8qG+atpqoiiaFEG+Kbp0dRaKfcobhaDmWUf+8SDqkRHSr2OJLKFTgkYFd8+pe3dHzt
fOqUUwpc10UCuwvokWOqlIptWIke6ZYkvjzuCweO7oPgkmzANqghuIoHTzba1wctJD07x9q2lD47
yDHcC4gkNM5UME4DuVVNGhSk+W8J2AM4j9RTWFjk6S4U913osCK2CF1Qk04sDZSGdkDrUKtuVeUB
4JEAAIoEABcFJhvee7il9s1/cHMH03MLwCMBAEI7AIAiAQDGSEAXYyQ8gpdgtQfrSOgJ7Y7mm59s
QGgHABgjAQAUCQA6BCYbAGADYLLhzaELjzdHv6S3tpn46PVmo/8Xz1sVMpN/VhGK9OZ6ZA+x67J8
q35Q0C2kqnr2ykZWQZWTitrCGAmos/7qmGbq/dExzFK54JGATbrhDvHX0cP3ImYKYyTgaOeV6on7
HXY/jxlCO6BLx3c0MygScKjZ75UZFAk4tLfqTplhQfbd1cKODQrWkcwfVKgPg2wzNYs9dZrx4l8p
KWUmryNBkQAAoR0AQJEAAIoEAAAUCQA2BXY2vDXGv4u69y/Vp34K/5luKdDzM+a0D8vlX+j/ylH8
M/5QpPcGt0Hh0V+nf3NCUywR2gEl1pnoafjJfJ8vbMoz35z7ccu5Gpw8YnJUSnIQTBuxpATNIGda
mKlWIR0eCchEOZMPcL/b8MaEYexee1dzGGSvp2S/3jkv1XrIGpZSgwG1BC37wYl0KBIgDZJ46r5f
HSfuJRx0cJY6PYvX0wV5aRykj50+GhLxiywppZscsktpMOfToUiA0C2yERVTzlOEd9mdM4imDEqc
EG/EklJXtJQrVVfmSUCRABPbZLUtM3sV3jXXXNeGO1LaiCUn1NOrJ6iU83WlnwQmGwAbTxFLtpqy
foWCb5Hlp2UXMUdjS7PNtSwpS1UmQgl1pawawyMBYyeeRxUmfHGSbEDzSAwDHCd/cO1X47YRXhVE
kJUsKUEzajui5Uo4q2yQLgC7v4Feg9VDAY8EdBmlHt0oPBIAbABMNgAAFAkAoEgAAEUCAACKBABQ
JACAIgEAFAkAAAn/A5KNCVqr4dMIAAAAAElFTkSuQmCC
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-60" MODIFIED="2008-10-20 02:04:17 +0200" MODIFIED_BY="[Empty name]" NO="60" REF_ID="CMP-006.26" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.26 Postoperative pain comparing conscious sedation and PCB with general anesthesia.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA10AAABgCAMAAADRqeiDAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-61" MODIFIED="2008-10-20 02:04:16 +0200" MODIFIED_BY="[Empty name]" NO="61" REF_ID="CMP-006.27" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.27 Apnea incidence comparing conscious sedation and PCB with genereal anesthesia.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA0wAAABgCAMAAAAZxQJVAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-62" MODIFIED="2008-10-20 02:04:16 +0200" MODIFIED_BY="[Empty name]" NO="62" REF_ID="CMP-006.28" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 6 General anesthesia, outcome: 6.28 Duration of sleep comparing conscious sedation and PCB with general anesthesia.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA9gAAABgCAMAAADRhSrGAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-63" MODIFIED="2008-10-20 02:04:16 +0200" MODIFIED_BY="[Empty name]" NO="63" REF_ID="CMP-007.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 General anesthesia with premedication, outcome: 7.1 Postoperative pain comparing paracetamol supp with placebo.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAuMAAADgCAMAAACeqJgRAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-64" MODIFIED="2008-10-20 02:04:16 +0200" MODIFIED_BY="[Empty name]" NO="64" REF_ID="CMP-007.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 General anesthesia with premedication, outcome: 7.2 Postoperative pain comparing paracetamol/codeine supp with placebo.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAuMAAADgCAMAAACeqJgRAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-65" MODIFIED="2008-10-20 02:04:16 +0200" MODIFIED_BY="[Empty name]" NO="65" REF_ID="CMP-007.03" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 General anesthesia with premedication, outcome: 7.3 Postoperative pain comparing paracetamol po with placebo.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqwAAABgCAMAAADvqdDkAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-66" MODIFIED="2008-10-20 02:04:15 +0200" MODIFIED_BY="[Empty name]" NO="66" REF_ID="CMP-007.04" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 General anesthesia with premedication, outcome: 7.4 Postoperative pain comparing paracetamol po with lornoxicam.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAArEAAABgCAMAAAA9+dq8AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-67" MODIFIED="2008-10-20 02:04:15 +0200" MODIFIED_BY="[Empty name]" NO="67" REF_ID="CMP-007.05" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 General anesthesia with premedication, outcome: 7.5 Postoperative pain comparing diclofenac with ketorolac and with NaCl.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAnwAAAFACAMAAAARY1EvAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-68" MODIFIED="2008-10-20 02:04:14 +0200" MODIFIED_BY="[Empty name]" NO="68" REF_ID="CMP-007.06" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 General anesthesia with premedication, outcome: 7.6 Postoperative pain comparing etoricoxib with placebo.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAq4AAAEQCAMAAABGCQasAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAAQzUlEQVR42u2d23KEqhKGXalJ8XLcredctW/65ajc7GREDoKA41m/
vyrxBDTiT9Mwrf2P6gC4Cr5oAgBdAYCu4Nl4nbRe+v1fOi2j0zKRXKYuzZQ3LeDTcmX4X5AsvYS/
dKW02zf6ySv7Om1HEs+i0cmpxIvlaS3H3OmfYEcC6c6MYyv7OnXb/LJVv7txZ//rYadzZ8Wr1pVa
LxIwbGzpen7f0KLTYuPhQLRNpLvxHY/Sjyu1eoufu7JfJ+/K/c3bdhhY83fozoZNnWjjz55YKMDJ
0RNS2ztBX56E5SV3m9xxVv6Caly7sq8za9aGsf+3q7tDWauP6JyN8WnpYm28cekyv+uuepuXrOzJ
bdemBpaVu4cOn1i3nhbTudJLSQvy9R7a4nyVPbft2mzertk9xvyXdZ58aAHP6quy0dzyipW95rqr
1iMjayONY+W8N3rVeiemYilpnC2s1D6NfJ7Kfp2YknpYK9FhC9nD0dkV7QLpG3csRyakNpQn43on
D1vSGki6X7r51UywU1f2H1xcwHXAj7AAugIAXQF0BQC6AgBdwZMR/qrlnBmjRbLSmtmQo56yhrqr
ZSo2lu4uBBXKV22GrOWS4p+HRtlmNLMMldGRG7D3S1uCq9Qz1K5/PxD1HjTtdykbewZVxI6liwx+
W77Nj5VkHZSCtfP5LeZ/uZPeCSp3aSEuUs9XrtpatHcl7YJ/kVejyxF46g5JrWuEJF6phf7V4GoZ
VbTfZF2qrW+s98ZcImuZpKIi8o6hkpxMqqJTZa472did/2T1jGxX++NjNLzrbP8ZFIvOeJy6TKED
ZJigqY8WXC2rP0H3RfTemEUtUZe1lqSku4wcQ3XYurp32c/c9t4j2dnq+RVrkVSOdcHNqrgkh4y2
U5pq6pJEan7KgJKu3WdCsilbZS2XlDSejn+Mz7aYTLRUzxK9CSGuUc+vkT02z8CYn6OpS+uKTT9H
bMW6r8haUVJY4rxp6eBzI4NRqWX7d6TOWc9XxuCeb6KvZyd1XZOrpSzlULMsWZet3fCuk8xq5P3n
s+es59ekmabrKxBBDh2RQE/xo/XR69ary13TSrLWkDTMV3VTV83qfh3bGlriifE6FLlEPb9iXW7t
lWHFbPyef8b11OawA0B01IUuj0GCyfaquFqOxXZTjpS+iGmLsknWCpLymeLEvrUnpgjazub8ZZ19
IKubs2erZ5u/6yxRWqYynP0d+o0n2XtlunE9X01knWfBbPYSPGx9ej15mwAAcH/8e4DMF9oVfIgD
qIMDIbgQoCu4EF7RAkDnv7sTrJxFe6nrZ26Bqn2q2JRSpz9UaBYfnk3X4Odx62rjSRzuTbrYdUnS
BiK2JoKcYLzuGvkzZtka6VqduLIO318N/D9DT/Xkq5/xB1zD69FHXa1/qjiXxtC3lof4eNvVO37J
WIfq8DfhwN0xcHwMv/sZfcQq+epn/IXQ+BOqMviQxq69m3/bFFyErl5VOUYkbA3IItnrmaFcsh9g
1cHbIxNFRD9Zjz0yJ91wwUOMgTrmsGN4xSzvD6Grzn3dxPdFUa3QdYPJtnglmPffmVgWkEqNUKgY
A4HZmu7lrrbM9X9Th45jo0vTCwp5KX41S+v4GDx5qlXwTqw4LnqPyNzXPcNPpI49RbOfUPWfWm2u
AbgzdvTIqpFsPgmh7ZE4IgjZhWMTaKxYtCsA59WuuLiAq0+1AICuAEBXAF0BgK7g2vj5OVZ+uO5q
VLgZTvavkCWbjV8sM06ASUW5U3/1KFUkrnVVVlpcsRrzJUWt2+8FwtWUyOCJ5K+a7iHrkZmfCdS4
df/aI9ps/xKkExTsZS4OXadcSqaIxuKK1ZgvKSrejCQE1ByJNMUKvVWH6R5L16jZVVlDbAVVOEr7
U1spTani4tRn9S11IJPsfVZSt4PSSB2N/hd7d74hx9J11lC9A4oj3co9Z+uOqD6g2hSx+3YxG2rW
svfmSX0GMo9Q7aBhBwFW2X9Iq6aEpQ4R2Jp7MX0wDspKIdsuDzQGjh+E9hbW8OB/ubNQjTXMwuIU
gT083S4PY+yrta/vjaJYd9GoVStfUONqaTOp1o45LsmUJ3mPouxXbQqbawtzFrauZAq09IvdOvW4
JKVUgerlq6vj+/tE2tWtO/qhz/RDlLWj4s2m0ytjx+iMLH+xrZRKde3lfL8sVGO+pAwlkxxTIu1C
jaurMl33POdP/F3PgkrvqyznHvAY8Xd9Nl8PyfqAlQGw/wqIOnj15ORTLQCgKwDQFUBXAKArANAV
QFcAoCsA0BVAVwCgKwDQFUBXAKArANAVQFcAoCsA0BXcFMHLL2EQWB3sxHu5YO1pwKD2186aUuo0
4htBih6uXUVcSGE9xCn24a0zAbSDnAl/m9namkhgJxi9WmhVlteghYDaug8yaP+io86Fiw/VsU0S
nddByvh68P+dyOUa9jqbGBpju+pMVNYktuUf0bTTtX7vL5nk1LEOTvSbMGV8vY9ELy5R2E2EoNvQ
NVRVASN8gNYxS6SsfiN+ZZLoZIBPipAwmLHl8uQxYGVgCSH0MIDndKFMR+8Ozmela3QrtmueG0vU
l3glKLmremJZQCrSUaho14zu0uFg26zSdFxWaPHqkiUcXs8L86tZ/XXBFoCug8kobtKlg3OS5VmY
UxyRkgwSnPAbn0SSDINBofOVAw/Djl8grJFsPgmh7ZE4aWyC0zYXVizaFYDzaldcXMDVp1oAQFcA
oCuArgBAV3AP/PwcIzdcdzW5uI3GxU2PN5sH1nJB/DKywuhsql5KW6pcwsKlTyRlCnQnTBK10N55
HF4rm988JZhG5meCJGC6jxjvAsfvEb94eGwq98zTZNOltKXKFVe49ImkTIFBDjW6OXsmKnMiv3pK
pKJXtkl9q6ipRt8WqiSrOSa6WpqqOZ67WnCHUzd3slCvJrYhTfffkttfj66zhupdmkkt5caFoI5p
5Zn96+f38KQ+A5lernbo+4EtMCmrHhi1rZrDcGyKZvIakqJ+WFfZxeCvpuueFhr2tbij7dmpSybu
yhZzpiLLJCW8SgocpVDFStko00Y9KkD8q1Xz7G4qqf1Kqcyh1pGkVtYCj/RN+qpZ1vm46fux1ZyD
rWbt3mUWpjh2LeD7+wTa1Qy91o4071PvIcqaSPFm0/mVsaNlwXRTtYrElf9AVks1ZkhyLWdUrSmT
FHahpjX/TYG/61lglszkjrDY8Hd9Nl8PyfqAlQGw9xJIzcZ4/FQLAOgKAHQF0BUA6AoAdAXQFQDo
CgB0BdAVAOgKAHQF0BUA6AoAdAXQFQDoCgB0BTdF8PJLH7tKhn234yJsxQG0uzBncqb5tbOmlDqN
+EaQoodrVxEXUlgP4YqD8NY6CaAd5Ez428zW1kQCO8Ho1UKrsrwGlZgyo7R6CDr43vVHnQsXH6pj
myQ6r4OU8fXg/zuRyzXsdTYxNMZ21S4qaxRuMx2itdO1fu8vgwx6OFTHOjjRb8KU8fU+IL24RGE3
kY6Y29A1UFWeEbk9z8qARzI9lIvkkuhkgE+KkDCYseXy5DFgZWAJ9DCA53ShTAfxDs5n6ajRrdiu
69uB4pWg5K7qiWUBqdQIhYp2zeiu370PFJmOywqjuY8uyWTWvFi/muVi1kNdjIHeZJTsnmR5FuYU
R6QkgwQn/MYnkSTDYFDoXOXA47DjFwhrJJtPQmh7JE4am+C0zYUVi3YF4LzaFRcXcPWpFgDQFQDo
CqArANAV3AA/P4eJDtddbbQbMwot9Q7UkGw2D6wVBExPRJkwmLqqlmIaYnW68lR7NeZLSgt0J0wY
VXOyzHx+85RgGpmfCdT4SfqI8S4C6R7xi/vHlgt6asKqmmoptbipZuLea9WYLyktMMihRrXJlTmR
Xz0lUtEr26S+VVRRGx0DEz6dUl3UzOKSslRrUZ81iKrdXKVotV+IIhMZkO+j/5bc+np0nTVUHwG1
bs9RB91XfgRXC/Pv0OY//dFJfQZy0cl31bBLRrp51cwZHqqxqLkNYmoR5324V6NK+R8UH/4z7bpn
+/hoyvuqkA0nj1PCTDpwFKj4SGePV4sWOBSLQvcurvx6ylV9fKfni158GL5qI3CuNfach5p1yPah
rM1MgdVu4gC2fn+fQ7u6ZUw/Apt+iLJ2VLzZ1gSwhuS0rPqDiitfZ0WS0BbwZyaWp2GtkpL7msrh
U/g65PKbg6e9OwN/17Ngkfo+wiLA3/XZfD3IYrr9ygDYf1lCHbakcYmpFgDQFQDoCqArANAVAOgK
oCsA0BUA6AqgKwDQFQDoCqArANAVAOgKoCsA0BUA6ApuiuDllz52lQz7Llj8KNB2ENRNkkhBhA4C
O9FVHGWHWNqexCNOh1kAOIKuXjnqHBPfJ/WgXrVltwyJXR7tj4b/EqQDYHXbVWs9Gvu1SB9BU5wh
MDDcRmrvGan70MT2SGRIqtMA8wAsoau3PFNqyTiucGjDypCpCwLIYjOAnVcGdC1Y+3vkT5VmLrFG
t4IVbdcsxwbOTs75+8G/YYEAHQvW165eCf4FYheZ4pn2iWrqU6NfwXbGgIQkjG1Xa9OKU6g2bZwl
tF1t0lyZAMzD9l8g1MKvB7fESWMTLISw4AquQ1eoCra1XQGArgBAVwBdAYCuAEBXsCN+fo6THS5k
mVwEUuPCsMebjcM3BNGi0iA8JoymruqltKXKJmyNA9ciycd47TobFMudUCMhU+Ulde2Dbj0lmEZm
3VWNH5ePGO/ClG7dOkE8VFO4WAmbOq51TVaa0GT2PpXkL1qaBanVSMhUeUld+416SqSir6wSMK7p
1FTD74WirCXBfeYJr9yyWuW2/MnPA8hu+zD+4Dbn0K7zhuqtcegop7aqRp79px/R3xX8ObCer4+a
Vp0m0HPNaptVzUWxbs0ujD5qkDuv7XpyjTeuyooPzWzVDevdYI0U0PXqfXi/ys+ysdPEqlqeutWD
WW+qFU9Sc41ymnmouQZb72UKfH+fRLsO64F/RpxdGzH9IGStuniz5RhvCgayv1ipSFz5uqyphA3c
aZCU3FNBXFxekiVJ8RT8gz10fpvlnKr2iLcJ+BH2ElbNttlvvjIAVl/fWHL5QeYA2hVAVwCgK4Cu
AEBXAKArgK4AQFcAoCuArgBAVwCgK4CuAEBXAKArgK4AQFcAoCt4Gni18Hb45DXDM+cJM6FdAcYA
ANAVYLuCm9mut7sjz1G+M9Dd+OneZKqFMQCwXQGArgAw1QLXA1Ot2y4QKDtNaVJI8yOlffJh2RlS
8tWHrndlq3vobbNx9UFvmD/PVwurj+16Z926VfLNKzWVEu16T8xWlrt8JLZZisJ2BWV+7KBhF0uB
rne0WtXc5GqvPsHKAFhEikutZDLVAt1ebjHLpfAzwb3XBmasu6rZ3Ptk3VUtqj50BRgDAEBXAF0B
gK4AQFdQh/7D/FyFI39SbyGsdtqBnwnuCNmoCNlIGNoVvBVfr7C03XcH/kyQLkil+5R6VIo9XiJM
d7HYSEpyhHZ9EFul/xvv94f+TL8nwTl33p37vWqz21OfCvP57blQSjc6Qrs+R63aUVp05slLeRyX
wkAvC4VlypZmywLtemPbtThx+WVWUzqXXNYRNjGvaputQdebGwNFTlsKtkyW9FrCJnK0TdgwBu7N
2FQv6iz/6gtLomu8bROm08vBRqNdH2sSaMexYTQOTvnxedj7m1BFJqW2Wbr35McysT/7sTCf314O
pYyPEuCRBXa3UD4HxgC4ENCu4EJAuwLoCgB0BdAVAOgKAHQF0BUA6ArAuvg/K6txCZYo+SUAAAAA
SUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-69" MODIFIED="2008-10-20 02:04:13 +0200" MODIFIED_BY="[Empty name]" NO="69" REF_ID="CMP-007.07" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 General anesthesia with premedication, outcome: 7.7 Side effects comparing COX inhibitors with placebo as premedication for general anesthesia.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAskAAALwCAMAAABSnhi6AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-70" MODIFIED="2008-10-20 02:04:13 +0200" MODIFIED_BY="[Empty name]" NO="70" REF_ID="CMP-007.08" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 General anesthesia with premedication, outcome: 7.8 Recovery time comparing COX inhibitors with placebo as premedication for general anesthesia.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA3QAAAIwCAMAAAD58NlHAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-71" MODIFIED="2008-10-20 02:04:12 +0200" MODIFIED_BY="[Empty name]" NO="71" REF_ID="CMP-007.09" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 General anesthesia with premedication, outcome: 7.9 Postoperative pain comparing Nalbuphine with fentanyl.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAo0AAACwCAMAAABdCKQlAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-72" MODIFIED="2008-10-20 02:04:12 +0200" MODIFIED_BY="[Empty name]" NO="72" REF_ID="CMP-007.10" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 General anesthesia with premedication, outcome: 7.10 Recovery (reaction time) comparing nalbuphine with fentanyl.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAA4kAAADgCAMAAACZ49NoAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAARBElEQVR42u2du67cthaG5Y0d8DjNCRAgSAq/Ebv06fIUAfIi6dKn
W49wXiRwkcCAAVcxCBc5M6MbrxKpuzTfB3vPSEORa0n8uUiOOHqjKgDYnRdOAQBKBACUCHAYXk9t
va6k+dNu9ht+Mjvh4dy44dumJe3yhoZJ+3fY9LtZ93RDaXc8vSfw4vXkLYkuOGNyXDckXjnOwK3u
3i5CV43lnPVofy/OrkSr3lqRsf3fB0lvh66O2XZbVt4bGXeP7KFPLdo+w7ZFXS3WTSJdOVbbf53T
vv3ZP4EXL1fQ4O3EibS1VItdX5st7X58O6FyuKjTGXU3UR6XXsQ3f2fjBiy6WyxNhW3qrrg+dZns
dvaP7MXZlShd3yLe0RN/5zF7T1rrSFe1c0uaNnn7bpO4p8yxaFL3W2SnWnJ0L87fO9XdXE3xUUdr
UHSkDdeHOs95FumxE63x4npKfJxSPb11O/K8zSHmP7RtXJ5FMnaiBS+uN05MnnM90m7pI85ODhm1
+8xkyriIWXZS97Bma7+zf1Qvzq9E8ceJ91Mq7dcb8S8YH+nlcI7YRjXzv3p/q8QyLmJRcCZtPwKf
ukwEL1zeXPoO8NN+vfUE3sDFxolPg64Q4pV5w6oogAPAHeAAKBEAUCIASgQAG3vutFul5czRDc2d
uwvr5syyZ60hk7xcfPMsK8sz8W5Q1HFvz2++e/dJ+rbMserQLhip1/hpcT6qD55wKjKSn9sBJybe
by6vbzPO91+2vKteClP05llWlmYiYt/vq69qfrPWwL7HufjK9qsTpF7PEPtokhdZZ/fkDrzGHNJi
rfFzVsbby7X6IrXVWkjVr7CzV3a5ywWj52F8DVmzFVklllws1t4mobVMz6S1yl41eDHzB6NEvzJP
gp3BFdVhCH7s8ntaE7yY1tk6hwPOOFE3mbhVJ9YytM2sd9dQu35Lt+2xv4grY6Hd8BoyXS+u9leJ
JRaLJW4WK8vEsspdNXhF84OivJV5uvIWUsauqM65SW+CF1OEeBoHXtzmN7RABlbGBUfIWGiW4XA+
vobMSqW9VWLBmjFJVeaSTKL9IH0584OLrN07NKNXVhJXtK6KerhKz/Pieg68+McXqbn8iKx2TGfM
/0iXTk83LyeTsjH/+c13K1PJLFxT65sjb8FIS87R07y4nAOvkWFv+UB5uS59VeWuIav7gNVYhdfz
M8msySc3P8xcaymbDp/4QztTvLieAy/JUYkOZ28HxjHuakCdqqeZfmY0LtaSlNRiMWd5WcqBsUym
B/WTmd/OPuis1jLaDdBu51eLOw+oJ5+KZ3DgxY3NTde6/SJFvO8WvTVZ1hHWakBxPchYLtimHVlD
VkVMGVos1ppXJVeSZWQSpEwPtE5tfvwgN3FfK5KrPsX7WEcrzkQvJmjzPA7krcUoylpLsg2fc4qz
Dh5LtEgm1zZfy9oHrezFSR3IudutUOOiV1qSrRdIsUwmFzZ//Xq8shdndYD1iQAAcDR+3KncV2Ii
gM1OimBVFMARQIkAR8C6x8a5Py94opL2302YH82aodLhfQT8vCA8kxLtuxy7Wyfb1Tj+3TRT0LmJ
0B08sxIrf8VzVETaT+6tQGwVHT5qLnwkYBU+pE63C/2k8vIjNMITjhMlvUPcfqS/HKtbuRgs2XIf
S+ceLO26OfF+++GAzzkEWFuJOnzc4IAQR5f9VJ6kxrSu7V8ncBeb7fPwQIC9Y+KyyOB97EE7kPgc
4EnGiesFnXYB11DojJdOGIRnjYmD6+SG0Mmt2B3hejj7/qsMrd1tgGfrnWattPJXIHb7wyVb3eo4
8T63x4nu9M8Rn3MIsAIrrcVYZKHdzCMAplTdnerZSZ6fyMMDgZgIQEzcdZwIACgRACUCAEoEQIkA
sAk/oESAA/CPK0X7+0Rz/zP4rYZRTToVvOzDDFNM7Wx/TF4mC3ht2oLjBkzJJLg4K5ofZhK4Yrrc
je+bUaNX4JHIVFf/fu3lnx/+SiixPr1quPLWKe6nynnZSYhzTFFWDkFeeSXOMbqpy4EBUzIJLs6K
5kcyCVzphege0u8YuAKNRM3VY+K/bxwpvg60t8p4Td/hzo4a2MqoTrNLnJmFa4OalUlzcdTq5neZ
qJmnMzhk6fZcb3pYMf/79+WzdRvBa7rNa9o9t+m7DmZ3hxbpShi1TjVexJWg7XZ2pK7AUi3+tJtl
NrvH5r9v1N+SiInGvaJqeIxVn0i1c402yu6bVUWdU7/+WG6tK6BUxS05k8nERm2mf1Nk7/gVuP7g
0B4n/uevqmyc6J/Ce6fVVIcYJ7oW3R3INkVVg27t1NkuGuaaA1db4xpondyhhr7rhD0DyhFizloM
tcpgY9GQuOTwZ4M+ZT9BsUJ03SMkmkQdMf4UjskxwFRPoca/vRBZ3rMwhxOimWCYGe89bd43nWP+
EfumSin7ew57x8AVcBI9D7FxojtUCgZO7gBx13GiqXtBU0xxjzG5mbglzjHatcOoSeYH+jLDM1EL
mN9lYiJd0GiugW9NRyZxBZ4U1ifCWl2VeYF5rw4q6xPhSlI8QA5n7p0CLMIC9xc8XV+NmAiAEgEA
JQKgRABAiQAoEQBQIgBKBACUCIASAQAlAqBEAECJACgRAFAiAEoEAJQIgBIBYBrWr2fUzwOQdkPq
PdJ95r3T1dSf3sn6zZ5bIr+E6SUCnCgmyg1HlbeaL+l3k9G5iQThwTPGRCvq+GKRyDs3cOr6f7vR
x007uD5edBPvqvYIK4/u7yNRd1T7ri0QhcKzjBOz6vpDUH6QfGz1u+w09Ys0EqyTuHk8Pu8S2YqX
zR6mBbC7ErtoI7HuomSksqUTSaODHqeEbYDW9oYTAv1tgIvHxBwhJrn3IHXB/srZH81fExHhecaJ
AxorEWITuiR/vx0a4/kTBuHpYmIQfrTOE6K2DpBgp7c/dlBC02J9LnRO4fl6p2JpR+tWKv07O5FY
wc4+TpoP3Zc+if25PU50Z4GiIga4EOs+K2pMP+X6QpGwLns9K+pcT6jRjBiBmAhATNxlnAgAKBEA
JQIASgRAiQCH5NfLefQdSoTz8faXy7n0/q2zaX+faO5/Br/VMKpJp4KXfQhMybelTWyU696IPwt4
7Vrb51SUZ8SO5uqoaj3zm8y7MvzsTOeL/xop17T+90f3iYxj4Pd/Xq9x+fbjN58TSvQrZrTy1ilu
/92XnYTo2VBkh7J86t+O+LOA1661fU5FeUbsML4/y5tvKreMMDvlpjAD5TYbKl6xlO3I2wsKsfpY
fbKl+JpuOI0yXoOnzMGcUc7borplEj6p7BJnGu1W3Rmee26Z9cxvMu/LmGiFf/Doqfg02sQsxx8b
1t9Pls+vA4123T717diBb8cx5X2uOrEqrD7L96yX6x+Yta+RypWzKjql4y2o+u2nzWrfZvfYmOrd
h1Tv1ARhZmiM1VRls69ETdOlNqowLiYTmxF/FuiLt53TZmDahISyM2kmnvaFhxL5/ekq6D0HLphw
yFDz87v31xsnfm0L0Z07VUpFGjFj3H3KNLX/kdhEj9mllzphlBirUhv5oyqvvMIz6SU2B+mx2LWl
t6mpM81LlTrTjx1eopoPv19Oia4Qc9ZiqBXGSts3yVmNdk5uS4XEFTq7G5k/mJ2K2zTQsR3OoouK
l1OiK8TM7xNNcuNIQjSFFddvj1U3qb6FEM2ss5ky/1B9094mk1OPzPHq14bExonugCUYvrgDxF3H
iaae9phiipvY7kcNZuKWuJzRRk0yvz96StmzVZiXnVFRc4MrcJCZh51gfSJsPljISrXXwJf1iXAJ
KR4uo1P2TgHmoRZL9XR9NWIiAEoEAJQIgBIBACUCoEQAQIkAKBEAUCIASgQAlAiAEgEAJQKgRABA
iQAoEQBQIgBKBIBpWL+eoR9/pd2Qeo90n0llfdS9TCDrN3tuifwSppcIcCIlSqfG5vVe87UW512f
ZDI6NxG6g6dUohV1fLFISi5d4NT1/3aj6uKmHVwfL7qJd1V7hJVH9/eRqDuqfdcWiEThWcaJQV3X
nUjF7UDe9out3MdWv8tOU79II8E6iZvH4/Muka14mR+LAc6ixC7ahEEnJgUZ6FtKNKd+fzKPezfY
3nBCoL8NcPGYODSRMopUtprG91fO/qjSNBERnmecmBVtdIYcH6FL8vfboTFuBGEQni4mBuHntqPf
dx/FJXShgzFl5c796IjK9HDU67/KqD8XOqfwfL1T6bQjURXZicQKdnZqaT50X/ok9uf2ONGdBUoX
D3AN1n1W1Jh+yvWFImFd9npW1LmeUKMZMQIxEYCYuMs4EQBQIgBKBACUCIASAQ7Jr5fz6DuUCOfj
7S8nMvbLl5xU7986m/b3ieb+Z/BbDaOadCp42ZKuSOMaUGiKUfZLc/TYSVjA64T546c/bkd/uOvP
WuZHzrjlg4rUlES5wT57h3EM/P7P6zUu33785nNCifVpGK6FTYrbf/dlUyGqvhJbW6WmGOelPVpZ
u9Jlz/E6Zf5IyYlMVDTXFc2PnHErOxWpKYlyg33ODmX78faCQqw+Vp9sKb6m2zyjjNfgKXMIF9TK
uQ7VUbW0+SoSpfMzKZWTWvZsqaRWzXhClW/gp5JGaiZ/LDH5kmnsJ8vf14E2r26f3Eb7SMxrGZqj
w0y2ivCLlBx0MzdpLs1IXVC5CTPzVb/9tFntW+Aemy9Zxprq3YdU79S4clODHTtVVwJl9pCoVWcd
A8xSuc5OVZDFxAzbzmnf3au2M9/pY5YkNL4t1vXrkgee/Pzu/fXGiV9/cAOp3fQoFWlRjXH3KVOP
R+rEJnrMhmrsDWgMmzRdU+3ZmCzR0+2uys7DA6e2+AljV8iqQCp9GT/8fjklukLMWYuhthmnlddi
41e8wp5Q3fG2Jk9VjkIWC4ltyXnhZdQO5bi1bgMwkJ0aTKhybInu/flySvzgDy4za21iY0ch3tpS
b76jqF2vj7Yy2bhv2pY8p29quWwct3YTYq65Aweb02vsq68mHBQbJ7pDv2Ag6A4QdxgnGmeeQrUz
vXNMuY9Qsr5ka1LN8dotqNkqVYhrR7bzC5hvn/GR7FIJW1nGXdhn5mF3WJ8Im8fIrFR7jeBZnwiX
kOLhMjoLr1QeWA61WKqn66sREwFQIgCgRACUCAAoEQAlAgBKBECJAIASAVAiAKBEAJQIACgRACUC
AEoEQIkAgBIBUCIATINflILjM+3XpY5/lH0YMRGA3ikAoEQAxokABcOpy3o2/PxEgMNW2BL9nmDG
ht4pAONEAECJAEeEGRuAI8CMDZyG7nGomeGjeR5oWRmTpoeKSoq7gRLhNELs6nHuTKWaJPYp86Bq
thuME+FUEXHNAzYxLZWWmAgnYUKA2+wxjAUlKcaJ8ITa3SguLlASSoRTjBBV+QFqS8nPBiXCBTum
J/xujhkbuHAkPVFJfLMP55FW+feJaoKopn2fqGa6gRIB6J0CAEoEQIkAgBIBUCJACfrO5IMf/6L7
rZclivUT62qg3Bh8sw8HR/bJuqxYPdtKYiKcJjbWMUU377uNfs9jR/3OimheYu3sjKSfUKy2P9Y6
umMwIhIT4SxClD7w2O/rTWtPvRXsCBOn0k8pVqyNx9tgBzERLhEMm86i6EillsiLpLqZ4u+UZYqN
lCf2azQLYiKcb5w42LW71XNPEqWTPHp+sbpgfgYlwpl7p4NydULOSPLsCZqSYqXsWHqncFYxNgOy
SNTRA1FOOzt0QVgsL1ant2VkrEhMhHP0UfWjL2h3Cq1dQe/U/cxKXG9ldG+Li/WyuM/a9MeOw1oM
eLZO7jGLpncKcIQ2gJgIcASIiQAoEQBQIgBKBACUCIASAQAlAqBEAEjxf/rfMeQrgjJyAAAAAElF
TkSuQmCC
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-73" MODIFIED="2008-10-20 02:04:11 +0200" MODIFIED_BY="[Empty name]" NO="73" REF_ID="CMP-007.11" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 General anesthesia with premedication, outcome: 7.11 Side effects comparing paracetamol/codeine supp with placebo.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAuMAAAJgCAMAAAAXh53gAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-74" MODIFIED="2008-10-20 02:04:10 +0200" MODIFIED_BY="[Empty name]" NO="74" REF_ID="CMP-007.12" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 7 General anesthesia with premedication, outcome: 7.12 Recovery time (discharge ready) comparing paracetamol/codeine supp with placebo.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAtkAAADgCAMAAADheYrgAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA
AMAAwMD////AwMD/gICA/4CAgP/g4OBAAAAAQAAAAECAgID/gAAAAAALCwsWFhYhISEsLCw3NzdC
QkJNTU1YWFhjY2Nubm55eXmEhISPj4+ampqlpaWwsLC7u7vGxsbR0dHc3Nzn5+cAAAAAADMAAGYA
AJkAAMwAAP8AMwAAMzMAM2YAM5kAM8wAM/8AZgAAZjMAZmYAZpkAZswAZv8AmQAAmTMAmWYAmZkA
mcwAmf8AzAAAzDMAzGYAzJkAzMwAzP8A/wAA/zMA/2YA/5kA/8wA//8zAAAzADMzAGYzAJkzAMwz
AP8zMwAzMzMzM2YzM5kzM8wzM/8zZgAzZjMzZmYzZpkzZswzZv8zmQAzmTMzmWYzmZkzmcwzmf8z
zAAzzDMzzGYzzJkzzMwzzP8z/wAz/zMz/2Yz/5kz/8wz//9mAABmADNmAGZmAJlmAMxmAP9mMwBm
MzNmM2ZmM5lmM8xmM/9mZgBmZjNmZmZmZplmZsxmZv9mmQBmmTNmmWZmmZlmmcxmmf9mzABmzDNm
zGZmzJlmzMxmzP9m/wBm/zNm/2Zm/5lm/8xm//+ZAACZADOZAGaZAJmZAMyZAP+ZMwCZMzOZM2aZ
M5mZM8yZM/+ZZgCZZjOZZmaZZpmZZsyZZv+ZmQCZmTOZmWaZmZmZmcyZmf+ZzACZzDOZzGaZzJmZ
zMyZzP+Z/wCZ/zOZ/2aZ/5mZ/8yZ///MAADMADPMAGbMAJnMAMzMAP/MMwDMMzPMM2bMM5nMM8zM
M//MZgDMZjPMZmbMZpnMZszMZv/MmQDMmTPMmWbMmZnMmczMmf/MzADMzDPMzGbMzJnMzMzMzP/M
/wDM/zPM/2bM/5nM/8zM////AAD/ADP/AGb/AJn/AMz/AP//MwD/MzP/M2b/M5n/M8z/M///ZgD/
ZjP/Zmb/Zpn/Zsz/Zv//mQD/mTP/mWb/mZn/mcz/mf//zAD/zDP/zGb/zJn/zMz/zP///wD//zP/
/2b//5n//8z///80TKWtAAARh0lEQVR42u1d267kKg6l+2yJn/PDSPOdR5oH/xzSfpiqCgQMhkAu
VUlqLXXvJASMk6wYQznwxxoAuCH+4hYAYDYAgNkA8FH8nEQPev3lnpzcksJqBpolU1cduVa1Uuuk
Va6E4kkvV4hXSo9Vv+8DOr3yP6d5x56cJO68w1tqOUKrNdKofEvaVRWl+XMP6PzKn4fZ4qLTv2JD
/n33lpSCQY33ispynApmX2z09irKxGZihaj0SoIcpmjMhNp6aTL8foZfRfmz+dnE7C+Ywz6ZZMMv
eoZMNFmKOc9sQGQ5iomR/KJIt2JS9kpRyZWUJaO+udqpIhw5xVvbsUFiX0T5s9ns9EqTfdYzcfWd
F6lM21yShjKHWByv77R5kEG0Gu8l8nWVPw+zo+9AmQUoXWwqyNrdBxp02RMvp6bM+DUOFGaKXS1P
i1UXv98Duoryp+pBZj1qKkz1qiGJqnnlkUJVZdaowCNFKI5DPF1ZenPH8arKX2Q8myjdtP3hMidJ
KYXYDcrQtgvKvJ2k4+U39DEiX135PyeJG6E4Gjo1Y3O7pw11xEzxfxj54HIYg2UOUaRLq1inlD02
zCKuMbkSzlv7oKLIQPGkvJL3jI1cTvk/iIgCbgn8ug6A2QAAZgMAmA0AYDYAgNnANyP9DdKPNWah
t63R9lBiOec6tKK218SWZvJIV3201nVSc0npQH5RQRb+GfIaNllk6PHP4Cp6/2R6vH4B7b/ofcOX
FXD7hg9Lk7/e71PrgNRqgHOolRdv+CSCA0fKU0c8gwvq/aM8pTl4do595vgrksl/Opp/j2ITs/pf
m5Jf/tLI6GGrESOlohwRILzCDi2JGK+1R+pStvI3UuWOUdlATBHShzbvF9Nb+NnklWKhr1Rtjp6O
JURbTbEQlyG8tCGMUcRE1wKEByTJUO/ttXZKbQc4FxXrwXFEbw/3u5ref2WjUlbsL0W1tUWJxXCw
4bfzcSsor5+z27itpSXav1ZeFWvlHzvnkUTanfcxSB/h+DX0/ik9kUG/1bzPzy5CzGh7z0O1LZtr
VaUuBTjHcE8RNSeqTvvsr84+HR/vfE29f0qmDvfJ3gbWat/2YnW8GStq1aX2BjgHa6G3ku830dfU
+2/mZRemqjUoQ5TlpnoHmtaPaCT1Sx2Pjf89sNZCoOrZhzMU90i6OsSy9TyaPVfS+690Dsl/q8bh
7ZO2KXOlkhIc2yOWipcZRv1stXKv5SqWRa0afvZwrYtS9Wy8mE/ecM50IvXRHPKiX0rvvvjsobqJ
awXO+H3IGdDjUBFD7w1+dtV/GupWvn+SFxAbeq+z2QAAAMB/T6DDD2w2sD9OwCpEsQL3BJgN3BMi
ivWJNAYrHeRIfznVhvU2jOhpRcOEOMbU5vMoS/X3w6lzom4qI9pAmesxOw0NCHOwzaGzYh5J4qOf
MEUm+TmzihherpTpl76cCTy+BbNNOidSxh3BhTBBW2Mq6WxCJiOnsC5mt84jwKsRCCIMmLOg4HLq
bJPP4lSbg7ucttuHqRsRpS00Ba7oZ/fM7qhPJZ3Of13OohxDtuN81I0JlpUgjXnKbJNw2WvIhU5G
znCtxRjLGbDnabu5jFsl0OWqzE6mhM1Sqsu0cCBs+BBID9jW3h0iQUnyXx3JiIuCUNKUNz7rYtay
lKHVXNfMlLHp1Vh14FJjI81nyGqQltodJOWQGh9pbfHQqapaPd1kcYtslq4BuJKfPTreocUpV7+9
yQ8PIvbcxugh1PXQal5QAWb68jabKHvE5azTczovGTRqWW0xCLHNUJIslHrn2an6kAotfJhOZMwx
EwgA7/dGlK/VKPreIRBXBjAn67kQGzWoOxSrRICbZLrqsgqNfGxE7HRagJMELcaYiwJCBaE0cB0c
GetHAwNkR/GGOmbC2FcicI6Y2yPXqekP1KbL+LEEjxs2G4DNPq2fDQD37EECAJgNAGA2AIDZALAG
GBsB9sfvCVY9TzVwzz8J050Vm+mcuvkAJq021+/GriJkXygg79xyxvJ+usc2VauUGM9Oe5NWzsBU
lcye7q2tP4PHf3XzCWKnSm0U0y/Fxdu0nK2dR+Yo76e8uaXEeNbvTVpZB04rzJ7eehvtQWIBzmUK
3N5P0I7Vus/rXFyFXaOwLVuAIzASxfu/odz8Hman9sBbkRPC7vuCdLbhto9CXury22cH9VyQeOyz
4gNzv43ZVr/z52O53cfPP9MbPKBI4qTDue5jtrmKs7bRzw5F7RHc3PFdWZJ42qb1dMx2ViP3De+e
W3dVC2XcfAfHheslVInO3v75bMHfmn34BmJbaw9ox73UVcL1m6xKTAcMz4b/fH44W9ps51tmq4we
uWnAxHu2cnNxP/vTV+Hm2+rSMeyQZlX2+6yxLCCB3yDP24NY5QudomlFfDbQctbfWOxrxkaAj3cB
Vp2CWwKbDYDZAABmAwCYDQBgNgCA2QAAZgNgNgCA2QAAZgMAmA0AYDYAZgMAmA0AYDYAgNkAAGYD
AJgNfC+Sr8Wmqdg4HHBYgzSc4zkTj6/324K6oPWsh1SkVar/u9KunFQuaooV8y5ps/kBwfLHc+R8
z/g9PvYRz2v/vmpLq0/UrZTpl76YiUHkO9jsxCYJ813YSyZ6LXxLRhrUxM7PK04n+eS5uBF/pmTy
ZrWw1bPEIDweBStb6ESitlm6UDFTO2SKOgaBZBim+8p+dldrbaRBfbGF2B8xB0IUBp+TjD5P4gLw
tNh08Eby5bGftdAsL+4Z9kTNjTwlCdMmzSnPTwpmKuSNFnA9ZidLjxeOpeoMh+aaORRK111vviEx
oyeaXwVdli8JxY3GRFOt9JR54SUWKkTN9GPgmmMjTWI/m2Xq6w6Scljhx1baEFVVq6dLHVUVCBb7
un52Y7xDfdiTU9FBTM1KHkRsX1xTrZWe6qirADN9eZsdjZN/xJS3vzGdlwwatax2OgixkdIkhSeq
5ae4WlS/iKgZkdlBU+Ac3sjcgUv3ol187rLgS+qkTv2wLIMoNufJnVwOA+dKFRr5eOZcUYCThLiJ
WbgoIFQQSgPXwZFzsdLAANlRvFmSO14vGN735M/kZ+8Npl7/lC7jxxI8bthsADb7tH42ANyzBwkA
YDYAgNkAAGYDAJgNXAC/v2+pJh3Pfq1LlYwCykWR/aqD6uYT8Msi2h2kdF9F71V3L1CdLlcqJD+X
Uo/V+IU6Rb1h8c75sU3rQ2INJoXZ07219WfgrL75CLGTvxuldF9F71U706mcq0uW1VhFT5s+tXDW
Ytk8jdmv++QS45BYgFOaArfbg7SDmew71VfoLF+tt1uXBb3/bZ38Z6M9siuZnRoHb0XOy2m7E7VG
2/B2fi91mbd2gEi5pUldk/c/pIUKm79B/r7HSv609LZV03Ev9L/BLnhsO9+LhbXTNUuTu0RYfr2D
2edf49jZPaX0C5uotVP3UWkl2xbStqzmB/s812G2d7UPYdN+jt4O+rhDrsrNd/A9twx87mJ2HOM7
8/3bxz7ZFZa1W+qOJlSTc106/3ygmtApe7hsRe/HTV0W783JzcXRfRUHXbWzqmR/UJydOC0O4GeX
QHz25ToSbWt9CluO+Gyg5ay/sdjXjI0AJ+hIrDgFfwQ2GwCzAQDMBgAwGwDAbAAAswEAzAbAbAAA
swEAzAYAMBsAwGwAzAYAMBsAwGwAALMBAMwGADAb+F4kX4tNyx9yOOCwBmk4x3Mmbq73Owx1QWtR
r7ZIWVmq/7vSrpxULmqKFfMuabP5AcHyx3PkfM/4PT72EdPMpNd60kn1ibp6mX7py5kYRL6DzU5s
kjDfhb1kotfCt7lBTez8vOJ0kk+eixvxZ0qmmlmdJQbh8ShY2UInErXN0oWKmdohU9QxCCTDMN1X
9rPL1clJcweEQX2xhdgfMQdCFAafk4w+T+IC8LTYNDd8BJrlxT3Dnqi5kackYdqkOeX5SUFFBbXV
AC7D7GTp8SJFe7AUmmvmUChdd92Y9mLpJCjpV0GX5fV3jpflz6qVnjIvvMRChaiZfgxcc2yk+QzZ
aCxUu4OkHFZki+RFnhu9Ll21errUUdWMYLGv62ePjndMTkVHEc1K9hB7do0HwFXVWumpjrpmMNOX
t9nROPlH/EiQBium85JBo5bVTgchGoaya4ROFkp7BdTuLcTz+kVEzYhMXVPgYt4IzY9zfp7znk9k
wZfUf5j6YVkGUWzOk/sfbOZ6uZCgkI9nzhU6cZIQNzELFwWECkJp4Do4ci5WGhggO4o3S3LH6wXD
+578mfzsvcG9vsTrp5+LPDN43LDZAGz2af1sALhnDxIAwGwAALMBAMwGADAbODV+f99YWTqe/VqX
KhkFlMss++UG1c0nsGYR6IqUgauYqluqtFu3OYdfinPW5LnAe1RLu9vi7FzWYQ0mhdnT3bP1Z+BX
tC82HyG22GySMnAVrqvSbt2cvPepJunN1e52epBkslg2T2P26y65xHQkFuDmpmBskeqd6BMFud6l
8I5ep3qfK/tXT/7n4OUqbZPZqT3wduKM8KTYSLJQvLcNn/LbvXSzRvEt2ryzOhvtJ97wOiq/Qf6+
0z7+tC7PHmgczvWafPzaoufR6g9IPZ0oi3XXO5h9/jWOd+w+mtHu4xG6BUWcaRl6K7zGkNWWjjfQ
8kaO9ed28Ae9llvUGi3el3+Dbrb/nQKJB5kdx/jOTGxvnzaaKTtuWTvyr9Ftwc4r6THpOob652OV
he6R1ii6qaPivTm5ufq4yIevwln1fvqDp3Mt7v3E5Hhwq2exHxCffeqOxLi3fwoLjvhsoOWsv7HY
14yNACfoSKw4BX8ENhsAswEAzAYAMBsAwGwAALMBAMwGwGwAALMBAMwGADAbAMBsAMwGADAbAMBs
AACzAQDMBgAwG/he4AvfG6Pna9/RL4K78p+hYthsAN4IAIDZAAA/GzjKz/6+S450xnwj3/Gcv6UH
CW8EgJ8NAGA2AKAHCQBHAj3IWyOZU7vogRXLTXbLWlyGqm9hCDt4JaY5b77rWVsMuAuxbX0Ri2K5
yX5ZS5x0Q5p1wrZrKwTCz/4ejg9zZqVF7mHsfnXWzsBmfwd27U4teBKHdN2qdVr42cA2MyvItMOi
IQfXCW8E+Kj9P6xOMBv4zLJNR9cJZgOjJHOXqBO/1Nybs9FBrYxnv5ab7Gruo6zFseiOMcRRF8Mt
LXCcZwCzgXsC3ggAZgMAmA0AYDYA7A/8Bnkn0PMP7yeOe5J21qZSAzGY/c1gaANv5Na2m2gymeT3
54OY8kqY9kKWeG5KYCMymFCuFEqJtK3a5PWFDPIINvsric2x9U73p8MkZToKCXHX72UZnv8WhGo+
w6A2xkgtpHaZANjsrzLW3gtgUjjAyobjOS49Ca74F1wTulEbo2ox7trAZt/Rz2422A+OZTQhdXdI
xI7a5CVo3a0As+/qjTQJJ8xnkn2hZFXEjtoUJVb2Q+GN3JTcL3PImu3TLHSZNjsPmv0kmUBLxnVQ
m0IkrTDdsNl39Eno1cinrX2SlLT/z9T83Os0Re+YFRlZgs8+l9qkTa5FyCCPloFYvy/3WvYTs1Ua
7Tv8nXgjbkKWwYWTLSljceFuKvAQ6dYEsbusSrdYk3Y94PXNIW22EjEep6RokW1sUpQgct0HQ87I
QPqGlOr1fOT7KOCd0HqQ3nC/Nm4yry/r5+ZdE4+8+QtFjMtye8M5W2efcUqSUuddIdHJ2h6wLlU0
V0gImVuHKCpVBZb7vvjRDZ03qM7al3Gz83FlXqHpfPjyKMktzpv4cVIQmUiVu+K031hNUSsVkoWk
cvKMszDdX2azI2wzzSqJVi9mF4TWZak5XF2APj+XLTIA32ezZ6PaYoF1O3HEtfuhui5Wc6AHakIv
8juZHc1eo7Heqym3XS2E7erEurEMsN5f6I24JYuWDbq5uh10ebLrNduurout2nd9VM/pqsBsf5XN
9k1/8ADmmWWFRxAzvUhmXXpUO29EllxqUYHNdXFZ/amGWU1zhYVyqSow2/fF7r9Bqk7D+4YgMFwN
TPg/T2jmMbK802oAAAAASUVORK5CYII=
</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-75" MODIFIED="2008-10-20 02:04:10 +0200" MODIFIED_BY="[Empty name]" NO="75" REF_ID="CMP-008.01" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 8 Non pharmacological interventions, outcome: 8.1 Level of comfort during procedure comparing hypnosis with control group.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAqIAAABgCAMAAADxYOBXAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-76" MODIFIED="2008-10-20 02:04:09 +0200" MODIFIED_BY="[Empty name]" NO="76" REF_ID="CMP-008.02" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 8 Non pharmacological interventions, outcome: 8.2 N2O request comparing hypnosis with a control group.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAnkAAABgCAMAAABWkZTpAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Forest plot.png" FILE_TYPE="PNG" ID="FIG-77" MODIFIED="2008-10-20 02:04:09 +0200" MODIFIED_BY="[Empty name]" NO="77" REF_ID="CMP-008.03" SETTINGS="SHOW_EFFECT_SIZE_COLUMN:YES;SHOW_WEIGHT_COLUMN:YES;SHOW_RAW_DATA_COLUMNS:YES;" SHORT_VERSION_FIGURE="YES" TYPE="FOREST_PLOT">
<CAPTION>
<P>Forest plot of comparison: 8 Non pharmacological interventions, outcome: 8.3 Pain with aspiration comparing music with methoxyflurane.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAq0AAABgCAMAAAAAa7vaAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2009-02-09 18:42:06 +0100" MODIFIED_BY="[Empty name]"/>
<APPENDICES MODIFIED="2008-10-18 20:34:17 +0200" MODIFIED_BY="[Empty name]"/>
<EXTENSIONS MODIFIED="2008-10-18 20:34:17 +0200" MODIFIED_BY="[Empty name]"/>
</COCHRANE_REVIEW>